ARC Schema

The ARC schema is made available as a machine-readable CSV (also as a HTML table at the bottom of this page) of clinical and research questions. This file provides the standardized structure that ensures interoperability across studies and outbreak contexts.

Each row in the CSV represents a variable used in the Case Report Forms (CRFs). Variables include metadata that ensures clarity, interoperability, and reusability across contexts. For more details on variable naming conventions see this, and for details on the variable data types see this.

For every variable, the following fields are included:

• Variable: Unique variable name identifier used in the dataset (e.g., comor_hypertensi).

• Form: The CRF form where the variable appears (e.g., Presentation, Daily, Outcome, …).

• Section: Subdivision within the form that groups related questions (e.g., Co-morbidities and Risk Factors,…).

• Type: Format of the response field (e.g., radio, checkbox, text, date).

• Question: Human-readable text shown to the data collector (e.g., Hypertension).

• Answer Options: Permissible responses to the question. These may reference predefined lists in /Lists (e.g., 1, Yes | 0, No | 99, Unknown).

• Validation: Input rules for the response, such as numeric range or pattern restrictions.

• Minimum / Maximum: Boundaries for numeric input when applicable.

• List: Links to option lists in /Lists.

• Skip Logic: Rules defining when the variable should be displayed, depending on other responses.

• Body System: Physiological system the variable belongs to (e.g., Cardiovascular).

• Definition: Description of the concept being captured, often linked to clinical definitions.

• Completion Guideline: Instruction text for data collectors to standardize responses.

• Standardized Term Codelist: Reference ontology or terminology system used for harmonization (e.g., SNOMED).

• Standardized Term Code: The specific code(s) from the ontology (e.g., 38341003, Hypertensive disorder, systemic arterial (disorder)).

• Templates / Presets: Links to where the variable is used in disease-specific CRFs (COVID, Dengue, Mpox, H5Nx, ARI) or risk scores (Charlson CI, mSOFA).

The CSV serves not only as a question bank, but also as a metadata dictionary that enables:

• Harmonized clinical data collection.

• Mapping to standard vocabularies.

• Adaptation for different diseases and study contexts.

The raw CSV is presented below as a HTML table - the display is cut off to the right but you can scroll across the table using the touchpad.

Form	Section	Variable	Type	Question	Answer Options	Validation	Minimum	Maximum	List	Skip Logic	Body System	Definition	Completion Guideline	Standardized Term Codelist	Standardized Term Code	Metathesaurus	Identifier	Research Category	preset_ARChetype Disease CRF_Covid	preset_ARChetype Disease CRF_H5Nx	preset_ARChetype Disease CRF_Dengue	preset_ARChetype Disease CRF_Chikungunya	preset_ARChetype Disease CRF_Mpox	preset_ARChetype Disease CRF_Mpox Pregnancy and Paediatric	preset_ARChetype Syndromic CRF_ARI	preset_ARChetype Syndromic CRF_Arbovirus	preset_Score_CharlsonCI	preset_Score_mSOFA	preset_Score_mSOFA_Dengue	preset_Recommended Outcomes_Dengue	preset_Populations_Paediatric	preset_Populations_Pregnancy	preset_User Generated CRF_Encephalitis
presentation		subjid	text	Participant Identification Number (PIN)								The Participant Identification Number or PIN is a unique number used to identify the patient’s (participant’s) data.	Write the Participant Identification Number (PIN).						1	1	1	1	1	1	1	1							1
presentation	INCLUSION CRITERIA	inclu_disease	user_list	Suspected or confirmed infection					inclusion_Diseases			This refers to any suspected or confirmed infection(s).	If more than one infection is suspected, select the most likely and complete the PATHOGEN TESTING section with laboratory confirmation.						1	1	1	1	1	1	1	1
presentation	INCLUSION CRITERIA	inclu_reason	radio	Is the suspected or confirmed infection the reason for hospital admission?	1, Yes | 0, No | 99, Unknown							This refers to whether suspected or confirmed infection with the pathogen of interest if the reason (indication) for the hospital admission.	Indicate ‘Yes’ if suspected or confirmed infection with the pathogen of interest if the reason (indication) for the hospital admission. Indicate ‘No’ if the suspected or confirmed infection with the pathogen of interest is not the reason (indication) for hospital admission.						1			1		1	1
presentation	INCLUSION CRITERIA	inclu_case	radio	Status of case	1, Confirmed | 2, Probable | 3, Suspected | 4, Discarded | 5, Error							Confirmed refers to a case that is laboratory confirmed and may fulfil the clinical criteria as described in the case definition. Probable refers to a clinically compatible illness that is epidemiologically linked to a confirmed case without laboratory confirmation of infection with pathogen of interest. Suspected refers to a clinically compatible illness without epidemiological link or laboratory confirmation. Discarded refers to a patient with a negative laboratory test and has failed to fulfil the criteria for a suspect, probable or confirmed case.	Select the most appropriate option that represents the status of the case.									1	1	1
presentation	INCLUSION CRITERIA	inclu_testreason	radio	Reason why the patient was tested	1, Symptomatic | 2, Asymptomatic, contact-traced | 3, Asymptomatic, mass testing campaign | 4, Not tested | 99, Unknown | 88, Other							This refers to the reason the patient was tested for the pathogen of interest.	Select the most appropriate option which corresponds to the reason the patient was tested for the pathogen of interest.										1	1
presentation	INCLUSION CRITERIA	inclu_testreason_otth	text	Specify other reason						[inclu_testreason]=’88’		This refers to the reason the patient was tested for the pathogen of interest.	Select the most appropriate option which corresponds to the reason the patient was tested for the pathogen of interest.										1	1
presentation	INCLUSION CRITERIA	inclu_consentdes	descriptive	Consent:
presentation	INCLUSION CRITERIA	inclu_consent	radio	Participant (or their representative) has provided consent to participate in this study.	1, Yes | 0, No, participant did not agree to participate in the study | 2, No, the ethics committee approved a waiver of consent | 99, Unknown							This refers to provision of informed consent by the patient or their representative for participation in this study.	Indicate ‘Yes’ if the patient or their representative has provided their informed consent for participation in this study.	SNOMED	61861000000100, Consent (record artifact)	C5702721, Consent (record artifact)
presentation	INCLUSION CRITERIA	inclu_consent_date	date_dmy	Date of consent		date_dmy		today		[inclu_consent]=’1’		This refers to date on which informed consent was given for the participants inclusion in this study.	Enter the date on which informed consent was given for the participants inclusion in this study. (Use the format DD/MM/YYYY)			C2985782, Informed Consent Date
presentation	INCLUSION CRITERIA	inclu_consent_who	radio	Consent provided by	1, Participant | 2, Parent/guardian | 3, Consultee | 4, Independent clinician					[inclu_consent]=’1’		This refers to who provided the consent for participation in this study.	Select the most appropriate option that represents who provided the consent for participation in this study.
presentation	INCLUSION CRITERIA	inclu_consent_whopg	radio	Does the child or young person give their assent?	1, Yes | 0, No | 2, Not competent					[inclu_consent_who]=’2’		This refers to assent given by a minor or adult who is unable to give consent on their own behalf, to participate in a study. Assent must be accompanied by consent from a parent or legal guardian for full participation in the study.	Select the most appropriate option that represents whether assent was provided for participation in this study.			C5205794, Informed Assent
presentation	INCLUSION CRITERIA	inclu_consent2des	descriptive	Secondary use of data collected, the participant agreed with the following statements:						[inclu_consent]=’1’
presentation	INCLUSION CRITERIA	inclu_consent_secrsch	radio	Future use of pseudonymised data in ethically approved research, including research in other countries	1, Yes | 0, No					[inclu_consent]=’1’		Refers to consent for future secondary use of pseudonymised data in ethically approved research	This is an optional consent question and is not required for completion of the remaining CRF.
presentation	INCLUSION CRITERIA	inclu_consent_secprod	radio	Future use of pseudonymised data to manufacture tests, treatments or other products, including commercial products	1, Yes | 0, No					[inclu_consent]=’1’		Refers to consent for future secondary use of pseudonymised data to manufacture tests, treatments or other products, including commercial products	This is an optional consent question and is not required for completion of the remaining CRF.
presentation	INCLUSION CRITERIA	inclu_consent_secgen	radio	Future use of pseudonymised genetic data in ethically approved research, including research in other countries	1, Yes | 0, No					[inclu_consent]=’1’		Refers to consent for future secondary use of pseudonymised genetic data in ethically approved research	This is an optional consent question and is not required for completion of the remaining CRF.
presentation	INCLUSION CRITERIA	inclu_consentsecsamp	descriptive	Secondary use of samples collected, the participant agreed with the following statements:						[inclu_consent]=’1’
presentation	INCLUSION CRITERIA	inclu_consent_secsamprsch	radio	Future use of pseudonymised samples in ethically approved research, including research in other countries	1, Yes | 0, No					[inclu_consent]=’1’		Refers to consent for future secondary use of pseudonymised samples in ethically approved research, including research in other countries	This is an optional consent question and is not required for completion of the remaining CRF.
presentation	INCLUSION CRITERIA	inclu_consent_secsampprod	radio	Future use of pseudonymised samples or materials or data derived from those samples to manufacture tests, treatments or other products, including commercial products	1, Yes | 0, No					[inclu_consent]=’1’		Refers to consent for future secondary use of pseudonymised samples or materials or data derived from those samples to manufacture tests, treatments or other products, including commercial products	This is an optional consent question and is not required for completion of the remaining CRF.
presentation	INCLUSION CRITERIA	inclu_consent_secsampgen	radio	Future use of pseudonymised genetic samples in ethically approved research, including research in other countries	1, Yes | 0, No					[inclu_consent]=’1’		Refers to consent for future secondary use of pseudonymised genetic samples in ethically approved research, including research in other countries	This is an optional consent question and is not required for completion of the remaining CRF.
presentation	INCLUSION CRITERIA	inclu_consentcont	descriptive	Contact						[inclu_consent]=’1’
presentation	INCLUSION CRITERIA	inclu_consent_contnstudy	radio	To be contacted to participate in future work, including research studies	1, Yes | 0, No					[inclu_consent]=’1’		Refers to contact to be contacted to participate in future work, including research studies	This is an optional consent question and is not required for completion of the remaining CRF.
presentation	ONSET & PRESENTATION	pres_onsetdate	date_dmy	Onset date of first / earliest symptom		date_dmy		today				This refers to the date of onset of the first / earliest symptom which is clinically related to the current episode of illness.	Enter the date of the first symptom that you clinically believe was related to this episode of illness. (Use the format DD/MM/YYYY)	SNOMED	405795006, Time of symptom onset (observable entity)				1	1	1	1	1	1	1	1							1
presentation	ONSET & PRESENTATION	pres_symptpres	radio	Symptomatic at initial presentation?	1, Yes | 0, No | 99, Unknown							This refers to whether the patient was symptomatic at the initial presentation.	Indicate ‘Yes’, if the patient was symptomatic at the initial presentation.											1		1
presentation	ONSET & PRESENTATION	pres_firstsym	multi_list	Symptom(s) during first 24 hours of illness (select all that apply)					conditions_Symptoms			This refers to the first symptom, or symptoms (if multiple occurred at the same time), that you clinically believe was related to this episode of illness.	Select all symptoms which the patient experienced during the first 24 hours of illness (select all that apply).										1	1	1	1
presentation	ONSET & PRESENTATION	pres_consultdate	date_dmy	Date of first clinical consultation		date_dmy		today				This refers to the date of first clinical consultation related to the current episode of illness.	Enter the date of first clinical consultation related to the current episode of illness. (Use the format DD/MM/YYYY)							1				1	1	1
presentation	ONSET & PRESENTATION	pres_date	date_dmy	Most recent presentation/admission date at this facility		date_dmy		today				This refers to the date of hospitalisation / admission of the patient to your site for the current illness.	Enter the date of hospitalisation / admission to your site. (Use the format DD/MM/YYYY)	SNOMED	32485007, Hospital admission (procedure)				1	1	1	1	1	1	1	1							1
presentation	ONSET & PRESENTATION	pres_adm	radio	Admitted to hospital	1, Yes | 0, No | 99, Unknown							This refers to admission of the patient to your site for the current illness.	Indicate ‘Yes’, if that patient was admitted to your site.	SNOMED	32485007, Presentation to hospital (event)					1	1	1	1	1	1	1				1
presentation	ONSET & PRESENTATION	pres_adm_reas	radio	Reason for hospitalisation	1, Infection of interest | 88, Other					[pres_adm] = ‘1’		This refers to the reason (indication) for hospitalisation.	If ‘Yes’, specify the reason (indication) for hospitalisation.							1		1		1	1
presentation	ONSET & PRESENTATION	pres_adm_reasoth	text	Specify other reason						[pres_adm_reas]=’88’												1		1
presentation	ONSET & PRESENTATION	pres_adm_time	time	Time of hospital admission		time				[pres_adm] = ‘1’		This refers to admission of the patient to your site for the current illness.	Enter the time of admission to your site. (Use 24-hour format (00:00 - 24:00 hours))								1
presentation	ONSET & PRESENTATION	pres_enrolmentdate	date_dmy	Date of enrolment / start of data collection		date_dmy		today				This refers to the date of enrolment / start of data collection.	Enter date of patient study enrolment. (Use the format DD/MM/YYYY)						1	1	1	1	1	1	1								1
presentation	RE-ADMISSION AND PREVIOUS PIN	readm_prev	radio	Was the patient admitted previously or transferred from any other facility during this illness episode?	1, YES-admitted previously to this facility and discharged | 2, YES-admitted to other facility and discharged | 3, YES-admitted to another facility, then transferred to this facility | 0, No | 99, Unknown							This refers to previous admission to a health facility or transfer from another health facility during the current episode of illness.	Select the most appropriate option that represents whether or not the patient admitted previously or transferred from any other facility during this illness episode.																				1
presentation	RE-ADMISSION AND PREVIOUS PIN	readm_prev_site	text	Name of transfer facility						[readm_prev] = ‘1’ or [readm_prev]=’2’ or [readm_prev]=’3’		This refers to the name of the facility from which the patient was previously admitted or transferred.	Enter the name of the facility from which the patient was previously admitted or transferred.																				1
presentation	RE-ADMISSION AND PREVIOUS PIN	readm_prev_date	date_dmy	Date of presentation at previous facility		date_dmy		today		[readm_prev] = ‘1’ or [readm_prev]=’2’ or [readm_prev]=’3’		This refers to the date of presentation to the facility at which the patient was previously admitted or transferred.	Enter the date of presentation to the facility at which the patient was previously admitted or transferred. (Use the format DD/MM/YYYY)																				1
presentation	RE-ADMISSION AND PREVIOUS PIN	readm_prev_num	number	Total number of previous admissions for this infection		number	1	50		[readm_prev] = ‘1’ or [readm_prev]=’2’ or [readm_prev]=’3’		This refers to the number of times (for this infection) the patient has been admitted to a health facility.	Indicate the number of times (for this infection) the patient has been admitted to a health facility.																				1
presentation	RE-ADMISSION AND PREVIOUS PIN	readm_firstadmdate	date_dmy	Date of earliest admission for this infection		date_dmy		today		[readm_prev] = ‘1’ or [readm_prev]=’2’ or [readm_prev]=’3’		This refers to the date of the first admission for this illness. If the patient was first ‘admitted to other facility, then transferred to this facility’ record the date the patient was admitted to the other health facility.	Enter the date of the first admission for this illness. (Use the format DD/MM/YYYY)																				1
presentation	RE-ADMISSION AND PREVIOUS PIN	readm_difpin	radio	Has the patient’s data been previously collected under a different participant identification number (PIN)?	1, Yes | 0, No | 99, Unknown							This refers to previous collection of the patient’s data under a different Participant Identification Number (PIN)	Indicate ‘Yes’ if the patient’s data has been previously collected under a different participant identification number (PIN)
presentation	RE-ADMISSION AND PREVIOUS PIN	readm_prevpin	text	Previous Participant Identification Number (PIN)						[readm_difpin] = ‘1’		The Participant Identification Number or PIN is a unique number used to identify the patient’s (participant’s) data.	Write the Participant Identification Number (PIN).
presentation	RE-ADMISSION AND PREVIOUS PIN	readm_reas	radio	Is the patient being re-admitted with or due to infection with pathogen of interest?	1, Yes | 0, No | 99, Unknown							This refers to re-admission of the patient with or due to infection with pathogen of interest.	Indicate ‘Yes’ if the patient is being re-admitted with or due to infection with pathogen of interest.												1
presentation	DEMOGRAPHICS	demog_birthknow	radio	Is the date of birth known?	1, Yes | 0, No							This refers to the calendar date on which the patient was born.	Record the participants date of birth in DD/MM/YYYY format.	SNOMED	184099003, Date of birth (observable entity)	C0421451, Patient date of birth			1	1	1	1	1	1	1	1	1						1
presentation	DEMOGRAPHICS	demog_birthdate	date_dmy	Date of birth		date_dmy		today		[demog_birthknow]=’1’		This refers to the calendar date on which the patient was born.	Enter the participant’s date of birth. (Use the format DD/MM/YYYY)	SNOMED	184099003, Date of birth (observable entity)	C0421451, Patient date of birth	1	risk_factor_demo	1	1	1	1	1	1	1	1	1						1
presentation	DEMOGRAPHICS	demog_age	number	Age		number	0	150		[demog_birthknow]=’0’		This refers to the patient’s age.	For participants over the age of two years, please report age in years. For children under the age of two years, please report in months. For neonates below the age of one month, please report in days.	SNOMED	424144002, Current chronological age (observable entity)			risk_factor_demo	1	1	1	1	1	1	1	1	1						1
presentation	DEMOGRAPHICS	demog_age_units	radio	Age units	1, Years | 2, Months | 3, Days					[demog_birthknow]=’0’		This refers to the patient’s age at presentation to the health facility.	Select the most appropriate units for age.	SNOMED	424144002, Current chronological age (observable entity)			risk_factor_demo	1	1	1	1	1	1	1	1	1						1
presentation	DEMOGRAPHICS	demog_calcage_days	calc	Calculated Age (days)	if([demog_birthknow]=’1’,datediff([demog_birthdate],[pres_date],”d”),if([demog_age_units]=’1’,[demog_age]*365,if([demog_age_units]=’2’,round([demog_age]*365/12,0),if([demog_age_units]=’3’,[demog_age],’’))))							This refers to the patient’s age in days.	Age is calculated, if the date of birth is known, as the difference between the date of birth and the most recent date of presentation or admission to the facility.	SNOMED	424144002, Current chronological age (observable entity)			risk_factor_demo	1	1	1	1	1	1	1		1						1
presentation	DEMOGRAPHICS	demog_sex	radio	Sex at birth	1, Male | 2, Female | 99, Not specified/Unknown | 88, Other							This refers to the physical sexual characteristics at birth.	Select the most appropriate option that represents the physical sexual characteristics at birth.	SNOMED	281053000, Sex of baby at delivery (observable entity)			risk_factor_demo	1	1	1	1	1	1	1	1							1
presentation	DEMOGRAPHICS	demog_sex_oth	text	Specify other sex at birth						[demog_sex]=’88’		This refers to the physical sexual characteristics at birth.	If ‘Other’, specify the physical sexual characteristics at birth.	SNOMED	281053000, Sex of baby at delivery (observable entity)			risk_factor_demo	1	1		1	1	1	1	1
presentation	DEMOGRAPHICS	demog_gender	radio	Gender	1, Male | 2, Female | 3, Non-binary | 99, Unknown | 88, Other					[demog_calcage_days]>3650		This refers to a person’s internally held sense of their gender, which may or may not correspond to the individual’s genotypic or phenotypic sex.	Select the most appropriate option that represents the patient’s gender identity.	SNOMED	263495000, Gender (observable entity)	C0079399, Gender			1	1	1		1	1	1	1
presentation	DEMOGRAPHICS	demog_gender_oth	text	Specify other gender						[demog_gender]=’88’		This refers to a person’s internally held sense of their gender, which may or may not correspond to the individual’s genotypic or phenotypic sex.	If ‘Other’ specify patient’s gender identity.	SNOMED	263495000, Gender (observable entity)	C0079399, Gender			1	1	1		1	1	1	1
presentation	DEMOGRAPHICS	demog_country	user_list	Country					demographics_Country			This refers to the country of enrolment	Indicate the country of enrolment
presentation	DEMOGRAPHICS	demog_outcountry	radio	Was the patient born outside the reporting country?	1, Yes | 0, No | 99, Unknown							This refers to birth of the particpant outside the reporting country	Indicate whether the particpant was born outside the reporting country
presentation	DEMOGRAPHICS	demog_height	number	Height		number	0	250				Actual or closest estimate to height at time of admission.	This refers to the distance from the sole to the crown of the head with body standing on a flat surface and fully extended. For children under the age of 2, please use body length (measured while lying supine).						1	1	1	1			1	1							1
presentation	DEMOGRAPHICS	demog_height_units	radio	Height (select units)	1, cm | 2, in	units													1	1	1	1			1								1
presentation	DEMOGRAPHICS	demog_height_cm	number	Height (cm)		number	0	250				Actual or closest estimate to height at time of admission.	This refers to the distance from the sole to the crown of the head with body standing on a flat surface and fully extended, measured in centimetres (cm). For children under the age of 2, please use body length (measured while lying supine).	SNOMED	1153637007, Body height (observable entity)	C0489786, Height			1	1	1				1	1
presentation	DEMOGRAPHICS	demog_height_in	number	Height (in)		number	0	98				Actual or closest estimate to height at time of admission.	This refers to the distance from the sole to the crown of the head with body standing on a flat surface and fully extended, measured in inches (in). For children under the age of 2, please use body length (measured while lying supine).		1153637007, Body height (observable entity)	C0489786, Height			1	1	1				1	1
presentation	DEMOGRAPHICS	demog_weight	number	Weight		number	0	1763				Actual or closest estimate to weight at time of admission.	Indicate the patient’s weight.						1	1	1	1			1	1				1			1
presentation	DEMOGRAPHICS	demog_weight_units	radio	Weight (select units)	1, kg | 2, lb	units													1	1	1	1			1					1			1
presentation	DEMOGRAPHICS	demog_weight_kg	number	Weight (kg)		number	0	800				Actual or closest estimate to weight at time of admission.	Indicate the patient’s weight in kilograms (kg).	SNOMED	27113001, Body weight (observable entity)	C0005910, Body Weight			1	1	1				1	1				1
presentation	DEMOGRAPHICS	demog_weight_lb	number	Weight (lb)		number	0	1763				Actual or closest estimate to weight at time of admission.	Indicate the patient’s weight in pounds (lb).		27113001, Body weight (observable entity)	C0005910, Body Weight			1	1	1				1	1				1
presentation	DEMOGRAPHICS	demog_race	multi_list	Race (select all that apply)					demographics_Race			This refers to a geographic ancestral origin category that is assigned to a population group based mainly on physical characteristics that are thought to be distinct and inherent.	Select all that apply.	SNOMED	103579009, Race (observable entity)	C3853635, Race						1
presentation	DEMOGRAPHICS	demog_healthcare	radio	Employed as a healthcare worker	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>5840		This refers to a patient that is employed in the healthcare industry.	Select the most appropriate option.	SNOMED	223366009, Healthcare professional (occupation)			risk_factor_socio	1				1	1	1								1
presentation	DEMOGRAPHICS	demog_healthcare_ptfacing	radio	Patient facing	1, Yes | 0, No | 99, Unknown					[demog_healthcare] = ‘1’		This refers to a patient that is employed in the healthcare industry delivering care in patient-facing settings (i.e. roles that involve interaction directly with patients).	Select the most appropriate option.	SNOMED	223366009, Healthcare professional (occupation)			risk_factor_socio	1				1	1	1								1
presentation	DEMOGRAPHICS	demog_healthcare_expbiosample	radio	Exposed to biological samples	1, Yes | 0, No | 99, Unknown					[demog_healthcare] = ‘1’		This refers to a patient that is employed in the healthcare industry delivering care in non-patient facing settings but are exposed to biological samples (e.g. laboratory staff, medical waste handlers).	Select the most appropriate option.	SNOMED	223366009, Healthcare professional (occupation)			risk_factor_socio	1				1	1	1								1
presentation	DEMOGRAPHICS	demog_riskoccupa	user_list	Does the patient practise any of these professions or a profession related to their infection					demographics_Occupation			This refers to the principal activity that a person does to earn a living.	Select all that apply.					risk_factor_socio		1					1
presentation	DEMOGRAPHICS	demog_occupation	radio	Primary location of occupation	1, Home-working or unemployed | 2, Indoors-office/health/education/hospitality/business/homes | 3, Indoors-factory | 8, Outdoors-animal contact (vet, animal farmer, abattoir worker) | 4, Outdoors-agriculture/forestry/fisheries | 5, Outdoors-construction/industrial/mining | 6, Armed Forces | 7, Student | 99, Unknown | 88, Other							This refers to the location in which the patient conducts the majority of work related to their current occupation.	Select the most appropriate option that represents the primary location of occupation.					risk_factor_socio			1	1				1
presentation	DEMOGRAPHICS	demog_occupation_oth	text	Specify other primary location of occupation						[demog_occupation]=’88’		This refers to the location in which the patient conducts the majority of work related to their current occupation.	If ‘Other’, specify the primary location of occupation.					risk_factor_socio			1	1				1
presentation	DEMOGRAPHICS	demog_residence	radio	Patient’s city of residence	1, Same as health care facility | 2, Different from health care facility | 99, Unknown							This refers to the city which a person dwells more than temporarily or lives permanently.	If the patient’s city of residence is different to the city in which this healthcare facility is located, Specify the patient’s region of residence below.	SNOMED	433178008, City of residence (observable entity)	C2316883, City of residence		risk_factor_socio			1					1							1
presentation	DEMOGRAPHICS	demog_residence_oth	text	If different from health case facility, specify the patient’s region of residence.						[demog_residence]=’2’		This refers to the city which a person dwells more than temporarily or lives permanently.	If ‘Different from health case facility’, specify the patient’s region of residence.	SNOMED	433178008, City of residence (observable entity)	C2316883, City of residence		risk_factor_socio			1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_travel	radio	Did the patient travel outside of their home region in the past 14 days?	1, Yes | 0, No | 99, Unknown							This refers to travel to another city/town or region, another part of the country or abroad to another country within 14 days before symptoms relating to the current illness began.	Indicate ‘Yes’, if the patient travelled to another city/town or region, another part of the country or abroad to another country within 14 days before symptoms relating to the current illness began.	SNOMED	129018004, Traveling (observable entity)	C0040802, travel					1	1				1							1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_travel_loc	notes	specify all city / cities or town(s) and region(s) of travel						[expo14_travel] = ‘1’		This refers to all city / cities or town(s) and region(s), which the patient travelled to within 14 days before symptoms relating to the current illness began.	If the patient has travelled away from their usual place of residence within 14 days of symptom onset, enter the location(s) that were visited.								1	1				1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_yn	radio	History of contact with suspected or confirmed human case of same pathogen?	1, Yes | 0, No | 99, Unknown							This refers to the patient having a history of contact with anyone presenting with similar symptoms or with known confirmed case, or with contaminated material from a suspected or confirmed case (e.g. body fluids, objects, bedding etc.).	Indicate ‘Yes’, if the patient has a history of contact with anyone presenting with similar symptoms or with known confirmed case, or with contaminated material from a suspected or confirmed case (e.g. body fluids, objects, bedding etc.).							1		1	1	1	1	1							1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_typecomm	radio	Community contact	1, Yes | 0, No | 99, Unknown					[expo14_yn]=’1’		This refers to the mode of exposure to a suspected or confirmed case. Community contact refers to exposure event outside of healthcare setting.	Indicate ‘Yes’ if the patient experienced this mode of exposure to a suspected or confirmed human case.	SNOMED	277057000, Community acquired (qualifier value) | 1290740005, Vertical transmission (qualifier value) | 8098009, Sexually transmitted infectious disease (disorder)	C5392207, Community Transmission | C0242648, Vertical Disease Transmission | C0036916, Sexually Transmitted Diseases							1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_typevert	radio	Vertical transmission	1, Yes | 0, No | 99, Unknown					[expo14_yn]=’1’ and [demog_calcage_days]<365		This refers to the mode of exposure to a suspected or confirmed case. Vertical transmission refers to transmission from mother-to-child.	Indicate ‘Yes’ if the patient experienced this mode of exposure to a suspected or confirmed human case.	SNOMED	277057000, Community acquired (qualifier value) | 1290740005, Vertical transmission (qualifier value) | 8098009, Sexually transmitted infectious disease (disorder)	C5392207, Community Transmission | C0242648, Vertical Disease Transmission | C0036916, Sexually Transmitted Diseases							1	1							1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_typehcw	radio	Healthcare worker exposure	1, Yes | 0, No | 99, Unknown					[expo14_yn]=’1’ and [demog_calcage_days]>5840		This refers to the mode of exposure to a suspected or confirmed case. Healthcare worker exposure refers to an exposure event in a healthcare setting.	Indicate ‘Yes’ if the patient experienced this mode of exposure to a suspected or confirmed human case.	SNOMED	277057000, Community acquired (qualifier value) | 1290740005, Vertical transmission (qualifier value) | 8098009, Sexually transmitted infectious disease (disorder)	C5392207, Community Transmission | C0242648, Vertical Disease Transmission | C0036916, Sexually Transmitted Diseases							1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_typesext	radio	Sexual transmission	1, Yes | 0, No | 99, Unknown					[expo14_yn]=’1’ and [demog_calcage_days]>5840		This refers to the mode of exposure to a suspected or confirmed case. Sexual transmission refers to infection propagated by sexual contact.	Indicate ‘Yes’ if the patient experienced this mode of exposure to a suspected or confirmed human case.	SNOMED	277057000, Community acquired (qualifier value) | 1290740005, Vertical transmission (qualifier value) | 8098009, Sexually transmitted infectious disease (disorder)	C5392207, Community Transmission | C0242648, Vertical Disease Transmission | C0036916, Sexually Transmitted Diseases							1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_typefaml	radio	Family / household contacts	1, Yes | 0, No | 99, Unknown					[expo14_yn]=’1’		This refers to the mode of exposure to a suspected or confirmed case. Family / household contact refers to infection transmission from individuals who expect to share living accommodation on most days (and therefore for whom continuing close contact is unavoidable)	Indicate ‘Yes’ if the patient experienced this mode of exposure to a suspected or confirmed human case.	SNOMED	277057000, Community acquired (qualifier value) | 1290740005, Vertical transmission (qualifier value) | 8098009, Sexually transmitted infectious disease (disorder)	C5392207, Community Transmission | C0242648, Vertical Disease Transmission | C0036916, Sexually Transmitted Diseases						1	1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_typeschool	radio	Childcare settings/school exposures	1, Yes | 0, No | 99, Unknown					[expo14_yn]=’1’		This refers to the mode of exposure to a suspected or confirmed case occuring within childcare settings or school-related exposures.	Indicate ‘Yes’ if the patient experienced this mode of exposure to a suspected or confirmed human case.											1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_typeoth	radio	Other type of human exposure	1, Yes | 0, No | 99, Unknown					[expo14_yn]=’1’		This refers to other mode(s) of exposure to a suspected or confirmed case not specified above.	Indicate ‘Yes’ if the patient experienced this mode of exposure to a suspected or confirmed human case.	SNOMED	277057000, Community acquired (qualifier value) | 1290740005, Vertical transmission (qualifier value) | 8098009, Sexually transmitted infectious disease (disorder)	C5392207, Community Transmission | C0242648, Vertical Disease Transmission | C0036916, Sexually Transmitted Diseases							1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_typeoth_spec	text	Specify other type of human exposure						[expo14_typeoth]=’1’		This refers to other mode(s) of exposure to a suspected or confirmed case not specified above.	If ‘Other’, specify the mode of exposure to a suspected or confirmed case.										1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_date	date_dmy	Date of contact with suspected or confirmed case		date_dmy		today		[expo14_yn]=’1’		This refers to the date of contact with anyone presenting with similar symptoms or with known confirmed case, or with contaminated material from a suspected or confirmed case (e.g. body fluids, objects, bedding etc.).	Enter the date of contact with suspected or confirmed human case. (Use the format DD/MM/YYYY)							1			1	1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_setting	radio	Contact setting	1, Household | 2, Occupational | 4, Healthcare facility | 99, Unknown | 88, Other							This refers to the environment within which the person may have come into contact with a suspected or confirmed case.	Select the most appropriate option that represents the contact setting with a confirmed or suspected human case.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_setting_oth	text	Specify other contact setting						[expo14_setting]=’88’		This refers to the environment within which the person may have come into contact with a suspected or confirmed case.	If ‘Other’, specify the contact setting with a confirmed or suspected case.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon	radio	Any contact with animals, animal homes, meats or other animal products in the last 14 days?	1, Yes | 0, No | 99, Unknown							This refers to contact with animals, animal homes, meats or other animal products which occurred in the last 14 days.	Indicate ‘Yes’ if the patient was in contact with animals, animal homes, meats or other animal products which occurred in the last 14 days.							1				1	1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_date	date_dmy	Date of contact with suspected or confirmed animal source		date_dmy		today		[expo14_ancon]=’1’		This refers to the date of contact with animals, animal homes, meats or other animal products which occurred in the last 14 days.	Enter the date of contact with animals, animal homes, meats or other animal products which occurred in the last 14 days. (Use the format DD/MM/YYYY)							1					1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_lstock	radio	Contact with livestock	1, Yes | 0, No | 99, Unknown					[expo14_ancon]=’1’		This refers to contact with live bird (e.g. chickens, turkeys, ducks) which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1					1								1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_lstock_type	checkbox	Livestock type	1, Poultry/birds | 2, Dairy cows/equipment | 3, Other cattle | 4, Pigs					[expo14_ancon_lstock] = ‘1’		This refers to contact with live bird (e.g. chickens, turkeys, ducks) which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_lstock_cttype	checkbox	Specify type of contact	1, Hunting | 2, Preparing | 3, Handling | 4, Consumption (unprocessed / undercooked / raw) | 5, Trading | 6, Animal faeces or nests | 7, Sick or dead animal | 99, Unknown | 88, Other					[expo14_ancon_lstock] = ‘1’		This refers to the type(s) of animal contact which occurred in the last 14 days. Hunting includes findings or killing animal(s) for food or sport. Preparing incudes skinning, dressing or butchering animal(s) for consumption. Handling includes touching, petting or sharing living area with animal(s). Consumption includes ingesting unprocessed, undercooked or raw animal part(s). Trading includes animal contact from selling, buying or exchanging animal(s). Animal faeces or nests includes contact with faeces, nests or homes of animal(s). Sick or dead animals refers to contact with a sick or dead animal but not participation in animal surgery or nercopsy (seperate question).	Select all the type(s) of animal contact which occurred in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_nhprim	radio	Contact with non-human primates	1, Yes | 0, No | 99, Unknown					[expo14_ancon]=’1’		This refers to contact with non-human primates (a group of mammals composed of simians monkeys and apes and prosimians, such as lemurs) which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_nhprim_type	checkbox	Non-human primates type	1, Monkeys | 2, Apes					[expo14_ancon_nhprim]=’1’		This refers to contact with monkeys which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_nhprim_cttype	checkbox	Specify type of contact	1, Hunting | 2, Preparing | 3, Handling | 4, Consumption (unprocessed / undercooked / raw) | 5, Trading | 6, Animal faeces or nests | 7, Sick or dead animal | 99, Unknown | 88, Other					[expo14_ancon_nhprim]=’1’		This refers to the type(s) of animal contact which occurred in the last 14 days. Hunting includes findings or killing animal(s) for food or sport. Preparing incudes skinning, dressing or butchering animal(s) for consumption. Handling includes touching, petting or sharing living area with animal(s). Consumption includes ingesting unprocessed, undercooked or raw animal part(s). Trading includes animal contact from selling, buying or exchanging animal(s). Animal faeces or nests includes contact with faeces, nests or homes of animal(s). Sick or dead animals refers to contact with a sick or dead animal but not participation in animal surgery or nercopsy (seperate question).	Select all the type(s) of animal contact which occurred in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_rodent	radio	Contact with rodents	1, Yes | 0, No | 99, Unknown					[expo14_ancon]=’1’		This refers to contact with rodents (e.g. rats, mice, squirrels) which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_rodent_type	checkbox	Rodents type	1, Rats | 2, Mice | 3, Squirrels					[expo14_ancon_rodent] = ‘1’		This refers to contact with rats which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_rodent_cttype	checkbox	Specify type of contact	1, Hunting | 2, Preparing | 3, Handling | 4, Consumption (unprocessed / undercooked / raw) | 5, Trading | 6, Animal faeces or nests | 7, Sick or dead animal | 99, Unknown | 88, Other					[expo14_ancon_rodent] = ‘1’		This refers to the type(s) of animal contact which occurred in the last 14 days. Hunting includes findings or killing animal(s) for food or sport. Preparing incudes skinning, dressing or butchering animal(s) for consumption. Handling includes touching, petting or sharing living area with animal(s). Consumption includes ingesting unprocessed, undercooked or raw animal part(s). Trading includes animal contact from selling, buying or exchanging animal(s). Animal faeces or nests includes contact with faeces, nests or homes of animal(s). Sick or dead animals refers to contact with a sick or dead animal but not participation in animal surgery or nercopsy (seperate question).	Select all the type(s) of animal contact which occurred in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_pets	radio	Contact with pets	1, Yes | 0, No | 99, Unknown					[expo14_ancon]=’1’		This refers to contact with household pets (excluding rodents) which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_pets_type	checkbox	Pets type	1, Cats | 2, Dogs					[expo14_ancon_pets]=’1’		This refers to contact with cats which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_pets_cttype	checkbox	Specify type of contact	1, Hunting | 2, Preparing | 3, Handling | 4, Consumption (unprocessed / undercooked / raw) | 5, Trading | 6, Animal faeces or nests | 7, Sick or dead animal | 99, Unknown | 88, Other					[expo14_ancon_pets]=’1’		This refers to the type(s) of animal contact which occurred in the last 14 days. Hunting includes findings or killing animal(s) for food or sport. Preparing incudes skinning, dressing or butchering animal(s) for consumption. Handling includes touching, petting or sharing living area with animal(s). Consumption includes ingesting unprocessed, undercooked or raw animal part(s). Trading includes animal contact from selling, buying or exchanging animal(s). Animal faeces or nests includes contact with faeces, nests or homes of animal(s). Sick or dead animals refers to contact with a sick or dead animal but not participation in animal surgery or nercopsy (seperate question).	Select all the type(s) of animal contact which occurred in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_wildlife	radio	Contact with wildlife	1, Yes | 0, No | 99, Unknown					[expo14_ancon]=’1’		This refers to contact with animals considered to be wild or feral or not adapted for domestic use which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.										1	1		1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_wildelife_type	checkbox	Wildlife type	1, Bats |88, Other					[expo14_ancon_wildlife]=’1’		This refers to contact with bats which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.																				1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_wildelife_oth	text	Specify other wildlife type						[expo14_ancon_wildelife_type(88)]=’1’
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_wildlife_cttype	checkbox	Specify type of contact	1, Hunting | 2, Preparing | 3, Handling | 4, Consumption (unprocessed / undercooked / raw) | 5, Trading | 6, Animal faeces or nests | 7, Sick or dead animal | 99, Unknown | 88, Other					[expo14_ancon_wildlife]=’1’		This refers to the type(s) of animal contact which occurred in the last 14 days. Hunting includes findings or killing animal(s) for food or sport. Preparing incudes skinning, dressing or butchering animal(s) for consumption. Handling includes touching, petting or sharing living area with animal(s). Consumption includes ingesting unprocessed, undercooked or raw animal part(s). Trading includes animal contact from selling, buying or exchanging animal(s). Animal faeces or nests includes contact with faeces, nests or homes of animal(s). Sick or dead animals refers to contact with a sick or dead animal but not participation in animal surgery or nercopsy (seperate question).	Select all the type(s) of animal contact which occurred in the last 14 days.										1	1		1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_unpasteur	radio	Contact with or consumption of unpasteurised milk or raw dairy products	1, Yes | 0, No | 99, Unknown					[expo14_ancon]=’1’		This refers to contact with or consumption of unpasteurised milk or dairy products which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1					1								1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_visitzoo	radio	Visit to live animal market, farm or zoo	1, Yes | 0, No | 99, Unknown					[expo14_ancon]=’1’		This refers to visit to live animal market, farm or zoo which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_animalsurg	radio	Participated in animal surgery or necropsy	1, Yes | 0, No | 99, Unknown					[expo14_ancon]=’1’		This refers to participation in animal surgery or necropsy which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1					1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_bite	radio	Any insect or arthropod bites (eg. mosquitoes, ticks)	1, Yes | 0, No | 99, Unknown					[expo14_ancon]=’1’																							1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_other	radio	Other animal contact not listed above	1, Yes | 0, No | 99, Unknown					[expo14_ancon]=’1’		This refers to other animal contact, not listed above, which occurred in the last 14 days.	Indicate ‘Yes’ if the patient experienced this in the last 14 days.							1			1	1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_other_spec	text	Specify animal contacts not listed above						[expo14_ancon_other]=’1’		This refers to other animal contact, not listed above, which occurred in the last 14 days.	If ‘Yes’, specify any other animal contact with occurred in the last 14 days.							1			1	1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ancon_other_cttype	checkbox	Specify type of contact	1, Hunting | 2, Preparing | 3, Handling | 4, Consumption (unprocessed / undercooked / raw) | 5, Trading | 6, Animal faeces or nests | 7, Sick or dead animal | 99, Unknown | 88, Other					[expo14_ancon_other]=’1’		This refers to the type(s) of animal contact which occurred in the last 14 days. Hunting includes findings or killing animal(s) for food or sport. Preparing incudes skinning, dressing or butchering animal(s) for consumption. Handling includes touching, petting or sharing living area with animal(s). Consumption includes ingesting unprocessed, undercooked or raw animal part(s). Trading includes animal contact from selling, buying or exchanging animal(s). Animal faeces or nests includes contact with faeces, nests or homes of animal(s). Sick or dead animals refers to contact with a sick or dead animal but not participation in animal surgery or nercopsy (seperate question).	Select all the type(s) of animal contact which occurred in the last 14 days.							1			1	1	1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_house	radio	Any unwell household members in the two weeks prior to the admission of case?	1, Yes | 0, No | 99, Unknown							This refers to any household members of the suspected/confirmed case being unwell in the two weeks prior to the admission of the case.	Indicate ‘Yes’ if any household members of the suspected/confirmed case were unwell in the two weeks prior to the admission of the case.													1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_house_sys	checkbox	Which system(s) are affected? (tick all that apply)	1, Respiratory | 2, Gastrointestinal | 3, Cardiovascular | 4, Central Nervous system | 5, Peripheral Nervous system | 6, Mucocutaneous | 7, Ocualar | 99, Unknown | 88, Other					[expo14_house]=’1’		This refers to the body system(s) of the unwell household members which were affected during the illness.	Select all the system(s) which were affected.													1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_house_sys_oth	text	Specify other system(s) affected						[expo14_house_sys(88)]=’1’		This refers to the body system(s) of the unwell household members which were affected during the illness.	If ‘Other’, specify the system(s) which were affected.													1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_housecon	radio	Have household members had any contact with a confirmed case of the same infection?	1, Yes | 0, No | 99, Unknown							This refers to any household member(s) having any form of contact with a confirmed case of the pathogen of interest.	Indicate ‘Yes’ if any household member(s) had any form of contact with a confirmed case of the pathogen of interest.
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_ferm	radio	Consumption of fermented or traditionally locally prepared food/drinks	1, Yes | 0, No | 99, Unknown																												1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_swim	radio	Patient swam or bathed in pools, ponds, or rivers	1, Yes | 0, No | 99, Unknown																												1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_floodwater	radio	Exposure to flood water/stagnant water bodies or contaminated water	1, Yes | 0, No | 99, Unknown																												1
presentation	EXPOSURE HISTORY IN PREVIOUS 14 DAYS	expo14_closeliving	radio	Lives in close quarters	1, Yes | 0, No | 99, Unknown																												1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_cns	descriptive	Neurological comorbidities							Nervous system	This refers to comorbidities relating to the nervous system.						risk_factor_comor	1	1	1		1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_chrneurolo	radio	Chronic neurological disorder	1, Yes | 0, No | 99, Unknown						Nervous system	Includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. This can include any of cerebral palsy, multiple sclerosis, motor neurone disease, muscular dystrophy, myasthenia gravis, Parkinson’s disease, stroke, and severe learning difficulty.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	118940003, Disorder of the nervous system (disorder)	C0027765, Nervous system disorder		risk_factor_comor	1	1	1		1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_epilepsy	radio	Epilepsy	1, Yes | 0, No | 99, Unknown						Nervous system	This refers to a disorder causing recurrent unprovoked seizures	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	84757009, Epilepsy (disorder)			risk_factor_comor				1		1									1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_dementia	radio	Dementia	1, Yes | 0, No | 99, Unknown						Nervous system	Defined as evidence from the history and mental status examination that indicates major impairment in learning and memory as well as impairment in at least one of the following: handling complex tasks; reasoning ability; spatial ability and orientation; language. The cognitive symptoms must significantly interfere with the individual’s work performance, usual social activities, or relationships with other people. This must represent a significant decline from a previous level of functioning. The disturbances are not occurring exclusively during the course of delirium, and the disturbances are not better accounted for by a major psychiatric diagnosis. Chronic cognitive deficit is included.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	52448006, Dementia	C1969275, Dementia		risk_factor_comor	1	1	1				1	1	1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_strokecva	radio	Stroke / cerebrovascular accident	1, Yes | 0, No | 99, Unknown						Nervous system	Defined as a sudden loss of neurological function secondary to haemorrhage or ischemia in the brain parenchyma due to a vascular event. Stroke may be a clinical diagnosis, with or without supportive radiological findings.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	230690007, Cerebrovascular accident	C3554760, Stroke		risk_factor_comor				1					1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_hemipleg	radio	Hemiplegia	1, Yes | 0, No | 99, Unknown						Nervous system	This refers to severe or complete loss of motor function on one side of the body; often caused by brain diseases that are localized to the cerebral hemisphere opposite to the side of weakness; less frequently, brain stem lesions; cervical spinal cord diseases, peripheral nervous system diseases, and other conditions may manifest as hemiplegia.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	50582007, Hemiplegia (disorder)	C0018991, Hemiplegia		risk_factor_comor									1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_parapleg	radio	Paraplegia	1, Yes | 0, No | 99, Unknown						Nervous system	This refers to complete paralysis of the lower half of the body including both legs, often caused by damage to the spinal cord.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	60389000, Paraplegia (disorder)	C0030486, Paraplegia		risk_factor_comor									1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_cvs	descriptive	Cardiovascular comorbidities							Cardiovascular	This refers to comorbidities relating to the cardiovascular system.						risk_factor_comor	1	1	1		1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_chrcardiac	radio	Chronic cardiac disease (not hypertension)	1, Yes | 0, No | 99, Unknown						Cardiovascular	Defined as a disease that progressively causes deterioration of the heart and its functioning. This includes congenital heart diseases (e.g. tetralogy of fallot)	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	128238001, Chronic heart disease (disorder)	C1290386, Chronic heart disease		risk_factor_comor	1	1	1	1	1	1	1	1	1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_chrcardiac_mi	radio	Myocardial infarction	1, Yes | 0, No | 99, Unknown					[comor_chrcardiac]=’1’	Cardiovascular	Defined as gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis. This includes previous (history of) myocardial infarction.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	22298006, Myocardial infarction (disorder)	C0027051, Myocardial Infarction		risk_factor_comor				1				1	1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_chrcardiac_chf	radio	Congestive heart failure	1, Yes | 0, No | 99, Unknown					[comor_chrcardiac]=’1’	Cardiovascular	Defined as failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and oedema.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	42343007, Congestive heart failure (disorder)	C0018802, Congestive heart failure		risk_factor_comor				1				1	1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_hypertensi	radio	Hypertension	1, Yes | 0, No | 99, Unknown						Cardiovascular	Defined as elevated arterial blood pressure diagnosed clinically (systolic blood pressure >140mmHg systolic and/or diastolic blood pressure >90mmHg), or for which a patient is prescribed an anti-hypertensive.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	38341003, Hypertensive disorder, systemic arterial (disorder)	C0020538, Hypertensive disease		risk_factor_comor	1	1	1	1	1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_perivascdis	radio	Peripheral vascular disease	1, Yes | 0, No | 99, Unknown						Cardiovascular	This refers to deviation from or interruption of the normal structure or function of the blood vessels outside the heart; diseases of the peripheral as opposed to the cardiac circulation.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	400047006, Peripheral vascular disease (disorder)	C0085096, Peripheral Vascular Diseases		risk_factor_comor									1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_resp	descriptive	Respiratory comorbidities							Respiratory	This refers to comorbidities relating to the respiratory system.						risk_factor_comor	1	1	1		1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_chrpulmona	radio	Chronic pulmonary disease (not asthma)	1, Yes | 0, No | 99, Unknown						Respiratory	Defined as any pulmonary condition other than asthma, that is a disease or disorder of slow progression and long duration which causes continuous or episodic periods of illness and/or incapacity.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	413839001, Chronic lung disease	C0746102, Chronic Lung Disorder		risk_factor_comor	1	1	1	1	1	1	1	1	1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_asthma	radio	Asthma	1, Yes | 0, No | 99, Unknown						Respiratory	This is defined as clinician-diagnosed asthma, a chronic airway disorder characterized by variable and recurring symptoms of airflow obstruction, bronchial hyper-responsiveness, and/or underlying inflammation. Current pharmaceutical intervention - for prevention or treatment of symptoms - is not a pre-requisite for the inclusion of this diagnosis.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	195967001, Asthma (disorder)	C4229310, Asthma		risk_factor_comor	1	1	1	1	1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_git	descriptive	Gastrointestinal comorbidities							Gastrointestinal	This refers to comorbidities relating to the gastrointestinal system.						risk_factor_comor	1	1	1		1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_peptulcdis	radio	Peptic ulcer disease	1, Yes | 0, No | 99, Unknown						Gastrointestinal	This refers to acid peptic injury of the digestive tract, resulting in mucosal break reaching the submucosa. Peptic ulcers are usually located in the stomach or proximal duodenum, but they can also be found in the oesophagus or Meckel’s diverticulum.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	13200003, Peptic ulcer (disorder)	C0030920, Peptic ulcer		risk_factor_comor									1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_liverdisease	radio	Liver disease	1, Yes | 0, No | 99, Unknown						Gastrointestinal	Defined as any disorder of the hepatobiliary system. Manifestations may include signs and symptoms of cholestasis, portal hypertension, and/or abnormal liver function tests.	Indicate ‘Yes’, if this is condition existed prior to admission and is ongoing.	SNOMED	235856003 | Disorder of liver (disorder)	C0023895, Liver diseases		risk_factor_comor	1	1	1	1	1	1	1	1	1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_liverdisease_type	radio	Type of liver disease	1, Mild | 2, Moderate or severe | 99, Unknown					[comor_liverdisease]=’1’	Gastrointestinal	Defined as mild - chronic hepatitis or cirrhosis without portal hypertension, and moderate or severe - cirrhosis with portal hypertension, with or without bleeding or a history of variceal bleeding.	Indicate the type of liver disease. Mild: chronic hepatitis or cirrhosis without portal hypertension. Moderate or severe: cirrhosis with portal hypertension, with or without bleeding or a history of variceal bleeding.	SNOMED	235856003 Disorder of liver (disorder) | 2448400 | 1, Mild (severity modifier) (qualifier value) | 2, 371924009 Moderate to severe (qualifier value)|	C0023895, Liver diseases | C2945599, mild (qualifier value) | C1299393, moderate to severe (qualifier value)		risk_factor_comor	1	1			1	1	1	1	1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_renalgut	descriptive	Renal / Genitourinary comorbidities							Renal	This refers to comorbidities relating to the renal / genitourinary system.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.						1	1	1		1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_chrkidney	radio	Chronic kidney disease	1, Yes | 0, No | 99, Unknown						Renal	This is defined as a clinician-diagnosed chronic kidney disease (CKD, also known as chronic kidney failure). The KDIGO and KDOQI definition of chronic kidney disease is kidney damage for 3 months, as defined by structural or functional abnormalities of the kidney, with or without decreased glomerular filtration rate (GFR), that can lead to decreased GFR, manifest by either: Pathologic abnormalities; or Markers of kidney damage, including abnormalities in the composition of the blood or urine, or abnormalities in imaging tests; or GFR <60 mL/min/1.73 m^2 for 3 months, with or without kidney damage.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	709044004, Chronic kidney disease (disorder)	C1561643		risk_factor_comor	1	1	1	1	1	1	1	1	1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_chrkidney_type	radio	Stage of chronic kidney disease	1, Stage 1 | 2, Stage 2 | 3, Stage 3a | 4, Stage 3b | 5, Stage 4 | 6, Stage 5 | 99, Unknown					[comor_chrkidney]=’1’	Renal	This refers to the stage of chronic kidney disease (CKD) based on estimated glomerular filtration rate (eGFR). CKD Stages: 1 - Kidney damage, normal eGFR (90ml/min); 2 - Kidney damage, mild GFR decrease (60-89ml/min); 3a - Moderate GFR decrease (45-59ml/min); 3b - Moderate to severe GFR decrease (30-44ml/min); 4 - Severe GFR decrease (15-29ml/min); 5 - Kidney failure (<15ml/min or on dialysis).	Select the most appropriate option that corresponds to the stage of CKD based on eGFR.	SNOMED				risk_factor_comor		1				1	1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_inf	descriptive	Infectious comorbidities							Infection	This refers to infection-related comorbidities.						risk_factor_comor	1	1	1		1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_aids	radio	HIV	1, Yes | 0, No | 99, Unknown						Infection	Defined as a person living with laboratory-confirmed Human Immunodeficiency Virus (HIV) 1 or 2 infection, or a patient with an Acquired Immunity Deficiency Syndrome (AIDS) defining illness. This is irrespective of the CD4 lymphocyte count/percentage or HIV viral load in blood. ART refers to anti-retroviral therapy and is distinct from pre-exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP).	Indicate the single most appropriate option that reflects the HIV/AIDS status of the patient and whether they are taking anti-retroviral therapy (ART).	SNOMED	19030005, Human immunodeficiency virus | 62479008, Acquired immune deficieny syndrome	C0019693, HIV Infection | C0001175, Acquired Immunodeficiency Syndrome		risk_factor_comor	1	1	1	1	1	1	1	1	1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_aids_art	radio	Is the patient on anti-retroviral therapy (ART)?	1, Yes | 0, No | 99, Unknown					[comor_aids] = ‘1’	Infection	Anti-retroviral therapy (ART) refers to drug therapy, for patients with HIV infection, which targets retrovirus function by multiple mechanisms to aggressively suppress HIV replication. It is distinct from pre-exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP).	Indicate the single most appropriate option that reflects the HIV/AIDS status of the patient and whether they are taking anti-retroviral therapy (ART).	SNOMED	416234007 |Highly active anti-retroviral therapy (procedure)|	C1963724, Antiretroviral therapy		risk_factor_comor	1	1	1	1	1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_aids_arttype	text	Specify ART						[comor_aids_art] = ‘1’	Infection	This refers to antiretroviral therapy (ART) used in treatment of HIV infections with medications that target the virus directly, limiting the ability of infected cells to produce new virus particles. It is distinct from pre-exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP).	Write the antiretroviral therapy (ART) drugs being used in treatment of HIV.	SNOMED	416234007, Highly active anti-retroviral therapy (procedure)			risk_factor_comor		1		1	1	1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_aids_cd4date	date_dmy	If HIV positive: CD4 count date		date_dmy		today		[comor_aids] = ‘1’	Infection	This refers to the date of the most recent laboratory-based CD4 cell count available.	Enter the date. (Use the format DD/MM/YYYY)					risk_factor_comor		1		1	1	1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_aids_cd4count	number	If HIV positive: Most recent CD4 count (cells/µL)		number	1	10000		[comor_aids] = ‘1’	Infection	This refers to the date of the most recent laboratory-based CD4 cell count available.	Write the date in DD/MM/YYYY format.					risk_factor_comor	1	1	1	1	1	1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_aids_vrl	radio	If HIV positive: Is HIV viral load detectable	1, Yes | 0, No | 99, Unknown					[comor_aids] = ‘1’	Infection	Detectable typically includes suppressed (detected but <= 1000 copies/mL) and unsuppressed (>1000 copies/mL). Undetectable refers to viral load not detected by test used.	Indicate ‘Yes’ if detectable (includes; suppressed (detected but <= 1000 copies/mL) and unsuppressed (>1000 copies/mL)). Indicate ‘No’ if undetectable (viral load not detected by test used).	SNOMED	165816005, Human immunodeficiency virus detected (finding)			risk_factor_comor		1			1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_aids_vrlno	number	Most recent HIV viral load (copies/mL)		number	1	5000000		[comor_aids_vrl] = ‘1’	Infection	Defined as the most recent laboratory-based HIV viral load available expressed in copies/mL.	Indicate the most recent laboratory-based HIV viral load available expressed in copies/mL.	SNOMED	315124004, Human immunodeficiency virus viral load (procedure)			risk_factor_comor		1			1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_aids_vrlnodate	date_dmy	HIV viral load date		date_dmy					Infection	This refers to the date of the most recent laboratory-based HIV viral load available.	Enter the date. (Use the format DD/MM/YYYY)					risk_factor_comor		1					1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_tuberculos	radio	Tuberculosis	1, Yes | 0, No | 99, Unknown						Infection	Defined as patients currently receiving treatment for tuberculosis, an infection caused by the bacterium Mycobacterium tuberculosis. Latent tuberculosis should not be included here. Patients who have been cured of tuberculosis should not be included here. Those who have chronic pulmonary sequelae following their tuberculosis should be included as chronic pulmonary disease.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	56717001, Tuberculosis	C0041296, Tuberculosis		risk_factor_comor	1	1	1		1	1	1	1	1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_tuberculos_type	radio	Specify tuberculosis type	1, Active pulmonary | 4, Active extra-pulmonary | 3, Latent | 99, Unknown					[comor_tuberculos]=’1’	Infection	This refers to the type of Mycobacterium tuberculosis infection. Active pulmonary TB refers to bacterial infection that affects the lungs and is caused by Mycobacterium tuberculosis, with signs and symptoms including chronic cough with blood-tinged sputum, night sweats, fever, fatigue, and weight loss. Active extra-pulmonary TB refers to Mycobacterium tuberculosis infection involving organs other than the lungs (e.g., pleura, lymph nodes, abdomen, genitourinary tract, skin, joints and bones, or meninges). Latent TB refers to the asymptomatic presence of Mycobacterium tuberculosis in the body, which is determined by a positive result to a tuberculin skin test or interferon-gamma release assay.	Select the most appropriate option(s) that represents the type of Mycobacterium tuberculosis infection.	SNOMED	154283005, Pulmonary tuberculosis (disorder) | 423997002, Tuberculosis, extrapulmonary (disorder) | 11999007, Inactive tuberculosis (finding)			risk_factor_comor		1			1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_hepbc	radio	Chronic hepatitis B/C infection	1, Yes | 0, No | 99, Unknown						Infection	Defined as chronic hepatitis due to infection by hepatitis B (HBV) or hepatitis C (HCV) virus. Do not include those with a documented cure of hepatitis C.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	66870002 |Chronic active viral hepatitis (disorder)|	C0276625		risk_factor_comor			1					1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_heme	descriptive	Haematological comorbidities							Haematology	This refers to comorbidities relating to the haematological system.							1	1	1		1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_chrhematol	radio	Chronic haematologic disease	1, Yes | 0, No | 99, Unknown						Haematology	This refers to chronic disorders of the blood and blood forming tissues. Examples include Polycythemia Vera, Myelodysplastic Syndromes (MDS). Does not include leukaemia, lymphoma or myeloma, which should be entered under malignancy. Does not include iron-deficiency anaemia which is explained by diet or chronic blood loss.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	398983000, Chronic disease of hematopoietic system	C1275398, Chronic disease of hematopoietic system		risk_factor_comor	1	1	1		1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_recentblood	radio	Blood transfusion in last month	1, Yes | 0, No | 99, Unknown						Haematology	This refers to a history of previous blood transfusion within the past month of a calendar year.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.											1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_sickle	radio	Sickle cell disease	1, Yes | 0, No | 99, Unknown						Haematology	This refers to a genetic blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_sys	descriptive	Systemic / general comorbidities							Systemic/General	This refers to systemic / general comorbidities.							1	1	1		1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_rheumatolo	radio	Rheumatologic disorder	1, Yes | 0, No | 99, Unknown						Systemic/General	Defined as an disorders of connective tissue, especially the joints and related structures characterised by inflammation, degeneration or metabolic derangement. It includes chronic arthropathies and arthritis, connective tissue disorders and vasculitides.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	396332003 | Rheumatism (disorder) |	C0035435, Rheumatologic disorder		risk_factor_comor	1	1	1	1	1	1	1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_rheumatolo_type	radio	Specify Rheumatologic disorder	1, Osteoarthritis| 2,Rheumatoid Arthritis| 3, Systemic Lupus Erythematosus | 4, Ankylosing Spondylitis | 5, Psoriatic Arthritis | 99, Unknown | 88, Other					[comor_rheumatolo] = ‘1’												1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_rheumatolo_type_oth	text	Specify Other Rheumatologic disorder						[comor_rheumatolo_type] = ‘88’												1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_asplenia	radio	Asplenia	1, Yes | 0, No | 99, Unknown						Systemic/General	Defined as the anatomical absence of the spleen or functional asplenia secondary to a variety of disease states. This can include congenital absence (born without a spleen), or acquired absence, for example secondary to surgical removal.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	707147002, Asplenia	CL534652, asplenia following surgical procedure; C3810472, Congenital absence of spleen; C0272405 functional asplenia		risk_factor_comor	1	1	1		1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_benignn	radio	Benign neoplasm	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to a neoplasm characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	20376005, Benign neoplastic disease (disorder)	C0086692, Benign Neoplasm		risk_factor_comor								1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_malignantn	radio	Malignant neoplasm	1, Yes | 0, No | 99, Unknown						Systemic/General	Defined as a tumour composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Includes haematological malignancies, that are considered to be biologically active. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukaemias, melanomas, and sarcomas. It specifically does not include malignancies that have been cured or where there is no evidence of on-going disease relating to that malignancy following treatment.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	363346000, Malignant neoplastic disease	C1861853, Malignant Neoplasm		risk_factor_comor	1	1	1	1		1	1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_malignantn_sol	radio	Malignant solid neoplasm	1, Yes | 0, No | 99, Unknown					[comor_malignantn]=’1’	Systemic/General	Defined as a malignant neoplasm arising from solid tissues that do not include fluid areas (e.g., blood or bone marrow). Representative examples include carcinomas (adenocarcinomas or squamous cell carcinomas) and sarcomas. Hematopoietic and lymphoid tissue malignancies are not considered solid neoplasms and are covered as leukaemia and lymphoma below.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.					risk_factor_comor						1			1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_malignantn_leuk	radio	Leukemia	1, Yes | 0, No | 99, Unknown					[comor_malignantn]=’1’	Systemic/General	Defined as a progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	93143009, Leukemia, disease (disorder)	C0023418, leukemia		risk_factor_comor						1			1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_malignantn_lymp	radio	Lymphoma	1, Yes | 0, No | 99, Unknown					[comor_malignantn]=’1’	Systemic/General	Defined as a malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	118600007, Malignant lymphoma (disorder)	C0024299, Lymphoma		risk_factor_comor						1			1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_obesity	radio	Obesity	1, Yes | 0, No | 99, Unknown						Systemic/General	Refers to body weight grossly above recommended standard. BMI >= 30 kg/m2 or other locally appropriate BMI cut off can be used to define obesity.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	414916001, Obesity (disorder)	C3809449, Obesity		risk_factor_comor	1	1	1	1	1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_malnutriti	radio	Malnutrition	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to any clinically identified deficiency in intake, either of total energy or of specific nutrients, that led to a dietetic intervention or referral prior to this admission.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	2492009, Nutritional disorder (disorder)	CL1378604, Malnutrition		risk_factor_comor	1	1	1		1	1	1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_diabetes	radio	Diabetes mellitus	1, Yes | 0, No | 99, Unknown						Systemic/General	Defined as a metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance or desensitization. This includes Type 1 diabetes mellitus, Type 2 diabetes mellitus, or Gestational diabetes (during previous pregnancy) requiring oral or subcutaneous treatment.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	73211009, Diabetes mellitus (disorder)	C4013416, Diabetes mellitus		risk_factor_comor	1	1	1	1	1	1	1	1	1						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_diabetes_type	radio	Diabetes mellitus type	1, Type 1| 2, Type 2 | 3, Gestational diabetes | 99, Unknown					[comor_diabetes] = ‘1’	Systemic/General	Refers to a subtype of diabetes mellitus that is characterized by insulin deficiency; it is manifested by the sudden onset of severe hyperglycemia, rapid progression to diabetic ketoacidosis, and death unless treated with insulin; the disease may occur at any age, but is most common in childhood or adolescence.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	46635009, Diabetes mellitus type 1 (disorder)	C5435660, TYPE 1 DIABETES MELLITUS 1		risk_factor_comor	1	1	1	1	1	1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_diabetes_endorg	radio	End organ damage from diabetes	1, Yes | 0, No | 99, Unknown					[comor_diabetes] = ‘1’	Systemic/General	Refers to irreparable damage to multiple organs/systems which is the result of chronic complications of diabetes. The affected organs/systems include the cardiovascular system, kidneys, eyes, nervous system, joints and feet.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.			C3830315, End Organ Damage from Diabetes		risk_factor_comor				1		1			1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_hba1c	number	HbA1C result within last 6 months		number				[comor_diabetes] = ‘1’	Systemic/General	Haemoglobin A1C (HbA1C) is a blood test that measures average blood glucose level over the three months preceding the test result. It can be reported in different units (mmol/mol or %).	Enter the numerical value for HbA1C level. If there is no result for the patient in the last six months proceed onto the next question.	SNOMED	43396009, Hemoglobin A1c measurement (procedure)	C0474680, Hemoglobin A1c measurement		risk_factor_comor	1			1			1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_hba1c_units	radio	HbA1C result within last 6 months (select units)	1, mmol/mol | 2, %	units				[comor_diabetes] = ‘1’	Systemic/General			SNOMED	43396009, Hemoglobin A1c measurement (procedure)	C0474680, Hemoglobin A1c measurement		risk_factor_comor	1			1			1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_hba1c_mmolmol	number	HbA1C result within last 6 months (mmol/mol)		number				[comor_diabetes] = ‘1’	Systemic/General	Haemoglobin A1C (HbA1C) is a blood test that measures average blood glucose level over the three months preceding the test result. It can be reported in different units (mmol/mol or %).	Enter the numerical value for HbA1C level expressed in mmol/mol. If there is no result for the patient in the last six months proceed onto the next question.	SNOMED	43396009, Hemoglobin A1c measurement (procedure)	C0474680, Hemoglobin A1c measurement		risk_factor_comor	1		1				1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_hba1c_pcnt	number	HbA1C results within last 6 months (%)		number	0	100		[comor_diabetes] = ‘1’	Systemic/General	Haemoglobin A1C (HbA1C) is a blood test that measures average blood glucose level over the three months preceding the test result. It can be reported in different units (mmol/mol or %).	Enter the numerical value for HbA1C level expressed as a percentage (%). If there is no result for the patient in the last six months proceed onto the next question.	SNOMED	43396009, Hemoglobin A1c measurement (procedure)			risk_factor_comor	1		1				1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_smoking	radio	Ever smoked	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>4745	Systemic/General	This refers to smoking cigarettes, cigars, pipes or equivalent. Never smoker is defined as a person who has never smoked at the time of the assessment or has smoked less than 100 of the above items in their life. Do not include smoke-free tobacco products such as chewed tobacco or electronic nicotine delivery devices.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition. Indicate ‘No’ if the patient has never smoked (defined as a person who has never smoked at the time of the assessment or has smoked less than 1 of the above items in their life).	SNOMED	77176002, Smoker (finding) | 266919005, Never smoked tobacco (finding)	C0302836, Smoking tobacco | C0425293, Never Smoker		risk_factor_comor	1	1	1	1	1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_smoking_type	radio	Smoking status	1, Current smoker | 2, Former Smoker					[comor_smoking]=’1’	Systemic/General	This refers to smoking cigarettes, cigars, pipes or equivalent. Never smoker is defined as a person who has never smoked at the time of the assessment or has smoked less than 100 of the above items in their life. Do not include smoke-free tobacco products such as chewed tobacco or electronic nicotine delivery devices.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition. Indicate ‘No’ if the patient has never smoked (defined as a person who has never smoked at the time of the assessment or has smoked less than 1 of the above items in their life).	SNOMED	77176002, Smoker (finding) | 266919005, Never smoked tobacco (finding)	C0302836, Smoking tobacco | C0425293, Never Smoker		risk_factor_comor	1	1	1	1	1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_smoking_passive	radio	Passive smoking (lives in same household as a smoker)	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to increased risk of exposure to tobacco smoke products among individuals who do not smoke. This can result from sharing space with a smoker or from placental transfer from mother to fetus.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_orgtrans	radio	Transplant recipient	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to an individual receiving (or has received) tissues or organs transferred from another individual of the same or different species, or from within the same individual.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	737294004, Transplant present			risk_factor_comor		1				1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_orgtrans_organ	checkbox	Specify transplanted organ(s)	1, Lung | 2, Heart | 3, Kidney | 4, Liver | 5, Bone | 6, Hematopoietic stem cell					[comor_orgtrans]=’1’	Systemic/General	This refers to the specific tissue(s) or organ(s) transferred from another individual of the same or different species, or from within the same individual.	Select all that apply.					risk_factor_comor		1				1	1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_primaryimmuno	radio	Primary immunodeficiency	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to immunodeficiency disease that arises independent of another pathologic process, disease, or injury.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.					risk_factor_comor						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_chemotherapy	radio	Chemotherapy	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.											1	1								1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_radiotherapy	radio	Radiation therapy	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to the use of high-energy radiation from x-rays, gamma rays, neutrons, protons, and other sources to kill cancer cells and shrink tumors.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.											1	1								1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_steroidtherapy	radio	Long term or high-dose corticosteroid therapy	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to use of exogenous corticosteroids in high-doses or for long term (typically for over 4 weeks) periods for the treatment of any disease or disorder.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.											1	1								1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_skincon	radio	Relevant skin condition(s) (atopic dermatitis or active exfoliative skin conditions)	1, Yes | 0, No | 99, Unknown						Skin	This refers to any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	95320005, Disorder of skin (disorder)			risk_factor_comor						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_skincondesc	text	Describe the skin condition(s)							Skin	This refers to any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.	If ‘Yes’, please give a description of the skin condition(s).	SNOMED	95320005, Disorder of skin (disorder)			risk_factor_comor						1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_paed	descriptive	Paediatric-specific Comorbidities						[demog_calcage_days]<=730	Paediatric													1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_premature	radio	Prematurity (<37 weeks)	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]<=730	Paediatric													1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_malnut_assess	descriptive	Malnutrition assessment							Systemic/General	This refers to any clinically identified deficiency in intake, either of total energy or of specific nutrients, that led to a dietetic intervention or referral prior to this admission.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	2492009, Nutritional disorder (disorder)	CL1378604, Malnutrition		risk_factor_comor															1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_malnut_muac	number	Mid-Upper Arm Circumference		number				[demog_calcage_days]<=5844																							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_malnut_acuteill	radio	Acute illness in past 3 months	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>23725																							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_malnut_fintake65	radio	Decline in food intake past 3 months (appetite, digestion, chewing/swallowing difficulties)	1, Yes | 0, No | 99, Unknown																												1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_malnut_wtloss65	radio	Weight loss during past 3 months	1, Weight loss greater than 3 kg (6.6 lbs) | 3, Weight loss between 1 and 3 kg (2.2 and 6.6 lbs) | 0, No weight loss | 99, Unknow																												1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_malnut_psychstress65	radio	Psychological stress in past 3 months	1, Yes | 0, No | 99, Unknown																												1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_otherdesc	descriptive	Other comorbidities							Other								1	1	1	1	1	1	1								1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_unlisted	list	Other relevant comorbidity(s)	1, Yes | 0, No | 99, Unknown				conditions_Comorbidities		Other	This refers to a comorbid condition(s) not listed above.	Indicate ‘Yes’, if this is condition(s) existed prior to admission with this current illness and remains an active medical condition.	SNOMED	398192003, Co-morbid conditions (finding)			risk_factor_comor	1	1	1	1	1	1	1	1							1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	comor_mhdesc	descriptive	Current Acute Conditions																			1	1									1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	medic_cpox	radio	Active chickenpox	1, Yes | 0, No | 99, Unknown							This refers to active chickenpox infection caused by varicella-zoster virus. Clinical manifestations are fever and pruritic, vesicular skin rash occurring ten to twenty-one days after exposure. Do not include those with reactived Varicella zoster virus (VZV) i.e. Shingles.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	38907003, Varicella (disorder)	C0008049, Chicken Pox							1	1									1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	medic_meas	radio	Active measles	1, Yes | 0, No | 99, Unknown								Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED																			1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	medic_actshingles	radio	Active shingles (herpes zoster)	1, Yes | 0, No | 99, Unknown							This refers to an active case of shingles or herpes zoster dues to the reactivation of the varicella-zoster virus that has remained dormant, after the patient’s initial exposure to the virus in the form of varicella (chickenpox).	Indicate ‘Yes’, if the patient currently has shingles (herpes zoster), a reactivation of varicella-zoster virus. Indicate ‘No’ if the patient has only had chickenpox in the past, or if the patient does not have a history of this condition.	SNOMED	4740000 | Herpes zoster (disorder) |	C0019360, Herpes zoster							1	1									1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	medic_acthcv	radio	Active Hepatitis C	1, Yes | 0, No | 99, Unknown							This refers to an active case of hepatitis C virus infection.	Indicate ‘Yes’, if the patient currently has active hepatitis C infection											1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	medic_acthbv	radio	Active Hepatitis B	1, Yes | 0, No | 99, Unknown							This refers to an active case of hepatitis B virus infection.	Indicate ‘Yes’, if the patient currently has active hepatitis B infection											1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	medic_sti	radio	Active sexually transmitted infection	1, Yes | 0, No | 99, Unknown							Defined as infections due to or propagated by sexual contact including, chlamydia, genital herpes/warts, gonorrhea, HPV, public lice, syphilis, trichomoniasis, lymphogranuloma venereum. Do not include HIV/AIDS and chronic hepatitis, as specified in separate questions.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	8098009, Sexually transmitted infectious disease (disorder)	CL1399179, Sexually transmitted infections							1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	medic_sti_type	checkbox	Specify active STI	1, Herpes Simplex Virus (HSV) | 2, Human Papillomavirus (HPV) | 3, Chlamydia | 4, Gonorrhoea | 5, Syphilis | 6, Mycoplasma genitalium | 99, Unknown | 88, Other					[medic_sti]=’1’		Defined as infections due to or propagated by sexual contact including, chlamydia, genital herpes/warts, gonorrhea, HPV, public lice, syphilis, trichomoniasis, lymphogranuloma venereum. Do not include HIV/AIDS and chronic hepatitis, as specified in separate questions.	Select all that apply.	SNOMED	721585006, Sexually transmissible infection caused by Herpes simplex virus (disorder) | 240532009, Human papillomavirus infection (disorder) | 105629000, Chlamydial infection (disorder) | 15628003, Gonorrhea (disorder) | 76272004, Syphilis (disorder) | 1163504003, Infection caused by Mycoplasma genitalium (disorder)								1	1
presentation	CO-MORBIDITIES AND RISK FACTORS: Existing prior to this current illness and is ongoing	medic_sti_oth	text	specify other active STI						[medic_sti_type(88)]=’1’		Defined as infections due to or propagated by sexual contact including, not listed above. Do not include HIV/AIDS and chronic hepatitis, as specified in separate questions.	If ‘Other’, specify the other active STI.	SNOMED	8098009, Sexually transmitted infectious disease (disorder)								1	1
presentation	MEDICAL HISTORY	medic_previnf	radio	Is the patient known to have had previous infection(s) with this pathogen?	1, Yes | 0, No | 99, Unknown							Defined as a previous diagnosis with the same pathogen in a clinical episode distinct from this presentation or admission.	Indicate ‘Yes’, if the patient has previously been infected with the same pathogen.						1		1		1	1	1	1
presentation	MEDICAL HISTORY	medic_firstadm	radio	Was the patient ever hospitalised in a previous episode of the same infection?	1, Yes-admitted to hospital or ICU | 0, No | 99, Unknown					[medic_previnf] = ‘1’		This refers to the patient’s previous history of infection(s) with the same pathogen and whether the patient was ever admitted to hospital or ICU.	Indicate ‘Yes’ if the patient was admitted to hospital or ICU for infection with the same pathogen.						1		1				1
presentation	MEDICAL HISTORY	medic_infstartdate	date_dmy	When did the previous episode begin?		date_dmy		today		[medic_previnf]=’1’		This refers to the exact date (or approximate date, if not known) when the previous episode of infection with the same pathogen begun.	Enter the exact date at which the previous infection with the same pathogen begun. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1				1	1	1	1
presentation	MEDICAL HISTORY	medic_infenddate	date_dmy	When did the previous episode end?		date_dmy		today		[medic_previnf]=’1’		This refers to the exact date (or approximate date, if not known) when the previous episode of infection with the same pathogen ended.	Enter the exact date at which the previous infection with the same pathogen ended. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1				1	1	1	1
presentation	MEDICAL HISTORY	medic_labtest	radio	Was the previous episode confirmed by laboratory testing?	1, Yes | 0, No | 99, Unknown					[medic_previnf]=’1’		This refers to confirmation of the previous infection episode with a laboratory test.	Indicate ‘Yes’, if the previous episode was confirmed with laboratory testing.						1				1	1	1	1
presentation	MEDICAL HISTORY	medic_previnf2	radio	Is the patient known to have had an infection(s) before the last reported with this pathogen?	1, Yes | 0, No | 99, Unknown							Defined as a previous diagnosis with the same pathogen in a clinical episode before the last reported infection.	Indicate ‘Yes’, if the patient has previously had an infection with the same pathogen in a clinical episode before the last reported infection.						1
presentation	MEDICAL HISTORY	medic_previnf2_adm	radio	Was the patient ever hospitalised in this previous episode of the same infection?	1, Yes-admitted to hospital or ICU | 0, No | 99, Unknown					[medic_previnf2] = ‘1’		This refers to the patient’s previous history of infection with the same pathogen and whether the patient was ever admitted to hospital or ICU.	Indicate ‘Yes’ if the patient was admitted to hospital or ICU for an infection with the same pathogen in a clinical episode before the last reported infection.						1
presentation	MEDICAL HISTORY	medic_previnf2_startdate	date_dmy	When did this previous episode begin?		date_dmy		today		[medic_previnf2]=’1’		This refers to the exact date (or approximate date, if not known) when the previous episode of infection with the same pathogen begun.	Enter the exact date at which the previous infection with the same pathogen begun. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1
presentation	MEDICAL HISTORY	medic_previnf2_enddate	date_dmy	When did this previous episode end?		date_dmy		today		[medic_previnf2]=’1’		This refers to the exact date (or approximate date, if not known) when the previous episode of infection with the same pathogen ended.	Enter the exact date at which the previous infection with the same pathogen ended. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1
presentation	MEDICAL HISTORY	medic_previnf3	radio	Is the patient known to have had an infection(s) before the last reported with this pathogen?	1, Yes | 0, No | 99, Unknown							Defined as a previous diagnosis with the same pathogen in a clinical episode before the last reported infection.	Indicate ‘Yes’, if the patient has previously had an infection with the same pathogen in a clinical episode before the last reported infection.						1
presentation	MEDICAL HISTORY	medic_previnf3_adm	radio	Was the patient ever hospitalised in this previous episode of the same infection?	1, Yes-admitted to hospital or ICU | 0, No | 99, Unknown					[medic_previnf3] = ‘1’		This refers to the patient’s previous history of infection with the same pathogen and whether the patient was ever admitted to hospital or ICU.	Indicate ‘Yes’ if the patient was admitted to hospital or ICU for an infection with the same pathogen in a clinical episode before the last reported infection.						1
presentation	MEDICAL HISTORY	medic_previnf3_startdate	date_dmy	When did this previous episode begin?		date_dmy		today		[medic_previnf3] = ‘1’		This refers to the exact date (or approximate date, if not known) when the previous episode of infection with the same pathogen begun.	Enter the exact date at which the previous infection with the same pathogen begun. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1
presentation	MEDICAL HISTORY	medic_previnf3_enddate	date_dmy	When did this previous episode end?		date_dmy		today		[medic_previnf3] = ‘1’		This refers to the exact date (or approximate date, if not known) when the previous episode of infection with the same pathogen ended.	Enter the exact date at which the previous infection with the same pathogen ended. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1
presentation	MEDICAL HISTORY	medic_cpoxpast	radio	Known to have previous chickenpox infection(s)?	1, Yes | 0, No | 99, Unknown							This refers to a previous chickenpox infection. It does not include a history of reactived Varicella zoster virus (VZV) i.e. Shingles.	Indicate ‘Yes’, if this is condition existed prior to admission with this current illness and remains an active medical condition.	SNOMED	161423008, History of chickenpox (situation)	C0455469, H/O: chickenpox							1	1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antiviral	radio	Antiviral	1, Yes | 0, No | 99, Unknown							An antiviral agent refers to any agent(s) prescribed to treat or prevent viral infections by interfering with the viral replication cycle. Examples of neuraminidase inhibitors include oseltamivir, ribavirin, acyclovir and lopinavir/ritonavir. Topical preparations are not included.	Indicate ‘Yes’, if the patient has taken an antiviral in the 14 days prior to this most recent admission / presentation						1	1			1	1	1								1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antiviral_type	multi_list	Antiviral					drugs_Antiviral	[drug14_antiviral] = ‘1’		An antiviral agent refers to any agent(s) prescribed to treat or prevent viral infections by interfering with the viral replication cycle. Examples of neuraminidase inhibitors include oseltamivir, ribavirin, acyclovir and lopinavir/ritonavir. Topical preparations are not included.	Select the antiviral(s) prescribed or taken by the patient in the 14 days prior to this most recent admission / presentation	SNOMED	788081006, Medicinal product acting as antiviral agent (product)|	C0003451, Antiviral agent			1	1			1	1	1								1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antiviral_route	checkbox	Antiviral administration route	1, Oral | 2, Inhaled | 3, IV | 4, Topical | 99, Unknown					[drug14_antiviral] = ‘1’		This refers to the part of the body through which or into which, or the way in which, the medicinal product (drug) is introduced. Oral refers to administering by mouth. Inhaled refers to administration through the respiratory route (insufflation into the respiratory tract). IV (intravenous) refers to administering into bloodstream through injection into a vein. Topical refers to administration by application of drug preparations to the surfaces of the body, especially the skin or mucous membranes.	Indicate the route of administration for the antiviral agent.	SNOMED	386359008, Administration of drug or medicament via oral route (procedure) | 243132000, Inhaled drug administration (procedure) | 386358000, Administration of drug or medicament via intravenous route (procedure) | 431695009, Administration of drug or medicament to skin via topical route (procedure)								1	1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antiviraldate	date_dmy	Antiviral start date		date_dmy		today		[drug14_antiviral] = ‘1’		This refers to the date the medication was started / first dose was administered.	Enter the date when the medication was started / first dose was given. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1	1			1	1	1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antiviralday	number	Number of days antivirals taken		number	0			[drug14_antiviral] = ‘1’		Includes all calendar days in which a dose was received or instructed to take on discharge prescription.	Enter the total number of days for which a dose was received or instructed to take on discharge prescription.						1	1			1	1	1								1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_steroid	radio	Corticosteroid	1, Yes | 0, No | 99, Unknown							Corticosteroids (commonly referred to as ‘steroids’) refers to all types of therapeutic corticosteroid, made in the adrenal cortex (the outer part of the adrenal gland). They are also made in the laboratory. Examples include: prednisolone, prednisone, methyl-prednisolone, dexamethasone, hydrocortisone, fluticasone, betametasone. Topical preparations are not included, but inhaled preparations are included.	Indicate ‘Yes’, if the patient has taken a ‘steroid’ in the 14 days prior to this most recent admission / presentation	SNOMED	788326005, Product containing adrenal cortex hormone (product)|	CL554601, Therapeutic corticosteroid			1	1	1	1	1	1	1	1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_steroid_type	multi_list	Corticosteroid					drugs_Steroids	[drug14_steroid]=’1’		Corticosteroids (commonly referred to as ‘steroids’) refers to all types of therapeutic corticosteroid, made in the adrenal cortex (the outer part of the adrenal gland). They are also made in the laboratory. Examples include: prednisolone, prednisone, methyl-prednisolone, dexamethasone, hydrocortisone, fluticasone, betametasone. Topical preparations are not included, but inhaled preparations are included.	Select the corticosteroids(s) prescribed or taken by the patient in the 14 days prior to this most recent admission / presentation	SNOMED	788326005, Product containing adrenal cortex hormone (product)|	CL554601, Therapeutic corticosteroid			1	1	1	1	1	1	1	1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_steroid_route	checkbox	Corticosteroid administration route	1, Oral | 2, Inhaled | 3, IV | 99, Unknown					[drug14_steroid]=’1’		This refers to the part of the body through which or into which, or the way in which, the medicinal product (drug) is introduced. Oral refers to administering by mouth. Inhaled refers to administration through the respiratory route (insufflation into the respiratory tract). IV (intravenous) refers to administering into bloodstream through injection into a vein. Topical refers to administration by application of drug preparations to the surfaces of the body, especially the skin or mucous membranes.	Indicate the route of administration for the corticosteroid.	SNOMED	386359008, Administration of drug or medicament via oral route (procedure) | 243132000, Inhaled drug administration (procedure) | 386358000, Administration of drug or medicament via intravenous route (procedure) | 431695009, Administration of drug or medicament to skin via topical route (procedure)				1	1	1		1	1	1	1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_steroid_date	date_dmy	Corticoteroid start date		date_dmy		today		[drug14_steroid]=’1’		This refers to the date the medication was started / first dose was administered.	Enter the date when the medication was started / first dose was given. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1	1			1	1	1	1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_steroid_day	number	Number of days corticosteroid taken		number	0			[drug14_steroid]=’1’		Includes all calendar days in which a dose was received or instructed to take on discharge prescription.	Enter the total number of days for which a dose was received or instructed to take on discharge prescription.						1	1			1	1	1	1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_steroid_dose	number	Dose of corticosteroid		number	0			[drug14_steroid]=’1’		This refers to the dose of the corticosteroid agent.	Indicate the dose of the corticosteroid agent.												1	1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_immunusupp	radio	Immunosuppressant agents (not corticosteroids)	1, Yes | 0, No | 99, Unknown							This refers to a patient who is known to have taken prescribed medications that are known to have an immunosuppressing effect (excluding steroids/corticosteroids). Topical preparations should not be recorded.	Indicate ‘Yes’, if the patient has taken an immunosuppressant agent in the 14 days prior to this most recent admission / presentation	SNOMED	69431002, Medicinal product acting as immunosuppressant (product)|	CL942512, Immunosuppressant agent		risk_factor_comor	1	1	1		1	1	1	1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_immunusupp_type	multi_list	Immunosuppressant agents (not corticosteroids)					drugs_Immunosuppressants	[drug14_immunusupp]=’1’		This refers to a patient who is known to have taken prescribed medications that are known to have an immunosuppressing effect (excluding steroids/corticosteroids). Topical preparations should not be recorded.	Select the immunosuppressant(s) prescribed or taken by the patient in the 14 days prior to this most recent admission / presentation	SNOMED	69431002, Medicinal product acting as immunosuppressant (product)|	CL942512, Immunosuppressant agent		risk_factor_comor	1	1	1		1	1	1	1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antibiotic	radio	Antibiotics	1, Yes | 0, No | 99, Unknown							Antibiotics refers to any agent(s) that selectively target bacteria. Topical preparations should not be recorded.	Indicate ‘Yes’, if the patient has taken an antibiotic in the 14 days prior to this most recent admission / presentation	SNOMED	346325008, Medicinal product acting as antibacterial agent (product)|	C0279516, Antibacterial			1	1	1		1	1	1	1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antibiotic_type	multi_list	Antibiotics					drugs_Antibiotics	[drug14_antibiotic]=’1’		Antibiotics refers to any agent(s) that selectively target bacteria. Topical preparations should not be recorded.	Select the antibiotic(s) prescribed or taken by the patient in the 14 days prior to this most recent admission / presentation	SNOMED	346325008, Medicinal product acting as antibacterial agent (product)|	C0279516, Antibacterial			1	1	1		1	1	1	1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_nsaid	radio	NSAIDs	1, Yes | 0, No | 99, Unknown							Non-steroidal anti-inflammatory drugs or NSAIDS refers to any agent that is not a corticosteroid and has potential anti-inflammatory, analgesic, antipyretic and anti-platelet activities. Most nonsteroidal anti-inflammatory drugs (NSAIDs) act by inhibiting the conversion of arachidonic acid to the precursors of prostaglandin and thromboxane by cyclooxygenase enzymes. Topical preparations should not be recorded.	Indicate ‘Yes’, if the patient has taken an NSAID in the 14 days prior to this most recent admission / presentation		16403005 |Non-steroidal anti-inflammatory agent (product)|	C0003211, Nonsteroidal Antiinflammatory Drug				1	1	1			1	1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_nsaid_type	multi_list	NSAIDs					drugs_nsaids	[drug14_nsaid]=’1’		Non-steroidal anti-inflammatory drugs or NSAIDS refers to any agent that is not a corticosteroid and has potential anti-inflammatory, analgesic, antipyretic and anti-platelet activities. Most nonsteroidal anti-inflammatory drugs (NSAIDs) act by inhibiting the conversion of arachidonic acid to the precursors of prostaglandin and thromboxane by cyclooxygenase enzymes. Topical preparations should not be recorded.	Indicate ‘Yes’, if the patient has taken an NSAID in the 14 days prior to this most recent admission / presentation		16403005 |Non-steroidal anti-inflammatory agent (product)|	C0003211, Nonsteroidal Antiinflammatory Drug				1	1	1			1	1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_nsaid_dose	number	total NSAID dose mg/day		number				[drug14_nsaid]=’1’												1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_nsaid_dur	number	Duration of NSAID use (days)		number				[drug14_nsaid]=’1’												1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_analg	radio	Analgesics/antipyretics (non-NSAID)	1, Yes | 0, No | 99, Unknown																	1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_analg_type	checkbox	Select Analgesics/antipyretics (non-NSAID)	1, Paracetamol (Acetaminophen) | 2, Metamizole (Dipyrone) | 88, Other					[drug14_analg]=’1’												1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_analg_type_oth	text	Specify other Analgesics/antipyretics (non-NSAID)						[drug14_analg_type(88)]=’1’												1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_opio	radio	Opioids	1, Yes | 0, No | 99, Unknown																	1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_dmard	radio	Disease-modifying antirheumatic drugs (DMARDs)	1, Yes | 0, No | 99, Unknown																	1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_dmard_type	checkbox	Disease-modifying antirheumatic drugs (DMARDs)	1, Methotrexate | 2, Sulfasalazine | 3, Hydroxychloroquine | 4, Leflunomide | 5, Azathioprine | 6, TNF inhibitors (e.g., adalimumab, infliximab, etanercept) | 7, IL-6 inhibitors (e.g., tocilizumab) | 8, B-cell inhibitors (e.g., rituximab) | 9, T-cell co-stimulation inhibitors (e.g., abatacept) | 88, Other					[drug14_dmard]=’1’												1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_anticoagul	radio	Anticoagulant	1, Yes | 0, No | 99, Unknown							An anticoagulant refers to any agent capable of preventing blood clot formation, or platelet aggregation. This includes agents such as heparin, warfarin, aspirin, clopidogrel, and subcutaneously administered anticoagulants, among many others. Topical preparations are not included.	Indicate ‘Yes’, if the patient has taken an anticoagulant in the 7 days prior to this most recent admission / presentation.	SNOMED	81839001 |Medicinal product acting as anticoagulant agent (product)|	C0003280, Anticoagulant agent					1					1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_anticoagul_type	multi_list	Anticoagulant					drugs_Anticoagulant	[drug14_anticoagul]=’1’		An anticoagulant refers to any agent capable of preventing blood clot formation, or platelet aggregation. This includes agents such as heparin, warfarin, aspirin, clopidogrel, and subcutaneously administered anticoagulants, among many others. Topical preparations are not included.	Select the analgesic(s) prescribed or taken by the patient in the 14 days prior to this most recent admission / presentation	SNOMED	81839001 |Medicinal product acting as anticoagulant agent (product)|	C0003280, Anticoagulant agent					1					1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_ivfluid	radio	Intravenous (parenteral) fluids	1, Yes | 0, No | 99, Unknown							Intravenous (IV) or parenteral fluids are prescribed as a replacement of fluid, electrolytes, calories, vitamins, and other nutritional substances. Intravenous fluids may be used for rehydration, maintenance requirements or resuscitation.	Indicate ‘Yes’ if the patient received intravenous fluids in the 7 days prior to this most recent admission / presentation.	SNOMED	354078009 |Intravenous fluids and electrolytes (product)|	CL524079, IV fluid					1												1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_ivfluid_type	multi_list	Intravenous fluid type					drugs_IVfluids	[drug14_ivfluid] = ‘1’		This refers to the type of parenteral or intravenous (IV) fluid is prescribed as a replacement of fluid, electrolytes, calories, vitamins, and other nutritional substances. Intravenous fluids may be crystalloids (commonly including 0.9% Sodium Chloride (Normal Saline), Lactated Ringer(USP), 0.45% Sodium Chloride (Half-normal saline), 0.45% normal saline + 4% Glucose (Half-normal saline with dextrose), 0.18%-0.3% Sodium Chloride + 4% Glucose (Hypotonic saline with dextrose), 5% Glucose (Dextrose 5% in Water), Ringeracetate or Plasmalyte) or colloids (commonly including gelatins, starches or albumin).	Select the intravenous fluid(s) prescribed or taken by the patient in the 14 days prior to this most recent admission / presentation	SNOMED							1												1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_ivfluid_vol	number	Total intravenous fluid volume in the previous 24 hours (mL)		number	0	3000		[drug14_ivfluid] = ‘1’		Parenteral or intravenous (IV) fluid is prescribed as a replacement of fluid, electrolytes, calories, vitamins, and other nutritional substances. Intravenous fluids (crystalloids and colloids) may be used for rehydration, maintenance requirements or resuscitation.	Specify the total volume of the intravenous fluids (crystalloids and colloids) received by the patient over the previous 24 hours. Record the volume in millilitres (mL).								1												1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_ivfluid_reas	checkbox	Indication / reason	1, Shock | 2, High/rising haematocrit | 3, Anorexia | 4, Persistent vomiting | 88, Other					[drug14_ivfluid] = ‘1’		This refers to the indication for intravenous fluids. Shock refers to circulatory failure, causing inadequate oxygen delivery to meet cellular metabolic needs. It is characterised by any two of the following: evidence of hypoperfusion (e.g. slow capillary refill, cold skin, and rapid and weak pulse), narrow pulse pressure (less than or equal to 20mmHg), hypotension for age, and tachycardia.	Indicate the indication for intravenous fluids.	SNOMED	27942005, Shock (disorder)	C0036974, Shock					1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_ivfluid_reas_oth	text	Specify other reason						[drug14_ivfluid_reas(88)]=’1’		This refers to the indication for intravenous fluids. Shock refers to circulatory failure, causing inadequate oxygen delivery to meet cellular metabolic needs. It is characterised by any two of the following: evidence of hypoperfusion (e.g. slow capillary refill, cold skin, and rapid and weak pulse), narrow pulse pressure (less than or equal to 20mmHg), hypotension for age, and tachycardia.	If ‘Other’, write the indication for intravenous fluids.
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antihypertensive	radio	Antihypertensives	1, Yes | 0, No | 99, Unknown							This refers to any substance used in the treatment of acute or chronic hypertension regardless of pharmacological mechanism. Examples include: ACE Inhibitors (Lisinopril (Zestril), Enalapril (Vasotec), Ramipril (Altace), Captopril); Angiotensin Receptor Blockers ((Losartan (Cozaar), Valsartan (Diovan), Irbesartan (Avapro), Olmesartan (Benicar)); Beta-Blockers (Metoprolol (Lopressor), Carvedilol (Coreg), Bisoprolol, Atenolol); Calcium Channel Blockers (Amlodipine (Norvasc), Diltiazem (Cardizem), Verapamil); Diuretics (Furosemide (Lasix), Spironolactone (Aldactone), Hydrochlorothiazide (HCTZ))	Indicate ‘Yes’, if the patient has taken this medication in the 14 days prior to this most recent admission / presentation	SNOMED	372586001, Hypotensive agent (substance)										1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antidiabetic	radio	Antidiabetic medications	1, Yes | 0, No | 99, Unknown							This refers to any substance used to reduce hyperglycemia or treat disorders associated with diabetes. Examples include: Metformin (Glucophage); SGLT2 Inhibitors (Empagliflozin (Jardiance), Dapagliflozin (Farxiga), Canagliflozin (Invokana)); DPP-4 Inhibitors (Sitagliptin (Januvia), Linagliptin (Tradjenta), Saxagliptin (Onglyza)); GLP-1 Receptor Agonists (Liraglutide (Victoza), Semaglutide (Ozempic), Dulaglutide (Trulicity)); Insulins (Glargine (Lantus), Aspart (NovoLog), Lispro (Humalog), Detemir (Levemir))	Indicate ‘Yes’, if the patient has taken this medication in the 14 days prior to this most recent admission / presentation												1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_lipidlowering	radio	Lipid-lowering drugs	1, Yes | 0, No | 99, Unknown							This refers to any substance used to lower the levels of certain lipids in the blood in the treatment of hyperlipidaemias. Examples include: Statins (Atorvastatin (Lipitor), Rosuvastatin (Crestor), Simvastatin (Zocor), Pravastatin (Pravachol)); Ezetimibe (Zetia)	Indicate ‘Yes’, if the patient has taken this medication in the 14 days prior to this most recent admission / presentation	SNOMED	373267003, Antilipemic agent (substance)										1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antireflux	radio	Anti-reflux or other GI medications	1, Yes | 0, No | 99, Unknown							This refers to any substance used in the treatment gastric reflux by preventing the backward flow of stomach acid contents into the esophagus, or other drugs taken for ailments of the gastrointestinal system. Examples include: Proton Pump Inhibitors (Omeprazole (Prilosec), Pantoprazole (Protonix), Esomeprazole (Nexium), Lansoprazole (Prevacid)); H2-Receptor Antagonists (Ranitidine (Zantac), Famotidine (Pepcid))	Indicate ‘Yes’, if the patient has taken this medication in the 14 days prior to this most recent admission / presentation												1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antidepress	radio	Antidepressants and Anxiolytics	1, Yes | 0, No | 99, Unknown							Antidepressants refers to mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Anxiolytics refers to drugs used to treat anxiety disorders. Examples include: Selective Serotonin Reuptake Inhibitors (Sertraline (Zoloft), Citalopram (Celexa), Fluoxetine (Prozac), Escitalopram (Lexapro)); Serotonin-Norepinephrine Reuptake Inhibitors (Venlafaxine (Effexor), Duloxetine (Cymbalta)); Benzodiazepines (Lorazepam (Ativan), Diazepam (Valium), Alprazolam (Xanax))	Indicate ‘Yes’, if the patient has taken this medication in the 14 days prior to this most recent admission / presentation	SNOMED	372720008, Antidepressant (substance)							1			1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_antiepileptic	radio	Antiepileptics	1, Yes | 0, No | 99, Unknown							This refers to any substance used stop, prevent, or control seizures (convulsions). Examples include: Levetiracetam (Keppra), Valproate (Depakote), Carbamazepine (Tegretol), Lamotrigine (Lamictal).	Indicate ‘Yes’, if the patient has taken this medication in the 14 days prior to this most recent admission / presentation									1			1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_herb	radio	Herbal or traditional treatment	1, Yes | 0, No | 99, Unknown							Herbal or traditional treatment refers to herbs, herbal materials, herbal preparations and finished herbal products, that contain as active ingredients parts of plants, and other knowledge, skills, and practices based on the theories, beliefs, and experiences indigenous to different cultures that are used to treat physical or mental illness.	Indicate ‘Yes’, if the patient has taken a ‘Herbal or traditional treatment in the 14 days prior to this most recent admission / presentation	SNOMED	349365008, Herbal medicine (product)	C2240391, Herbal medicine (product)							1	1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_herbreas	text	Specify active ingredient in herbal or traditional treatment						[drug14_herb]=’1’		This refers to the pharmaceutically active component(s) of a preparation of herbal or traditional medication(s).	If ‘Yes’, specify the pharmaceutically active component(s) of a preparation of herbal or traditional medication(s).										1	1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_hivprep	radio	HIV PrEP / PEP	1, Yes | 0, No | 99, Unknown							This refers to pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to prevent HIV.	Indicate ‘Yes’, if the patient received anti-retroviral therapy, for the purposes of PrEP and PEP to prevent HIV, in the 14 days prior to this most recent admission / presentation.	SNOMED	1287783000, Administration of human immunodeficiency virus pre-exposure prophylaxis (procedure) | 235921000112100, Administration of human immunodeficiency virus post-exposure prophylaxis (procedure)								1	1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_chemo	radio	Cancer chemotherapy	1, Yes | 0, No | 99, Unknown							This refers to a history of exposure to cancer chemotherapy in the 14 days prior to this most recent admission / presentation.	Indicate ‘Yes’ if the patients has a history of exposure to cancer chemotherapy in the 14 days prior to this most recent admission / presentation.
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_unlisted	radio	Other pathogen-targeted medications	1, Yes | 0, No | 99, Unknown							This refers to other pathogen-targeted medication, not listed above.	Indicate ‘Yes’, if pathogen-targeted medications (other than those specified above) have been taken in the 14 days prior to this most recent admission / presentation.						1		1	1	1	1	1	1							1
presentation	MEDICATION PRIOR TO THIS ADMISSION / PRESENTATION	drug14_unlisted_type	text	Specify other pathogen-targeted medications						[drug14_unlisted]=’1’		This refers to other pathogen-targeted medication, not listed above.	Indicate ‘Yes’, if pathogen-targeted medications (other than those specified above) have been taken in the 14 days prior to this most recent admission / presentation.						1		1	1	1	1	1	1							1
presentation	VACCINATION	vacci_covid19	radio	Vaccinated for COVID-19 (ever)	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeted against SARS-Cov-2. Examples include Spikevax (Moderna), Comirnaty (Pfizer/BioNTech), Nuvaxovid (Novavax), Vaxzevria (AstraZeneca/Oxford), Janssen COVID-19 Vaccine (Johnson & Johnson), Valneva (Valneva).	Indicate ‘Yes’, if the patient has ever received a vaccine targetted against SARS-Cov-2					risk_factor_comor	1						1								1
presentation	VACCINATION	vacci_covid19_date1	date_dmy	Date of first COVID-19 vaccine		date_dmy		today		[vacci_covid19] = ‘1’		This refers to the date on which the first dose of COVID-19 vaccine was received in the format DD/MM/YYYY. If precise date unknown, estimate.	Enter the date of first COVID-19 vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1
presentation	VACCINATION	vacci_covid19_type1	radio	Type of first COVID-19 vaccine	1, Pfizer/BioNTech | 2, AstraZeneca/University of Oxford (Covishield in India) | 3, Moderna | 4, Novavax |5, Janssen (Johnson & Johnson) | 6, Sinopharm | 7, Sinovac | 8, Sputnik V | 9, Covaxin | 10, CanSinoBIO | 99, Unknown | 0, Other, please specify					[vacci_covid19] = ‘1’		Refers to the type of the first COVID-19 vaccine the patient received.	Select the type of first COVID-19 vaccine.						1
presentation	VACCINATION	vacci_covid19_type1_oth	text	Specify other type of COVID-19 vaccine						[vacci_covid19_type1] = ‘0’		Refers to the type of the first COVID-19 vaccine the patient received.	If ‘Other’, specify the type of COVID-19 vaccine.						1
presentation	VACCINATION	vacci_covid19_date2	date_dmy	Date of second COVID-19 vaccine		date_dmy		today		[vacci_covid19] = ‘1’		This refers to the date on which the second dose of COVID-19 vaccine was received in the format DD/MM/YYYY. If precise date unknown, estimate.	Enter the date of second COVID-19 vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1
presentation	VACCINATION	vacci_covid19_type2	radio	Type of second COVID-19 vaccine	1, Pfizer/BioNTech | 2, AstraZeneca/University of Oxford (Covishield in India) | 3, Moderna | 4, Novavax |5, Janssen (Johnson & Johnson) | 6, Sinopharm | 7, Sinovac | 8, Sputnik V | 9, Covaxin | 10, CanSinoBIO | 99, Unknown | 0, Other, please specify					[vacci_covid19] = ‘1’		Refers to the type of the second COVID-19 vaccine the patient received.	Select the type of second COVID-19 vaccine.						1
presentation	VACCINATION	vacci_covid19_type2_oth	text	Specify other type of COVID-19 vaccine						[vacci_covid19_type2] = ‘0’		Refers to the type of the second COVID-19 vaccine the patient received.	If ‘Other’, specify the type of COVID-19 vaccine.						1
presentation	VACCINATION	vacci_covid19_date3	date_dmy	Date of third COVID-19 vaccine		date_dmy		today		[vacci_covid19] = ‘1’		This refers to the date on which the third dose of COVID-19 vaccine was received in the format DD/MM/YYYY. If precise date unknown, estimate.	Enter the date of third COVID-19 vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1
presentation	VACCINATION	vacci_covid19_type3	radio	Type of third COVID-19 vaccine	1, Pfizer/BioNTech | 2, AstraZeneca/University of Oxford (Covishield in India) | 3, Moderna | 4, Novavax |5, Janssen (Johnson & Johnson) | 6, Sinopharm | 7, Sinovac | 8, Sputnik V | 9, Covaxin | 10, CanSinoBIO | 99, Unknown | 0, Other, please specify					[vacci_covid19] = ‘1’		Refers to the type of the third COVID-19 vaccine the patient received.	Select the type of third COVID-19 vaccine.						1
presentation	VACCINATION	vacci_covid19_type3_oth	text	Specify other type of COVID-19 vaccine						[vacci_covid19_type3] = ‘0’		Refers to the type of the third COVID-19 vaccine the patient received.	If ‘Other’, specify the type of COVID-19 vaccine.						1
presentation	VACCINATION	vacci_covid19_lastdate	date_dmy	Date of most recent COVID-19 vaccine		date_dmy		today		[vacci_covid19] = ‘1’		This refers to the date on which the most recent COVID-19 vaccine was received in the format DD/MM/YYYY. If precise date unknown, estimate.	Enter the date of most recent COVID-19 vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)						1						1
presentation	VACCINATION	vacci_covid19_lasttype	radio	Type of most recent COVID-19 vaccine	1, Pfizer/BioNTech | 2, AstraZeneca/University of Oxford (Covishield in India) | 3, Moderna | 4, Novavax |5, Janssen (Johnson & Johnson) | 6, Sinopharm | 7, Sinovac | 8, Sputnik V | 9, Covaxin | 10, CanSinoBIO | 99, Unknown | 88, Other					[vacci_covid19] = ‘1’		Refers to the type of the most recent COVID-19 vaccine the patient received.	Select the type of most recent COVID-19 vaccine.						1						1
presentation	VACCINATION	vacci_covid19_lasttype_oth	text	Specify other type of COVID-19 vaccine						[vacci_covid19_lasttype] = ‘88’		Refers to the type of the most recent COVID-19 vaccine the patient received.	If ‘Other’, specify the type of COVID-19 vaccine.						1						1
presentation	VACCINATION	vacci_influenza	radio	Vaccinated for seasonal influenza (ever)	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting seasonal influenza.	Indicate ‘Yes’, if the patient has ever received a seasonal influenza vaccine.					risk_factor_comor	1	1					1								1
presentation	VACCINATION	vacci_influenza_date	date_dmy	Date of most recent seasonal influenza vaccine		date_dmy		today		[vacci_influenza] = ‘1’		This refers to the date of the most recent seasonal influenza vaccine	Enter the date of most recent seasonal influenza vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)					risk_factor_comor	1	1					1
presentation	VACCINATION	vacci_influenza_type	radio	Type of last influenza vaccine	1, Inactivated Influenza Vaccine (IIV) | 2, Live Attenuated Influenza Vaccine (LAIV) | 3, Recombinant Influenza Vaccine (RIV) | 4, Cell-Based Influenza Vaccine (ccIIV) | 5, Egg-Based Influenza Vaccine | 6, mRNA-Based Influenza Vaccines (Emerging Technology) | 99, Unknown | 88, Other					[vacci_influenza] = ‘1’		This refers to the type of the most recent seasonal influenza vaccine	Select the most appropriate option which represents the type of most recent seasonal influenza vaccine.												1
presentation	VACCINATION	vacci_influenza_type_oth	text	Specify type of Influenza vaccine						[vacci_influenza_type] = ‘88’		This refers to the type of the most recent seasonal influenza vaccine	If ‘Other’, specify the type of most recent seasonal infuenza vaccine.												1
presentation	VACCINATION	vacci_aviinflu	radio	Vaccinated for avian influenza	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting avian influenza.	Indicate ‘Yes’, if the patient has ever received an avian influenza vaccine.					risk_factor_comor	1	1					1
presentation	VACCINATION	vacci_aviinflu_date	date_dmy	Date of most recent avian influenza vaccine		date_dmy		today		[vacci_aviinflu] = ‘1’		This refers to the date of the most recent avian influenza vaccine	Enter the date of most recent avian influenza vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)					risk_factor_comor	1	1					1
presentation	VACCINATION	vacci_aviinflu_type	radio	Type of most recent avian influenza vaccine	1, Quadrivalent, recombinant | 2, Quadrivalent, adjuvanted inactivated | 3, Quadrivalent, high dose | 4, Quadrivalent, cell-based | 5, Influenza Tetra MYL | 6, Trivalent, recombinant | 7, Trivalent, high dose | 8, Trivalent, adjuvant inactivated | 9, Trivalent, intranasal | 10, H5N1 (Audenz, Aflunov) | 99, Unknown | 88, Other					[vacci_aviinflu] = ‘1’		This refers to the type of the most recent avian influenza vaccine	Select the most appropriate option which represents the type of most recent avian influenza vaccine.												1
presentation	VACCINATION	vacci_aviinflu_type_oth	text	Specify type of avian Influenza vaccine						[vacci_aviinflu_type]=’88’		This refers to the type of the most recent avian influenza vaccine	If ‘Other’, specify the type of most recent avian infuenza vaccine.												1
presentation	VACCINATION	vacci_rsv	radio	Vaccinated for Respiratory Syncytial Virus (RSV)	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting Respiratory Syncytial Virus.	Indicate ‘Yes’, if the patient has ever received a RSV vaccine.					risk_factor_comor	1	1					1
presentation	VACCINATION	vacci_rsv_date	date_dmy	Date of most recent Respiratory Syncytial Virus (RSV) vaccine		date_dmy		today		[vacci_rsv] = ‘1’		This refers to the date of the most recent avian influenza vaccine	Enter the date of most recent RSV vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)					risk_factor_comor	1	1					1
presentation	VACCINATION	vacci_rsv_type	radio	Type of most recent Respiratory Syncytial Virus (RSV) vaccine	1, Abrysvo (Pfizer) | 2, Arexvy (GlaxoSmithKline) | 3, mResvia (Moderna) | 99, Unknown | 88, Other					[vacci_rsv] = ‘1’		This refers to the type of the most recent Respiratory Syncytial Virus (RSV) influenza vaccine	Select the most appropriate option which represents the type of most recent Respiratory Syncytial Virus (RSV) influenza vaccine.												1
presentation	VACCINATION	vacci_rsv_type_oth	text	Specify type of Respiratory Syncytial Virus (RSV) vaccine						[vacci_rsv_type]=’88’		This refers to the type of the most recent Respiratory Syncytial Virus (RSV) influenza vaccine	If ‘Other’, specify the type of most recent Respiratory Syncytial Virus (RSV) infuenza vaccine.												1
presentation	VACCINATION	vacci_pneumococo	radio	Vaccinated for pneumococcal disease	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting Pneumococcus (Streptococcus pneumoniae).	Indicate ‘Yes’, if the patient has ever received a Pneumococcal vaccine.												1
presentation	VACCINATION	vacci_pneumococo_date	date_dmy	Date of most recent pneumococcal disease vaccine		date_dmy		today		[vacci_pneumococo]=’1’		This refers to the date of the most recent Pneumococcal vaccine	Enter the date of most recent pneumococcal vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)												1
presentation	VACCINATION	vacci_dengue	radio	Vaccinated for dengue	1, YES-once | 2, YES-twice | 3, YES-thrice | 0, No | 99, Unknown							This refers to whether the patient has ever received the dengue vaccine prior to this illness episode and the number of previous dengue vaccines received.	Select the most appropriate option that represents whether the patient has ever received the dengue vaccine prior to this illness episode and the number of previous dengue vaccines received.	SNOMED	827179001, Administration of vaccine product containing only Dengue virus antigen (procedure)	C5231315, Administration of dengue vaccine		risk_factor_comor			1					1
presentation	VACCINATION	vacci_dengue_date1	date_dmy	Date of first dengue vaccine		date_dmy		today		[vacci_dengue]=’1’ or [vacci_dengue]=’2’ or [vacci_dengue]=’3’		This refers to the date on which the first dose of dengue vaccine was received in the format DD/MM/YYYY. If precise date unknown, estimate.	Enter the date of first dengue vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)								1					1
presentation	VACCINATION	vacci_dengue_type1	radio	Type of first dengue vaccine	1, CYD-TVD (Dengvaxia) | 2, TAK-003 (QDENGA)					[vacci_dengue]=’1’ or [vacci_dengue]=’2’ or [vacci_dengue]=’3’		Refers to the type of the first dengue vaccine the patient received.	Select the most appropriate option that represents the type of the first dengue vaccine the patient received.			C5196214, Dengvaxia |					1					1
presentation	VACCINATION	vacci_dengue_date2	date_dmy	Date of second dengue vaccine		date_dmy		today		[vacci_dengue]=’2’ or [vacci_dengue]=’3’		This refers to the date on which the second dose of dengue vaccine was received in the format DD/MM/YYYY. If precise date unknown, estimate.	Enter the date of second dengue vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)								1					1
presentation	VACCINATION	vacci_dengue_type2	radio	Type of second dengue vaccine	1, CYD-TVD (Dengvaxia) | 2, TAK-003 (QDENGA)					[vacci_dengue]=’2’ or [vacci_dengue]=’3’		Refers to the type of the second dengue vaccine the patient received.	Select the most appropriate option that represents the type of the second dengue vaccine the patient received.			C5196214, Dengvaxia |					1					1
presentation	VACCINATION	vacci_dengue_date3	date_dmy	Date of third dengue vaccine		date_dmy		today		[vacci_dengue]=’3’		This refers to the date on which the third dose of dengue vaccine was received in the format DD/MM/YYYY. If precise date unknown, estimate.	Enter the date of third dengue vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)								1					1
presentation	VACCINATION	vacci_chick	radio	Vaccinated for chikungunya (ever)	1, Yes | 0, No | 99, Unknown																	1
presentation	VACCINATION	vacci_chick_type	radio	Type of CHIKV vaccine	1, IXCHIQ | 2, VIMKUNYA| 88, Other					[vacci_chick]=’1’												1
presentation	VACCINATION	vacci_chick_type_oth	text	Specify other Type of CHIKV vaccine						[vacci_chick_type]=’88’												1
presentation	VACCINATION	vacci_chick_date	date_dmy	Date of CHIKV vaccine		date_dmy				[vacci_chick]=’1’												1
presentation	VACCINATION	vacci_dengue_type3	radio	Type of third dengue vaccine	1, CYD-TVD (Dengvaxia) | 2, TAK-003 (QDENGA)					[vacci_dengue]=’3’		Refers to the type of the third dengue vaccine the patient received.	Select the most appropriate option that represents the type of the third dengue vaccine the patient received.			C5196214, Dengvaxia |					1					1
presentation	VACCINATION	vacci_spox80	radio	Received smallpox vaccine prior to 1980?	1, Yes | 0, No | 99, Unknown							This refers to receiving a smallpox vaccine prior to 1980 and thus unrelated to the current event.	Indicate ‘Yes’, if the patient recieved a smallpox vaccine prior to 1980.										1	1
presentation	VACCINATION	vacci_spox80_year	number	Year vaccinated (estimate if uncertain)		number		1980		[vacci_spox80]=’1’		This refers to receiving a smallpox vaccine prior to 1980 and thus unrelated to the current event.	Write the year in which the patient received the smallpox vaccine. Estimate if uncertain. Note it must not exceed 1980. Leave response empty if year is unknown.										1	1
presentation	VACCINATION	vacci_spox80_scar	radio	Is a smallpox vaccination scar visible (usually on the upper arm if present)?	1, Yes | 0, No | 99, Unknown					[vacci_spox80]=’1’		This refers to a scar at the site of smallpox vaccination (usually on the upper arm if present)) which is generally round, may have irregular edges and appear lower than the skin around it.	Indicate ‘Yes’, if the patient has a visible smallpox vaccine scar.										1	1
presentation	VACCINATION	vacci_mpox	radio	Received smallpox or mpox vaccination after 1980?	1, Yes | 0, No | 99, Unknown							This refers to any smallpox or mpox vaccination after 1980.	Indicate ‘Yes’, if the patient received the smallpox vaccination after 1980.	SNOMED	229881000001106, Smallpox vaccine (product) |	C0037355, smallpox vaccine | C5703650, Mpox Vaccine							1	1
presentation	VACCINATION	vacci_mpox_number	number	Number of mpox or smallpox vaccines received		number	1	4		[vacci_mpox]=’1’		This refers to the number of Mpox or smallpox vaccines received.	Write the number of Mpox or smallpox vaccines received.										1	1
presentation	VACCINATION	vacci_mpox_type	checkbox	Mpox or smallpox vaccine type	1, Imvanex/Imvamune/Jyneos (MVA-BN) | 2, ACAM2000 | 3, LC16m8 | 99, Unknown | 88, Other					[vacci_mpox]=’1’		This refers to the type of Mpox or smallpox vaccine.	Select the option(s) corresponding to the vaccine(s) received. If ‘Other’, Specify the other vaccine(s) below.										1	1
presentation	VACCINATION	vacci_mpox_type_oth	text	Name of other mpox or smallpox vaccine						[vacci_mpox_type(88)]=’1’		This refers to the type of Mpox or smallpox vaccine.	If ‘Other’, Write the name(s) of the other smallpox/mpox vaccine(s).										1	1
presentation	VACCINATION	vacci_mpox_date1	date_dmy	Date of first mpox or smallpox vaccine		date_dmy		today		[vacci_mpox_number] >= 1		This refers to the first mpox of smallpox vaccine.	Enter the date of first mpox or smallpox vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)										1	1
presentation	VACCINATION	vacci_mpox_route1	radio	Route of administration for first mpox or smallpox vaccine	1, Intramuscular | 2, Subcutaneous | 3, Intradermal | 99, Unknown | 88, Other					[vacci_mpox_number] >= 1
presentation	VACCINATION	vacci_mpox_route1_oth	text	Please specify other route						[vacci_mpox_route1] = ‘88’
presentation	VACCINATION	vacci_mpox_date2	date_dmy	Date of second mpox or smallpox vaccine		date_dmy		today		[vacci_mpox_number] >= 2		This refers to the second mpox of smallpox vaccine.	Enter the date of second mpox or smallpox vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)										1	1
presentation	VACCINATION	vacci_mpox_route2	radio	Route of administration for second mpox or smallpox vaccine	1, Intramuscular | 2, Subcutaneous | 3, Intradermal | 99, Unknown | 88, Other					[vacci_mpox_number] >= 2
presentation	VACCINATION	vacci_mpox_route2_oth	text	Please specify other route						[vacci_mpox_route2] = ‘88’
presentation	VACCINATION	vacci_mpox_date3	date_dmy	Date of third mpox or smallpox vaccine		date_dmy		today		[vacci_mpox_number] >= 3		This refers to the third mpox of smallpox vaccine.	Enter the date of third mpox or smallpox vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)										1	1
presentation	VACCINATION	vacci_mpox_route3	radio	Route of administration for third mpox or smallpox vaccine	1, Intramuscular | 2, Subcutaneous | 3, Intradermal | 99, Unknown | 88, Other					[vacci_mpox_number] >= 3
presentation	VACCINATION	vacci_mpox_route3_oth	text	Please specify other route						[vacci_mpox_route3] = ‘88’
presentation	VACCINATION	vacci_mpox_date4	date_dmy	Date of fourth mpox or smallpox vaccine		date_dmy		today		[vacci_mpox_number] >= 4		This refers to the fourth mpox of smallpox vaccine.	Enter the date of fourth mpox or smallpox vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)										1	1
presentation	VACCINATION	vacci_mpox_route4	radio	Route of administration for fourth mpox or smallpox vaccine	1, Intramuscular | 2, Subcutaneous | 3, Intradermal | 99, Unknown | 88, Other					[vacci_mpox_number] >= 4
presentation	VACCINATION	vacci_mpox_route4_oth	text	Please specify other route						[vacci_mpox_route4] = ‘88’
presentation	VACCINATION	vacci_yellowfever	radio	Vaccinated for yellow fever	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting Yellow Fever Virus.	Indicate ‘Yes’, if the patient has ever received a Yellow fever vaccine.																				1
presentation	VACCINATION	vacci_yellowfever_date	date_dmy	Most recent yellow fever vaccination date		date_dmy		today		[vacci_yellowfever]=’1’		This refers to the date of the most recent yellow fever vaccine	Enter the date of most recent yellow fever vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)
presentation	VACCINATION	vacci_hepatitisb	radio	Vaccinated for hepatitis B	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting Hepatitis B virus.	Indicate ‘Yes’, if the patient has ever received a hepatitis B vaccine.
presentation	VACCINATION	vacci_hepatitisb_date	date_dmy	Most recent hepatitis B vaccination date		date_dmy		today		[vacci_hepatitisb]=’1’		This refers to the date of the most recent Hepatitis B virus vaccine	Enter the date of most recent Hepatitis B vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)
presentation	VACCINATION	vacci_chickenpox	radio	Vaccinated for chickenpox (varicella)	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting varicella-zoster virus.	Indicate ‘Yes’, if the patient has ever received a Yellow Chickenpox vaccine.																				1
presentation	VACCINATION	vacci_chickenpox_date	date_dmy	Most recent chickenpox(varicella) vaccination date		date_dmy		today		[vacci_chickenpox]=’1’		This refers to the date of the most recent varicella-zoster virus vaccine	Enter the date of most recent chickenpox vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)
presentation	VACCINATION	vacci_polio	radio	Vaccinated for polio (oral)	1, Yes | 0, No | 99, Unknown																												1
presentation	VACCINATION	vacci_hib	radio	Vaccinated for Haemophilus influenzae type b (Hib)	1, Yes | 0, No | 99, Unknown																												1
presentation	VACCINATION	vacci_pcv	radio	Vaccinated for Pneumococcal Conjugate (PCV)	1, Yes | 0, No | 99, Unknown																												1
presentation	VACCINATION	vacci_mmr	radio	Vaccinated for Measles, Mumps, Rubella (MMR)	1, Yes | 0, No | 99, Unknown																												1
presentation	VACCINATION	vacci_je	radio	Vaccinated for Japanese Encephalitis	1, Yes | 0, No | 99, Unknown																												1
presentation	VACCINATION	vacci_marburg	radio	Vaccinated for Marburg virus disease	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting Marburg virus.	Indicate ‘Yes’, if the patient has ever received a Yellow Chickenpox vaccine.
presentation	VACCINATION	vacci_marburg_date	date_dmy	Most recent Marburg virus disease vaccination date		date_dmy		today		[vacci_marburg]=’1’		This refers to the date of the most recent Marburg virus vaccine	Enter the date of most recent chickenpox vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)
presentation	VACCINATION	vacci_ebola	radio	Vaccinated for Ebola virus disease	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting Ebola virus.	Indicate ‘Yes’, if the patient has ever received a Yellow Chickenpox vaccine.
presentation	VACCINATION	vacci_ebola_date	date_dmy	Most recent Ebola virus disease vaccination date		date_dmy		today		[vacci_ebola]=’1’		This refers to the date of the most recent Ebola virus vaccine	Enter the date of most recent chickenpox vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)
presentation	VACCINATION	vacci_lassa	radio	Vaccinated for Lassa fever disease	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting Lassa fever virus.	Indicate ‘Yes’, if the patient has ever received a Yellow Chickenpox vaccine.
presentation	VACCINATION	vacci_lassa_date	date_dmy	Most recent Lassa fever disease vaccination date		date_dmy		today		[vacci_lassa]=’1’		This refers to the date of the most recent Lassa fever virus vaccine	Enter the date of most recent chickenpox vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)
presentation	VACCINATION	vacci_crimean	radio	Vaccinated for Crimean-Congo haemorrhagic fever	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting Crimean-Congo haemorrhagic fever virus.	Indicate ‘Yes’, if the patient has ever received a Yellow Chickenpox vaccine.
presentation	VACCINATION	vacci_crimean_date	date_dmy	Most recent Crimean-Congo haemorrhagic feve vaccination date		date_dmy		today		[vacci_crimean]=’1’		This refers to the date of the most recent Crimean-Congo haemorrhagic fever virus vaccine	Enter the date of most recent chickenpox vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)
presentation	VACCINATION	vacci_vhf	radio	Vaccinated for Other viral haemorrhagic fever	1, Yes | 0, No | 99, Unknown							Ever received a vaccine targeting a Viral hemorragic fever virus( different from above).	Indicate ‘Yes’, if the patient has ever received a Yellow Chickenpox vaccine.
presentation	VACCINATION	vacci_vhf_spec	text	Specify Other viral haemorrhagic fever Vaccine						[vacci_vhf]=’1’		Specify the Viral hemorragic fever virus.	Indicate ‘Yes’, if the patient has ever received a Yellow Chickenpox vaccine.
presentation	VACCINATION	vacci_vhf_date	date_dmy	Most recent Other viral haemorrhagic fever vaccination date		date_dmy		today		[vacci_vhf]=’1’		This refers to the date of the most recent Viral hemorragic fever virus vaccine	Enter the date of most recent chickenpox vaccine. If the precise date is unknown, enter an estimate. (Use the format DD/MM/YYYY)
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_sys	descriptive	Systemic / general symptoms							Systemic/General	This refers to systemic / general / non-specific signs and symptoms	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.						1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_fever	radio	Fever	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to sensation of elevated body temperature without formal measurement, or a measured body temperature greater or equal to 38-degrees Celsius (38°C) or 100.4-Fahrenheit (100.4°F).	Indicate ‘Yes’, if the patient experienced this at any time during the date of assessment.	SNOMED	386661006, Fever	C0015967, Fever		clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_rigchill	radio	Chills or rigors	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Systemic/General	This refers to severe chills with violent shivering. A rigor is an episode of shaking or exaggerated shivering which can occur with a high fever.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	43724002, Chill (finding)_38880002 Rigor (finding)						1	1	1	1		1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_nightsweat	radio	Night sweats	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Systemic/General	This refers to perspiration experienced nocturnally that is unrelated to environmental temperature.	Indicate ‘Yes’, if the patient experienced this at any time during the date of assessment.		42984000, Night sweats (finding)									1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_coldsweat	radio	Cold sweats	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=28	Systemic/General	This refers to sweats accompanied by sensation of feeling cold, different from sweats caused by heat or exertion.	Indicate ‘Yes’, if the patient experienced this at any time during the date of assessment.		83547004, Cold sweat (finding)									1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_excesssweat	radio	Excessive sweating (hyperhidrosis)	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to excessive sweating that is not always related to fever, heat exposure or vigorous exercise.	Indicate ‘Yes’, if the patient experienced this at any time during the date of assessment.		312230002, Hyperhidrosis (disorder)									1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_restlessne	radio	Restlessness	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to a state of unease, characterised by an inability to rest or relax, diffuse motor activity with limited control, nonproductive or disorganized behaviour, and subjective distress.	Indicate ‘Yes’, if the patient experienced this at any time during the date of assessment.	SNOMED	162221009, Restlessness	C3887611, Restlessness		clinical_features			1					1				1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_fatigue	radio	Fatigue / malaise / lethargy	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Systemic/General	This refers to a constellation of non-specific sensations: the feeling of tiredness characterised by a lack of energy or motivation; general discomfort or uneasiness; disinterestedness, listlessness, and indifference, resulting in difficulty performing simple tasks or concentrating.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	84229001, Fatigue |367391008, Malaise |214264003, Lethargy	C0015672, Fatigue | C0231218, Malaise | C0023380 Lethargy		clinical_features	1	1	1	1	1	1	1	1				1			1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_weak	radio	Weakness	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to a decrease in muscle strength.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	13791008			clinical_features												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_weight	radio	Weight loss	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to reduction in total body weight (patient-reported or objectively measured) that has occurred since the onset of this illness and has been unintentional or not attributable to active dieting, exercise or dedicated medication based weight-loss interventions.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	448765001 Unintentional weight loss	C2363736 Unintentional Weight loss		clinical_features					1	1									1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_anosmia	radio	Loss of smell (anosmia)	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to patient reported and/or clinician-diagnosed inability of the patient to perceive odours	Indicate ‘Yes’, if the patient experienced this at any time during the date of assessment.	SNOMED	44169009, Loss of sense of smell	C0003126, Anosmia		clinical_features	1	1					1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_ageusia	radio	Loss of taste (ageusia)	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to patient reported and/or clinician-diagnosed loss of taste function of the tongue.	Indicate ‘Yes’, if the patient experienced this at any time during the date of assessment.	SNOMED	36955009, Loss of taste	C2364111, Ageusia		clinical_features	1	1					1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_dizzy	radio	Feeling dizzy / faint	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=1825	Systemic/General	This refers to the subjective feeling of light-headedness or dizziness which may precede an episode of syncope or a sensation of unsteadiness, spinning or rocking.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	248223005, Feeling faint	C0581879, Felt faint		clinical_features		1				1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_myalgia	radio	Muscle aches (myalgia)	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Systemic/General	This refers to pain localised to a muscle or group of muscles.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	68962001, Muscle pain	C0231528, Myalgia		clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_myalgia_scal	number	Myalgia intensity (Numeric Pain Rating Scale)		number	1	10		[adsym_myalgia]=’1’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia	radio	Joint pain (arthralgia)	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Systemic/General	This refers to a sensation of marked discomfort or pain localised to one or more joints, including small and big joints.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	57676002, Joint pain	C3805780, Arthralgia		clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_scal	number	Artralgia intensity (Numeric Pain Rating Scale)		number	1	10		[adsym_arthralgia]=’1’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_site	checkbox	Site where joint pain occurred	1, Shoulder | 2, Elbow | 3, Wrist | 4, Small joints of hand | 5, Knee | 6, Ankle |7, Small joints of foot | 88, Other					[adsym_arthralgia]=’1’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_site_shoulder	radio	How many shoulder joints are affected?	1, 1 | 2, 2 | 99, Unknown					[adsym_arthralgia_site(1)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_site_elbow	radio	How many elbow joints are affected?	1, 1 | 2, 2 | 99, Unknown					[adsym_arthralgia_site(2)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_site_wrist	radio	How many wrist joints are affected?	1, 1 | 2, 2 | 99, Unknown					[adsym_arthralgia_site(3)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_site_knee	radio	How many knee joints are affected?	1, 1 | 2, 2 | 99, Unknown					[adsym_arthralgia_site(5)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_site_ankle	radio	How many ankle joints are affected?	1, 1 | 2, 2 | 99, Unknown					[adsym_arthralgia_site(6)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_site_foot	number	How many small joints of the foot are affected?		number	1	14		[adsym_arthralgia_site(7)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_hand	checkbox	Small joints of hand	1, MCP (metacarpophalangeal) joint | 2, PIP (proximal interphalangeal) joint | 3, DIP (distal interphalangeal) joint | 99, Unknown					[adsym_arthralgia_site(4)]=’1’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_hand_num	number	How many small joints of hand affected?		number	1	20		([adsym_arthralgia_hand(1)]=’1’ OR [adsym_arthralgia_hand(2)]=’1’ OR [adsym_arthralgia_hand(3)]=’1’) AND [adsym_arthralgia_hand(99)]=’0’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_add	checkbox	Indicate other affected joints	1, TMJ | 2, Sternoclavicular (SC) | 3, Acromioclavicular (AC) | 4, Sacroiliac (SI) | 5, Hip | 6, Subtalar | 7, Thoracic spine | 8, Lumbar spine | 88, Other (specify)					[adsym_arthralgia_site(88)]=’1’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_arthralgia_add_oth	text	Specify other joint(s)						[adsym_arthralgia_add(88)]=’1’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell	radio	Joint swelling	1, Yes | 0, No | 99, Unknown						Systemic/General	Defined as the buildup of fluid in the soft tissue SURROUNDING the joint or in the joint itself	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	271771009, Joint swelling			clinical_features				1				1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell_site	checkbox	Site where joint swelling occurred	1, Shoulder | 2, Elbow | 3, Wrist | 4, Small joints of hand | 5, Knee | 6, Ankle |7, Small joints of foot | 88, Other					[adsym_jointswell]= ‘1’	Systemic/General,This refers to the location where joint swelling first occurred											1				1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell_site_shoulder	radio	How many shoulder joints are affected?	1, 1 | 2, 2 | 99, Unknown					[adsym_jointswell_site(1)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell_site_elbow	radio	How many elbow joints are affected?	1, 1 | 2, 2 | 99, Unknown					[adsym_jointswell_site(2)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell_site_wrist	radio	How many wrist joints are affected?	1, 1 | 2, 2 | 99, Unknown					[adsym_jointswell_site(3)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell_site_knee	radio	How many knee joints are affected?	1, 1 | 2, 2 | 99, Unknown					[adsym_jointswell_site(5)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell_site_ankle	radio	How many ankle joints are affected?	1, 1 | 2, 2 | 99, Unknown					[adsym_jointswell_site(6)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell_site_foot	number	How many small joints of the foot are affected?		number	1	14		[adsym_jointswell_site(7)]=’1’	Systemic/General											1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell_hand	checkbox	Small joints of hand	1, MCP (metacarpophalangeal) joint | 2, PIP (proximal interphalangeal) joint | 3, DIP (distal interphalangeal) joint | 99, Unknown					[adsym_jointswell_site(4)]=’1’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell_hand_num	number	How many small joints of hand affected?		number	1	20		([adsym_jointswell_hand(1)]=’1’ OR [adsym_jointswell_hand(2)]=’1’ OR [adsym_jointswell_hand(3)]=’1’) AND [adsym_jointswell_hand(99)]=’0’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell_add	checkbox	Indicate other affected joints	1, TMJ | 2, Sternoclavicular (SC) | 3, Acromioclavicular (AC) | 4, Sacroiliac (SI) | 5, Hip | 6, Subtalar | 7, Thoracic spine | 8, Lumbar spine | 88, Other (specify)					[adsym_jointswell_site(88)]=’1’												1				1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointswell_add_oth	text	Specify other joint(s)						[adsym_jointswell_add(88)]=’1’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointstiff	radio	Joint stiffness	1, Yes | 0, No | 99, Unknown																	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointstiff_scal	number	Stiffness NRS - Patient-reported (0-10)		number	0	10		[adsym_jointstiff]=’1’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointstiff_dur	number	Morning stiffness duration (min)		number	0			[adsym_jointstiff]=’1’												1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointtender	radio	Joint tenderness	1, Yes | 0, No | 99, Unknown						Systemic/General	Defined as pain and discomfort in a joint, often accompanied by sensitivity to touch	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	110288007, Tenderness of joint			clinical_features				1				1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointtender_site	checkbox	Site where joint tenderness occurred	1, Fingers | 2, Wrists | 3, Shoulders | 4, Elbow | 5, Hips | 8, Knees | 9, Ankles | 10, Toes | 99, Unknown | 88, Other					[adsym_jointtender]= ‘1’	Systemic/General	This refers to the location where joint tenderness first occurred						clinical_features								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_jointtender_site_oth	text	Specify other first joint tenderness location						[adsym_jointtender_site(88)]=’1’	Systemic/General	This refers to the location where joint tenderness first occurred						clinical_features								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_stissueswell	radio	Small tissue swelling	1, Yes | 0, No | 99, Unknown						Systemic/General	Defined as painful swelling of the interphalangeal tissue, leading to tension and pain when flexing the fingers	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	298349001, Soft tissue swelling			clinical_features								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_backpain	radio	Back Pain	1, Yes | 0, No | 99, Unknown						Systemic/General
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_neckpain	radio	Neck Pain	1, Yes | 0, No | 99, Unknown						Systemic/General																						1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_skinrash	radio	Skin rash	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body or affect all the skin. Rashes may cause the skin to change colour, itch, become warm, bumpy, dry, cracked, or blistered, swell and may be painful.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	271807003, Eruption of skin	C4227880, Skin Rash		clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_skinrash_site	checkbox	Site where rash first occurred	1, Skin, genital | 2, Skin, non-genital | 3, Mucosa, genital | 4, Mucosa, non-genital | 5, Mouth | 6, Perianal skin | 7, Rectum | 99, Unknown| 88, Other					[adsym_skinrash]=’1’	Systemic/General	This refers to the location where the rash first occurred.	Select the most appropriate option(s) corresponding to the location where the rash first occurred.									1	1	1		1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_skinrash_site_oth	text	Specify other first rash location						[adsym_skinrash_site(88)]=’1’	Systemic/General	This refers to the location where the rash first occurred.	If “other’, Specify the first location the rash developed.										1	1		1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_skinrash_date	date_dmy	Date first rash was observed by patient		date_dmy		today		[adsym_skinrash]=’1’	Systemic/General	This refers to the date the patient reports to have first identified the rash.	Enter the date the patient reports to have first identified the rash. (Use the format DD/MM/YYYY)			A27176536, Date of rash onset							1	1		1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_paresthesia	radio	Skin paresthesia	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Systemic/General	This refers to percieved cutaneous sensations (e.g., cold, warmth, tingling, pressure, etc.) that are experienced spontaneously in the absence of stimulation.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.		91019004, Paresthesia (finding)									1		1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_skinchange	radio	Changes in skin texture	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to alterations in the surface appearance and feel of the skin, such as roughness, unevenness, or the presence of bumps.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.		274672009, Changes in skin texture (finding)	C0159040, Changes in skin texture								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_skinpallor	radio	Skin pallor	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to unnatural pale appearance of the skin.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.		1209208002, Pallor of skin or face	C0241137, Pallor of skin								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_pruritus	radio	Itch (pruritus)	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=183	Systemic/General	Defined as an unpleasant or intense itching sensation that produces the urge to rub or scratch the skin to obtain relief. Itching is an irritating sensation that makes you want to scratch your skin.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	418363000, Itching of skin	C0033774, Pruritus		clinical_features		1			1	1	1								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_mobilchg	radio	Change in mobility from baseline	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to the patient’s ability to walk or mobilise.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features	1	1			1	1	1								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_mobile	radio	Mobility status	1, Fully ambulant | 2, Ambulant, but with some assistance | 3, Bedridden					[demog_calcage_days]>=1825	Systemic/General	This refers to the patient’s ability to walk or mobilise.	Indicate the patient’s mobility status at the time of presentation.	SNOMED	160680006, Fully mobile | 427512004, Dependent for walking | 160685001, Bed-ridden	C0231435, Mobile | CL573260, Walks with assistance | C0425251, Bed-ridden		clinical_features	1	1			1	1	1								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_sleepmore	radio	Sleeping more than usual / lethargic / sluggish / listlessness	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to excessive sleepiness during the daytime / marked by drowsiness and an unusual lack of energy and mental alertness / infant having little energy, is drowsy, or sleeps more than usual	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	214264003, Lethargy (finding)	C0023380, Lethargy								1									1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_polydipsia	radio	Increased thirst (polydipsia)	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Systemic/General	This refers to excessive thirst	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	82800008, Primary polydipsia	C0085602, Polydipsia								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_irregmenstruation	radio	Changes in menstruation / Irregular menstruation	1, Yes | 0, No | 99, Unknown					[demog_sex]=’2’ and [demog_calcage_days]>=2920	Systemic/General	This refers to any deviations from the normal process; e.g. delayed, difficult, profuse, scanty, unusual bleeding, etc.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.		80182007, Irregular periods	C0156404, Irregular menstruation								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_resp	descriptive	Respiratory symptoms							Respiratory	This refers to signs and symptoms relating to the respiratory system.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.						1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_cough	radio	Cough	1, Yes | 0, No | 99, Unknown						Respiratory	This refers to the presence of a cough and its characteristics. A productive cough refers to a cough accompanied by expectorated secretions (phlegm or mucus), while a non-productive cough refers to one which is not accompanied by expectorated secretions. Haemoptysis refers to the presence of blood or blood-streaked sputum from the respiratory tract.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	49727002, Cough (finding)	C0010200, Coughing		clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_cough_type	radio	Cough type	1, Non Productive | 2, Productive |3, Haemoptysis |99, Unknown					[adsym_cough] = ‘1’	Respiratory	This refers to the type of cough. A productive cough refers to a cough accompanied by expectorated secretions (phlegm or mucus)	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	28743005 Productive Cough	C0451597 Productive Cough		clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_sorethroat	radio	Sore throat	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Respiratory	Defined as an unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) and perceived to originate in the throat.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	267102003, Sore throat	C3854544, Sore throat		clinical_features	1	1		1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_rhinorrhoe	radio	Runny nose (rhinorrhoea)	1, Yes | 0, No | 99, Unknown						Respiratory	Defined as increased mucosal discharge of the nose.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	64531003, Nasal Discharge	C1260880, Rhinorrhea		clinical_features	1	1				1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_wheezing	radio	Wheezing	1, Yes | 0, No | 99, Unknown						Respiratory	Defined as a high-pitched breath sound resulting from a narrowing or obstruction of the small airway.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	56018004, Wheezing	C0043144, Wheezing		clinical_features	1	1				1	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_shortbreat	radio	Shortness of breath	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Respiratory	Defined as the uncomfortable sensation of difficult or laboured breathing that is out of proportion to the patient’s level of physical activity.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	267036007, Dyspn	C4230442, Dyspnea		clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_nasalcongestion	radio	Nasal congestion	1, Yes | 0, No | 99, Unknown						Respiratory	Defined as reduced ability to pass air through the nasal cavity often leading to mouth breathing.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.		68235000, Nasal congestion	C0027424, Nasal congestion		clinical_features				1		1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_chestpain	radio	Chest pain	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Respiratory	Defined as the unpleasant, uncomfortable or painful sensation characterised by physical discomfort localised to the chest.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	29857009, Chest pain	C0008031, Chest pain		clinical_features	1	1		1	1	1	1								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_sneez	radio	Sneezing	1, Yes | 0, No | 99, Unknown						Respiratory	This refers to a sudden violent, spasmodic, audible expiration of breath through the nose and mouth.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	76067001, Sneezing	C0037383, Sneezing								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_hiccups	radio	Hiccups	1, Yes | 0, No | 99, Unknown						Respiratory
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_cvs	descriptive	Cardiovascular symptoms							Cardiovascular	This refers to signs and symptoms relating to the cardiovascular system.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features		1				1	1								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_palpitations	radio	Palpitations	1, Yes | 0, No | 99, Unknown						Cardiovascular	Refers to the unpleasant awareness of one’s own heartbeat.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	80313002, Palpitations (finding)			clinical_features		1				1	1								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_git	descriptive	Gastrointestinal symptoms							Gastrointestinal	This refers to signs and symptoms relating to the gastrointestinal system.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_abdpain	radio	Abdominal pain	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Gastrointestinal	Defined as an unpleasant sensation of discomfort, distress or agony in the abdominal region.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	21522001, Abdominal pain	C3553274, Abdominal pain		clinical_features	1	1	1	1	1	1	1	1				1			1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_diarrhoea	radio	Diarrhoea	1, Yes | 0, No | 99, Unknown						Gastrointestinal	Defined as abnormally increased frequency (usually defined as three or more) loose or liquid bowel movement per day (or more frequent passage than is normal for the individual).	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	62315008, Diarrhea	C3554472, Diarrhea		clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_consti	radio	Constipation	1, Yes | 0, No | 99, Unknown						Gastrointestinal	Defined as irregular and infrequent or difficult evacuation of the bowels.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	14760008, Constipation	C3551741, Constipation		clinical_features					1	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_vomit	radio	Vomiting	1, Yes | 0, No | 99, Unknown						Gastrointestinal	Defined as the expulsion of the stomach or small intestines through the mouth.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	422400008, Vomiting	C4230730, Vomiting		clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_vomit2d	radio	Persistent vomiting? (>=2/day)	1, Yes | 0, No | 99, Unknown					[adsym_vomit]=’1’	Gastrointestinal	This refers to persistent vomiting, defined here as vomiting two times or more per day.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	196746003, Persistent vomiting	C0152165, Persistent vomiting		clinical_features	1	1	1		1	1	1	1				1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_vomitbld	radio	Vomiting blood (haematemesis)	1, Yes | 0, No | 99, Unknown					[adsym_vomit]=’1’	Gastrointestinal	This refers to vomiting of blood.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	8765009, Haematemesis	C0018926, Haematemesis		clinical_features						1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_nausea	radio	Nausea	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=1095	Gastrointestinal	Defined as the the unpleasant painless subjective feeling that one will imminently vomit.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	422587007, Nausea	C3554470, Nausea		clinical_features	1	1			1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_anorexia	radio	Anorexia	1, Yes | 0, No | 99, Unknown						Gastrointestinal	Defined as lack or loss of appetite.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	79890006, Loss of appetite	C3554473, Anorexia		clinical_features	1	1	1			1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_exsal	radio	Excessive salivation	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=1460	Gastrointestinal	Defined as excessive salivation or sialorrhea, is a symptom best assessed by the patient.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	53827007 | Excessive salivation (disorder) |	C0037036, Sialorrhea		clinical_features					1	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_diffswallow	radio	Difficulty swallowing (dysphagia)	1, Yes | 0, No | 99, Unknown						Gastrointestinal	Defined as difficulty swallowing food, liquids, or saliva.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	40739000, Dysphagia (disorder)	C0011168, Deglutition Disorders		clinical_features					1	1									1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_faecalincont	radio	Faecal incontinence	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=1825	Gastrointestinal	Defined as failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	72042002, Incontinence of feces (finding)	C0015732, Fecal Incontinence		clinical_features						1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_renalgut	descriptive	Renal / Genitourinary symptoms							Genitourinary	This refers to signs and symptoms relating to the renal / genitourinary system.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features					1	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_urine	radio	Urinary retention	1, Yes | 0, No | 99, Unknown						Genitourinary	Defined as the accumulation of urine within the bladder because of the inability to urinate.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	267064002, Retention of urine	C0080274, Urinary retention		clinical_features					1	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_urineincont	radio	Urinary incontinence	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=1825	Genitourinary	This refers to loss of bladder control, or being unable to control urination.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	165232002, Urinary incontinence (finding)	C0042024, Urinary Incontinence		clinical_features						1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_polyuria	radio	Increased urination (polyuria)	1, Yes | 0, No | 99, Unknown						Genitourinary	This refers to excessive or frequent urination.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	28442001, Polyuria	C0032617, Polyuria		clinical_features						1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_dysuria	radio	Pain during urination (dysuria)	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Genitourinary	This refers to painful or difficult urination.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	49650001, Dysuria	C0013428, Dysuria		clinical_features						1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_dyspareunia	radio	Painful intercourse (dyspareunia)	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=5475	Genitourinary	Defined as recurrent or persistent genital pain associated with sexual intercourse.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	71315007, Dyspareunia (finding)	C1384606, Dyspareunia		clinical_features					1	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_heme	descriptive	Haematological symptoms							Haematology	This refers to signs and symptoms relating to the haematological system.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features	1	1	1		1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_haemorrhag	radio	Bleeding (haemorrhage)	1, Yes | 0, No | 99, Unknown						Haematology	Defined as the presence of blood in a location in which it is not physiologically normal or loss of blood from the circulation, either internally or externally. This can include epistaxis (blood from nose), gingival bleeding (blood from gums/gingiva), blood from any part of the gastrointestinal tract (gastrointestinal bleeding) or genitourinary tracts (vagina or urethra) including hematuria.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	131148009, Bleeding	C3163616, Blood loss		clinical_features	1	1	1	1	1	1	1	1				1			1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_haemorrhag_sev	radio	Severe bleeding (requires intervention)	1, Yes | 0, No | 99, Unknown					[adsym_haemorrhag] = ‘1’	Haematology	Defined as the severe bleeding / hemorrhage requiring medical intervention for hemostasis and/or hemodynamic support.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features	1	1	1		1	1	1	1				1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_haemorrhag_site	multi_list	Specify bleeding site(s)					conditions_Site	[adsym_haemorrhag] = ‘1’	Haematology	This refers to the location of bleeding/haemorrhage site(s).	Select the most appropriate option(s) corresponding to the location of bleeding/haemorrhage site(s).	SNOMED	297968009, Bleeding skin | 271813007 Petechiae | 249366005, Bleeding from nose | 86276007, Bleeding gums | 74474003, Gastrointestinal haemorrhage |34436003, blood in urine | 289530006, Bleeding from vagina	C0574741, Bleeding skin | C3808808, Epistaxis | C0017565, Gingival haemorrrhage | C0017181, Gastrointestinal haemorrhage |C3805433, haematuria | C0566961, Fresh bleeding from vagina		clinical_features	1	1	1	1	1	1	1	1				1			1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_haemorrhag_site_oth	text	Specify other bleeding / haemorrhage site(s)						[adsym_haemorrhag_site(88)]=’1’	Haematology	This refers to the location of bleeding/haemorrhage site(s). Petechiae refer to small reddish or purplish spots in skin or mucous membrane as a result of localised haemorrhage. Nose bleeding refers to haemorrhage localized in the nose. Gum bleeding refers to haemorrhage affecting the gingiva. Gastrointestinal (GI) bleeding refers to haemorrhage in any segment of the gastrointestinal tract from oesophagus to rectum. Urinary tract bleeding refers to haemorrhage originating from any part of the urinary system. Vaginal bleeding refers to haemorrhage originating from vagina, unrelated to normal menstruation.	Enter the other site	SNOMED	297968009, Bleeding skin | 271813007 Petechiae | 249366005, Bleeding from nose | 86276007, Bleeding gums | 74474003, Gastrointestinal haemorrhage |34436003, blood in urine | 289530006, Bleeding from vagina			clinical_features	1	1	1	1	1	1	1	1				1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_cns	descriptive	Neurological symptoms							Nervous system	This refers to signs and symptoms relating to the neurological system.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.						1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_headache	radio	Headache	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Nervous system	Defined as the experience of pain in various parts of the head.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	25064002, Headache	C0018681, Headache		clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_photoph	radio	Photophobia	1, Yes | 0, No | 99, Unknown						Nervous system	Refers to increased sensitivity of the eyes to light.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	409668002 | Photophobia (finding) |	C3807325, Photophobia		clinical_features				1		1		1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_seizconv	radio	Seizures / convulsions	1, Yes | 0, No | 99, Unknown						Nervous system	Defined as an intermittent abnormality of nervous system physiology characterised by a transient occurrence of sudden, violent, irregular movement of the body, caused by involuntary contraction of muscles due to abnormal excessive or synchronous neuronal activity in the brain.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	91175000, Seizure	C2748942, Seizure		clinical_features	1	1	1	1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_confusion	radio	Altered consciousness / confusion	1, Yes | 0, No | 99, Unknown						Nervous system	Defined as a level of awareness or arousal other than the patient’s normal baseline.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	443371007, Decreased level of consciousness	C0150450, Altered level of consciousness		clinical_features	1	1		1	1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_paralysis	radio	Paralysis	1, Yes | 0, No | 99, Unknown						Nervous system	This refers to inability to fully move or control movement	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	44695005, Paralysis (finding)	C0522224, Paralysed		clinical_features						1		1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_irritable	radio	Irritability	1, Yes | 0, No | 99, Unknown						Nervous system	Refers to an abnormal or excessive excitability with easily triggered anger, annoyance, or impatience.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	55929007, Feeling irritable (finding)	C0022107, Irritable Mood		clinical_features						1		1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_tremor	radio	Tremor	1, Yes | 0, No | 99, Unknown						Nervous system	Refers to an unintentional, oscillating to-and-fro muscle movement about a joint axis.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	26079004 | Tremor (finding) |	C0040822, Tremor		clinical_features						1		1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_diffwalk	radio	Difficulty in walking	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=292	Nervous system	This refers to any persistent problem with walking.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	719232003, Difficulty walking (finding)	C0311394, Difficulty walking		clinical_features						1									1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_neurologic	radio	Other neurological symptoms	1, Yes | 0, No | 99, Unknown						Nervous system	This refers the presence of an alternative neurological abnormality not listed above.	Indicate ‘Yes’, if the patient has another neurological abnormality not listed above.					clinical_features				1				1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_neurologic_spec	text	Specify other neurological symptoms						[adsym_neurologic] = ‘1’	Nervous system	This refers the presence of another neurological abnormality not listed above.	If ‘Other’, specify neurological abnormality.					clinical_features								1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_eye	descriptive	Ophthalmological symptoms							Ocular	This refers to signs and symptoms relating to the eye.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.							1			1	1	1	1							1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_itchyeye	radio	Itching of eye(s)	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]>=365	Ocular	Defined as itching of one or both eyes.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	74776002, Itching of eye (finding)	C0022281, Itching of eye		clinical_features		1			1	1	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_redeye	radio	Red / Pink eye(s)	1, Yes | 0, No | 99, Unknown						Ocular	Defined as inflammation or infection of the conjunctiva, characterized by redness in one or both eyes.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	703630003, Red eye	C0235267, Redness of eye		clinical_features		1		1	1	1	1								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_paineyes	radio	Pain in eye(s)	1, Yes | 0, No | 99, Unknown						Ocular	Defined as discomfort or aching localized within or around the eye area.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	41652007, Pain in eye	C0151827, Eye pain		clinical_features		1			1	1	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_eyelidedema	radio	Oedema of eyelid(s)	1, Yes | 0, No | 99, Unknown						Ocular	Defined as swelling due to fluid accumulation in the tissues of the eyelid.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	89091004, Oedema of eyelid	C0162285, Oedema of eyelid		clinical_features		1					1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_eyedischarg	radio	Discharge from eye(s)	1, Yes | 0, No | 99, Unknown						Ocular	Defined as the release of fluids ranging from clear to pus-like from the eye, often indicative of infection or irritation.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	246679005, Discharge from eye	C0423006, Discharge from eye		clinical_features		1				1	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_hazyvision	radio	Hazy / Blurred vision	1, Yes | 0, No | 99, Unknown						Ocular	Defined as a loss of visual acuity, resulting in unclear or distorted sight.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	246636008, Hazy vision	C0344232, Blurred vision		clinical_features		1				1	1	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_eyelightsensi	radio	Sensitivity of eye to light	1, Yes | 0, No | 99, Unknown						Ocular	Defined as an abnormal intolerance to light, causing discomfort or pain in the eyes when exposed to bright light.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	1285284009, Sensitivity of eye to light	C1698258, Sensitivity of eye to light		clinical_features		1					1	1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_visdist	radio	Visual disturbance	1, Yes | 0, No | 99, Unknown						Ocular	Refers to an interference to normal eyesight without necessarily affecting visual acuity.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	63102001, Visual distrubance	C0547030, Visual disturbance		clinical_features					1	1		1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_ocularoth	radio	Other opthalmological symptoms	1, Yes | 0, No | 99, Unknown						Ocular	This refers to other signs and symptoms relating to the eye, not specified above.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.										1	1		1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_ocularoth_spec	text	Specify other opthalmological symptoms							Ocular	This refers to other signs and symptoms relating to the eye, not specified above.	If ‘Yes’, specify other opthalmological signs and symptoms										1	1		1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_ent	descriptive	Ear/Nose/Throat symptoms							ENT	This refers to signs and symptoms relating to the ear, nose and throat.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features						1									1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_earpain	radio	Ear pain	1, Yes | 0, No | 99, Unknown						ENT	This refers to painful sensation in the ear	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	301354004, Pain of ear	C0013456, Earache		clinical_features						1									1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_tinnitus	radio	Tinnitus	1, Yes | 0, No | 99, Unknown						ENT	This refers to an abnormal perception of sounds experienced by an individual in the absence of auditory stimulation.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	60862001, Tinnitus (finding)	C0040264, Tinnitus		clinical_features						1									1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_parot	radio	Parotitis	1, Yes | 0, No | 99, Unknown						Respiratory	This refers to inflammation of the parotid glands.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	14756005, Parotitis (disorder)	C0030583, Parotitis		clinical_features
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_paed	descriptive	Paediatric-specific symptoms						[demog_calcage_days]<=365	Paediatric													1							1		1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_contcry	radio	Continuous crying	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]<=365	Paediatric													1							1		1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_feedingdiff	radio	Feeding difficulty	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]<=365	Paediatric													1							1		1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_otherdesc	descriptive	Other symptoms							Other								1	1	1		1	1	1								1
presentation	SYMPTOMS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsym_unlisted	list	Other symptom(s)	1, Yes | 0, No | 99, Unknown				conditions_Symptoms		Other	This refers to the presence of an alternative sign or abnormality not listed above.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features	1	1	1	1	1	1	1								1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_sys	descriptive	Systemic / general signs							Systemic/General	This refers to systemic / general / non-specific signs and symptoms	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.									1											1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_hypotherm	radio	Hypothermia	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to abnormally reduced body temperature due to failed thermoregulation.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	386689009, Hypothermia	C0020672, Hypothermia, natural		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_coldperiph	radio	Cold / clammy peripheries	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to skin that feels cool and moist to the touch, often associated with circulatory failure and symptoms like restlessness and hypotension.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	771542000, Cold extremity (finding)	C0277925, Cold extremities		clinical_features				1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_dehyrdation	radio	Dehydration	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to excessive loss of water from the body.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	34095006, Dehydration (disorder)	C0011175, Dehydration		clinical_features				1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_dehyrdation_type	radio	Dehydration Status	1, Mild | 2, Moderate| 3, Severe					[adsign_dehyrdation]=’1’	Systemic/General	This refers to excessive loss of water from the body.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	34095006, Dehydration (disorder)	C0011175, Dehydration		clinical_features				1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_oedema	radio	Oedema	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to accumulation of an excessive amount of fluid in cells or intercellular tissues.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	267038008, Oedema (finding)	C0013604, Oedema					1	1								1			1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_oedema_site	checkbox	Oedema site(s)	1, Feet | 2, Ankle | 3, Legs (below knee) | 4, Legs (above knees) | 5, Scrotum/Labia | 6, Sacrum | 7, Abdomen | 8, Neck | 9, Face | 99, Unknown | 88, Other					[adsign_oedema] = ‘1’	Systemic/General	This refers to the location of the odema.	If ‘Yes’, specify the location of the oedema. Select all that apply.									1											1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_oedema_site_oth	text	Specify other oedema site(s)						[adsign_oedema_site(88)] = ‘1’	Systemic/General	This refers to the location of the odema.	If ‘Other’, specify the site of oedema
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_lymph	radio	Lymphadenopathy	1, Yes-painful | 2, Yes-not painful | 0, No | 99, Unknown						Systemic/General	Defined as a clinical finding of abnormal enlargement of the lymph nodes.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	30746006, Lymphadenopathy	C4014613, Lymphadenopathy		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_lymph_site	checkbox	Specify lymphadenopathy site(s)	1, Axillary (arm pits) | 2, Cervical (neck)| 3, Inguinal (groin) | 99, Unknown | 88, Other					[adsign_lymph]=’1’ or [adsign_lymph]=’2’	Systemic/General	This refers to the location in which lymphadenopathy was identified.	Select the most appropriate option(s) corresponding to the location of lymphadenopathy.	SNOMED				clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_lymph_site_oth	text	Specify other lymphadenopathy site(s)						[adsign_lymph_site(88)]=’1’	Systemic/General	This refers to the location in which lymphadenopathy was identified.	If ‘Other’, write the location in which lymphadenopathy was identified.					clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_bruise	radio	Bruising	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to spontaneous extravasation of blood into the subcutaneous space, also referred to as spontaneous ecchymoses.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	125667009, Bruising	C0009938, Contusions		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_alopecia	radio	Alopecia	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to absence of hair (nonscarring hair loss) from areas where it is normally present.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	56317004, Alopecia	C0002170, Alopecia		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_dryskin	radio	Dry skin	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to skin characterized by the lack of natural or normal moisture resulting from inadequate hydrolipids in the skin, also called xerosis cutis.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	52475004, Xeroderma (disorder)	C0151908, Dry skin		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_oralulcer	radio	Oral ulcers	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to recurrent episodes of ulceration of the oral mucosa (recurrent oral aphthae), typically presenting as painful, sharply circumscribed fibrin-covered mucosal defects with a h	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	26284000, Ulcer of mouth	C0149745, Oral ulcer		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_mastitis	radio	Mastitis	1, Yes | 0, No | 99, Unknown						Breast	Defined as a inflammation of the breast, with or without accompanying infection	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	266579006, Inflammatory disorder of breast (disorder)	C0149613, Acute mastitis		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_bacsi	radio	Bacterial super-infection	1, Yes | 0, No | 99, Unknown						Systemic/General	Defined as a physician-diagnosed secondary bacterial infection that occurs during an existing wound, infection or immediately following an earlier infection.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED		C0442886, Secondary infections		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_bacsi_spec	checkbox	Specify bacterial super-infection.	7, Deep tissue abscess | 1, Folliculitis / cellulitis | 2, Pneumonia | 3, Gastroenteritis | 4, CNS | 5, Bacteraemia | 6, Urinary tract | 88, Other					[adsign_bacsi]=’1’	Systemic/General	This refers to the type or location of the bacterial super-infection.	Select the most appropriate option(s) represents the type or location of the bacterial super-infection.	SNOMED		C0037278, Skin Infection | C0339952, Secondary bacterial pneumonia | C0558348, Bacterial gastroenteritis | C0752180, Bacterial infection of central nervous system | C1096222, Urinary tract infection bacterial		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_bacsi_oth	text	Specify other bacterial super-infection						[adsign_bacsi_spec(88)]=’1’	Systemic/General	This refers to the other type(s) or location(s) of the bacterial super-infection, not specified above.	If ‘Other’, write the type or location of the bacterial super-infection.					clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_resp	descriptive	Respiratory signs							Respiratory	This refers to signs and symptoms relating to the respiratory system.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.									1											1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_respdistress	radio	Respiratory distress	1, Yes | 0, No | 99, Unknown						Respiratory	This refer to a pathological increase in the effort and frequency of breathing movements.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	271825005, Respiratory distress	C0476273, Respiratory distress		clinical_features				1											1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_chestindrw	radio	Lower chest wall indrawing	1, Yes | 0, No | 99, Unknown						Respiratory	Defined as a clinical sign of respiratory distress, distinguished by the abnormal inward movement of the lower chest wall during inspiration. If only the soft tissue between the ribs or above the clavicle goes in when the patient breathes, this is not lower chest wall in-drawing.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	67909005, Chest wall retraction (finding)	C0231906, Chest wall retraction		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_tachypnoea	radio	Fast breathing (tachypnoea)	1, Yes | 0, No | 99, Unknown						Respiratory	Defined as an abnormal increase of rate of breathing.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	271823003, Tachypnea (finding)	C0231835, Tachypnea		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_apnoea	radio	Apnoea	1, Yes | 0, No | 99, Unknown						Respiratory	Defined as a transient absence in spontaneous respiration.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	1023001, Apnea (finding)	C0003578, Apnea		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_rhinitis	radio	Rhinitis	1, Yes | 0, No | 99, Unknown						Respiratory	Defined as inflammation of the mucous membrane lining the nose, usually associated with nasal discharge.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	70076002, Rhinitis (disorder)	C0035455, Rhinitis		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_phary	radio	Pharyngitis	1, Yes | 0, No | 99, Unknown						Respiratory	This refers to the presence of inflammation of the throat..	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	405737000, Pharyngitis (disorder)	C0031350, Pharyngitis		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_pharery	radio	Pharyngeal erythema	1, Yes | 0, No | 99, Unknown						Respiratory		Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_pharexu	radio	Pharyngeal exudate	1, Yes | 0, No | 99, Unknown						Respiratory		Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_tonsil	radio	Tonsillitis	1, Yes | 0, No | 99, Unknown						Respiratory	This refers to the presence of inflammation of the tonsils.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	90176007, Tonsillitis (disorder)	C0040425, Tonsillitis		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_plueeff	radio	Pleural effusion	1, Yes | 0, No | 99, Unknown						Respiratory	This refers to presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	60046008, Pleural effusion (disorder)	C0032227, Pleural effusion (disorder)						1											1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_cvs	descriptive	Cardiovascular signs							Cardiovascular	This refers to signs and symptoms relating to the cardiovascular system.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features				1											1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_tachycardia	radio	Rapid heart rate (tachycardia)	1, Yes | 0, No | 99, Unknown						Cardiovascular	Refers to an abnormally rapid heart rate (typically > 100bpm for adults), that exceeds the range of the normal resting heart rate for age.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	3424008, Tachycardia (finding)	C0039231, Tachycardia		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_arrhythmia	radio	Cardiac arrhythmia	1, Yes | 0, No | 99, Unknown						Cardiovascular	Refers to an abnormality in rhythm of heartbeat, including rate, regularity, and/or sequence of activation abnormalities	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	698247007, Cardiac arrhythmia (disorder)	C0003811, Cardiac Arrhythmia		clinical_features				1											1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_cyan	radio	Peripheral cyanosis	1, Yes | 0, No | 99, Unknown						Cardiovascular											1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_git	descriptive	Gastrointestinal signs							Gastrointestinal	This refers to signs and symptoms relating to the gastrointestinal system.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.									1											1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_ascites	radio	Ascites	1, Yes | 0, No | 99, Unknown						Gastrointestinal	Defined as an excessive accumulation or retention of free fluid within the peritoneal cavity.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	389026000, Ascites (disorder)	C0003962, Ascites		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_hepatomegally	radio	Palpable liver/Hepatomegaly	1, Yes | 0, No | 99, Unknown						Gastrointestinal	Defined as an pathological enlargement of the liver	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	80515008, Large liver (disorder)	C0019209, Hepatomegaly		clinical_features			1									1			1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_splenomegaly	radio	Palpable spleen/splenomegaly	1, Yes | 0, No | 99, Unknown						Gastrointestinal		Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features												1			1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_tenabd	radio	Tender abdomen	1, Yes | 0, No | 99, Unknown						Gastrointestinal		Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_jaund	radio	Jaundice	1, Yes | 0, No | 99, Unknown						Gastrointestinal	Defined as a clinical manifestation of hyperbilirubinemia, characterized by the yellowish staining of the skin, mucous membrane and/or sclera.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	18165001, Jaundice	C3549846, Jaundice		clinical_features				1						1					1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_melaena	radio	Dark / tarry blood in faeces (melaena)	1, Yes | 0, No | 99, Unknown						Gastrointestinal	This refers to abnormally dark tarry feces containing blood, usually from gastrointestinal bleeding.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	2901004, Melena (disorder)	C0025222, Melena		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_haematochezia	radio	Fresh blood in stools (haematochezia)	1, Yes | 0, No | 99, Unknown						Gastrointestinal	This refers to the presence of blood in stool. It is the result of gastrointestinal hemorrhage and it may be easily seen in stool or may be identified microscopically.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	405729008, Hematochezia (finding)	C0018932, Hematochezia		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_rectalbleed	radio	Rectal bleeding	1, Yes | 0, No | 99, Unknown						Gastrointestinal	This refers to bleeding originating from the rectal wall and discharged from the anus.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	12063002, Rectal bleeding	C0267596, Rectal bleeding		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_lowurine	radio	Reduced urine output	1, Yes | 0, No | 99, Unknown						Genitourinary	This refers to a finding indicating that the urine production is less than 500 milliliters during a 24 hour period.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	167372005, 24 hour urine volume below reference range (finding)	C5933437, Reduced urine output		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_heme	descriptive	Haematological signs							Haematology	This refers to signs and symptoms relating to the haematological system.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.																				1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_anaemia	radio	Anaemia	1, Yes | 0, No | 99, Unknown						Haematology	This refers to a reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Common manifestations include pallor, fatigue, dizziness, shortness of breath, and tachycardia.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	271737000, Anaemia	C0002871, Anemia		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_cns	descriptive	Neurological signs							Nervous system	This refers to signs and symptoms relating to the neurological system.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.																				1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_neckstiff	radio	Neck stiffness	1, Yes | 0, No | 99, Unknown						Nervous system	Defined as a sensation of tightness in the neck when attempting to move it, especially after a period of inactivity. Neck stiffness often involves soreness and difficulty moving the neck, especially when trying to turn the head to the side.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	161882006, Stiff neck (finding)	C0151315, Neck Stiffness		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_hemiplegia	radio	Hemiplegia	1, Yes | 0, No | 99, Unknown						Nervous system	This refers to severe or complete loss of motor function on one side of the body; often caused by brain diseases that are localized to the cerebral hemisphere opposite to the side of weakness; less frequently, brain stem lesions; cervical spinal cord diseases, peripheral nervous system diseases, and other conditions may manifest as hemiplegia.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	50582007, Hemiplegia (disorder)	C0018991, Hemiplegia		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_cogimpair	radio	Cognitive impairment	1, Yes | 0, No | 99, Unknown						Nervous system	This refers to diminished or impaired mental and/or intellectual function.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	386806002, Impaired cognition (finding)	C0338656, Impaired cognition		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_neurodist	radio	Psychological disturbance	1, Yes | 0, No | 99, Unknown						Nervous system	This refers to the presence of signs or symptoms that affect an individual’s thoughts, emotions, behaviours or mental well-being. The presence of psychological disturbances should be identified through a Mental Status Examination (MSE) or equivalent tool.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.			C0233395, Psychological sign or symptom		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_speechdist	radio	Speech disturbance	1, Yes | 0, No | 99, Unknown						Nervous system	This refers to difficulties with speech and communication that may result from pathologies in the brain.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	29164008, Disturbance in speech (finding)	C0233715, Speech impairment		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_agitation	radio	Agitation	1, Yes | 0, No | 99, Unknown						Nervous system	This refers to a state of excessive motor activity that is associated with mental distress or a feeling of substantial unease or inner tension. Distinguished from restlessness by the increased level of emotional distress and negative intensity of the experience. Agitation has a significant level of physical activity that is typically threatening to the self or others.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	24199005, Feeling agitated (finding)	C0085631, Agitation		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_cerebesig	radio	Cerebellar signs	1, Yes | 0, No | 99, Unknown						Nervous system	Refers to the presence of a constellation of neurological signs typically indicate cerebellar dysfunction. Signs include dysdiadochokinesia, dysmetria, ataxia, nystagmus, intention tremor, slurred or scanning speech, hypotonia.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.			C3807868, Cerebellar signs		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_neurologic	radio	Other neurological abnormality	1, Yes | 0, No | 99, Unknown						Nervous system	This refers the presence of an alternative neurological abnormality not listed above.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_neurologic_spec	text	Specify other neurological abnormality						[adsign_neurologic] = ‘1’	Nervous system	This refers the presence of another neurological abnormality not listed above.	If ‘Other’, specify neurological abnormality.					clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_eye	descriptive	Opthalmological signs							Nervous system	This refers to signs and symptoms relating to the eye.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_retroorbit	radio	Retro-orbital pain	1, Yes | 0, No | 99, Unknown						Nervous system	Defined as the experience of pain in the retro-orbital region (behind the eyes).	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	MedDRA	10033381, Pain behind eyes	C0743724, Retro-orbital pain		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_conjunhemor	radio	Subconjunctival haemorrhage	1, Yes | 0, No | 99, Unknown						Ocular	Defined as the accumulation of blood underneath the conjunctiva, presenting as a bright red or dark patch in the eye.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	78768009, Subconjunctival hemorrhage (disorder)	C0038534, Subconjunctival hemorrhage		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_conjunctiv	radio	Conjunctivitis	1, Yes | 0, No | 99, Unknown						Ocular	Defined as inflammation of the conjunctiva	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	9826008, Conjunctivitis (disorder)	C4011653, Conjunctivitis		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_keratitis	radio	Keratitis	1, Yes | 0, No | 99, Unknown						Ocular	This refers to inflammation of the cornea of the eye.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	5888003, Keratitis (disorder)	C0022568, Keratitis (disorder)		clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_newvision	radio	Newly reduced visual acuity	1, Yes | 0, No | 99, Unknown						Ocular	Defined as decreased clarity or sharpness of vision.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	13164000, Reduced visual acuity (finding)	C0234632, Reduced visual acuity		clinical_features															1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_sunkeyes	radio	Sunken eyes	1, Yes | 0, No | 99, Unknown						Ocular		Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_ocularoth	radio	Other opthalmological signs	1, Yes | 0, No | 99, Unknown						Ocular	This refers to other signs and symptoms relating to the eye, not specified above.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.																				1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_ocularoth_spec	text	Specify other opthalmological signs							Ocular	This refers to other signs and symptoms relating to the eye, not specified above.	If ‘Yes’, specify other opthalmological signs and symptoms																		1		1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_paed	descriptive	Paediatric-specific signs						[demog_calcage_days]<=1825	Paediatric																				1		1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_nasalflar	radio	Nasal flaring	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]<=1825	Paediatric																				1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_grunt	radio	Grunting	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]<=1825	Paediatric																				1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_ftt	radio	Failure to thrive	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]<=28	Paediatric																				1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_hypotonia	radio	Decreased tone / hypotonia	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]<=28	Paediatric																				1		1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_bulgefont	radio	Bulging fontanelle	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]<=28	Paediatric																				1		1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_otherdesc	descriptive	Other signs							Other											1											1
presentation	SIGNS ON ADMISSION: Indicate if experienced at any time from onset of this illness to the day of presentation.	adsign_unlisted	list	Other sign(s)	1, Yes | 0, No | 99, Unknown				conditions_Symptoms		Other	This refers to other signs and symptoms, not specified above.	Indicate other signs and symptoms, not specified above, the patient has exeprienced at any time from onset of this illness to presentation.					clinical_features				1											1
presentation	PREGNANCY PRESENTATION	preg_pregnant	radio	Pregnant	1, Yes | 0, No | 99, Unknown					[demog_sex]=’2’ and [demog_calcage_days]>=4380		This refers to women who reports to be pregnant at presentation and/or have had a positive pregnancy test in recent days prior to presentation.	Indicate ‘Yes’, if the patient is pregnant at presentation. If the patient is of fertile age with no negative pregnancy test select ‘Unknown’.	SNOMED	77386006, Pregnant (finding)	C0549206, Pregnant		risk_factor_demo	1	1	1	1	1	1	1	1						1	1
presentation	PREGNANCY PRESENTATION	preg_postpartum	radio	Post-partum (within 6 weeks of delivery)	1, Yes | 0, No | 99, Unknown					[demog_sex]=’2’ and [preg_pregnant]=’0’ and [demog_calcage_days]>=4380		This refers to the temporal period relating to mother from completion of labour until six weeks post-delivery.	Indicate ‘Yes’, if the patient is in post-partum period (within 6 weeks of delivery).	SNOMED	86569001, Postpartum state (finding)	C0086839, Postpartum Period		risk_factor_demo	1	1	1	1	1	1	1	1						1	1
presentation	PREGNANCY PRESENTATION	preg_formdesc	descriptive	Please complete the Pregnancy Form with information from the most recent pregnancy.						[preg_postpartum]=1												1		1								1
presentation	PREGNANCY PRESENTATION	preg_geswek	number	Gestational weeks at presentation		number	0	45		[preg_pregnant] = ‘1’		This refers to the gestational age of the foetus (written in weeks). It can be calculated from the woman’s last menstrual period (LMP) or calculated using the best obstetrical estimated due date (EDD) based on the following formula: Gestational Age = (280 - (EDD - Reference Date)). The reference date is the date in which you are trying to determine the gestational age.	Indicate the estimated gestational age of the foetus (in weeks).	SNOMED	57036006 |Fetal gestational age (observable entity)|	CL1385889, Gestational weeks			1	1	1	1	1	1	1	1						1	1
presentation	PREGNANCY PRESENTATION	preg_recent1	radio	Was patient pregnant either within <=21 days of symptoms onset or within 22-42 days from admission	1, Yes | 0, No | 99, Unknown					[preg_postpartum] = ‘1’		If non-pregnant currently, this refers to whether the patient was pregnant within 21 days of onset of symptoms.	Indicate ‘Yes, if the patient was pregnant within 21 days of onset of symptoms.											1								1
presentation	PREGNANCY PRESENTATION	preg_delvdate	date_dmy	Delivery date		date_dmy				[preg_postpartum] = ‘1’		This refers to the actual date of delivery.	Enter the date of delivery in DD/MM/YYYY format.	SNOMED	386216000, Human parturition, function (observable entity)				1	1	1		1		1	1
presentation	PREGNANCY PRESENTATION	preg_bboutc	radio	Pregnancy outcome	1, Livebirth (even if infant died after birth) | 2, Miscarriage (<22 weeks) | 3, Termination by choice | 4, Termination - ultrasound abnormality | 5, Termination - other/unknown reason | 6, Stillbirth (intra-uterine / intrapartum death from 22 gest weeks) | 7, Ectopic pregnancy | 99, Unknown					[preg_postpartum] = ‘1’		This refers to the outcome of previous conception and ensuing pregnancy.	Indicate the outcome of the previous pregnancy.	SNOMED	1, 281050002 Livebirth (finding)| 2, 237364002 Stillbirth (finding) | 4, 17369002 Miscarriage (disorder) | 3, 386639001 Termination of pregnancy (procedure) |	C0032972, Pregnancy Outcome | 1, C0419373 Livebirth | 2, C0595939 Stillbirth | 4, C4552766 Miscarriage | 3, C0392535 Termination of pregnancy			1	1	1		1		1	1							1
presentation	PREGNANCY PRESENTATION	preg_brefed	radio	Breastfeeding	1, Yes-currently breastfeeding | 2, Yes-breastfeeding discontinued | 0, No | 99, Unknown					[preg_postpartum] = ‘1’		Provision of human breast milk to the infant, either directly at the breast or expressed, regardless of exclusivity.												1							1	1
presentation	PREGNANCY PRESENTATION	preg_brefedduration	number	How long did breastfeeding last? (weeks)		number	0			[preg_postpartum] = ‘1’		Total duration from initiation of breastfeeding to complete cessation, recorded in completed weeks.												1							1	1
presentation	PREGNANCY PRESENTATION	pregdet_labour	radio	Is the patient in labour at presentation?	1, Yes | 0, No | 99, Unknown					[preg_pregnant] = ‘1’												1		1								1
presentation	PREGNANCY PRESENTATION	preg_bbtest	radio	Baby tested for mother’s infection of interest	1, Yes | 0, No | 99, Unknown					[preg_postpartum] = ‘1’		This refers to testing the baby for the mother’s infection of interest.	Indicate ‘Yes’ if the baby was tested for the mother’s infection of interest.						1	1	1		1		1	1
presentation	PREGNANCY PRESENTATION	preg_bbresl	radio	If yes: specify test result from mother’s infection of interest	1, Positive | 0, Negative | 99, Unknown					[preg_bbtest] = ‘1’		This refers to the result of testing the baby for the mother’s infection of interest.	Indicate the test result.						1	1	1		1		1	1
presentation	INFANT: LESS THAN 12 MONTHS OLD	infa_neonate	descriptive	The patient is a neonate. Please do not forget to complete the neonate-specific form.						[demog_calcage_days]<=28														1							1
presentation	INFANT: LESS THAN 12 MONTHS OLD	infa_brtwei	number	Birth weight		number	0			[demog_calcage_days]<=365		This refers to the first weight of a newborn obtained after birth.	Indicate the birth weight.	SNOMED	47340003, Birth weight (finding)	C0005612, Birth weight			1	1			1	1	1						1		1
presentation	INFANT: LESS THAN 12 MONTHS OLD	infa_brtwei_units	radio	Birth weight (select units)	1, g | 2, lb	units				[demog_calcage_days]<=365				SNOMED	47340003, Birth weight (finding)	C0005612, Birth weight			1	1			1	1	1						1		1
presentation	INFANT: LESS THAN 12 MONTHS OLD	infa_brtwei_g	number	Birth weight (g)		number	0			[demog_calcage_days]<=365		This refers to the first weight of a newborn obtained after birth.	Indicate the birth weight in kilograms (kg).	SNOMED	364589006, Birth weight (observable entity)				1	1			1	1	1						1
presentation	INFANT: LESS THAN 12 MONTHS OLD	infa_brtwei_lb	number	Birth weight (lb)		number	0			[demog_calcage_days]<=365		This refers to the first weight of a newborn obtained after birth.	Indicate the birth weight in pounds (lb).	SNOMED	364589006, Birth weight (observable entity)	C0005612, Birth weight			1	1			1	1	1						1
presentation	INFANT: LESS THAN 12 MONTHS OLD	infa_outcome	radio	Preterm birth (< 37wk GA)	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]<=365		This refers to the gestational age (GA) of the infant at delivery. Pre-term refers to an infant born before 37 weeks and 0 days gestational age.	Indicate ‘Term birth’ if gestational age (GA) at delivery >= 37 weeks and ‘Preterm birth’ if GA at delivery < 37 weeks.	SNOMED	1, 21243004 |Term birth of newborn (finding)| 2, 367494004 |Premature birth of newborn (finding)|	1, C0233324 Term birth| 2, C4011994 Preterm birth			1	1			1	1	1						1		1
presentation	INFANT: LESS THAN 12 MONTHS OLD	infa_brefed	radio	Breastfed	1, Yes-currently breastfeeding | 2, Yes-breastfeeding discontinued | 0, No | 99, Unknown					[demog_calcage_days]<=730		This refers to the current breastfeeding regimen for the infant.	Indicate the breastfeeding status of infant.	SNOMED	1, 1260078007 | Maternal breastfeeding (finding) | 2, 169746009 | Breastfeeding stopped (finding) |	C0006147, Breast feeding			1	1			1	1	1						1
presentation	INFANT: LESS THAN 12 MONTHS OLD	infa_brefedduration	number	How long did breastfeeding last? (weeks)		number	0	260		[infa_brefed] = ‘2’		This refers to the duration of breastfeeding, in weeks, if breastfeeding was discontinued.	Indicate the duration of breastfeeding, in weeks, if breastfeeding was discontinued.	SNOMED	1, 1260078007 | Maternal breastfeeding (finding) | 2, 169746009 | Breastfeeding stopped (finding) |	C0006147, Breast feeding								1							1
presentation	INFANT: LESS THAN 12 MONTHS OLD	infa_aprvac	radio	Vaccinations appropriate for age/country	1, Yes | 0, No | 99, Unknown					[demog_calcage_days]<=730		This refers to the vaccination status according to the age of the infant and country-specific recommendations.	Indicate ‘Yes’, if the infant is appropriately vaccinated for age with respect to country-specific recommendations.	SNOMED	713404003, Vaccination given (situation)	C0042196, Vaccination			1	1					1						1
daily	DAILY ASSESSMENT	daily_date	date_dmy	DATE OF ASSESSMENT		date_dmy		today				This indicates the day of data collection and sampling (may not be the date of completion). This may be retrospective information at the time of discharge (transfer to other hospital or dead in hospital).	Enter the date of assessment. (Use the format DD/MM/YYYY)						1	1	1	1	1	1	1	1							1
daily	DAILY ASSESSMENT	asses_lvlcare	radio	Current level of care	1, Outpatient | 2, Admitted to normal ward for isolation only | 3, Admitted to normal ward for clinical care | 4, High dependency | 5, Intensive care admission							Refers to the level of care on date of assessment.	Select the highest level of care on the date of assessment.	SNOMED	SNOMED	C4545175, Outpatient care management | C0583229, Admission to ward | C1301858, Admission to high dependency unit | C0583239, Admission to intensive care unit			1	1	1	1	1	1	1	1							1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_dailydata	radio	Enter Vital Signs data for this date?	1, Yes | 0, No							This refers to vital signs data recorded for this date.	Indicate ‘Yes’, if you want to record vital sign data for this day of assessment. If ‘Yes’, for the following questions unless otherwise specified, Record the value furthest from the normal physiological range recorded between 00:00 and 24:00 hours on day of assessment. Results that were rejected by the clinical team should not be included.	SNOMED	SNOMED	C0150404, Taking vital signs			1	1	1	1	1	1	1	1							1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_highesttem	number	Highest temperature		number	32	106.7		[vital_dailydata]=’1’		Refers to the highest peripheral body temperature (rectal if <3 months) between 00:00 and 24:00 on day of assessment.	Enter the highest peripheral body temperature recorded between 00:00 and 24:00 on day of assessment.					clinical_features	1	1	1	1	1	1	1	1							1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_highesttem_units	radio	Highest temperature (select units)	1, °C | 2, °F	units				[vital_dailydata]=’1’								clinical_features	1	1	1	1	1	1	1								1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_highesttem_c	number	Highest temperature (°C)		number	32	41.5		[vital_dailydata]=’1’		Refers to the highest peripheral body temperature (rectal if <3 months) between 00:00 and 24:00 on day of assessment.	Enter the highest peripheral body temperature (°C) recorded between 00:00 and 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features	1	1	1		1	1	1	1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_highesttem_f	number	Highest temperature (°F)		number	89.5	106.7		[vital_dailydata]=’1’		Refers to the highest peripheral body temperature (rectal if <3 months) between 00:00 and 24:00 on day of assessment.	Enter the highest peripheral body temperature (°F) recorded between 00:00 and 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features	1	1	1		1	1	1	1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_hr	number	HR (bpm)		number	0	299		[vital_dailydata]=’1’		Refers to heart rate measured in beats per minute. This may be measured manually or by electronic monitoring.	Enter the heart rate measured in beats per minute. Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features	1	1	1	1	1	1	1	1				1			1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_rr	number	RR (breaths/min)		number	0	120		[vital_dailydata]=’1’		Refers to respiratory rate in breaths per minute. Manual rather than electronic measurement is preferred where possible (this is achieved by counting the number of breaths for one minute, counting how many times the chest rises within this time period). If both abnormal low and high rate observed, record the abnormally high rate.	Enter the respiratory rate measured in breaths per minute. Record the value furthest from normal range between 00:00 to 24:00 on day of assessment. If both abnormal low and high rate observed, record the abnormally high rate.	SNOMED	SNOMED			clinical_features	1	1	1	1	1	1	1	1							1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_systolicbp	number	Systolic BP (mmHg)		number	0	299		[vital_dailydata]=’1’		This refers to the systolic blood pressure from the observation with the lowest mean arterial pressure (if mean arterial pressure has not been calculated, report the measurement with lowest systolic blood pressure). For example, if the blood pressure is 120/85 mmHg, enter 120 in the section marked ‘systolic BP’.	Enter the systolic blood pressure measured in millimetres of mercury (mmHg). Record the systolic blood pressure from the observation with the lowest mean arterial pressure (MAP) (if mean arterial pressure has not been calculated, report the measurement with lowest systolic blood pressure) that occurred between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features	1	1	1	1	1	1	1	1			1	1			1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_diastolicbp	number	Diastolic BP (mmHg)		number	0	200		[vital_dailydata]=’1’		This refers to the diastolic blood pressure from the observation with the lowest mean arterial pressure (if mean arterial pressure has not been calculated, report the measurement with lowest systolic blood pressure). For example, if the blood pressure is 120/85 mmHg, enter 85 in the section marked ‘diastolic BP’.	Enter the diastolic blood pressure measured in millimetres of mercury (mmHg). Record the diastolic blood pressure from the observation with the lowest mean arterial pressure (MAP) (if mean arterial pressure has not been calculated, report the measurement with lowest systolic blood pressure) that occurred between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features	1	1	1	1	1	1	1	1			1	1			1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_meanbp	number	Mean arterial blood pressure (mmHg)		number	0	200		[vital_dailydata]=’1’		Mean arterial blood pressure (MAP) may be directly measured (via intra-arterial catheter) or be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure.	Enter the lowest recorded MAP that occurred between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features	1	1	1				1			1	1	1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_spo2room	number	Oxygen saturation at room air (no oxygen support) (%)		number	0	100		[vital_dailydata]=’1’		This refers to the measurement of the ratio of oxygenated hemoglobin to total hemoglobin in the blood, measured at room air with no oxygen support.	Indicate the measurement of oxygen saturation at room air with no oxygen support.					clinical_features	1	1	1	1	1	1	1	1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_spo2roomhow	radio	How was oxygen saturation at room air measured?	1, Pulse Oximetry | 2, Arterial blood gas measurement | 88, Other | 99, Unknown					[vital_dailydata]=’1’		This refers to the method of measurement of oxygen saturation.	Select the most appropriate option which represents the method of measurement of oxygen saturation.					clinical_features							1	1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_o2supp	radio	Supplemental oxygen?	1, Yes | 0, No | 99, Unknown					[vital_dailydata]=’1’		This refers to the delivery of supplemental oxygen at the time of the above, lowest SpO2 (%), recording.	Indicate ‘Yes’, if the FiO2 was measured along-side the lowest oxygen saturation (SpO2) reported above.	SNOMED	SNOMED			clinical_features	1	1	1	1	1	1	1	1							1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_o2supp_type	radio	Type of supplemental oxygen?	1, Nasal Prongs | 2, Face mask | 3, High flow nasal oxygen | 4, Non-invasive ventilation | 5, Invasive ventilation | 6, ECMO / ECLS | 99, Unknown					[vital_o2supp]=’1’		This refers to the type / mode of delivery for supplemental oxygen at the time of the above, lowest SpO2 (%), recording.	Select the most approproate option which represents the type / mode of delivery for supplemental oxygen at the time of the above, lowest SpO2 (%), recording.	SNOMED	SNOMED	C0445087, Nasal prongs | C1299377, Oxygen administration by mask | C4761117, High-flow nasal cannula oxygen therapy | C1997883, Noninvasive Ventilation | C0015357, Extracorporeal Membrane Oxygenation		clinical_features	1	1	1	1	1	1	1	1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_o2supp_spo2	number	Oxygen saturation with supplemental oxygen (%)		number	0	100		[vital_o2supp]=’1’		This refers to the oxygen saturation, that may be measured by pulse oximetry or by arterial blood gas analysis. It is irrespective of ventilation or supplemental oxygen requirement.	Enter the percentage oxygen saturation. Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features	1	1	1	1	1	1	1	1		1	1	1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_o2supp_spo2how	radio	How was oxygen saturation with supplemental oxygen measured?	1, Pulse Oximetry | 2, Arterial blood gas measurement | 88, Other | 99, Unknown					[vital_o2supp]=’1’		This refers to the method of measurement of oxygen saturation.	Select the most appropriate option which represents the method of measurement of oxygen saturation.												1	1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_fio2spo2	number	FiO2 at time of lowest SpO2		number	0	100		[vital_o2supp]=’1’		This refers to the measured fraction of inspired oxygen (FiO2) delivered at the time of lowest oxygen saturation (%) recording.	Enter the FiO2 that was measured along-side the lowest oxygen saturation (SpO2) reported above. FiO2 can be reported as either a fraction or a percentage. Note that 0.21 and 21% are equivalent to the FiO2 of room-air.	SNOMED	SNOMED	C0428648, Inspired oxygen concentration		clinical_features	1	1	1		1	1	1	1		1	1	1			1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_fio2spo2_units	radio	FiO2 at time of lowest SpO2 (select units)	1, Fraction, 0.21-1.0 | 2, %, 21-100 | 3, Highest L/min	units				[vital_o2supp]=’1’				SNOMED	SNOMED	C0428648, Inspired oxygen concentration		clinical_features	1	1	1		1	1	1			1	1	1			1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_fio2spo2_02110	number	FiO2 at time of lowest SpO2 (Fraction, 0.21-1.0)		number	0.21	1		[vital_o2supp]=’1’		This refers to the measured fraction of inspired oxygen (FiO2) delivered at the time of lowest oxygen saturation (%) recording.	Enter the FiO2 (0.21-1.0) that was measured along-side the lowest oxygen saturation (SpO2) reported above. 0.21 is equivalent to the FiO2 of room-air.	SNOMED	SNOMED	C0428648, Inspired oxygen concentration		clinical_features	1	1	1		1	1	1	1		1	1	1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_fio2spo2_pcnt	number	FiO2 at time of lowest SpO2 (%, 21-100)		number	21	100		[vital_o2supp]=’1’		This refers to the measured fraction of inspired oxygen (FiO2) delivered at the time of lowest oxygen saturation (%) recording.	Enter the FiO2 (21-100%) that was measured along-side the lowest oxygen saturation (SpO2) reported above. 21% is equivalent to the FiO2 of room-air.	SNOMED	SNOMED	C0428648, Inspired oxygen concentration		clinical_features	1	1	1		1	1	1	1		1	1	1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_fio2spo2_ltr	number	FiO2 at time of lowest SpO2 (Highest L/min)		number	0	100		[vital_o2supp]=’1’		This refers to the measured fraction of inspired oxygen (FiO2) delivered at the time of lowest oxygen saturation (%) recording.	Enter the FiO2 (L/min) that was measured along-side the lowest oxygen saturation (SpO2) reported above.	SNOMED	SNOMED	C0428648, Inspired oxygen concentration		clinical_features	1	1	1		1	1	1	1		1	1	1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_capillaryr	radio	Capillary refill time >2 seconds	1, Yes | 0, No | 99, Unknown					[vital_dailydata]=’1’		Capillary refill time is measured by pressing on the sternum for five seconds with a finger or thumb until the underlying skin turns white and then noting the time in seconds needed for the colour to return once the pressure is released.	Indicate ‘Yes’, if the capillary refill time was greater than 2 seconds at any time between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features	1	1	1	1	1	1	1	1				1			1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_avpu	radio	ACVPU	1, Alert | 5, Confusion | 2, Verbal | 3, Pain | 4, Unresponsive					[vital_dailydata]=’1’		Refers to the scoring system for consciousness: alert; confused (new-onset or worsening); responding to voice; responding to pain; unresponsive.	Select the single option corresponding to the least responsive condition of the patient between 00:00 to 24:00 on day of assessment. If the patient is being sedated on the day of assessment record the value before the sedation.	SNOMED	SNOMED			clinical_features	1	1	1	1	1	1	1	1							1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_gcs	number	Glasgow Coma Score (GCS / 15)		number	3	15		[vital_dailydata]=’1’		The Glasgow Coma Scale is a scoring system for consciousness. It is scored out of 15 and requires an assessment of responsiveness to stimulus. Glasgow Coma Score: https://www.glasgowcomascale.org/downloads/GCS-Assessment-Aid-English.pdf?v=3	Enter the lowest GCS recorded between 00:00 to 24:00 on day of assessment. For intubated patients and patients with a non-fenestrated tracheostomy, give 1 point for the voice component and calculate the total as usual. Suffixes such as ‘t’ for tracheostomy cannot be entered on to the database. If the patient is sedated on the day of assessment these parameters should correspond to the values observed before sedation.	SNOMED	SNOMED			clinical_features	1	1	1	1	1	1	1	1		1	1	1			1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_rass	number	Richmond Agitation-Sedation Scale (RASS)		number	-5	4		[vital_dailydata]=’1’		Richmond Agitation-Sedation Scale (RASS) is a medical scale used to measure the agitation or sedation level of a person. It ranges from -5 to +4, where 0 refers to an ‘Alert and calm’ patient that spontaneously pays attention.	If performed, enter the lowest value (between -5 and +4) between 00:00 to 24:00 hours on day of assessment.			C4720839, Richmond Agitation-Sedation Scale		clinical_features	1						1
daily	VITAL SIGNS & ASSESSMENTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	vital_urineflow	number	Urine output (mL/day)		number	0	20000		[vital_dailydata]=’1’		This refers to the amount of urine the patient has produced over a 24-hour period, specifically the date of assessment. This may be measured e.g. via use of a urinary catheter or estimated.	Record the patient’s urine output (in ml/24hours) over the day of assessment	SNOMED	SNOMED			clinical_features	1		1	1			1	1			1	1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dailydata	radio	Enter patient reported symptoms data for this date?	1, Yes | 0, No							This refers to signs and symptoms recorded o this date.	Indicate ‘Yes’, if you want to record signs and symptoms data for this day of assessment.	SNOMED	SNOMED	C0037088, Signs and Symptoms				1	1	1	1	1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_sys	descriptive	Systemic / general symptoms						[sympt_dailydata]=’1’	Systemic/General	This refers to systemic / general / non-specific signs and symptoms	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.							1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_fever	radio	Fever	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	Defined as the sensation of elevated body temperature without formal measurement, or a measured body temperature greater or equal to 38-degrees Celsius (38°C) or 100.4-Fahrenheit (100.4°F).	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0015967, Fever		clinical_features		1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_rigchill	radio	Chills or rigors	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=28	Systemic/General	Defined as severe chills with violent shivering. A rigor is an episode of shaking or exaggerated shivering which can occur with a high fever.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.									1	1	1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_nightsweat	radio	Night sweats	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Systemic/General	This refers to perspiration experienced nocturnally that is unrelated to environmental temperature.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_coldtsweat	radio	Cold sweats	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=28	Systemic/General	This refers to sweats accompanied by sensation of feeling cold, different from sweats caused by heat or exertion.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_excesssweat	radio	Excessive sweating (hyperhidrosis)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	This refers to excessive sweating that is not always related to fever, heat exposure or vigorous exercise.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_fatigue	radio	Fatigue / malaise / lethargy	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Systemic/General	This refers to a constellation of non-specific sensations: the feeling of tiredness characterised by a lack of energy or motivation; general discomfort or uneasiness; disinterestedness, listlessness, and indifference, resulting in difficulty performing simple tasks or concentrating.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0015672, Fatigue | C0231218, Malaise | C0023380 Lethargy		clinical_features		1	1	1	1	1		1				1			1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_restlessne	radio	Restlessness	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	This refers to a state of unease, characterised by an inability to rest or relax, diffuse motor activity with limited control, nonproductive or disorganized behaviour, and subjective distress.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3887611, Restlessness		clinical_features			1					1				1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_weak	radio	Weakness	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	This refers to a decrease in muscle strength.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	13791008			clinical_features												1			1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_weight	radio	Weight loss	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	This refers to reduction in total body weight (patient-reported or objectively measured) that has occurred since the onset of this illness and has been unintentional or not attributable to active dieting, exercise or dedicated medication based weight-loss interventions.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C2363736 Unintentional Weight loss		clinical_features					1	1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_anosmia	radio	Loss of smell (anosmia)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	This refers to patient reported and/or clinician-diagnosed inability of the patient to perceive odours	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0003126, Anosmia		clinical_features		1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_ageusia	radio	Loss of taste (ageusia)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	This refers to patient reported and/or clinician-diagnosed loss of taste function of the tongue.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C2364111, Ageusia		clinical_features		1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dizzy	radio	Feeling dizzy / faint	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=1825	Systemic/General	This refers to the subjective feeling of light-headedness or dizziness which may precede an episode of syncope or a sensation of unsteadiness, spinning or rocking.	Indicate ‘Yes’, if the patient experienced this at any time during the date of assessment.	SNOMED	SNOMED	C0581879, Felt faint		clinical_features		1				1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_myalgia	radio	Muscle aches (myalgia)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Systemic/General	This refers to pain localised to a muscle or group of muscles.	Indicate ‘Yes’, if the patient experienced this at any time during the date of assessment.	SNOMED	SNOMED	C0231528, Myalgia		clinical_features		1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_myalgia_scal	number	Myalgia intensity (Numeric Pain Rating Scale)		number	1	10		[sympt_myalgia]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell	radio	Joint swelling	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	Defined as the buildup of fluid in the soft tissue SURROUNDING the joint or in the joint itself	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	271771009, Joint swelling			clinical_features				1				1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell_site	checkbox	Site where joint swelling occurred	1, Shoulder | 2, Elbow | 3, Wrist | 4, Small joints of hand | 5, Knee | 6, Ankle |7, Small joints of foot | 88, Other					[sympt_jointswell]= ‘1’												1				1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell_site_shoulder	radio	How many shoulder joints are affected?	1, 1 | 2, 2 | 99, Unknown					[sympt_jointswell_site(1)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell_site_elbow	radio	How many elbow joints are affected?	1, 1 | 2, 2 | 99, Unknown					[sympt_jointswell_site(2)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell_site_wrist	radio	How many wrist joints are affected?	1, 1 | 2, 2 | 99, Unknown					[sympt_jointswell_site(3)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell_site_knee	radio	How many knee joints are affected?	1, 1 | 2, 2 | 99, Unknown					[sympt_jointswell_site(5)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell_site_ankle	radio	How many ankle joints are affected?	1, 1 | 2, 2 | 99, Unknown					[sympt_jointswell_site(6)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell_site_foot	number	How many small joints of the foot are affected?		number	1	14		[sympt_jointswell_site(7)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell_hand	checkbox	Small joints of hand	1, MCP (metacarpophalangeal) joint | 2, PIP (proximal interphalangeal) joint | 3, DIP (distal interphalangeal) joint | 99, Unknown					[sympt_jointswell_site(4)]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell_hand_num	number	How many small joints of hand affected?		number	1	20		([sympt_jointswell_hand(1)]=’1’ OR [sympt_jointswell_hand(2)]=’1’ OR [sympt_jointswell_hand(3)]=’1’) AND [sympt_jointswell_hand(99)]=’0’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell_add	checkbox	Indicate other affected joints	1, TMJ | 2, Sternoclavicular (SC) | 3, Acromioclavicular (AC) | 4, Sacroiliac (SI) | 5, Hip | 6, Subtalar | 7, Thoracic spine | 8, Lumbar spine | 88, Other (specify)					[sympt_jointswell_site(88)]=’1’												1				1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointswell_add_oth	text	Specify other joint(s)						[sympt_jointswell_add(88)]=’1’												1				1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender	radio	Joint tenderness	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	Defined as pain and discomfort in a joint, often accompanied by sensitivity to touch	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	110288007, Tenderness of joint			clinical_features				1				1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender_site	checkbox	Indicate affected joints	1, Shoulder | 2, Elbow | 3, Wrist | 4, Small joints of hand | 5, Knee | 6, Ankle |7, Small joints of foot | 88, Other					[sympt_jointtender]=’1’												1				1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender_site_shoulder	radio	How many shoulder joints are affected?	1, 1 | 2, 2 | 99, Unknown					[sympt_jointtender_site(1)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender_site_elbow	radio	How many elbow joints are affected?	1, 1 | 2, 2 | 99, Unknown					[sympt_jointtender_site(2)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender_site_wrist	radio	How many wrist joints are affected?	1, 1 | 2, 2 | 99, Unknown					[sympt_jointtender_site(3)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender_site_knee	radio	How many knee joints are affected?	1, 1 | 2, 2 | 99, Unknown					[sympt_jointtender_site(5)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender_site_ankle	radio	How many ankle joints are affected?	1, 1 | 2, 2 | 99, Unknown					[sympt_jointtender_site(6)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender_site_foot	number	How many small joints of the foot are affected?		number	1	14		[sympt_jointtender_site(7)]=’1’	Systemic/General											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender_hand	checkbox	Small joints of hand	1, MCP (metacarpophalangeal) joint | 2, PIP (proximal interphalangeal) joint | 3, DIP (distal interphalangeal) joint | 99, Unknown					[sympt_jointtender_site(4)]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender_hand_num	number	How many small joints of hand affected?		number	1	20		([sympt_jointtender_hand(1)]=’1’ OR [sympt_jointtender_hand(2)]=’1’ OR [sympt_jointtender_hand(3)]=’1’) AND [sympt_jointtender_hand(99)]=’0’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender_add	checkbox	Indicate other affected joints	1, TMJ | 2, Sternoclavicular (SC) | 3, Acromioclavicular (AC) | 4, Sacroiliac (SI) | 5, Hip | 6, Subtalar | 7, Thoracic spine | 8, Lumbar spine | 88, Other (specify)					[sympt_jointtender_site(88)]=’1’												1				1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_jointtender_add_oth	text	Specify other joint(s)						[sympt_jointtender_add(88)]=’1’												1				1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_stissueswell	radio	Small tissue swelling	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	Defined as painful swelling of the interphalangeal tissue, leading to tension and pain when flexing the fingers	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	298349001, Soft tissue swelling											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_arthralgia	radio	Joint pain (arthralgia)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Systemic/General	This refers to a sensation of marked discomfort or pain localised to one or more joints, including small and big joints.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3805780, Arthralgia		clinical_features		1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_arthralgia_scal	number	Artralgia intensity (Numeric Pain Rating Scale)		number	1	10		[sympt_arthralgia]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_neurpain	radio	Neuropathic pain	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_neurpain_scal	number	DN4 neuropathic pain scale		number				[sympt_neurpain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4	descriptive	DN4 — Douleur Neuropathique 4 Questions (Neuropathic Pain Screening)						[sympt_neurpain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_pain	radio	Does the patient have pain at time of assessment?	1, Yes | 0, No | 99, Unknown					[sympt_neurpain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q1	descriptive	QUESTION 1 — Does the pain have one or more of the following characteristics?						[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q1_burning	radio	Burning	1, Yes | 0, No					[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q1_cold	radio	Painful cold	1, Yes | 0, No					[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q1_shock	radio	Electric shocks	1, Yes | 0, No					[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q2	descriptive	QUESTION 2 — Is the pain associated with one or more of the following symptoms in the same area?						[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q2_tingling	radio	Tingling	1, Yes | 0, No					[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q2_pins	radio	Pins and needles	1, Yes | 0, No					[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q2_numb	radio	Numbness	1, Yes | 0, No					[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q2_itch	radio	Itching	1, Yes | 0, No					[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q3	descriptive	QUESTION 3 — Is the pain located in an area where the physical examination reveals one or more of the following? (clinician examination)						[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q3_touch	radio	Hypoesthesia to touch	1, Yes | 0, No					[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q3_pin	radio	Hypoesthesia to pinprick	1, Yes | 0, No					[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q4	descriptive	QUESTION 4 — Is the pain provoked or increased by one or more of the following? (clinician examination)						[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_q4_brush	radio	Brushing	1, Yes | 0, No					[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_score	calc	DN4 Total Score (0–10)	if([sympt_dn4_pain]=’1’,if([sympt_dn4_q1_burning]=’1’,1,0)+if([sympt_dn4_q1_cold]=’1’,1,0)+if([sympt_dn4_q1_shock]=’1’,1,0)+if([sympt_dn4_q2_tingling]=’1’,1,0)+if([sympt_dn4_q2_pins]=’1’,1,0)+if([sympt_dn4_q2_numb]=’1’,1,0)+if([sympt_dn4_q2_itch]=’1’,1,0)+if([sympt_dn4_q3_touch]=’1’,1,0)+if([sympt_dn4_q3_pin]=’1’,1,0)+if([sympt_dn4_q4_brush]=’1’,1,0),’’)					[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_result	text	DN4 Result						[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dn4_notes	notes	Clinical notes (optional)						[sympt_dn4_pain]=’1’												1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_cramps	radio	Muscle cramps	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’		sudden, involuntary, painful contractions of one or more muscles that are temporary and usually resolve spontaneously after seconds to minutes.										1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_skinrash	radio	Skin rash	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	This refers to any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body or affect all the skin. Rashes may cause the skin to change colour, itch, become warm, bumpy, dry, cracked, or blistered, swell and may be painful.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C4227880, Skin Rash		clinical_features		1		1				1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_paresthesia	radio	Skin paresthesia	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Systemic/General	This refers to percieved cutaneous sensations (e.g., cold, warmth, tingling, pressure, etc.) that are experienced spontaneously in the absence of stimulation.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1		1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_skinchange	radio	Changes in skin texture	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	This refers to alterations in the surface appearance and feel of the skin, such as roughness, unevenness, or the presence of bumps.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_skinpallor	radio	Skin pallor	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	This refers to unnatural pale appearance of the skin.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_pruritus	radio	Itch (pruritus)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=183	Systemic/General	Defined as an unpleasant or intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0033774, Pruritus		clinical_features		1			1	1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_mobilchg	radio	Change in mobility from baseline	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	This refers to the patient’s ability to walk or mobilise.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C4228638, Unable to walk		clinical_features		1			1	1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_mobile	radio	Mobility status	1, Fully ambulant | 2, Ambulant, but with some assistance | 3, Bedridden					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=1825	Systemic/General	This refers to the patient’s ability to walk or mobilise.	Select the most appropriate option(s) represents patient’s mobility status.	SNOMED	SNOMED	C0231435, Mobile | CL573260, Walks with assistance | C0425251, Bed-ridden		clinical_features		1			1	1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_sleepmore	radio	Sleeping more than usual / lethargic / sluggish / listlessness	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General	This refers to excessive sleepiness during the daytime / marked by drowsiness and an unusual lack of energy and mental alertness / infant having little energy, is drowsy, or sleeps more than usual	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_polydipsia	radio	Increased thirst (polydipsia)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Systemic/General	This refers to excessive thirst	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_irregmenstruation	radio	Changes in menstruation / Irregular menstruation	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_sex]=’2’ and [initial_assessment_arm_1][demog_calcage_days]>=2920	Systemic/General	This refers to any deviations from the normal process; e.g. delayed, difficult, profuse, scanty, unusual bleeding, etc.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_backpain	radio	Back Pain	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_neckpain	radio	Neck Pain	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Systemic/General																						1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_resp	descriptive	Respiratory symptoms						[sympt_dailydata]=’1’	Respiratory	This refers to signs and symptoms relating to the respiratory system.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.							1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_cough	radio	Cough	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Respiratory	This refers to the presence of a cough and its characteristics. A productive cough refers to a cough accompanied by expectorated secretions (phlegm or mucus), while a non-productive cough refers to one which is not accompanied by expectorated secretions. Haemoptysis refers to the presence of blood or blood-streaked sputum from the respiratory tract.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0010200, Coughing		clinical_features		1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_cough_type	radio	Cough type	1, Non Productive | 2, Productive |3, Haemoptysis |99, Unknown					[sympt_cough] = ‘1’	Respiratory	This refers to the type of cough. A productive cough refers to a cough accompanied by expectorated secretions (phlegm or mucus)	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0451597 Productive Cough		clinical_features		1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_sorethroat	radio	Sore throat	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Respiratory	Defined as an unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) and perceived to originate in the throat.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3854544, Sore throat		clinical_features		1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_rhinorrhoe	radio	Runny nose (rhinorrhoea)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Respiratory	Defined as increased mucosal discharge of the nose.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C1260880, Rhinorrhea		clinical_features		1				1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_wheezing	radio	Wheezing	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Respiratory	Defined as a high-pitched breath sound resulting from a narrowing or obstruction of the small airway.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0043144, Wheezing		clinical_features		1				1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_shortbreat	radio	Shortness of breath	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Respiratory	Defined as the uncomfortable sensation of difficult or laboured breathing that is out of proportion to the patient’s level of physical activity.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C4230442, Dyspnea		clinical_features		1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_nasalcongestion	radio	Nasal congestion	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Respiratory	Defined as reduced ability to pass air through the nasal cavity often leading to mouth breathing.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features				1		1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_chestpain	radio	Chest pain	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Respiratory	Defined as the unpleasant, uncomfortable or painful sensation characterised by physical discomfort localised to the chest.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3807341, Chest pain		clinical_features		1		1	1	1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_sneez	radio	Sneezing	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Respiratory	This refers to a sudden violent, spasmodic, audible expiration of breath through the nose and mouth.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	76067001									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_hiccups	radio	Hiccups	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Respiratory
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_cvs	descriptive	Cardiovascular symptoms						[sympt_dailydata]=’1’	Cardiovascular	This refers to signs and symptoms relating to the cardiovascular system.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features		1				1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_palpitations	radio	Palpitations	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Cardiovascular	Refers to the unpleasant awareness of one’s own heartbeat.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	80313002, Palpitations (finding)			clinical_features		1				1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_git	descriptive	Gastrointestinal symptoms						[sympt_dailydata]=’1’	Gastrointestinal	This refers to signs and symptoms relating to the gastrointestinal system.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.							1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_abdpain	radio	Abdominal pain	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Gastrointestinal	Defined as an unpleasant sensation of discomfort, distress or agony in the abdominal region.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3553274, Abdominal pain		clinical_features		1	1	1	1	1		1				1			1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_diarrhoea	radio	Diarrhoea	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Gastrointestinal	Defined as three or more loose or liquid bowel movement per day (or more frequent passage than is normal for the individual).	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3554472, Diarrhea		clinical_features		1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_consti	radio	Constipation	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Gastrointestinal	This refers to irregular and infrequent or difficult evacuation of the bowels.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3551741, Constipation		clinical_features					1	1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_vomit	radio	Vomiting	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Gastrointestinal	Defined as the expulsion of the stomach or small intestines through the mouth.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C4230730, Vomiting		clinical_features		1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_vomit2d	radio	Persistent vomiting? (>=2/day)	1, Yes | 0, No | 99, Unknown					[sympt_vomit]=’1’	Gastrointestinal	Persistent vomiting is defined here as vomiting two times or more per day.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0152165, Persistent vomiting		clinical_features		1	1		1	1		1				1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_vomitbld	radio	Vomiting blood (haematemesis)	1, Yes | 0, No | 99, Unknown					[sympt_vomit]=’1’	Gastrointestinal	This refers to vomiting of blood.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_nausea	radio	Nausea	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=1095	Gastrointestinal	Defined as the the unpleasant painless subjective feeling that one will imminently vomit.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3554470, Nausea		clinical_features		1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_anorexia	radio	Anorexia	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Gastrointestinal	Defined as lack or loss of appetite.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3554473, Anorexia		clinical_features		1				1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_exsal	radio	Excessive salivation	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=1460	Gastrointestinal	Excessive salivation or sialorrhea is a symptom best assessed by the patient.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0037036, Sialorrhea		clinical_features					1	1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_diffswallow	radio	Difficulty swallowing (dysphagia)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Gastrointestinal	Defined as difficulty swallowing food, liquids, or saliva.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0011168, Deglutition Disorders		clinical_features					1	1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_faecalincont	radio	Faecal incontinence	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=1825	Gastrointestinal	Defined as failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_renalgut	descriptive	Renal / Genitourinary symptoms						[sympt_dailydata]=’1’	Genitourinary	This refers to signs and symptoms relating to the renal / genitourinary system.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.										1	1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_urine	radio	Urinary retention	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Genitourinary	Defined as the accumulation of urine within the bladder because of the inability to urinate.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0080274, Urinary retention		clinical_features					1	1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_urineincont	radio	Urinary incontinence	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=1825	Genitourinary	This refers to loss of bladder control, or being unable to control urination.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_polyuria	radio	Increased urination (polyuria)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Genitourinary	This refers to excessive or frequent urination.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dysuria	radio	Pain during urination (dysuria)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Genitourinary	This refers to painful or difficult urination.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_dyspareunia	radio	Painful intercourse (dyspareunia)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=5475	Genitourinary	Defined as recurrent or persistent genital pain associated with sexual intercourse.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C1384606, Dyspareunia		clinical_features					1	1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_heme	descriptive	Haematological symptoms						[sympt_dailydata]=’1’	Haematology	This refers to signs and symptoms relating to the haematological system.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.							1	1	1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_haemorrhag	radio	Bleeding (haemorrhage)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Haematology	Defined as the presence of blood in a location in which it is not physiologically normal or loss of blood from the circulation, either internally or externally. This can include epistaxis (blood from nose), gingival bleeding (blood from gums/gingiva), blood from any part of the gastrointestinal tract (gastrointestinal bleeding) or genitourinary tracts (vagina or urethra) including hematuria.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3163616, Blood loss		clinical_features	1	1	1	1	1	1		1				1			1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_haemorrhag_sev	radio	Severe bleeding (requires intervention)	1, Yes | 0, No | 99, Unknown					[sympt_haemorrhag]=’1’	Haematology	Defined as the severe bleeding / hemorrhage requiring medical intervention for hemostasis and/or hemodynamic support.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features	1	1	1		1	1		1				1			1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_haemorrhag_site	multi_list	Specify bleeding site(s)					conditions_Site	[sympt_haemorrhag] = ‘1’	Haematology	This refers to the location of bleeding/haemorrhage site(s). Petechiae refer to small reddish or purplish spots in skin or mucous membrane as a result of localised haemorrhage. Nose bleeding refers to haemorrhage localized in the nose. Gum bleeding refers to haemorrhage affecting the gingiva. Gastrointestinal (GI) bleeding refers to haemorrhage in any segment of the gastrointestinal tract from oesophagus to rectum. Urinary tract bleeding refers to haemorrhage originating from any part of the urinary system. Vaginal bleeding refers to haemorrhage originating from vagina, unrelated to normal menstruation.	Select the most appropriate option(s) corresponding to the location of bleeding/haemorrhage site(s).	SNOMED	SNOMED	C0574741, Bleeding skin | C3808808, Epistaxis | C0017565, Gingival haemorrrhage | C0017181, Gastrointestinal haemorrhage |C3805433, haematuria | C0566961, Fresh bleeding from vagina		clinical_features	1	1	1	1	1	1		1				1			1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_cns	descriptive	Neurological symptoms						[sympt_dailydata]=’1’	Nervous system	This refers to signs and symptoms relating to the neurological system.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.							1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_headache	radio	Headache	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Nervous system	Defined as the experience of pain in various parts of the head, not confined to the area of distribution of any nerve.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0018681, Headache		clinical_features		1		1	1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_photoph	radio	Photophobia	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Nervous system	Refers to increased sensitivity of the eyes to light.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3807325, Photophobia		clinical_features				1											1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_seizconv	radio	Seizures / convulsions	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Nervous system	Defined as an intermittent abnormality of nervous system physiology characterised by a transient occurrence of sudden, violent, irregular movement of the body, caused by involuntary contraction of muscles due to abnormal excessive or synchronous neuronal activity in the brain.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C2748942, Seizure		clinical_features	1	1	1	1	1	1		1				1			1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_confusion	radio	Altered consciousness / confusion	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Nervous system	Defined as a level of awareness or arousal other than the patient’s normal baseline.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0150450, Altered level of consciousness		clinical_features	1	1	1	1	1	1		1				1			1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_paralysis	radio	Paralysis	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Nervous system	This refers to inability to fully move or control movement	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_irritable	radio	Irritability	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Nervous system	Refers to an abnormal or excessive excitability with easily triggered anger, annoyance, or impatience.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_tremor	radio	Tremor	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Nervous system	Refers to an unintentional, oscillating to-and-fro muscle movement about a joint axis.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0040822, Tremor		clinical_features						1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_diffwalk	radio	Difficulty in walking	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=292	Nervous system	This refers to any persistent problem with walking.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features				1		1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_neurologic	radio	Other neurological abnormality	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Nervous system	This refers the presence of an alternative neurological abnormality not listed above.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features				1				1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_neurologic_spec	text	Specify other neurological abnormality						[sympt_neurologic] = ‘1’	Nervous system	This refers the presence of another neurological abnormality not listed above.	If ‘Other’, specify neurological abnormality.					clinical_features								1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_eye	descriptive	Opthalmological symptoms						[sympt_dailydata]=’1’	Nervous system	This refers to signs and symptoms relating to the eye.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.							1			1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_itchyeye	radio	Itching of eye(s)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’ and [initial_assessment_arm_1][demog_calcage_days]>=365	Ocular	Defined as itching of one or both eyes.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features		1			1	1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_redeye	radio	Red / Pink eye(s)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Ocular	Defined as inflammation or infection of the conjunctiva, characterized by redness in one or both eyes.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features		1			1	1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_paineyes	radio	Pain in eye(s)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Ocular	Defined as discomfort or aching localized within or around the eye area.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features		1			1	1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_eyelidedema	radio	Oedema of eyelid(s)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Ocular	Defined as swelling due to fluid accumulation in the tissues of the eyelid.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features		1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_eyedischarg	radio	Discharge from eye(s)	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Ocular	Defined as the release of fluids ranging from clear to pus-like from the eye, often indicative of infection or irritation.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features		1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_hazyvision	radio	Hazy / Blurred vision	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Ocular	Defined as a loss of visual acuity, resulting in unclear or distorted sight.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features		1						1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_eyelightsensi	radio	Sensitivity of eye to light	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Ocular	Defined as an abnormal intolerance to light, causing discomfort or pain in the eyes when exposed to bright light.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features		1						1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_visdist	radio	Visual disturbance	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Ocular	Refers to an interference to normal eyesight without necessarily affecting visual acuity.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.		63102001, Visual distrubance			clinical_features					1	1		1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_ocularoth	radio	Other opthalmological symptoms	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	Ocular	This refers to other signs and symptoms relating to the eye, not specified above.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.										1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_ocularoth_spec	text	Specify other opthalmological symptoms						[sympt_dailydata]=’1’	Ocular	This refers to other signs and symptoms relating to the eye, not specified above.	If ‘Yes’, specify other opthalmological signs and symptoms										1	1		1							1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_ent	descriptive	Ear/Nose/Throat symptoms						[sympt_dailydata]=’1’	ENT	This refers to signs and symptoms relating to the ear, nose and throat.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_earpain	radio	Ear pain	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	ENT	This refers to painful sensation in the ear	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_tinnitus	radio	Tinnitus	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	ENT	This refers to an abnormal perception of sounds experienced by an individual in the absence of auditory stimulation.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_parot	radio	Parotitis	1, Yes | 0, No | 99, Unknown					[sympt_dailydata]=’1’	ENT	This refers to inflammation of the parotid glands.	Indicate ‘Yes’, if the patient has experienced between 00:00 to 24:00 on day of assessment.					clinical_features						1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_paed	descriptive	Paediatric-specific symptoms						[sympt_dailydata] = ‘1’ and [initial_assessment_arm_1][demog_calcage_days]<=365														1							1		1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_contcry	radio	Continuous crying	1, Yes | 0, No | 99, Unknown					[sympt_dailydata] = ‘1’ and [initial_assessment_arm_1][demog_calcage_days]<=365														1							1		1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_feedingdiff	radio	Feeding difficulty	1, Yes | 0, No | 99, Unknown					[sympt_dailydata] = ‘1’ and [initial_assessment_arm_1][demog_calcage_days]<=365														1							1		1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_otherdesc	descriptive	Other symptoms						[sympt_dailydata]=’1’	Other									1			1	1									1
daily	SYMPTOMS: Indicate if experienced between 00:00 to 24:00 on day of assessment.	sympt_unlisted	list	Other symptom(s)	1, Yes | 0, No | 99, Unknown				conditions_Symptoms	[sympt_dailydata]=’1’	Other	This refers the presence of an alternative sign(s) or symptom(s) not listed above.	Indicate ‘Yes’, if the patient has experienced another sign or symptom not listed above between 00:00 to 24:00 on day of assessment.					clinical_features		1			1	1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_dailydata	radio	Enter clinical signs data for this date?	1, Yes | 0, No							This refers to signs and symptoms recorded o this date.	Indicate ‘Yes’, if you want to record signs and symptoms data for this day of assessment.	SNOMED	SNOMED	C0037088, signs			1	1		1	1	1	1	1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_sys	descriptive	Systemic / general signs						[sign_dailydata]=’1’	Systemic/General	This refers to systemic / general / non-specific signs and symptoms	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.						1	1		1	1	1	1	1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_hypotherm	radio	Hypothermia	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Systemic/General	This refers to abnormally reduced body temperature due to failed thermoregulation.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_coldperiph	radio	Cold / clammy peripheries	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Systemic/General	This refers to skin that feels cool and moist to the touch, often associated with circulatory failure and symptoms like restlessness and hypotension.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED		C2106366, cold and clammy extremities			1		1	1		1						1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_dehyrdation	radio	Dehydration	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Systemic/General	This refers to excessive loss of water from the body.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_dehyrdation_type	radio	Dehydration Status	1, Mild | 2, Moderate| 3, Severe					[sign_dehyrdation]=’1’	Systemic/General	This refers to excessive loss of water from the body.	Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.	SNOMED	34095006, Dehydration (disorder)	C0011175, Dehydration		clinical_features
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_oedema	radio	Oedema	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Systemic/General	This refers to accumulation of an excessive amount of fluid in cells or intercellular tissues.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.							1	1	1		1	1					1			1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_oedema_site	checkbox	Oedema site(s)	1, Feet | 2, Ankle | 3, Legs (below knee) | 4, Legs (above knees) | 5, Scrotum/Labia | 6, Sacrum | 7, Abdomen | 8, Neck | 9, Face | 99, Unknown | 88, Other					[sign_oedema] = ‘1’	Systemic/General	This refers to the location of the odema.	If ‘Yes’, specify the location of the oedema. Select all that apply.							1		1		1	1								1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_oedema_site_oth	text	Specify other oedema site(s)						[sign_oedema_site(88)] = ‘1’	Systemic/General	This refers to the location of the odema.	If ‘Other’, specify the site of oedema							1				1	1								1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_lymph	radio	Lymphadenopathy	1, Yes-painful | 2, Yes-not painful | 0, No | 99, Unknown					[sign_dailydata]=’1’	Systemic/General	Defined as a clinical finding of abnormal enlargement of the lymph nodes.	Indicate ‘Yes’, if the patient has experienced between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C4014613, Lymphadenopathy		clinical_features	1	1		1	1	1	1								1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_lymph_site	checkbox	Specify lymphadenopathy site(s)	1, Axillary (arm pits) | 2, Cervical (neck)| 3, Inguinal (groin) | 99, Unknown | 88, Other					[sign_lymph]=’1’ or [sign_lymph]=’2’	Systemic/General	This refers to the location in which lymphadenopathy was identified.	Select the most appropriate option(s) corresponding to the location of lymphadenopathy.	SNOMED	SNOMED			clinical_features	1	1			1	1	1								1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_lymph_site_oth	text	Specify other lymphadenopathy site(s)						[sign_lymph_site(88)]=’1’	Systemic/General	This refers to the location in which lymphadenopathy was identified.	If ‘Other’, write the location in which lymphadenopathy was identified.					clinical_features	1	1			1	1	1								1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_lowurine	radio	Reduced urine output	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Genitourinary	This refers to a finding indicating that the urine production is less than 500 milliliters during a 24 hour period.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.									1		1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_bruise	radio	Bruising	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Systemic/General	This refers to spontaneous extravasation of blood into the subcutaneous space, also referred to as spontaneous ecchymoses.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1		1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_alopecia	radio	Alopecia	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Systemic/General	This refers to absence of hair (nonscarring hair loss) from areas where it is normally present.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_dryskin	radio	Dry skin	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Systemic/General	This refers to skin characterized by the lack of natural or normal moisture resulting from inadequate hydrolipids in the skin, also called xerosis cutis.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_oralulcer	radio	Oral ulcers	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Systemic/General	This refers to recurrent episodes of ulceration of the oral mucosa (recurrent oral aphthae), typically presenting as painful, sharply circumscribed fibrin-covered mucosal defects with a h	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_presinj	radio	Pressure injury to skin	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’																							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_mastitis	radio	Mastitis	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Breast	Defined as a inflammation of the breast, with or without accompanying infection	Indicate ‘Yes’, if the patient experienced this at any time during the date of assessment.	SNOMED	SNOMED	C0149613, Acute mastitis		clinical_features		1					1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_bacsi	radio	Bacterial super-infection	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Systemic/General	Defined as a physician-diagnosed secondary bacterial infection that occurs during an existing wound, infection or immediately following an earlier infection.	Indicate ‘Yes’, if the patient has experienced between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0442886, Secondary infections		clinical_features
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_bacsi_spec	checkbox	Specify bacterial super-infection.	7, Deep tissue abscess | 1, Folliculitis / cellulitis | 2, Pneumonia | 3, Gastroenteritis | 4, CNS | 5, Bacteraemia | 6, Urinary tract | 88, Other					[sign_bacsi]=’1’	Systemic/General	This refers to the type or location of the bacterial super-infection.	Select the most appropriate option(s) represents the type or location of the bacterial super-infection.	SNOMED	SNOMED	C0037278, Skin Infection | C0339952, Secondary bacterial pneumonia | C0558348, Bacterial gastroenteritis | C0752180, Bacterial infection of central nervous system | C1096222, Urinary tract infection bacterial		clinical_features
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_bacsi_oth	text	Specify other bacterial super-infection						[sign_bacsi_spec(88)]=’1’	Systemic/General	This refers to the other type(s) or location(s) of the bacterial super-infection, not specified above.	If ‘Other’, write the type or location of the bacterial super-infection.					clinical_features
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_resp	descriptive	Respiratory signs						[sign_dailydata]=’1’	Respiratory	This refers to signs and symptoms relating to the respiratory system.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.						1	1		1	1	1	1								1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_respdistress	radio	Respiratory distress	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Respiratory	This refer to a pathological increase in the effort and frequency of breathing movements.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.						1		1	1		1						1			1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_chestindrw	radio	Lower chest wall indrawing	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Respiratory	Defined as a clinical sign of respiratory distress, distinguished by the abnormal inward movement of the lower chest wall during inspiration. If only the soft tissue between the ribs or above the clavicle goes in when the patient breathes, this is not lower chest wall in-drawing.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0231906, Chest wall retraction		clinical_features	1	1				1	1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_tachypnoea	radio	Fast breathing (tachypnoea)	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Respiratory	Defined as an abnormal increase of rate of breathing.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_apnoea	radio	Apnoea	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Respiratory	Defined as a transient absence in spontaneous respiration.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_rhinitis	radio	Rhinitis	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Respiratory	Defined as inflammation of the mucous membrane lining the nose, usually associated with nasal discharge.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_phary	radio	Pharyngitis	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Respiratory	This refers to the presence of inflammation of the throat..	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0031350, Pharyngitis		clinical_features		1			1	1	1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_pharery	radio	Pharyngeal erythema	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Respiratory		Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_pharexu	radio	Pharyngeal exudate	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Respiratory		Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_tonsil	radio	Tonsillitis	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Respiratory	This refers to the presence of inflammation of the tonsils.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0040425, Tonsillitis		clinical_features		1				1	1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_plueeff	radio	Pleural effusion	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Respiratory	This refers to presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.						1		1	1								1			1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_cvs	descriptive	Cardiovascular signs						[sign_dailydata]=’1’	Cardiovascular	This refers to signs and symptoms relating to the cardiovascular system.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features				1		1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_tachycardia	radio	Rapid heart rate (tachycardia)	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Cardiovascular	Refers to an abnormally rapid heart rate (typically > 100bpm for adults), that exceeds the range of the normal resting heart rate for age.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_arrhythmia	radio	Cardiac arrhythmia	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Cardiovascular	Refers to an abnormality in rhythm of heartbeat, including rate, regularity, and/or sequence of activation abnormalities	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features				1		1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_cyan	radio	Peripheral cyanosis	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Cardiovascular											1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_git	descriptive	Gastrointestinal signs						[sign_dailydata]=’1’	Gastrointestinal	This refers to signs and symptoms relating to the gastrointestinal system.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.							1		1	1	1	1	1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_ascites	radio	Ascites	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Gastrointestinal	Defined as an excessive accumulation or retention of free fluid within the peritoneal cavity.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features	1		1			1						1			1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_hepatomegally	radio	Palpable liver/Hepatomegaly	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Gastrointestinal	Defined as an pathological enlargement of the liver	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features			1	1		1		1				1			1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_splenomegaly	radio	Palpable spleen/splenomegaly	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Gastrointestinal		Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features												1			1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_tenabd	radio	Tender abdomen	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Gastrointestinal		Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_jaund	radio	Jaundice	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Gastrointestinal	Defined as a clinical manifestation of hyperbilirubinemia, characterized by the yellowish staining of the skin, mucous membrane and/or sclera.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C3549846, Jaundice		clinical_features		1		1	1	1	1	1		1					1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_melaena	radio	Dark / tarry blood in faeces (melaena)	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Gastrointestinal	This refers to abnormally dark tarry feces containing blood, usually from gastrointestinal bleeding.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_haematochezia	radio	Fresh blood in stools (haematochezia)	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Gastrointestinal	This refers to the presence of blood in stool. It is the result of gastrointestinal hemorrhage and it may be easily seen in stool or may be identified microscopically.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_rectalbleed	radio	Rectal bleeding	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Gastrointestinal	This refers to bleeding originating from the rectal wall and discharged from the anus.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1		1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_feeding	radio	Feeding	1, Able | 0,Unable | 2, NBM order					[sign_dailydata]=’1’	Gastrointestinal
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_feeding_route	radio	If able to feed, specify route:	1, Oral | 2, Feeding Tube | 3, Breastfeeding					[sign_feeding]=’1’	Gastrointestinal
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_heme	descriptive	Haematological signs						[sign_dailydata]=’1’	Haematology	This refers to signs and symptoms relating to the haematological system.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.													1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_anaemia	radio	Anaemia	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Haematology	This refers to a reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Common manifestations include pallor, fatigue, dizziness, shortness of breath, and tachycardia.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.													1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_cns	descriptive	Neurological signs						[sign_dailydata]=’1’	Nervous system	This refers to signs and symptoms relating to the neurological system.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.							1		1	1	1	1	1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_neckstiff	radio	Neck stiffness	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Nervous system	Defined as a sensation of tightness in the neck when attempting to move it, especially after a period of inactivity. Neck stiffness often involves soreness and difficulty moving the neck, especially when trying to turn the head to the side.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0151315, Neck Stiffness		clinical_features		1					1	1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_retroorbit	radio	Retro-orbital pain	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Nervous system	Defined as the experience of pain in the retro-orbital region (behind the eyes).	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	MedDRA	MedDRA	C0743724, Retro-orbital pain		clinical_features								1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_hemiplegia	radio	Hemiplegia	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Nervous system	This refers to severe or complete loss of motor function on one side of the body; often caused by brain diseases that are localized to the cerebral hemisphere opposite to the side of weakness; less frequently, brain stem lesions; cervical spinal cord diseases, peripheral nervous system diseases, and other conditions may manifest as hemiplegia.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_cogimpair	radio	Cognitive impairment	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Nervous system	This refers to diminished or impaired mental and/or intellectual function.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_neurodist	radio	Psychological disturbance	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Nervous system	This refers to the presence of signs or symptoms that affect an individual’s thoughts, emotions, behaviours or mental well-being. The presence of psychological disturbances should be identified through a Mental Status Examination (MSE) or equivalent tool.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C0233395, Psychological sign or symptom		clinical_features					1	1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_speechdist	radio	Speech disturbance	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Nervous system	This refers to difficulties with speech and communication that may result from pathologies in the brain.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1		1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_agitation	radio	Agitation	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Nervous system	This refers to a state of excessive motor activity that is associated with mental distress or a feeling of substantial unease or inner tension. Distinguished from restlessness by the increased level of emotional distress and negative intensity of the experience. Agitation has a significant level of physical activity that is typically threatening to the self or others.				C0085631, Agitation		clinical_features	1		1	1								1			1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_cerebesig	radio	Cerebellar signs	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Nervous system	Refers to the presence of a constellation of neurological signs typically indicate cerebellar dysfunction. Signs include dysdiadochokinesia, dysmetria, ataxia, nystagmus, intention tremor, slurred or scanning speech, hypotonia.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.			C3807868, Cerebellar signs		clinical_features				1											1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_neurologic	radio	Other neurological abnormality	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Nervous system	This refers the presence of an alternative neurological abnormality not listed above.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features				1				1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_neurologic_spec	text	Specify other neurological abnormality						[sign_neurologic] = ‘1’	Nervous system	This refers the presence of another neurological abnormality not listed above.	If ‘Other’, specify neurological abnormality.					clinical_features								1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_eye	descriptive	Opthalmological signs						[sign_dailydata]=’1’	Nervous system	This refers to signs and symptoms relating to the eye.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.						1	1		1		1	1								1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_conjunhemor	radio	Subconjunctival haemorrhage	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Ocular	Defined as the accumulation of blood underneath the conjunctiva, presenting as a bright red or dark patch in the eye.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features		1					1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_conjunctiv	radio	Conjunctivitis	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Ocular	Defined as inflammation of the conjunctiva	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED	C4011653, Conjunctivitis		clinical_features	1			1		1	1								1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_keratitis	radio	Keratitis	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Ocular	This refers to inflammation of the cornea of the eye.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.					clinical_features						1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_newvision	radio	Newly reduced visual acuity	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Ocular	Defined as decreased clarity or sharpness of vision.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.	SNOMED	SNOMED			clinical_features		1					1								1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_sunkeyes	radio	Sunken eyes	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Ocular		Indicate ‘Yes’, if the patient has experienced this at any time from onset of this illness to presentation.					clinical_features
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_ocularoth	radio	Other opthalmological signs	1, Yes | 0, No | 99, Unknown					[sign_dailydata]=’1’	Ocular	This refers to other signs and symptoms relating to the eye, not specified above.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.											1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_ocularoth_spec	text	Specify other opthalmological signs						[sign_dailydata]=’1’	Ocular	This refers to other signs and symptoms relating to the eye, not specified above.	If ‘Yes’, specify other opthalmological signs and symptoms											1									1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_paed	descriptive	Paediatric-specific signs						[sign_dailydata] = ‘1’ and [initial_assessment_arm_1][demog_calcage_days]<=1825	Paediatric													1							1		1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_nasalflar	radio	Nasal flaring	1, Yes | 0, No | 99, Unknown					[sign_dailydata] = ‘1’ and [initial_assessment_arm_1][demog_calcage_days]<=1825	Paediatric													1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_grunt	radio	Grunting	1, Yes | 0, No | 99, Unknown					[sign_dailydata] = ‘1’ and [initial_assessment_arm_1][demog_calcage_days]<=1825	Paediatric													1							1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_ftt	radio	Failure to thrive	1, Yes | 0, No | 99, Unknown					[sign_dailydata] = ‘1’ and [initial_assessment_arm_1][demog_calcage_days]<=28	Paediatric																						1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_hypotonia	radio	Decreased tone / hypotonia	1, Yes | 0, No | 99, Unknown					[sign_dailydata] = ‘1’ and [initial_assessment_arm_1][demog_calcage_days]<=28	Paediatric																						1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_bulgefont	radio	Bulging fontanelle	1, Yes | 0, No | 99, Unknown					[sign_dailydata] = ‘1’ and [initial_assessment_arm_1][demog_calcage_days]<=28	Paediatric																						1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_otherdesc	descriptive	Other signs						[sign_dailydata]=’1’	Other									1			1	1	1								1
daily	SIGNS: Record the clinical findings observed between 00:00 and 24:00 on the day of assessment	sign_unlisted	list	Other sign(s)	1, Yes | 0, No | 99, Unknown				conditions_Symptoms	[sign_dailydata]=’1’	Other	This refers the presence of an alternative sign(s) or symptom(s) not listed above.	Indicate ‘Yes’, if the patient has experienced another sign or symptom not listed above between 00:00 to 24:00 on day of assessment.					clinical_features	1	1			1	1	1								1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_dailydata	radio	Enter Skin and Mucosa Assessment data for this date?	1, Yes | 0, No							The following questions pertain to clinical inspection of skin lesions. Data recorded in this section should detail the conditions present on the date of assessment. This section should be completed for date of admission and any subsequent day as per the local protocol.	Indicate ‘Yes’, to enter information pertaining to clinical inspection of skin lesions on the day of assessment.					clinical_features					1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_dist	radio	Rash distribution	1, Generalised | 2, Localised around the genitals | 3, Centrifugal-more on the extremities | 4, Centripetal-more on the trunk | 88, Other distribution | 99, Unknown distribution					[lesion_dailydata]=’1’	Skin	This refers to the pattern of distribution of the skin rash. Generalised rash refers to a widespread rash covering the entire surface of the skin. Centrifugal rash is concentrated on the distal extremities, with fewer lesions on the trunk. Centripetal rash is concentrated on the trunk, with fewer lesions on the extremities. Localised around the genitals refers to a rash concentrated around the skin on the genitals.	Select the most appropriate pattern of distribution of the skin rash on the day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_distoth	text	Specify other rash distribution						[lesion_dist]=’88’	Skin	This refers to the pattern of distribution of the skin rash.	If ‘Other’, write the pattern of distribution of the skin rash on the day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_morph	radio	Rash morphology	1, Mostly discrete lesions | 2, Semi-confluent lesions | 3, Confluent lesions | 4, Mixed morphology | 99, Unknown					[lesion_dailydata]=’1’	Skin	This refers to the predominant morphology of the skin rash. Discrete lesions refer to separate, distinct lesions that are not joined to one another. Confluent lesions refer to lesions that are joining or running together.	Select the most appropriate morphology of the skin rash on the day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_morphsize	radio	Rash size (skin) - widest diameter of any lesion	1, Less than 0.5cm | 2, 0.5-0.99cm | 3, 1-1.99cm | 4, 2+ cm					[lesion_dailydata]=’1’	Skin	This refers to the size of the skin rash, recorded as the widest diameter of any lesion in centimetres (cm).	Indicate the widest diameter of any skin lesion measured in centimetres (cm) on the day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_skinles	radio	Current skin lesion status	1, There are active skin lesions | 2, There are skin lesions and none of them are active (lesions in the process of healing & resolving, including scabbed lesions) | 3, All skin lesions have completely resolved (all scabs have fallen off with intact skin) | 4, No skin lesions have developed to date					[lesion_dailydata]=’1’	Skin	This refers to the status of the skin lesions. Active skin lesions refer to macules (flat lesions), papules (raised lesions), vesicles (raised and filled with clear fluid) or pustules (raised and filed with pus, an opaque fluid) which can develop a depression in the centre (umbilication) or ulcerate. Skin lesions which are not active refer to those which have begun to crust (dry) over, in the process of healing & resolving, to form scabs (consisting of dried serum, blood, or pus). Skin lesions which have completely resolved refer to all scabs having fallen off, leaving intact underlying skin.	Indicate the most appropriate dermatological status of the skin lesions on the day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_res	radio	Is there residual evidence of resolved skin lesions (scar/discolouration)?	1, Yes | 0, No | 99, Unknown					[lesion_skinles]=’2’ or [lesion_skinles]=’3’ or [lesion_skinles]=’4’		This refers to the presence of sequalae secondary to resolved or resolving skin lesions i.e. lesions that are no longer active (including scabbed lesions and lesions where all scabs have fallen off with intact skin). This can include scars or discoloration.	Indicate ‘Yes’, if there is residual evidence of resolved skin lesions on the day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_mucos	radio	Current mucosal lesion status	1, There are mucosal lesions | 2, There is a history of mucosal lesions but none at present (all have resolved and mucosa is healed) | 3, No mucosal lesions have developed to date					[lesion_dailydata]=’1’		This refers to the presence of mucosal membrane involvement. It includes the lining of the digestive tract, respiratory tract and genitourinary tract.	Select the single most appropriate option that represents the extent of mucosal involvement between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_orophar	radio	If there are mucosal lesions: Persistent symptoms or signs of mucosal oropharyngeal lesions	1, Yes | 0, No | 99, Unknown					[lesion_mucos]=’1’		This refers to the presence of mucosal membrane involvement in the oropharyngeal cavity, as evidenced by active mucosal lesions, erythema, inflammatory changes. Symptoms may include sore throat, painful ulcerations, painful or difficult swallowing.	Indicate ‘Yes’, if the patient had symptoms of mucosal oropharyngeal lesions between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_oropharles	radio	Oro-pharyngeal ulcerated lesion (active)	1, Yes | 0, No | 99, Unknown					[lesion_orophar]=’1’		This refers to active ulcerated mucosal lesions in the area between the soft palate and the upper portion of the epiglottis.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_head	radio	Are there any lesions on the head, face or neck?	1, Yes | 0, No | 99, Unknown					[lesion_skinles]=’1’		This refers to presence of skin lesions involving the head, face or neck.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_head_type	checkbox	Type of head, face or neck lesions	1, Vesicle | 2, Pustule | 3, Ulcerated lesions | 4, Necrotising lesions | 5, Fungating lesions | 6, Haemorrhagic lesions | 88, Other					[lesion_head]=’1’		This refers to the type of skin lesions involving the head, face or neck. Vesicle refers to raised lesion and filled with clear fluid. Pustule refers to raised lesion and filed with pus, an opaque fluid. Ulcerated lesion refers to a lesion with break in the skin. Necrotising lesion refers to a lesion with necrotic (dead) tissue. Fungating lesion refers to a lesion from underlying tissues which is breaking through the skin’s surface.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_head_type_oth	text	Specify other type of head, face or neck lesions						[lesion_head_type(88)]=’1’		This refers to the type of skin lesions involving the head, face or neck.	If ‘Other’. Write the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_head_num	text	Number of head, face or neck lesions						[lesion_head]=’1’		This refers to the number of skin lesions involving the head, face or neck.	Write the number of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_ocular	radio	Are there any ocular lesions within the orbit?	1, Yes | 0, No | 99, Unknown					[lesion_skinles]=’1’	Ocular	This refers to the presence of ocular lesions.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_ocular_type	checkbox	Type of ocular lesions	1, Vesicle | 2, Pustule | 3, Ulcerated lesions | 4, Necrotising lesions | 5, Fungating lesions | 6, Haemorrhagic lesions | 88, Other					[lesion_ocular]=’1’	Ocular	This refers to the type of ocular lesion. Vesicle refers to raised lesion and filled with clear fluid. Pustule refers to raised lesion and filed with pus, an opaque fluid. Ulcerated lesion refers to a lesion with break in the skin. Necrotising lesion refers to a lesion with necrotic (dead) tissue. Fungating lesion refers to a lesion from underlying tissues which is breaking through the skin’s surface.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_ocular_type_oth	text	Specify other type of ocular lesions						[lesion_ocular_type(88)]=’1’	Ocular	This refers to the type of ocular lesion.	If ‘Other’. Write the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_ocular_num	text	Number of ocular lesions						[lesion_ocular]=’1’	Ocular	This refers to the number of ocular lesions.	Write the number of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_torso	radio	Are there any lesions on the torso / trunk?	1, Yes | 0, No | 99, Unknown					[lesion_skinles]=’1’	Skin	This refers to presence of skin lesions involving the torso / trunk.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_torso_type	checkbox	Type of torso / trunk lesions	1, Vesicle | 2, Pustule | 3, Ulcerated lesions | 4, Necrotising lesions | 5, Fungating lesions | 6, Haemorrhagic lesions | 88, Other					[lesion_torso]=’1’	Skin	This refers to the type of skin lesions involving the torso / trunk. Vesicle refers to raised lesion and filled with clear fluid. Pustule refers to raised lesion and filed with pus, an opaque fluid. Ulcerated lesion refers to a lesion with break in the skin. Necrotising lesion refers to a lesion with necrotic (dead) tissue. Fungating lesion refers to a lesion from underlying tissues which is breaking through the skin’s surface.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_torso_type_oth	text	Specify other type of torso / trunk lesions						[lesion_torso_type(88)]=’1’	Skin	This refers to the type of skin lesions involving the torso / trunk.	If ‘Other’. Write the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_torso_num	text	Number of torso / trunk lesions						[lesion_torso]=’1’	Skin	This refers to the number of skin lesions involving the torso / trunk.	Write the number of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_arms	radio	Are there any lesions on the arms and/or hands?	1, Yes | 0, No | 99, Unknown					[lesion_skinles]=’1’	Skin	This refers to presence of skin lesions involving the arms and/or hands.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_arms_type	checkbox	Type of arms / hands lesions	1, Vesicle | 2, Pustule | 3, Ulcerated lesions | 4, Necrotising lesions | 5, Fungating lesions | 6, Haemorrhagic lesions | 88, Other					[lesion_arms]=’1’	Skin	This refers to the type of skin lesions involving the arms and/or hands. Vesicle refers to raised lesion and filled with clear fluid. Pustule refers to raised lesion and filed with pus, an opaque fluid. Ulcerated lesion refers to a lesion with break in the skin. Necrotising lesion refers to a lesion with necrotic (dead) tissue. Fungating lesion refers to a lesion from underlying tissues which is breaking through the skin’s surface.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_arms_type_oth	text	Specify other type of arms / hands lesions						[lesion_arms_type(88)]=’1’	Skin	This refers to the type of skin lesions involving the arms and/or hands.	If ‘Other’. Write the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_arms_num	text	Number of arms / hands lesions						[lesion_arms]=’1’	Skin	This refers to the number of skin lesions involving the arms and/or hands.	Write the number of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_legs	radio	Are there any lesions on the legs and/or feet?	1, Yes | 0, No | 99, Unknown					[lesion_skinles]=’1’	Skin	This refers to presence of skin lesions involving the legs and/or feet.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_legs_type	checkbox	Type of legs / feet lesions	1, Vesicle | 2, Pustule | 3, Ulcerated lesions | 4, Necrotising lesions | 5, Fungating lesions | 6, Haemorrhagic lesions | 88, Other					[lesion_legs]=’1’	Skin	This refers to the type of skin lesions involving the legs and/or feet. Vesicle refers to raised lesion and filled with clear fluid. Pustule refers to raised lesion and filed with pus, an opaque fluid. Ulcerated lesion refers to a lesion with break in the skin. Necrotising lesion refers to a lesion with necrotic (dead) tissue. Fungating lesion refers to a lesion from underlying tissues which is breaking through the skin’s surface.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_legs_type_oth	text	Specify other type of legs / feet lesions						[lesion_legs_type(88)]=’1’	Skin	This refers to the type of skin lesions involving the legs and/or feet.	If ‘Other’. Write the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_legs_num	text	Number of legs / feet lesions						[lesion_legs]=’1’	Skin	This refers to the number of skin lesions involving the legs and/or feet.	Write the number of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_palm	radio	Are there any lesions on the palms?	1, Yes | 0, No | 99, Unknown					[lesion_skinles]=’1’	Skin	This refers to presence of skin lesions involving the palms.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_palm_type	checkbox	Type of palm lesions	1, Vesicle | 2, Pustule | 3, Ulcerated lesions | 4, Necrotising lesions | 5, Fungating lesions | 6, Haemorrhagic lesions | 88, Other					[lesion_palm]=’1’	Skin	This refers to the type of skin lesions involving the palms. Vesicle refers to raised lesion and filled with clear fluid. Pustule refers to raised lesion and filed with pus, an opaque fluid. Ulcerated lesion refers to a lesion with break in the skin. Necrotising lesion refers to a lesion with necrotic (dead) tissue. Fungating lesion refers to a lesion from underlying tissues which is breaking through the skin’s surface.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_palm_type_oth	text	If other: Specify other type of palm lesions						[lesion_palm_type(88)]=’1’	Skin	This refers to the type of skin lesions involving the palms.	If ‘Other’. Write the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_palm_num	text	Number of palm lesions						[lesion_palm]=’1’	Skin	This refers to the number of skin lesions involving the palms.	Write the number of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_sole	radio	Are there any lesions on the soles?	1, Yes | 0, No | 99, Unknown					[lesion_skinles]=’1’	Skin	This refers to presence of skin lesions involving the soles.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_sole_type	checkbox	Type of sole lesions	1, Vesicle | 2, Pustule | 3, Ulcerated lesions | 4, Necrotising lesions | 5, Fungating lesions | 6, Haemorrhagic lesions | 88, Other					[lesion_sole]=’1’	Skin	This refers to the type of skin lesions involving the soles. Vesicle refers to raised lesion and filled with clear fluid. Pustule refers to raised lesion and filed with pus, an opaque fluid. Ulcerated lesion refers to a lesion with break in the skin. Necrotising lesion refers to a lesion with necrotic (dead) tissue. Fungating lesion refers to a lesion from underlying tissues which is breaking through the skin’s surface.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_sole_oth	text	If other: Specify other type of sole lesions						[lesion_sole_type(88)]=’1’	Skin	This refers to the type of skin lesions involving the soles.	If ‘Other’. Write the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_sole_num	text	Number of sole lesions						[lesion_sole]=’1’	Skin	This refers to the number of involving the soles.	Write the number of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_genit	radio	Are there any lesions on the external genitalia?	1, Yes | 0, No | 99, Unknown					[lesion_skinles]=’1’	Skin	This refers to presence of skin lesions involving the external genitalia.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_genit_type	checkbox	Type of external genitalia lesions	1, Vesicle | 2, Pustule | 3, Ulcerated lesions | 4, Necrotising lesions | 5, Fungating lesions | 6, Haemorrhagic lesions | 88, Other					[lesion_genit]=’1’	Skin	This refers to the type of skin lesions involving the external genitalia. Vesicle refers to raised lesion and filled with clear fluid. Pustule refers to raised lesion and filed with pus, an opaque fluid. Ulcerated lesion refers to a lesion with break in the skin. Necrotising lesion refers to a lesion with necrotic (dead) tissue. Fungating lesion refers to a lesion from underlying tissues which is breaking through the skin’s surface.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_genit_type_oth	text	If other: Specify other type of external genitalia lesions						[lesion_genit_type(88)]=’1’	Skin	This refers to the type of skin lesions involving the external genitalia.	If ‘Other’. Write the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_genit_num	text	Number of external genitalia lesions						[lesion_genit]=’1’	Skin	This refers to the number of involving the external genitalia.	Write the number of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_peri	radio	Are there any perianal lesions?	1, Yes | 0, No | 99, Unknown					[lesion_skinles]=’1’	Skin	This refers to presence of skin lesions involving the perianal region.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_peri_type	checkbox	Type of perianal lesions	1, Vesicle | 2, Pustule | 3, Ulcerated lesions | 4, Necrotising lesions | 5, Fungating lesions | 6, Haemorrhagic lesions | 88, Other					[lesion_peri]=’1’	Skin	This refers to the type of skin lesions involving the perianal region. Vesicle refers to raised lesion and filled with clear fluid. Pustule refers to raised lesion and filed with pus, an opaque fluid. Ulcerated lesion refers to a lesion with break in the skin. Necrotising lesion refers to a lesion with necrotic (dead) tissue. Fungating lesion refers to a lesion from underlying tissues which is breaking through the skin’s surface.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_peri_type_oth	text	Specify other type of perianal lesions						[lesion_peri_type(88)]=’1’	Skin	This refers to the type of skin lesions involving the perianal region.	If ‘Other’. Write the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_peri_num	text	Number of perianal lesions						[lesion_peri]=’1’	Skin	This refers to the number of involving the perianal region.	Write the number of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_mouth	radio	Are there any lesions inside the mouth?	1, Yes | 0, No | 99, Unknown					[lesion_mucos]=’1’		This refers to presence of mucosal lesions inside the mouth (oral cavity).	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_mouth_stat	checkbox	Inside mouth lesion status	1, Causing pain | 2, Bleeding or Discharge | 3, Ulceration					[lesion_mouth]=’1’		This refers to the status of mucosal lesions in the mouth (oral cavity). A lesion causing pain is associated with an unpleasant, uncomfortable or painful sensation at the site of the lesion. A lesion which is bleeding or discharging is associated with bleeding from blood vessels or serous / purulent fluid discharge at the site of the lesion. An ulcerated lesion is associated with erosion of the mucous membrane of the mouth, showing local excavation of the surface at the site of the lesion.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_vagin	radio	Are there any lesions in the vaginal canal?	1, Yes | 0, No | 99, Unknown					[lesion_mucos]=’1’		This refers to presence of mucosal lesions in the vaginal canal.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_vagin_stat	checkbox	Vaginal canal lesion status	1, Causing pain | 2, Bleeding or Discharge | 3, Ulceration					[lesion_vagin]=’1’		This refers to the status of mucosal lesions in the vaginal canal. A lesion causing pain is associated with an unpleasant, uncomfortable or painful sensation at the site of the lesion. A lesion which is bleeding or discharging is associated with bleeding from blood vessels or serous / purulent fluid discharge at the site of the lesion. An ulcerated lesion is associated with erosion of the mucous membrane of the mouth, showing local excavation of the surface at the site of the lesion.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_rectum	radio	Are there any lesions in the rectum?	1, Yes | 0, No | 99, Unknown					[lesion_mucos]=’1’		This refers to presence of mucosal lesions in the rectum.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_rectum_stat	checkbox	Rectal lesion status	1, Causing pain | 2, Bleeding or Discharge | 3, Ulceration | 4, Tenesmus					[lesion_rectum]=’1’		This refers to the status of mucosal lesions in the rectum. A lesion causing pain is associated with an unpleasant, uncomfortable or painful sensation at the site of the lesion. A lesion which is bleeding or discharging is associated with bleeding from blood vessels or serous / purulent fluid discharge at the site of the lesion. An ulcerated lesion is associated with erosion of the mucous membrane of the mouth, showing local excavation of the surface at the site of the lesion.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_anorec	radio	Ano-rectitis	1, Yes | 0, No | 99, Unknown					[lesion_rectum]=’1’	Gastrointestinal	Defined as inflammation of the mucosal membranes of the anus and/or rectum which can be accompanied by pain or bleeding.	Indicate ‘Yes’, if the patient experienced this at any time during the date of assessment.	SNOMED	SNOMED	C0033246, Proctitis		clinical_features					1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_penis	radio	Are there any lesions on the penis?	1, Yes | 0, No | 99, Unknown					[lesion_mucos]=’1’		This refers to presence of mucosal lesions on the penis.	Indicate ‘Yes’, if there are active lesions involving this area between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_penis_stat	checkbox	Penile lesion status	1, Causing pain | 2, Bleeding or Discharge | 3, Ulceration					[lesion_penis]=’1’		This refers to the status of mucosal lesions on the penis. A lesion causing pain is associated with an unpleasant, uncomfortable or painful sensation at the site of the lesion. A lesion which is bleeding or discharging is associated with bleeding from blood vessels or serous / purulent fluid discharge at the site of the lesion. An ulcerated lesion is associated with erosion of the mucous membrane of the mouth, showing local excavation of the surface at the site of the lesion.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_othsite	radio	Other site(s)	1, Yes | 0, No | 99, Unknown					[lesion_mucos]=’1’		This refers to presence of mucosal lesions involving other site(s).	Indicate ‘Yes’, if there are active lesions involving other site(s) between 00:00 to 24:00 on day of assessment, not specified above.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_othsite_spec	text	Specify other site(s)						[lesion_othsite]=’1’		This refers to presence of mucosal lesions involving other site(s).	If ‘Yes’, write the location of mucosal lesions involving other site(s).										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_othstat	checkbox	Other site(s) lesion status	1, Causing pain | 2, Bleeding or Discharge | 3, Ulceration					[lesion_othsite]=’1’		This refers to the status of mucosal lesions involving other site(s). A lesion causing pain is associated with an unpleasant, uncomfortable or painful sensation at the site of the lesion. A lesion which is bleeding or discharging is associated with bleeding from blood vessels or serous / purulent fluid discharge at the site of the lesion. An ulcerated lesion is associated with erosion of the mucous membrane of the mouth, showing local excavation of the surface at the site of the lesion.	Select the single most appropriate option that represents the type of lesions involving this area, between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_24hr	radio	Have new skin or mucosal lesions appeared in the previous 24 hours? (may be best assessed by patients)	1, Yes | 0, No | 99, Unknown					[lesion_dailydata]=’1’		This refers to appearance of a new skin or mucosal lesion(s) in the previous 24-hours.	Indicate ‘Yes’, if new lesions have appeared in the previous 24-hours.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_sl	radio	Estimated total number of skin lesions on the body	0, None | 1, 1 | 2, 2-5 | 3, 6-9 | 4, 10-24 | 5, 25-49 | 6, 50-99 | 7, 100-250 | 8, 251-1000 | 9, >1000					[lesion_dailydata]=’1’		Document only skin lesions related to infection by pathogen of interest. Healed lesions (scab absent, fresh skin present) should not be included. Rash from erythema multiform or any other cause should not be included.	Select the single most appropriate option that best represents the number of skin lesions between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_ml	radio	Estimated total number of mucosal lesions on the body	0, None | 1, 1 | 2, 2-5 | 3, 6-9 | 4, 10-24 | 5, 25-49 | 6, 50-99 | 7, 100-250 | 8, 251-1000 | 9, >1000					[lesion_dailydata]=’1’		Document only mucosal lesions related to infection by pathogen of interest. Healed lesions (scab absent, fresh skin present) should not be included. Rash from erythema multiform or any other cause should not be included.	Select the single most appropriate option that best represents the number of mucosal lesions between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_slpain	radio	Pain at any skin lesion site(s)	1, Yes | 0, No | 99, Unknown					[lesion_dailydata]=’1’		This refers to an unpleasant, uncomfortable or painful sensation at the site(s) of the skin lesion.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_slpain_score	number	Maximal pain score, where 0 means “no pain”, and 10 means “the worst possible pain.”		number	0	10		[lesion_slpain]=’1’		This refers to the patient’s objective rating of the severity of pain at the site(s) of the lesion, on a scale of 0 to 10. Where 0 represents “no pain” and 10 represents the “worst imaginable pain”.	Indicate the patient’s rating of the severity of the pain at the site(s) of lesion.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_mlpain	radio	Pain at any mucosal lesion site(s)	1, Yes | 0, No | 99, Unknown					[lesion_dailydata]=’1’		This refers to an unpleasant, uncomfortable or painful sensation at the site(s) of the mucosal lesion.	Indicate ‘Yes’, if the patient experienced this between 00:00 to 24:00 on day of assessment.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_mlpain_score	number	Maximal pain score, where 0 means “no pain”, and 10 means “the worst possible pain.”		number	0	10		[lesion_mlpain]=’1’		This refers to the patient’s objective rating of the severity of pain at the site(s) of the lesion, on a scale of 0 to 10. Where 0 represents “no pain” and 10 represents the “worst imaginable pain”.	Indicate the patient’s rating of the severity of the pain at the site(s) of lesion.										1	1
daily	SKIN & MUCOSA ASSESSMENT: Record the information furthest from normal between 00:00 to 24:00 on day of assessment.	lesion_desc	text	Describe any other lesion complication(s)						[lesion_dailydata]=’1’		This refers to other lesion complication(s) which have not been specified above.	Describe other lesion complication(s) that occurred or were first identified between 00:00 to 24:00 on day of assessment, that have not been specified above.										1	1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_dailydata	radio	Enter Treatments & Interventions data for this date?	1, Yes | 0, No							This section refers to treatments or interventions that are typically conducted and recorded in the emergency room and/or the ward or acute medical unit to which the patient was admitted between 00:00 and 24:00 hours on day of assessment.	Indicate ‘Yes’, if treatments or interventions were conducted and recorded between 00:00 and 24:00 hours on day of assessment.								1	1			1	1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_fluid	radio	Any fluids prescribed	1, Yes | 0, No | 99, Unknown					[treat_dailydata]=’1’		This refers to any prescribed fluids (oral or intravenous), excluding those the patient consumes in a non-prescribed dietary manner.	Indicate ‘Yes’, if the patient was received oral rehydration fluids between 00:00 and 24:00 hours on day of assessment.			C44192, Administration of fluid therapy					1	1				1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_fluid_oral	radio	Oral rehydration	1, Yes | 0, No | 99, Unknown					[treat_dailydata]=’1’		This refers to oral (enteral) rehydration fluids, excluding those the patient consumes in a non-prescribed dietary manner.	Indicate ‘Yes’, if the patient received oral rehydration fluids between 00:00 and 24:00 hours on day of assessment.	SNOMED	243222002, Oral rehydration therapy (procedure)	C0029168, Oral Rehydration Therapy					1	1				1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_fluid_oralvol	text	Oral rehydration volume (mL/24 hours)						[treat_fluid_oral] = ‘1’		This refers to oral (enteral) rehydration fluids, excluding those the patient consumes in a non-prescribed dietary manner.	If ‘Yes’, record the amount of oral rehydration fluids given between 00:00 and 24:00 on day of assessment in millilitres (mL).	SNOMED	243222002, Oral rehydration therapy (procedure)	C0029168, Oral Rehydration Therapy					1	1				1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_fluid_parent	radio	Intravenous (parenteral) fluids	1, Yes | 0, No | 99, Unknown					[treat_dailydata]=’1’		This refers to intravenous fluids, adminstered via a central or peripheral catheter into the venous system, for fluid resuscitation or replacement of electrolytes, calories, vitamins, or other medical reasons. Examples: 0.9% Sodium Chloride (Normal Saline), 5% Glucose (Dextrose 5% in Water), Albumin etc.	Indicate ‘Yes’, if the patient received intravenous fluids between 00:00 and 24:00 hours on the day of assessment.	SNOMED	118431008, Fluid for intravenous administration (substance)	C2735346, Intravenous fluids administered					1	1				1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_fluid_parent_type	multi_list	Intravenous fluid type					drugs_IVfluids	[treat_fluid_parent] = ‘1’		This refers to intravenous fluids, adminstered via a central or peripheral catheter into the venous system, for fluid resuscitation or replacement of electrolytes, calories, vitamins, or other medical reasons. Examples: 0.9% Sodium Chloride (Normal Saline), 5% Glucose (Dextrose 5% in Water), Albumin etc.	Select the most appropriate option corresponding to the type of intravenous fluid(s) administered.	SNOMED	118431008, Fluid for intravenous administration (substance)	C2735346, Intravenous fluids administered					1	1				1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_fluid_cryst	number	Crystalloid volume (mL/24 hours)		number	0	30000		[treat_fluid_parent] = ‘1’		Crystalloid intravenous fluids refer to aqueous solutions of mineral salts and other small, water-soluble molecules. They are commonly used for fluid replacement or resuscitation. Examples: 0.9% Sodium Chloride (Normal Saline), Lactated Ringer (USP), 5% Glucose (Dextrose 5% in Water) etc.	Record the volume of crystalloid fluids the patient received between 00:00 and 24:00 on day of assessment in millilitres (mL).			C0056562, crystalloid solutions					1					1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_fluid_colloid	number	Colloid volume (mL/24 hours)		number	0	10000		[treat_fluid_parent] = ‘1’		Colloid intravenous fluids are solutions containing large molecules, such as proteins or polysaccharides, which remain in the bloodstream for a longer duration compared and help maintain or expand intravascular volume. Examples: albumin, gelatin etc.	Record the volume of colloid fluids the patient received between 00:00 and 24:00 on day of assessment in millilitres (mL).			C3267204, Colloid fluid replacement					1					1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_blood	radio	Blood / blood products transfusion	1, Yes | 0, No | 99, Unknown					[treat_dailydata]=’1’		This refers to a transfusion of whole blood or blood products such as packed red blood cells, platelets, fresh-frozen plasma, cryoprecipitate, fibrinogen concentrate, granulocytes etc. Excludes transfusion of human intravenous immunoglobulin.	Indicate ‘Yes’, if the patient received blood product transfusion any time between 00:00 and 24:00 hours on day of assessment. If ‘Yes’ Select the product(s) below.	SNOMED	Transfusion of blood product (procedure)	C0005841, Blood Transfusion			1		1					1				1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_blood_type	checkbox	Select all blood products that were administered.	1, Platelets | 2, Cryoprecipitate | 3, Whole blood | 4, Frozen fresh plasma | 5, Fibrinogen concentrate | 6, Packed RBC (red cell concentrate)					[treat_blood] = ‘1’		Platelets refers to the transfer of blood platelets from a donor to a recipient or reinfusion to the donor. Cryoprecipitate refers to a frozen blood product prepared from frozen plasma that contains fibrinogen (factor I), antihemophilic factor (factor VIII), factor XIII, von Willebrand factor (vWF) and fibronectin. Whole blood refers to intravenous administration of whole blood (blood that contains plasma and red blood cells) into an individual. Packed RBC refers to red blood cells from a unit of whole blood following removal of most of the plasma, leaving a unit with a haematocrit of about 6%. Fresh frozen plasma refers to the plasma that is separated from the whole blood and frozen quickly after a blood donation in order to be used for blood transfusions. Fibrinogen concentrate is a haemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.	Select the most appropriate option(s) corresponding to the blood product(s) that were administered.	SNOMED	180208003, Intravenous blood transfusion of platelets (procedure) | 256401009, Cryoprecipitate (product) | 420135007, Whole blood (substance) | 346447007, Fresh frozen plasma (product) | 23295004, Coagulation factor I (substance) | 431069006, Packed red blood cells (product)	C0086818, Platelet Transfusion | C0443121, Cryoprecipitate (product) | C0370231, whole blood | C0016709, Fresh frozen plasma | C0016006, fibrinogen | C2316467, packed red blood cells			1		1					1				1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_blood_plate	text	Platelets (units/24 hours)						[treat_blood_type(1)] = ‘1’		Platelets refers to the transfer of blood platelets from a donor to a recipient or reinfusion to the donor.	Record the number of units the patient received between 00:00 and 24:00 on day of assessment in millilitres (mL).	SNOMED	180208003, Intravenous blood transfusion of platelets (procedure)	C0086818, Platelet Transfusion					1					1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_blood_cryo	text	Cryoprecipitate (units/24 hours)						[treat_blood_type(2)]=’1’		Cryoprecipitate refers to a frozen blood product prepared from frozen plasma that contains fibrinogen (factor I), antihemophilic factor (factor VIII), factor XIII, von Willebrand factor (vWF) and fibronectin.Cryoprecipitate refers to a frozen blood product prepared from frozen plasma that contains fibrinogen (factor I), antihemophilic factor (factor VIII), factor XIII, von Willebrand factor (vWF) and fibronectin.	Record the number of units the patient received between 00:00 and 24:00 on day of assessment in millilitres (mL).	SNOMED	256401009, Cryoprecipitate (product)	C0443121, Cryoprecipitate (product)					1					1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_blood_whole	text	Whole blood volume (units/24 hours)						[treat_blood_type(3)]=’1’		Whole blood refers to intravenous administration of whole blood (blood that contains plasma and red blood cells) into an individual.	Record the number of units the patient received between 00:00 and 24:00 on day of assessment in millilitres (mL).	SNOMED	420135007, Whole blood (substance)	C0370231, whole blood			1		1					1				1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_blood_plasma	text	Frozen fresh plasma (units/24 hours)						[treat_blood_type(4)]=’1’		Fresh frozen plasma refers to the plasma that is separated from the whole blood and frozen quickly after a blood donation in order to be used for blood transfusions.	Record the number of units the patient received between 00:00 and 24:00 on day of assessment in millilitres (mL).	SNOMED	346447007, Fresh frozen plasma (product)	C0016709, Fresh frozen plasma					1					1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_blood_fibrin	text	Fibrinogen concentrate (units/24 hours)						[treat_blood_type(5)]=’1’		Fibrinogen concentrate is a haemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.	Record the number of units the patient received between 00:00 and 24:00 on day of assessment in millilitres (mL).	SNOMED	23295004, Coagulation factor I (substance)	C0016006, fibrinogen					1					1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_blood_rcc	text	Packed red blood cells (red cell concentrate) (units/24 hours)						[treat_blood_type(6)]=’1’		Packed RBC refers to red blood cells from a unit of whole blood following removal of most of the plasma, leaving a unit with a haematocrit of about 6%.	Record the number of units the patient received between 00:00 and 24:00 on day of assessment in millilitres (mL).	SNOMED	431069006, Packed red blood cells (product)	C2316467, packed red blood cells			1		1					1				1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_intravenim	radio	Intravenous immunoglobulin	1, Yes | 0, No | 99, Unknown					[treat_dailydata]=’1’		This refers to immunoglobulin preparations, containing primarily Immunoglobulin G (IgG), that are used as intravenous infusions. Examples: Octagam®, Intragam P®, KIOVIG®, Flebogamma 5% DIF®, Carimune NF®, Gamunex®, Gammagard S/D®, Gammagard Liquid®, Gammaked® and Privigen®.	Indicate ‘Yes’, if the patient received intravenous immunoglobulin between 00:00 and 24:00 hours on the day of assessment.	SNOMED		C0085297, immunoglobulins, intravenous					1				1	1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_plasmapher	radio	Plasmapheresis / plasma exchange	1, Yes | 0, No | 99, Unknown					[treat_dailydata]=’1’		Plasmapheresis (plasma exchange) refers to a procedure that separate and extracts plasma from the peripheral blood while returning the rest of the blood components to the donor.	Indicate ‘Yes’, if the patient received plasmapheresis between 00:00 and 24:00 hours on the day of assessment.	SNOMED	20720000, Plasmapheresis (procedure)	C32134, Plasmapheresis					1					1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_antibiotic	radio	Antibiotics	1, Yes | 0, No | 99, Unknown					[treat_dailydata]=’1’		Antibiotic refers to any agent(s) that selectively target bacteria. Topical preparations should not be recorded.	Indicate ‘Yes’, if the patient received antibiotics between 00:00 and 24:00 hours on day of assessment	SNOMED	281789004, Antibiotic therapy (procedure)	C279516, Antibacterial						1				1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_steroids	radio	Corticosteroids	1, Yes | 0, No | 99, Unknown					[treat_dailydata]=’1’		Corticosteroids (commonly referred to as ‘steroids’) refers to all types of therapeutic corticosteroid, made in the adrenal cortex (the outer part of the adrenal gland). They are also made in the laboratory. Examples include: prednisolone, prednisone, methyl-prednisolone, dexamethasone, hydrocortisone, fluticasone, betametasone. Topical preparations are not included, but inhaled preparations are included.	Indicate ‘Yes’, if the patient received ‘steroids’ between 00:00 and 24:00 hours on day of assessment.	SNOMED	1290388005, Systemic corticosteroid therapy (procedure)	CL55461, Therapeutic corticosteroid										1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_other	radio	Other intervention(s) or procedure(s)	1, Yes | 0, No | 99, Unknown					[treat_dailydata]=’1’		Refers to treatment with corticosteroids via a delivery method that will affect the entire body (oral, intramuscular, intravenous or inhaled). Examples: prednisolone, prednisone, methyl-prednisolone, dexamethasone, hydrocortisone, fluticasone, betametasone. Topical preparations are not included.	Indicate ‘Yes’, if the patient received systemic corticosteroid therapy between 00:00 and 24:00 hours on day of assessment.	SNOMED	1290388005, Systemic corticosteroid therapy (procedure)	CL55461, Therapeutic corticosteroid					1	1				1
daily	TREATMENTS & INTERVENTIONS: Record all interventions given between 00:00 to 24:00 on day of assessment.	treat_other_spec	text	Please specify other intervention(s) or procedure(s)						[treat_other] = ‘1’		This refers to any other specific therapeutic intervention(s) or procedure(s) not otherwise characterised that you believe may be relevant.	Indicate ‘Yes’ if other intervention(s) or procedure(s) were used between 00:00 and 24:00 hours on day of assessment.	SNOMED		C184661, Interventional procedure					1	1			1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_o2supp	radio	Supplemental oxygen	1, Yes | 0, No | 99, Unknown							This refers to any method of oxygen therapy that may be delivered via nose cannula, mask or non-invasive or invasive ventilation.	Indicate ‘Yes’, if the patient received supplemental oxygen between 00:00 and 24:00 hours on day of assessment.	SNOMED	57485005, Oxygen therapy (procedure)	C428648, Inspired oxygen concentration			1	1	1	1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_nasalprongs	radio	Nasal prongs	1, Yes | 0, No | 99, Unknown					[treat_o2supp] = ‘1’		This refers to nasal prongs or nasal cannluae which deliver oxygen through two small prongs or cannulae insterted into the nostrils.	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen to the patient between 00:00 and 24:00 hours on day of assessment.	SNOMED	261974006, Nasal prongs (physical object)	C44587, Nasal prongs			1	1	1	1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_facemask	radio	Face mask	1, Yes | 0, No | 99, Unknown					[treat_o2supp] = ‘1’		This refers to a simple oxygen face mask which is a device placed over a patient’s nose, mouth, or tracheostomy to administer oxygen to the airway.	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen to the patient between 00:00 and 24:00 hours on day of assessment.	SNOMED	261352009, Face mask (physical object)	C1299377, Oxygen administration by mask			1	1	1	1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_hfno	radio	High flow nasal oxygen	1, Yes | 0, No | 99, Unknown					[treat_o2supp] = ‘1’		This refers to high -flow nasal oxygen therapy which is a non-invasive respiratory support that delivers warmed, humidified, oxygen-enriched air to patients at flow rates greater than those typically delivered by standard-flow oxygen devices.	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen to the patient between 00:00 and 24:00 hours on day of assessment.	SNOMED		C4761117, High-flow nasal cannula oxygen therapy			1	1	1	1	1	1	1					1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_niv	radio	Non-invasive ventilation	1, Yes | 0, No | 99, Unknown					[treat_o2supp] = ‘1’		This refers to non-invasive ventilation which provides ventilatory support through the patient’s upper airway using a mask or similar device, without the need for tracheal intubation. Examples include Continuous Positive Airway Pressure (CPAP) and Biphasic Continuous Positive Airway Pressure (BiPAP).	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen to the patient between 00:00 and 24:00 hours on day of assessment.	SNOMED		C1997883, Noninvasive Ventilation			1	1	1	1	1	1	1					1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_niv_type	radio	Type of non-invasive ventilation	1, CPAP | 2, BIPAP | 99, Unknown | 88, Other					[treat_niv]=’1’		This refers to the type of non-invasive respiratory support or ventilation (NIV) used. Continuous positive airway pressure (CPAP) is a technique which uses a continuously maintains airway pressure above atmospheric pressure throughout the respiratory cycle to support spontaneous breathing activity. Biphasic Continuous Positive Airway Pressure (BPAP) uses a time-cycled change of the applied positive airway pressure level to support spontaneous breathing activity.	Select the single most appropriate option corresponding to the type of NIV used between 00:00 and 24:00 hours on day of assessment.	SNOMED		C0199451, Continuous Positive Airway Pressure | C0419004, Dual pressure spontaneous ventilation support’			1	1	1	1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_niv_type_oth	text	Specify other type of non-invasive ventilation						[treat_niv_type]=’88’		This refers to the type of non-invasive respiratory support or ventilation (NIV) used.	If ‘Other’, specify other type of non-invasive ventilation.						1	1	1	1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_imv	radio	Invasive ventilation	1, Yes | 0, No | 99, Unknown					[treat_o2supp] = ‘1’		Thsi refers to invasive mechanical ventilation (IMV) which indicates that patient has undergone tracheal intubation, to mechanically assist or replace spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs. The mode of intubation may be orotracheal, nasotracheal, or via a cricothyrotomy or tracheotomy.	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen to the patient between 00:00 and 24:00 hours on day of assessment.	SNOMED	1258985005, Invasive mechanical ventilation (regime/therapy)	C1868981, Invasive mechanical ventilation			1	1	1	1	1	1	1					1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_ecmo	radio	Extracorporeal life support therapy (ECLS) / Extracorporeal membrane oxygenation (ECMO)	1, Yes | 0, No | 99, Unknown					[treat_o2supp] = ‘1’		This refers to Extracorporeal Membrane Oxygenation (ECMO) also called to as Extracorporeal life support (ECLS) which is application of a life support system that circulates the blood through an oxygenating system, and may consist of a pump, a membrane oxygenator, and a heat exchanger.	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen to the patient between 00:00 and 24:00 hours on day of assessment.	SNOMED	233573008, Extracorporeal membrane oxygenation (procedure)	C15357, Extracorporeal Membrane Oxygenation			1	1	1	1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_ecmo_type	radio	Type of ECLS / ECMO	1, Veno-venous (VV) | 2, Veno-arterial (VA) | 99, Unknown					[treat_ecmo]=’1’		This refers to the type of Extracorporeal Membrane Oxygenation (ECMO), also called Extracorporeal life support (ECLS). Veno-venous (venous-venous) ECMO / ECLS is used to support the lungs and veno-arterial (venous-arterial) ECLS / ECMO is used to support the lungs and heart.	Select the single most appropriate option corresponding to the type of ECLS / ECMO used between 00:00 and 24:00 hours on day of assessment.	SNOMED	786453001, Venovenous extracorporeal membrane oxygenation (procedure) | 786451004, Venoarterial extracorporeal membrane oxygenation (procedure)	C519299, Venovenous ECMO | C519297, Venoarterial ECMO			1	1	1	1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_prone	radio	Prone positioning	1, Yes | 0, No | 99, Unknown							This refers to prone positioning which is the act of having the patient lying in the prone position to assist ventilation. It may be implemented for patients on invasive ventilation (intubated) as well as non-intubated or self-ventilating patients.	Indicate ‘Yes’, for any patients if they have been in the prone position to aid their ventilation at any time during admission. If ‘Yes’ Indicate what type of ventilation was occurring while prone positioning below.	SNOMED	431182000, Placing subject in prone position (procedure	CL147586, Prone ventilation			1	1		1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_prone_when	radio	When was the prone positioning?	1, During invasive ventilation | 2, Whilst self-ventilating | 99, Unknown					[treat_prone] = ‘1’		This refers to prone positioning which is the act of having the patient lying in the prone position to assist ventilation. It may be implemented for patients on invasive ventilation (intubated) as well as non-intubated or self-ventilating patients.	Specify the type of assisted ventilation administered when the patient was placed in prone position.	SNOMED	431182000, Placing subject in prone position (procedure	CL147586, Prone ventilation			1	1		1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_pao2yn	radio	PaO2 sample type	1, Arterial | 2, Capillary | 3, Venous | 99, Unknown | 0, Not done							This refers to the type of blood sample used to measure partial pressure of oxygen in blood (PaO2) using blood gas analysis.	Select the single most appropriate option corresponding to the type of blood sample used to measure partial pressure of oxygen.	SNOMED	122552005, Arterial blood specimen (specimen) | 28520004, Venous blood specimen (specimen) | 122554006, Capillary blood specimen (specimen)	C444253, Arterial blood specimen | C444255, Venous blood specimen | C444254, Capillary blood specimen (specimen)			1	1	1	1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_pao2	number	PaO2		number	2.53	450		[treat_pao2yn] = ‘1’ or [treat_pao2yn] = ‘2’ or [treat_pao2yn] = ‘3’		Record the lowest PaO2 that was measured between 00:00 and 24:00 hours on day of assessment.	Record the lowest PaO2 that was measured between 00:00 and 24:00 hours on day of assessment.						1	1		1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_pao2_units	radio	PaO2 (select units)	1, mmHg | 2, kPa	units				[treat_pao2yn] = ‘1’ or [treat_pao2yn] = ‘2’ or [treat_pao2yn] = ‘3’									1	1		1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_pao2_kpa	number	PaO2 (kPa)		number	2.53	60		[treat_pao2yn] = ‘1’ or [treat_pao2yn] = ‘2’ or [treat_pao2yn] = ‘3’		Record the lowest PaO2 that was measured between 00:00 and 24:00 hours on day of assessment.	Record the lowest PaO2 (in kPa) that was measured between 00:00 and 24:00 hours on day of assessment.	SNOMED	250546000, Measurement of partial pressure of oxygen in blood (procedure)	C1318112, Partial pressure of oxygen in blood			1	1	1		1		1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_pao2_mmhg	number	PaO2 (mmHg)		number	19	450		[treat_pao2yn] = ‘1’ or [treat_pao2yn] = ‘2’ or [treat_pao2yn] = ‘3’		Record the lowest PaO2 that was measured between 00:00 and 24:00 hours on day of assessment.	Record the lowest PaO2 (in mmHg) that was measured between 00:00 and 24:00 hours on day of assessment.	SNOMED	250546000, Measurement of partial pressure of oxygen in blood (procedure)	C1318112, Partial pressure of oxygen in blood			1	1	1		1		1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_highfio	number	FiO2 at time of PaO2		number	0.21	100		[treat_pao2yn] = ‘1’ or [treat_pao2yn] = ‘2’ or [treat_pao2yn] = ‘3’		This refers to the measured fraction of inspired oxygen (FiO2) delivered at the time of the lowest PaO2 (partial pressure of oxygen in blood).	Write the FiO2 at time of the lowest PaO2 (recorded above) that occurred any time between 00:00 and 24:00 on day of assessment.	SNOMED	250774007, Inspired oxygen concentration (observable entity)	C428648, Inspired oxygen concentration			1	1	1	1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_highfio_units	radio	FiO2 at time of PaO2 (select units)	1, Fraction, 0.21-1.0 | 2, %, 21-100	units				[treat_pao2yn] = ‘1’ or [treat_pao2yn] = ‘2’ or [treat_pao2yn] = ‘3’				SNOMED	250774007, Inspired oxygen concentration (observable entity)	C428648, Inspired oxygen concentration			1	1	1	1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_highfio_02110	number	FiO2 at time of PaO2 (Fraction, 0.21-1.0)		number	0.21	1		[treat_pao2yn] = ‘1’ or [treat_pao2yn] = ‘2’ or [treat_pao2yn] = ‘3’		This refers to the measured fraction of inspired oxygen (FiO2) delivered at the time of the lowest PaO2 (partial pressure of oxygen in blood).	Write the FiO2 at time of the lowest PaO2 (recorded above), expressed as a fraction, that occurred any time between 00:00 and 24:00 on day of assessment.	SNOMED	250774007, Inspired oxygen concentration (observable entity)	C428648, Inspired oxygen concentration			1	1	1		1		1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_highfio_pcnt	number	FiO2 at time of PaO2 (%, 21-100)		number	21	100		[treat_pao2yn] = ‘1’ or [treat_pao2yn] = ‘2’ or [treat_pao2yn] = ‘3’		This refers to the measured fraction of inspired oxygen (FiO2) delivered at the time of the lowest PaO2 (partial pressure of oxygen in blood).	Write the FiO2 at time of the lowest PaO2 (recorded above), expressed as a percentage, that occurred any time between 00:00 and 24:00 on day of assessment.	SNOMED	250774007, Inspired oxygen concentration (observable entity)	C428648, Inspired oxygen concentration			1	1	1		1		1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_o2supp_oth	radio	Other respiratory support intervention(s) or procedure(s)	1, Yes | 0, No | 99, Unknown							This refers to any other specific respiratory support intervention(s) or procedure(s) not otherwise characterised that you believe may be relevant.	Indicate ‘Yes’ if other respiratory support intervention(s) or procedure(s) were used between 00:00 and 24:00 hours on day of assessment.	SNOMED		C184661, Interventional procedure			1		1	1	1	1	1
daily	RESPIRATORY SUPPORT: Record all respiratory interventions given between 00:00 to 24:00 on day of assessment.	treat_o2supp_oth_spec	text	Please specify other respiratory support intervention(s) or procedure(s)						[treat_o2supp_oth] = ‘1’		This refers to any other specific respiratory support intervention(s) or procedure(s) not otherwise characterised that you believe may be relevant.	If ‘Yes’, please specify the respiratory support intervention(s) or procedure(s) not otherwise characterised that you believe may be relevant.	SNOMED		C184661, Interventional procedure			1		1	1	1	1	1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_critcare	radio	Were advanced care (including acute organ support and critical care) therapeutic interventions administered on this date?	1, Yes | 0, No | 99, Unknown							This refers to any advanced care (including acute organ support and critical care) therapeutic intervention(s) that were administered between 00:00 and 24:00 hours on day of assessment. This section does not include any respiratory organ support intervention(s), which are recorded seperately.	Indicate ‘Yes’, if any advanced care (including acute organ support and critical care) therapeutic intervention(s) or procedure(s) were administered between 00:00 and 24:00 hours on day of assessment.						1	1	1	1	1	1	1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_icu	radio	ICU / ITU / HDU / Intermediate Care Unit admission	1, Yes | 0, No | 99, Unknown					[critd_critcare]=’1’		This refers to admission of the patient to intensive care units (ICU), intensive therapy/treatment units (ITU), critical care units, high dependency units (HDU) or unit of similar level between 00:00 and 24:00 hours on day of assessment.	Indicate ‘Yes’, if the patient was admitted to ICU (or unit of similar level) between 00:00 and 24:00 hours on day of assessment.	SNOMED	305351004, Admission to intensive care unit (procedure)				1	1	1	1	1	1	1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_neuromusc	radio	Neuromuscular blocking agents	1, Yes | 0, No | 99, Unknown					[critd_critcare]=’1’		This refers to the use of neuromuscular blockers between 00:00 and 24:00 hours on day of assessment.. Examples include Atracurium, Cisatracurium, Nimbex etc.	Indicate ‘Yes’, if neuromuscular blockers were used between 00:00 and 24:00 hours on day of assessment.	SNOMED	373295003, Neuromuscular blocking agent (substance)	C27866, Neuromuscular Blocking Agents			1	1	1	1	1	1	1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_nitricoxide	radio	Inhaled nitric oxide	1, Yes | 0, No | 99, Unknown					[critd_critcare]=’1’		This refers to nitric oxide adminstered as in inhalant, typically used to manage hypoxic respiratory failure in patients.	Indicate ‘Yes’ if inhaled nitric oxide was used any time between 00:00 and 24:00 hours on day of assessment.	SNOMED	1255879001, Administration of nitric oxide (procedure)	C1135443, Administration of inhaled nitric oxide			1	1	1	1	1	1	1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_tracheostmy	radio	Tracheostomy inserted	1, Yes | 0, No | 99, Unknown					[critd_critcare]=’1’		This refers to the surgical formation of an opening into the trachea through the neck, or the opening so created.	Indicate ‘Yes’ if a tracheostomy was inserted at any time between 00:00 and 24:00 on day of assessment.	SNOMED	232685002, Insertion of tracheostomy tube (procedure)	C39663, Insertion of tracheostomy tube			1	1		1	1	1	1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_rtt	radio	Renal replacement therapy (RRT) or dialysis / hemofiltration	1, Yes | 0, No | 99, Unknown					[critd_critcare]=’1’		This refers to treatments that substitute for the blood-filtering function of the kidneys. They may be adminstered to patients intermittently or continuously and include dialysis (hemodialysis or peritoneal dialysis), hemofiltration, and hemodiafiltration.	Indicate ‘Yes’ if renal replacement therapy was done any time between 00:00 and 24:00 on day of assessment.	SNOMED	714749008, Continuous renal replacement therapy (procedure)	C3649547, Continuous Renal Replacement Therapy | C5197699, Prolonged Intermittent Renal Replacement Therapy			1	1	1	1	1	1	1					1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_rtt_typ	radio	Type of renal replacement therapy (RRT) or dialysis / hemofiltration	1, Intermittent | 2, Continuous | 99, Unknown					[critd_rtt]=’1’		This refers to the mode of administering renal replacement therapy (RRT) (dialysis (hemodialysis or peritoneal dialysis), hemofiltration, or hemodiafiltration). Intermittent RRT refers to procedures with non-continuous blood purification via vascular access by increasing blood flow rate. Continuous RRT refers to procedures with continuous blood purification via vascular access designed to mimic kidney function in kidney diseases.	Select the single most appropriate option corresponding to the type of renal replacement therapy (RRT) or dialysis / hemofiltration.	SNOMED	714749008, Continuous renal replacement therapy (procedure) | 895382009, Prolonged intermittent renal replacement therapy (procedure)	C3649547, Continuous Renal Replacement Therapy | C5197699, Prolonged Intermittent Renal Replacement Therapy			1	1	1	1	1	1	1					1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_vasopress	radio	Any vasopressor / inotropic support	1, Yes | 0, No | 99, Unknown					[critd_critcare]=’1’		This refers to continuous use of a vasopressor or inotrope for at least one hour. A vasopressor is a pharmaceutical agent that causes vasoconstriction. Examples: norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. An inotrope is a pharmaceutical agent that alters the force of myocardial contractility. Examples of common ‘positive’ inotropes: dobutamine, dopamine, milrinone and epinephrine.	Indicate ‘Yes’, if this agent was used for at least one hour between 00:00 and 24:00 hours on day of assessment. Indicate the amount used below.	SNOMED	870386000, Vasopressor therapy (procedure)	C5396785, Vasopressor therapy | C588944, Inotropic therapy			1	1	1	1	1	1	1			1		1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_vasopress_reas	checkbox	Reason for vasopressor / inotrope use	1, Shock | 2, Persistent hypotension | 88, Other | 99, Unknown					[critd_vasopress] = ‘1’		This refers to the reason for vasopressor or inotrope use. Shock is defined as circulatory failure with inadequate oxygen delivery to tissues and is assessed by measuring objective haemodynamic parameters, including pulse pressure, systolic blood pressure, and clinical sigs of hypoperfusion. A patient is classified as having shock if they meet the following objective haemodynamic markers: EITHER - pulse pressure <= 20mmHg or shock index (heart rate / SBP) >= 1.0 in adults and children > 5 years; OR SBP below absolute cutoffs: adults SBP < 90mmHg or MAP < 60; children < 1 year: SBP <70 mmHg; 1-10 years: SBP < [70 + (2 * age in years)]mmHg; > 10 years: SBP < 90mmHg; AND objective evidence of hypoperfusion with at least one of the following: peripheral CRT > 2s; urine output < 0.5 ml/kg/hr for >= 6 hours (if feasible); cold/clammy peripheries; or agitation or altered mental state. Persistent hypotension is confirmed when additional fluid boluses (>= 10ml/kg per bolus) or continuous IV fluids at >= 2 times maintenance rate are required (patients whose hypotension resolves after a single bolus or those with hypotension due to non-infectious causes (e.g. haemorrhage, cardiogenic shock) are excluded from this definition).	Select the most appropriate option(s) which represent the reason(s) for vasopressor / inotrope use.						1		1	1								1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_vasopress_reasoth	text	Specify other reason for vaspressor / inotrope use						[critd_vasopress_reas(88)] = ‘1’		This refers to the reason for vasopressor or inotrope use.	If ‘Other’, specify the reason for vasopressor or inotrope use.						1		1	1								1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_vasopress1	radio	Dopamine < 5ug/kg/min OR dobutamine OR milrinone OR levosimendan	1, Yes | 0, No | 99, Unknown					[critd_vasopress] = ‘1’		This refers to the type of vasopressors used.	Indicate ‘Yes’, if this agent(s) was used for at least one hour between 00:00 and 24:00 hours on day of assessment.									1		1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_vasopress2	radio	Dopamine 5-15ug/kg/min OR epinephrine(adrenaline) / norepinephrine(noradrenaline) <0.1ug/kg/min OR vasopressin OR phenylephrine	1, Yes | 0, No | 99, Unknown					[critd_vasopress] = ‘1’		This refers to the type of vasopressors used.	Indicate ‘Yes’, if this agent(s) was used for at least one hour between 00:00 and 24:00 hours on day of assessment.									1		1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_vasopress3	radio	Dopamine >15ug/kg/min OR epinephrine(adrenaline) / norepinephrine(noradrenaline) >0 .1ug/kg/min	1, Yes | 0, No | 99, Unknown					[critd_vasopress] = ‘1’		This refers to the type of vasopressors used.	Indicate ‘Yes’, if this agent(s) was used for at least one hour between 00:00 and 24:00 hours on day of assessment.									1		1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_vasopress_type	checkbox	Vasopressor / Inotropic support type	1, Dopamine (<5ug/kg/min) | 2, Dopamine (5-15ug/kg/min) | 3, Dopamine (>15ug/kg/min) | 4, Norepinephrine (noradrenaline) < 0.1ug/kg/min | 5, Norepinephrine (noradrenaline) > 0.1ug/kg/min |6, Epinephrine (adrenaline) | 7, Dobutamine | 8, Milrinone | 9, Levosimendan | 10, Vasopressin|11,Phenylephrine| 12,Terlipressin |13,Angiotensin-II					[critd_vasopress] = ‘1’		This refers to the type of vasopressors used.	Select the most appropriate option(s) if these agent(s) were used for at least one hour between 00:00 and 24:00 hours on day of assessment.						1	1	1	1	1		1					1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_critcareunlst	radio	Other advanced care intervention(s) or procedure(s)	1, Yes | 0, No | 99, Unknown					[critd_critcare]=’1’		This refers to any other specific advanced care (including acute organ support and critical care) therapeutic intervention(s) or procedure(s) not otherwise characterised that you believe may be relevant.	Indicate ‘Yes’ if other advanced care intervention(s) or procedure(s) were used between 00:00 and 24:00 hours on day of assessment.							1		1			1
daily	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given between 00:00 to 24:00 on day of assessment.	critd_critcareunlst_oth	text	Please specify other advanced care intervention(s) or procedure(s)						[critd_critcareunlst] = ‘1’		This refers to any other advanced care (including acute organ support and critical care) therapeutic intervention(s) or procedure(s) not otherwise characterised that you believe may be relevant.	If ‘Yes’, please specify the advanced care therapeutic intervention(s) or procedure(s)not otherwise characterised that you believe may be relevant.							1		1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_dailydata	radio	Enter Laboratory Results data for this date?	1, Yes | 0, No							This section refers only to laboratory tests performed at the time the patient stayed in the clinical facility (hospital) and collected on the date of assessment. In general, results that were rejected by the clinical team (e.g. haemolysed blood samples, contaminated microbiology results) should not be reported.	Indicate ‘Yes’, if laboratory samples were taken on the date of assessment. If no laboratory samples were taken on the date of assessment indicate ‘No’ and skip to the next section. In general, do not report results that have been rejected by the clinical team (e.g. haemolysed sample). Unless otherwise specified, if there are multiple measurements, please report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.						1	1	1	1	1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_fbc	descriptive	Full blood count						[labs_dailydata]=’1’		This refers to results from full blood count.	Indicate ‘Yes’ to enter full blood count results.						1	1	1		1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_haemo	number	Haemoglobin		number	0	2000		[labs_dailydata]=’1’	Full Blood Count	Refers to the haemoglobin concentration in blood.	Write haemoglobin concentration level. If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.					clinical_features	1	1	1	1	1	1	1	1				1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_haemo_units	radio	Haemoglobin (select units)	1, g/dL | 2, g/L	units				[labs_dailydata]=’1’	Full Blood Count							clinical_features	1	1	1	1	1	1	1					1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_haemo_gdl	number	Haemoglobin (g/dL)		number	0	200		[labs_dailydata]=’1’	Full Blood Count	Refers to the haemoglobin concentration in blood.	Write haemoglobin concentration level (g/dL). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	250220000, Hemoglobin finding (finding)	C0518015, Hemoglobin measurement		clinical_features	1	1	1		1	1	1	1				1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_haemo_gl	number	Haemoglobin (g/L)		number	0	2000		[labs_dailydata]=’1’	Full Blood Count	Refers to the haemoglobin concentration in blood.	Write haemoglobin concentration level (g/L). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	250220000, Hemoglobin finding (finding)	C0518015, Hemoglobin measurement		clinical_features	1	1	1		1	1	1	1				1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_wbccount	number	White blood cell (WBC) count (10^9/L)		number	0	300		[labs_dailydata]=’1’	Full Blood Count	Refers to the total white blood cell count in blood.	Write the total white blood cell (WBC) count (10^9/L). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	767002, White blood cell count (procedure)	C0023508, White Blood Cell Count procedure		clinical_features	1	1	1	1	1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_neutrophil	number	Neutrophils		number	0	100		[labs_dailydata]=’1’	Full Blood Count	Refers to the neutrophil count in blood.	Write the neutrophil count. If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.					clinical_features	1	1	1	1	1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_neutrophil_units	radio	Neutrophils (select units)	1, % | 2, 10^9/L	units				[labs_dailydata]=’1’	Full Blood Count							clinical_features	1	1	1	1	1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_neutrophil_109l	number	Neutrophils (10^9/L)		number	0.2	50		[labs_dailydata]=’1’	Full Blood Count	Refers to the neutrophil count in blood.	Write the neutrophil count (10^9/L). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	30630007, Neutrophil count (procedure)	C0200633, Neutrophil count (procedure)		clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_neutrophil_pcnt	number	Neutrophils (%)		number	0	100		[labs_dailydata]=’1’	Full Blood Count	Refers to the neutrophil count in blood.	Write the neutrophil count (%). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	30630007, Neutrophil count (procedure)	C0200633, Neutrophil count (procedure)		clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_lymphocyte	number	Lymphocytes		number	0	100		[labs_dailydata]=’1’	Full Blood Count	Refers to the lymphocyte count in blood.	Write the Lymphocyte count. If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.					clinical_features	1	1	1	1	1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_lymphocyte_units	radio	Lymphocytes (select units)	1, % | 2, 10^9/L	units				[labs_dailydata]=’1’	Full Blood Count							clinical_features	1	1	1	1	1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_lymphocyte_109l	number	Lymphocytes (10^9/L)		number	0.1	15		[labs_dailydata]=’1’	Full Blood Count	Refers to the lymphocyte count in blood.	Write the Lymphocyte count (10^9/L). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	74765001, Lymphocyte count (procedure)	C0200635, Lymphocyte count (procedure)		clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_lymphocyte_pcnt	number	Lymphocytes (%)		number	0	100		[labs_dailydata]=’1’	Full Blood Count	Refers to the lymphocyte count in blood.	Write the Lymphocyte count (%). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	74765001, Lymphocyte count (procedure)	C0200635, Lymphocyte count (procedure)		clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_eosinophil	number	Eosinophils		number	0	100		[labs_dailydata]=’1’	Full Blood Count	Refers to the eosinophil count in blood.	Write the eosinophil count. If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.					clinical_features		1		1	1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_eosinophil_units	radio	Eosinophils (select units)	1, % | 2, 10^9/L	units				[labs_dailydata]=’1’	Full Blood Count							clinical_features		1		1	1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_eosinophil_109l	number	Eosinophils (10^9/L)		number	0	5		[labs_dailydata]=’1’	Full Blood Count	Refers to the eosinophil count in blood.	Write the eosinophil count (10^9/L). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	71960002, Eosinophil count (procedure)	C0200638, Eosinophil count (procedure)		clinical_features		1			1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_eosinophil_pcnt	number	Eosinophils (%)		number	0	100		[labs_dailydata]=’1’	Full Blood Count	Refers to the eosinophil count in blood.	Write the eosinophil count (%). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	71960002, Eosinophil count (procedure)	C0200638, Eosinophil count (procedure)		clinical_features		1			1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_hematocrit	number	Haematocrit		number	0	100		[labs_dailydata]=’1’	Full Blood Count	Haematocrit (Ht or HCT), also known as packed cell volume (PCV) or erythrocyte volume fraction (EVF), is the volume of red blood cells in a blood specimen.	Write the haematocrit. If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.					clinical_features	1	1	1	1	1	1	1	1				1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_hematocrit_units	radio	Haematocrit (select units)	1, % | 2, L/L	units				[labs_dailydata]=’1’	Full Blood Count							clinical_features	1	1	1	1	1	1	1					1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_hematocrit_pcnt	number	Haematocrit (%)		number	0	100		[labs_dailydata]=’1’	Full Blood Count	Haematocrit (Ht or HCT), also known as packed cell volume (PCV) or erythrocyte volume fraction (EVF), is the volume of red blood cells in a blood specimen.	Write the haematocrit (%). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	365618006, Finding of hematocrit - packed cell volume level (finding)	C0518014, Hematocrit level		clinical_features	1	1	1		1	1	1	1				1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_hematocrit_ll	number	Haematocrit (L/L)		number	0	1		[labs_dailydata]=’1’	Full Blood Count	Haematocrit (Ht or HCT), also known as packed cell volume (PCV) or erythrocyte volume fraction (EVF), is the volume of red blood cells in a blood specimen.	Write the haematocrit (L/L). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	365618006, Finding of hematocrit - packed cell volume level (finding)	C0518014, Hematocrit level		clinical_features	1	1	1		1	1	1	1				1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_platelets	number	Platelets		number	0	1659		[labs_dailydata]=’1’	Full Blood Count	Refers to the platelet count in blood.	Write the platelet count. If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.					clinical_features	1	1	1	1	1	1	1	1			1	1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_platelets_units	radio	Platelets (select units)	1, 10^9/L | 2, 10^3/µL	units				[labs_dailydata]=’1’	Full Blood Count							clinical_features	1	1	1	1	1	1	1				1	1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_platelets_109l	number	Platelets (10^9/L)		number	0	1659		[labs_dailydata]=’1’	Full Blood Count	Refers to the platelet count in blood.	Write the platelet count (10^9/L). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	365632008, Finding of platelet count (finding)	C0032181, Platelet count (procedure)		clinical_features	1	1	1		1	1	1	1			1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_platelets_103ul	number	Platelets (10^3/µL)		number	0	1659		[labs_dailydata]=’1’	Full Blood Count	Refers to the platelet count in blood.	Write the platelet count (10^3/L). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	365632008, Finding of platelet count (finding)	C0032181, Platelet count (procedure)		clinical_features	1	1	1		1	1	1	1			1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_erymeancorvol	number	Ery. mean corpuscular volume (MCV) (fL)		number	0	150		[labs_dailydata]=’1’	Full Blood Count	Refers to the average volume of a red blood cell in a blood specimen.	Write the MCV (fL)	SNOMED	104133003, Erythrocyte mean corpuscular volume determination (procedure)	C0524587, Mean Corpuscular Volume		clinical_features
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_erymeancorhgb	number	Ery. mean corpuscular haemoglobin concentration (MCHC)		number	0	450		[labs_dailydata]=’1’	Full Blood Count	Refers to the average concentration of hemoglobin per red blood cell in a blood specimen.	Write the mean corpuscular hemaglobin concentration.
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_erymeancorhgb_units	radio	Ery. mean corpuscular haemoglobin concentration (MCHC) (select units)	1, g/L | 2, g/dL	units				[labs_dailydata]=’1’	Full Blood Count
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_erymeancorhgb_gl	number	Ery. mean corpuscular haemoglobin concentration (MCHC) (g/L)		number	0	450		[labs_dailydata]=’1’	Full Blood Count	Refers to the average concentration of hemoglobin per red blood cell in a blood specimen.	Write the mean corpuscular hemaglobin concentration (g/L).	SNOMED	37254006, Mean corpuscular hemoglobin concentration determination (procedure)	C0474535, Mean corpuscular hemoglobin concentration determination		clinical_features
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_erymeancorhgb_gdl	number	Ery. mean corpuscular haemoglobin concentration (MCHC) (g/dL)		number	0	45		[labs_dailydata]=’1’	Full Blood Count	Refers to the average concentration of hemoglobin per red blood cell in a blood specimen.	Write the mean corpuscular hemaglobin concentration (g/dL).	SNOMED	37254006, Mean corpuscular hemoglobin concentration determination (procedure)	C0474535, Mean corpuscular hemoglobin concentration determination		clinical_features
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_erymeancorhe	number	Ery. mean corpuscular haemoglobin (MCH) (pg)		number	0	45		[labs_dailydata]=’1’	Full Blood Count	Refers to the average amount (mass) of hemoglobin per red blood cell in a blood specimen.	Write the mean corpuscular hemaglobin concentration (pg).	SNOMED	54706004, Mean corpuscular hemoglobin determination (procedure)	C0369183, Mean corpuscular hemoglobin determination		clinical_features
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_coag	descriptive	Coagulation profile						[labs_dailydata]=’1’	Coagulation	This refers to results from coagulation profile	Indicate ‘Yes’ to enter coagulation profile results						1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_prothrombin	number	Prothrombin Time (PT) (s)		number	0	100		[labs_dailydata]=’1’	Coagulation	Refers to the time it takes for blood plasma to clot. It evaluates the extrinsic and common pathways of blood clotting.	Write the PT (seconds).	SNOMED	396451008, Prothrombin time (procedure)	C0033707, Prothrombin time (procedure)		clinical_features	1	1	1	1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_aptt	number	Activated Partial Thromboplastin Time (APTT) (s)		number	0	300		[labs_dailydata]=’1’	Coagulation	Refers to the time it takes for clotting to occur when activating reagents are added to a plasma specimen. It evaluates the intrinsic and common pathways of blood clotting.	Write the APTT (sec).	SNOMED	42525009, Partial thromboplastin time, activated (procedure)	C1318441, Activated partial thromboplastin time result		clinical_features	1	1	1	1			1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_aptr	number	Activated Partial Thromboplastin Time Ratio (APTR)		number	0	10		[labs_dailydata]=’1’	Coagulation	Refers to the activated partial thromboplastin ratio which is calculated by dividing the patient’s aPTT result by the mean normal aPTT value for the laboratory. The result is a ratio and therefore has no units.	Write the APTR.	SNOMED	391085004, Activated partial thromboplastin time ratio (procedure)	C1272061, Activated partial thromboplastin time ratio		clinical_features	1		1	1			1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_tqinr	number	International Normalized Ratio (INR)		number	0	15		[labs_dailydata]=’1’	Coagulation	Refers to international normalised ratio (INR), which is used to standardize prothrombin time (PT) results and is derived from the ratio of a patient’s PT to a control PT, adjusted for the sensitivity of the thromboplastin reagent. The result is a ratio and therefore has no units.	Write the serum INR.	SNOMED	165581004, International normalized ratio (observable entity)	C0525032, International Normalized Ratio		clinical_features	1	1	1	1	1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_fibrinogen	number	Fibrinogen		number	0	1500		[labs_dailydata]=’1’	Coagulation	Fibrinogen is a fibrillar protein present in blood plasma; it converts to fibrin during the process of blood clot formation.	Write the serum Fibrinogen.					clinical_features	1	1	1	1			1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_fibrinogen_units	radio	Fibrinogen (select units)	1, g/L | 2, mg/dL	units				[labs_dailydata]=’1’	Coagulation							clinical_features	1	1	1	1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_fibrinogen_gl	number	Fibrinogen (g/L)		number	0	15		[labs_dailydata]=’1’	Coagulation	Fibrinogen is a fibrillar protein present in blood plasma; it converts to fibrin during the process of blood clot formation.	Write the serum Fibrinogen (g/L).	SNOMED	250346004, Fibrinogen measurement (procedure)	C0337428, Fibrinogen measurement		clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_fibrinogen_mgdl	number	Fibrinogen (mg/dL)		number	0	1500		[labs_dailydata]=’1’	Coagulation	Fibrinogen is a fibrillar protein present in blood plasma; it converts to fibrin during the process of blood clot formation.	Write the serum Fibrinogen (mg/dL).	SNOMED	250346004, Fibrinogen measurement (procedure)	C0337428, Fibrinogen measurement		clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ddimer	number	D-Dimer		number	0	67000		[labs_dailydata]=’1’	Coagulation	D-Dimer is a measure for the concentration of fibrin degradation products (FDPs) in a sample. FDPs are protein fragments produced by the enzymatic action of plasmin on fibrinogen and fibrin) and are an aid in detecting the presence and degree of intravascular coagulation and fibrinolysis (the dissolution of the fibrin in a blood clot) and in monitoring therapy for disseminated intravascular coagulation (nonlocalized clotting in the blood vessels).	Write the serum D-dimer.					clinical_features	1	1	1	1			1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ddimer_units	radio	D-Dimer (select units)	1, µg/L | 2, mg/L	units				[labs_dailydata]=’1’	Coagulation							clinical_features	1	1	1	1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ddimer_mgl	number	D-Dimer (mg/L)		number	0	67		[labs_dailydata]=’1’	Coagulation	D-Dimer is a measure for the concentration of fibrin degradation products (FDPs) in a sample. FDPs are protein fragments produced by the enzymatic action of plasmin on fibrinogen and fibrin) and are an aid in detecting the presence and degree of intravascular coagulation and fibrinolysis (the dissolution of the fibrin in a blood clot) and in monitoring therapy for disseminated intravascular coagulation (nonlocalized clotting in the blood vessels).	Write the serum D-dimer (mg/L)	SNOMED	70648006, D-dimer assay (procedure)	C0200462, D-dimer assay		clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ddimer_ugl	number	D-Dimer (µg/L)		number	0	67000		[labs_dailydata]=’1’	Coagulation	D-Dimer is a measure for the concentration of fibrin degradation products (FDPs) in a sample. FDPs are protein fragments produced by the enzymatic action of plasmin on fibrinogen and fibrin) and are an aid in detecting the presence and degree of intravascular coagulation and fibrinolysis (the dissolution of the fibrin in a blood clot) and in monitoring therapy for disseminated intravascular coagulation (nonlocalized clotting in the blood vessels).	Write the serum D-dimer (ug/L)	SNOMED	70648006, D-dimer assay (procedure)	C0200462, D-dimer assay		clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_liver	descriptive	Liver profile						[labs_dailydata]=’1’	Liver profile	This refers to results from liver profile	Indicate ‘Yes’ to enter liver profile testing results						1	1	1		1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_bilirubin	number	Total bilirubin		number	0	750		[labs_dailydata]=’1’	Liver profile	This refers to a measurement of the total concentration of bilirubin in blood.	Write the Bilirubin.					clinical_features	1	1	1	1	1	1	1	1			1	1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_bilirubin_units	radio	Total bilirubin (select units)	1, µmol/L | 2, mg/dL	units				[labs_dailydata]=’1’	Liver profile							clinical_features	1	1	1	1	1	1	1				1	1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_bilirubin_umoll	number	Total bilirubin (µmol/L)		number	0	750		[labs_dailydata]=’1’	Liver profile	This refers to a measurement of the total concentration of bilirubin in blood.	Write the Bilirubin (umol/L).	SNOMED	359986008, Bilirubin, total measurement (procedure)	C0201913, Bilirubin, total measurement		clinical_features	1	1	1		1	1	1	1			1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_bilirubin_mgdl	number	Total bilirubin (mg/dL)		number	0	43.9		[labs_dailydata]=’1’	Liver profile	This refers to a measurement of the total concentration of bilirubin in blood.	Write the Bilirubin (mg/dL).	SNOMED	359986008, Bilirubin, total measurement (procedure)	C0201913, Bilirubin, total measurement		clinical_features	1	1	1		1	1	1	1			1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_altsgpt	number	Alanine aminotransferase (ALT) / SGPT (U/L)		number	0	20000		[labs_dailydata]=’1’	Liver profile	Alanine aminotransferase (ALT), also referred to as serum glutamic-pyruvic transaminase (SGPT), level in blood.	Write the ALT or SGPT (U/L).	SNOMED	34608000, Alanine aminotransferase measurement (procedure)	C0201836, Alanine aminotransferase measurement		clinical_features	1	1	1	1	1	1	1	1				1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_astsgot	number	Aspartate aminotransferase (AST) / SGOT (U/L)		number	0	20000		[labs_dailydata]=’1’	Liver profile	Aspartate aminotransferase (AST), also referred to serum glutamic-oxaloacetic transaminase (SGOT)m level in blood.	Write the AST or SGOT (U/L).	SNOMED	45896001, Aspartate aminotransferase measurement (procedure)	C0201899, Aspartate aminotransferase measurement		clinical_features	1	1	1	1	1	1	1	1				1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_alp	number	Alkaline phosphatase (ALP) / (IU/L)		number	0	5000		[labs_dailydata]=’1’	Liver profile	Alkaline phosphatase (ALP) level in blood.	Write the ALP (IU/L).	SNOMED	365771003, Finding of alkaline phosphatase level (finding)	C0201850, Alkaline phosphatase measurement		clinical_features		1			1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ggt	number	Gamma Glutamyl Transferase (GGT) (U/L)		number	0	1220		[labs_dailydata]=’1’	Liver profile	Gamma Glutamyl Transferase or GGT level in blood.	Write the GGT (U/L).	SNOMED	69480007, Gamma glutamyl transferase measurement (procedure)	C0202035, Gamma glutamyl transferase measurement		clinical_features		1	1	1	1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_albumin	number	Albumin		number	0	80		[labs_dailydata]=’1’	Liver profile	This refers to the measurement of albumin present in serum.	Write the serum albumin.					clinical_features		1	1	1	1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_albumin_units	radio	Albumin (select units)	1, g/L | 2, mmol/L	units				[labs_dailydata]=’1’	Liver profile							clinical_features		1	1	1	1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_albumin_gl	number	Albumin (g/L)		number	0	80		[labs_dailydata]=’1’	Liver profile	This refers to the measurement of albumin present in serum.	Write the serum albumin (g/L).	SNOMED	104485008, Albumin measurement, serum (procedure)	C0523465, Serum albumin measurement		clinical_features		1	1		1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_albumin_mmoll	number	Albumin (mmol/L)		number	0	1.2		[labs_dailydata]=’1’	Liver profile	This refers to the measurement of albumin present in serum.	Write the serum albumin (mmol/L).	SNOMED	104485008, Albumin measurement, serum (procedure)	C0523465, Serum albumin measurement		clinical_features		1	1		1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_bloodglucose	descriptive	Blood glucose						[labs_dailydata]=’1’	Liver profile	This refers to blood glucose related laboratory testing.							1		1		1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_glucose	number	Random blood glucose		number	0	1801		[labs_dailydata]=’1’	Blood glucose	This refers to the measurement of blood sugar (glucose) levels at any given time, regardless of time of last meal.	Write the random blood glucose. If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.					clinical_features	1		1	1	1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_glucose_units	radio	Random blood glucose (select units)	1, mmol/L | 2, mg/dL | 3, g/L	units				[labs_dailydata]=’1’	Blood glucose							clinical_features	1		1	1	1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_glucose_mmoll	number	Random blood glucose (mmol/L)		number	0	100		[labs_dailydata]=’1’	Blood glucose	This refers to the measurement of blood sugar (glucose) levels at any given time, regardless of time of last meal, in mmol/L.	Write the random blood glucose (mmol/L). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	271061004, Random blood glucose measurement (procedure)	C0428567, Random blood glucose measurement		clinical_features	1		1		1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_glucose_mgdl	number	Random blood glucose (mg/dL)		number	0	1801		[labs_dailydata]=’1’	Blood glucose	This refers to the measurement of blood sugar (glucose) levels at any given time, regardless of time of last meal, in mg/dL.	Write the random blood glucose (mg/dL). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	271061004, Random blood glucose measurement (procedure)	C0428567, Random blood glucose measurement		clinical_features	1		1		1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_glucose_gl	number	Random blood glucose (g/L)		number	0	18.01		[labs_dailydata]=’1’	Blood glucose	This refers to the measurement of blood sugar (glucose) levels at any given time, regardless of time of last meal, in g/L.	Write the random blood glucose (g/L). If there are multiple, report the measure furthest from the normal physiological or laboratory range between 00:00 and 24:00 hours on day of assessment.	SNOMED	271061004, Random blood glucose measurement (procedure)	C0428567, Random blood glucose measurement		clinical_features	1		1		1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_hba1c	number	HbA1C (%)		number	0	100		[labs_dailydata]=’1’	Blood glucose	Haemoglobin A1C (HbA1C) is a blood test that measures average blood glucose level over the three months preceding the test result, expressed in %.	Write the HbA1C result (%).	SNOMED	43396009, Hemoglobin A1c measurement (procedure)	C0474680, Hemoglobin A1c measurement		clinical_features		1			1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_renal	descriptive	Renal and electrolyte profile						[labs_dailydata]=’1’	Renal profile	This refers to results from renal profile	Indicate ‘Yes’ to enter renal profile testing results						1	1	1		1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ureanitro	number	Blood Urea Nitrogen (BUN)		number	0	126		[labs_dailydata]=’1’	Renal profile	This refers to blood urea nitrogen (BUN) also called blood urea.	Write the urea/BUN.					clinical_features	1	1	1	1	1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ureanitro_units	radio	Blood Urea Nitrogen (BUN) (select units)	1, mg/dL | 2, mmol/L	units				[labs_dailydata]=’1’	Renal profile							clinical_features	1	1	1	1	1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ureanitro_mmoll	number	Blood Urea Nitrogen (BUN) (mmol/L)		number	0	45		[labs_dailydata]=’1’	Renal profile	This refers to blood urea nitrogen (BUN) also called blood urea.	Write the urea/BUN (mmol/L).	SNOMED	105011006, Blood urea nitrogen measurement (procedure)	C0005845, Blood urea nitrogen measurement		clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ureanitro_mgdl	number	Blood Urea Nitrogen (BUN) (mg/dL)		number	0	126		[labs_dailydata]=’1’	Renal profile	This refers to blood urea nitrogen (BUN) also called blood urea.	Write the Urea/BUN (mg/dL).	SNOMED	105011006, Blood urea nitrogen measurement (procedure)	C0005845, Blood urea nitrogen measurement		clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_creatinine	number	Creatinine		number	0	4421		[labs_dailydata]=’1’	Renal profile	This refers to creatinine level in blood.	Write the serum creatinine					clinical_features	1	1	1	1	1	1	1	1		1	1	1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_creatinine_units	radio	Creatinine (select units)	1, µmol/L | 2, mg/dL	units				[labs_dailydata]=’1’	Renal profile							clinical_features	1	1	1	1	1	1	1			1	1	1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_creatinine_umoll	number	Creatinine (µmol/L)		number	0	4421		[labs_dailydata]=’1’	Renal profile	This refers to creatinine level in blood.	Write the serum creatinine (umol/L).	SNOMED	365756002, Finding of creatinine level (finding)	C0201975, Creatinine measurement		clinical_features	1	1	1		1	1	1	1		1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_creatinine_mgdl	number	Creatinine (mg/dL)		number	0	50		[labs_dailydata]=’1’	Renal profile	This refers to creatinine level in blood.	Write the serum Creatinine (mg/dL).	SNOMED	365756002, Finding of creatinine level (finding)	C0201975, Creatinine measurement		clinical_features	1	1	1		1	1	1	1		1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_sodium	number	Sodium (mmol/L or mEq/L)		number	0	300		[labs_dailydata]=’1’	Renal profile	This refers to the serum sodium (Na) level in blood.	Write the serum sodium (mmol/L).	SNOMED	104934005, Sodium measurement, serum (procedure)	C0523891, Serum sodium measurement		clinical_features	1	1	1	1	1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_potassium	number	Potassium (mmol/L or mEq/L)		number	0	10		[labs_dailydata]=’1’	Renal profile	This refers to the serum potassium (K) level in blood.	Write the serum potassium (mmol/L).	SNOMED	271236005, Serum potassium measurement (procedure)	C0302353, Serum potassium measurement		clinical_features	1	1	1	1	1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_creatineki	number	Creatine kinase (U/L)		number	0	10000		[labs_dailydata]=’1’	Renal profile	Creatine kinase or CPK (creatine phosphokinase) refers to the creatinine kinase level in blood.	Write the creatine kinase (U/L).	SNOMED	398137007, Finding of creatine kinase level (finding)	C0201973, Creatine kinase measurement		clinical_features	1	1	1		1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ldh	number	Lactate dehydrogenase (LDH) (U/L)		number	0	14000		[labs_dailydata]=’1’	Renal profile	Lactate dehydrogenase or LDH refers to the LDH level in blood.	Write the LDH (U/L).	SNOMED	11274001, Lactate dehydrogenase measurement (procedure)	C0202113, Lactate dehydrogenase measurement		clinical_features	1	1	1		1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_glomerular	number	Estimated glomerular filtration rate (eGFR) (mL/min/1.73m^2)		number	0	180		[labs_dailydata]=’1’	Renal profile	This refers to the estimated GFR (eGFR), estimated by laboratory calculation.	Write the estimated GFR (mL/min/1.73m^2)	SNOMED	80274001, Glomerular filtration rate (observable entity)	C3811844, Estimated Glomerular Filtration Rate		clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_calcium	number	Calcium		number	0	20		[labs_dailydata]=’1’	Renal profile	This refers to serum calcium (Ca) level in blood.	Write the serum calcium.					clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_calcium_units	radio	Calcium (select units)	1, mmol/L | 2, mEq/L | 3, mg/dL	units				[labs_dailydata]=’1’	Renal profile							clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_calcium_mmoll	number	Calcium (mmol/L)		number	0	5		[labs_dailydata]=’1’	Renal profile	This refers to serum calcium (Ca) level in blood.	Write the serum calcium (mmol/L).	SNOMED	271240001, Serum calcium measurement (procedure)	C0036785, Serum Calcium Level		clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_calcium_meql	number	Calcium (mEq/L)		number	0	10		[labs_dailydata]=’1’	Renal profile	This refers to serum calcium (Ca) level in blood.	Write the serum calcium (mEq/L).	SNOMED	271240001, Serum calcium measurement (procedure)	C0036785, Serum Calcium Level		clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_calcium_mgdl	number	Calcium (mg/dL)		number	0	20		[labs_dailydata]=’1’	Renal profile	This refers to serum calcium (Ca) level in blood.	Write the serum calcium (mg/dL).	SNOMED	271240001, Serum calcium measurement (procedure)	C0036785, Serum Calcium Level		clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_chlor	number	Chloride		number	0	567		[labs_dailydata]=’1’	Renal profile							clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_chlor_units	radio	Chloride (select units)	1, mmol/L | 2, mEq/L	units				[labs_dailydata]=’1’	Renal profile							clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_chlor_mmoll	number	Chloride (mmol/L)		number	0	160		[labs_dailydata]=’1’	Renal profile							clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_chlor_mgdl	number	Chloride (mEq/L)		number	0	567		[labs_dailydata]=’1’	Renal profile			SNOMED				clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_magn	number	Magnesium		number	0	12.2		[labs_dailydata]=’1’	Renal profile							clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_magn_units	radio	Magnesium (select units)	1, mmol/L | 2, mg/dL	units				[labs_dailydata]=’1’	Renal profile							clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_magn_mmoll	number	Magnesium (mmol/L)		number	0	5		[labs_dailydata]=’1’	Renal profile							clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_magn_mgdl	number	Magnesium (mg/dL)		number	0	12.2		[labs_dailydata]=’1’	Renal profile			SNOMED				clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_inflammatory	descriptive	Inflammatory markers						[labs_dailydata]=’1’	Inflammatory markers	This refers to results from inflammatory marker testing	Indicate ‘Yes’ to enter inflammatory marker testing results						1	1	1		1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_procalcito	number	Procalcitonin		number	0			[labs_dailydata]=’1’	Inflammatory markers	Procalcitonin or PCT refers to serum procalcitonin.	Write the Procalcitonin.					clinical_features	1		1	1			1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_procalcito_units	radio	Procalcitonin (select units)	1, ng/mL | 2, µg/L	units				[labs_dailydata]=’1’	Inflammatory markers							clinical_features	1		1	1			1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_procalcito_ngml	number	Procalcitonin (ng/mL)		number	0	20		[labs_dailydata]=’1’	Inflammatory markers	Procalcitonin or PCT refers to serum procalcitonin.	Write the Procalcitonin (ng/mL).	SNOMED	418752001, Procalcitonin (substance)	C1535922, Procalcitonin measurement		clinical_features	1		1				1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_procalcito_ugl	number	Procalcitonin (µg/L)		number	0			[labs_dailydata]=’1’	Inflammatory markers	Procalcitonin or PCT refers to serum procalcitonin.	Write the Procalcitonin (ng/mL).	SNOMED	418752001, Procalcitonin (substance)	C1535922, Procalcitonin measurement		clinical_features	1		1				1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_crp	number	C-reactive protein / CRP		number	0			[labs_dailydata]=’1’	Inflammatory markers	C-reactive protein or CRP refers to the serum CRP.	Write the CRP.					clinical_features	1	1	1	1	1	1	1	1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_crp_units	radio	C-reactive protein / CRP (select units)	1, mg/L | 2, mg/dL	units				[labs_dailydata]=’1’	Inflammatory markers							clinical_features	1	1	1	1	1	1	1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_crp_mgl	number	C-reactive protein (CRP) (mg/L)		number	0			[labs_dailydata]=’1’	Inflammatory markers	C-reactive protein or CRP refers to the serum CRP.	Write the CRP (mg/L).	SNOMED	55235003, C-reactive protein measurement (procedure)	C0201657, C-reactive protein measurement		clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_crp_mgdl	number	C-reactive protein (CRP) (mg/dL)		number	0			[labs_dailydata]=’1’	Inflammatory markers	C-reactive protein or CRP refers to the serum CRP.	Write the CRP (mg/dL).	SNOMED	55235003, C-reactive protein measurement (procedure)	C0201657, C-reactive protein measurement		clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_esr	number	Erythrocyte sedimentation rate (ESR) (mm/h)		number	0	200		[labs_dailydata]=’1’	Inflammatory markers	Erythrocyte Sedimentation Rate or ESR.	Write the ESR (mm/h).	SNOMED	416838001, Erythrocyte sedimentation rate measurement (procedure)	C1176468, Erythrocyte sedimentation rate measurement		clinical_features		1			1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_bloodgas	descriptive	Blood gas testing						[labs_dailydata]=’1’	Blood gas	This refers to results from blood gas analysis	Indicate ‘Yes’ to enter blood gas analysis results					clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_bloodgas_type	radio	Blood gas specimen type	1, Arterial | 2, Capillary | 3, Venous | 99, Unknown					[labs_dailydata]=’1’	Blood gas	This refers to the type of blood specimen from which blood gas analysis was conducted.	Select the signle most appropriate option which represents the type of blood specimen used for blood gas analysis.					clinical_features
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_lactate	number	Serum lactate		number	0			[labs_dailydata]=’1’	Blood gas	This refers to the serum lactate level in blood.	Write the serum lactate.					clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_lactate_units	radio	Serum lactate (select units)	1, mmol/L | 2, mg/dL	units				[labs_dailydata]=’1’	Blood gas							clinical_features	1	1	1		1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_lactate_mmoll	number	Serum lactate (mmol/L)		number	0			[labs_dailydata]=’1’	Blood gas	This refers to the serum lactate level in blood.	Write the serum lactate (mmol/L).	SNOMED	270982000, Serum lactate measurement (procedure)			clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_lactate_mgdl	number	Serum lactate (mg/dL)		number	0			[labs_dailydata]=’1’	Blood gas	This refers to the serum lactate level in blood.	Write the serum Lactate (mg/dL).	SNOMED	270982000, Serum lactate measurement (procedure)			clinical_features	1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_paco2	number	PaCO2		number	1.33	79		[labs_dailydata]=’1’	Blood gas	This refers to the partial pressure of carbon dioxide measured in the arterial blood recorded in mmHg.	Write the PaCO2. If there are multiple, report the measures from the blood gas with the lowest pH (most acidotic) between 00:00 and 24:00 hours on day of assessment.					clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_paco2_units	radio	PaCO2 (select units)	1, mmHg | 2, kPa	units				[labs_dailydata]=’1’	Blood gas							clinical_features	1	1	1				1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_paco2_mmhg	number	PaCO2 (mmHg)		number	10	79		[labs_dailydata]=’1’	Blood gas	This refers to the partial pressure of carbon dioxide measured in the arterial blood recorded in mmHg.	Write the PaCO2 (mmHg). If there are multiple, report the measures from the blood gas with the lowest pH (most acidotic) between 00:00 and 24:00 hours on day of assessment.	SNOMED	250564007, Measurement of partial pressure of carbon dioxide in blood (procedure)	C0391839, Carbon dioxide, partial pressure		clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_paco2_kpa	number	PaCO2 (kPa)		number	1.33	10.5		[labs_dailydata]=’1’	Blood gas	This refers to the partial pressure of carbon dioxide measured in the arterial blood recorded in kPa.	Write the PaCO2 (kPa). If there are multiple, report the measures from the blood gas with the lowest pH (most acidotic) between 00:00 and 24:00 hours on day of assessment.	SNOMED	250564007, Measurement of partial pressure of carbon dioxide in blood (procedure)	C0391839, Carbon dioxide, partial pressure		clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ph	number	pH		number	0	14		[labs_dailydata]=’1’	Blood gas	The measurement of the pH of plasma of an arterial blood sample.	Write the pH. If there are multiple, report the measure with the lowest pH (most acidotic) between 00:00 and 24:00 hours on day of assessment.	SNOMED	27051004, pH measurement, arterial (procedure) | 9456006, pH measurement, venous (procedure)	C0853363, Blood pH		clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_hco3	number	Bicarbonate (HCO3-) (mmol/L or mEq/L)		number	0	50		[labs_dailydata]=’1’	Blood gas	The measurement of the bicarbonate from plasma of a blood sample.	Write the bicarbonate level (mmol/L or mEq/L). If there are multiple, report the measures from the blood gas with the lowest pH (most acidotic) between 00:00 and 24:00 hours on day of assessment.	SNOMED	365722008, Finding of bicarbonate level (finding)	C0428196, Bicarbonate level - finding		clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_baseexcess	number	Base Excess (mmol/L)		number	-9	20		[labs_dailydata]=’1’	Blood gas	The measurement of the base excess/deficit of plasma of an arterial blood sample.	Write the Base Excess (mmol/L). If there are multiple, report the measures from the blood gas with the lowest pH (most acidotic) between 00:00 and 24:00 hours on day of assessment.	SNOMED	129907001, Base excess (finding)	C1330956, Base excess (finding)		clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_other	descriptive	Other blood testing						[labs_dailydata]=’1’		This refers to results from other tests / analyses, not specified above	Indicate ‘Yes’ to enter results from other tests / analyses, not specified above						1	1	1		1	1	1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_cd4	number	CD4 cell count		number	0	2000		[labs_dailydata]=’1’	Other	Defined as laboratory-based CD4 expressing lymphocyte count, expressed in 10^6 cells/L	Write the CD4+ cell count (cells/mm^3 or 10^6 cells/L or cells/µL).	SNOMED				clinical_features					1	1									1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_cd4_units	radio	CD4 cell count (select units)	1, cells/mm^3 | 2, 10^6 cells/L | 3, cells/µL	units				[labs_dailydata]=’1’	Other			SNOMED				clinical_features					1	1									1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_cd4_celmm	number	CD4 cell count (cells/mm3)		number	0	2000		[labs_dailydata]=’1’	Other	Defined as laboratory-based CD4 expressing lymphocyte count, expressed in 10^6 cells/L	Write the CD4+ cell count (cells/mm^3 or 10^6 cells/L or cells/µL).	SNOMED	313660005, Absolute CD4 count procedure (procedure)	C3541261, CD4 Expressing Cell Count		clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_cd4_106cell	number	CD4 cell count (10^6 cells/L)		number	0	2000		[labs_dailydata]=’1’	Other	Defined as laboratory-based CD4 expressing lymphocyte count, expressed in 10^6 cells/L	Write the CD4+ cell count (cells/mm^3 or 10^6 cells/L or cells/µL).	SNOMED	313660005, Absolute CD4 count procedure (procedure)	C3541261, CD4 Expressing Cell Count		clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_cd4_celul	number	CD4 cell count (cells/µL)		number	0	2000		[labs_dailydata]=’1’	Other	Defined as laboratory-based CD4 expressing lymphocyte count, expressed in 10^6 cells/L	Write the CD4+ cell count (cells/mm^3 or 10^6 cells/L or cells/µL).	SNOMED	313660005, Absolute CD4 count procedure (procedure)	C3541261, CD4 Expressing Cell Count		clinical_features					1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_preg	radio	Pregnancy test	1, Positive | 0, Negative | 99, Unknown					[labs_dailydata]=’1’ and [demog_sex]=’2’	Other	This refers to tests to determine whether or not an individual is pregnant. They include either serum- or urine-based tests to determine the presence of human chorionic gonadotropin (hCG).	Indicate the result of pregnancy test.	SNOMED	74036000, Pregnancy detection examination (procedure)	C0032976, Pregnancy Tests		clinical_features					1	1		1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_tropi	number	Troponin I		number	0	1113		[labs_dailydata]=’1’	Other							clinical_features	1	1	1	1			1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_tropi_units	radio	Troponin I (select units)	1, ng/L | 2, ng/mL	units				[labs_dailydata]=’1’	Other							clinical_features	1	1	1	1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_tropi_ngl	number	Troponin I (ng/L)		number	0	1113		[labs_dailydata]=’1’	Other	Troponin I, cardiac muscle (210 aa, ~24 kDa) is encoded by the human TNNI3 gene. This protein is involved in muscle filament movement in cardiac cells.	Write the Troponin I.	SNOMED	121870001, Troponin I measurement (procedure)	C0920210, Troponin I measurement		clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_tropi_ngml	number	Troponin I (ng/mL)		number	0	1.113		[labs_dailydata]=’1’	Other	Troponin I, cardiac muscle (210 aa, ~24 kDa) is encoded by the human TNNI3 gene. This protein is involved in muscle filament movement in cardiac cells.	Write the Troponin I (ng/mL).	SNOMED	121870001, Troponin I measurement (procedure)	C0920210, Troponin I measurement		clinical_features	1	1	1				1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_ferritin	number	Ferritin (µg/L or ng/mL)		number	0	50000		[labs_dailydata]=’1’	Other	Ferritin refers to an iron protein complex, containing up to 23% iron, formed by the union of ferric iron with apoferritin; it is found in the intestinal mucosa, spleen, bone marrow, reticulocytes, and liver, and regulates iron storage and transport from the intestinal lumen to plasma.	Write the serum Ferritin (ug/L or ng/mL).	SNOMED	489004, Ferritin measurement (procedure)	C0696113, Serum ferritin measurement		clinical_features	1		1	1			1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_uric	number	Uric acid		number	0.5	1200		[labs_dailydata]=’1’												1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_uric_units	radio	Uric acid (select units)	1, µmol/L | 2, mg/dL	units				[labs_dailydata]=’1’												1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_uric_umoll	number	Uric acid (µmol/L)		number	30	1200		[labs_dailydata]=’1’												1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_uric_mgdl	number	Uric acid (mg/dL)		number	0.5	20		[labs_dailydata]=’1’												1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_il6	number	Interleukin-6 (IL-6) (pg/mL or ng/L)		number	0	2526		[labs_dailydata]=’1’	Other	Refers to a cytokine that stimulates the growth and differentiation of B-lymphocyte and is also a growth factor for hybridomas and plasmacytomas. It is produced by many different cells including T-lymphocytes; monocytes; and fibroblasts.	Write the IL-6 (pg/mL).	SNOMED	22766004, Interleukin-6 assay (procedure)	C0919829, Interleukin 6 Measurement		clinical_features	1		1				1								1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_protein	number	Total protein (TP)		number	0	150		[labs_dailydata]=’1’	Other	This refers to the amount of total protein in blood.						clinical_features			1		1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_protein_units	radio	Total protein (TP) (select units)	1, g/L | 2, g/dL	units				[labs_dailydata]=’1’	Other							clinical_features			1		1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_protein_gdl	number	Total protein (TP) (g/dL)		number	0	15		[labs_dailydata]=’1’	Other	This refers to the amount of total protein in blood.	Write the total plasma protein.	SNOMED	304383000, Total protein measurement (procedure)	C0555903, Total protein measurement		clinical_features			1		1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_protein_gl	number	Total protein (TP) (g/L)		number	0	150		[labs_dailydata]=’1’	Other	This refers to the amount of total protein in blood.	Write the total plasma protein.	SNOMED	304383000, Total protein measurement (procedure)	C0555903, Total protein measurement		clinical_features			1		1	1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csfdesc	descriptive	Cerebrospinal fluid (CSF) analysis						[labs_dailydata]=’1’	CSF	Refers to the cerebrospinal fluid (CSF) analyses that were performed at the time that the patient stayed in the clinical facility (hospital) and collected on the date of assessment. In general, results that were rejected by the clinical team (e.g. haemolysed blood samples, contaminated microbiology results) should not be reported.						clinical_features				1				1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_pres	number	Opening pressure (cm H2O)		number	0	500		[labs_dailydata]=’1’	CSF	Refers to the opening pressure (in cm of water (H2O)) of CSF measured during a lumbar puncture.	Indicate the opening pressure (cm H2O)	SNOMED	86189008, Cerebrospinal fluid pressure (observable entity)	C2026642, cerebrospinal fluid opening pressure		clinical_features								1							1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_app	radio	Appearance	1, Clear / colourless | 2, Turbid / cloudy | 3, Xanthochromic | 4, Blood stained | 99, Unknown | 88, Other					[labs_dailydata]=’1’	CSF	Refers to the macroscopic appearance of the CSF.	Select the single most appropriate option corresponding to the macroscopic appearance of the CSF.	SNOMED	365665000, Finding of cerebrospinal fluid appearance (finding)	C0427834, CSF (cerebrospinal fluid) appearance clear | C0427835, CSF (cerebrospinal fluid) appearance turbid | C0427823, CSF appearance: xanthochromia | C0427822, CSF appearance: blood-stained		clinical_features															1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_appoth	text	Specify other appearance						[labs_dailydata]=’1’	CSF	Refers to the macroscopic appearance of the CSF.	If ‘Other’, indicate the macroscopic appearance of the CSF.	SNOMED	365665000, Finding of cerebrospinal fluid appearance (finding)	C1287288, CSF appearance - finding		clinical_features															1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_mm3	number	CSF total cell count (cells/mm^3)		number	0	100000		[labs_dailydata]=’1’	CSF	Refers to the number of red and white blood cells that are in cerebrospinal fluid (CSF).	Indicate the CSF cell count.	LOINC	19075-1, CSF cellscounted.total	C4063897, total CSF cell count		clinical_features				1											1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_wbc	number	CSF White blood cell count (cells/mm^3)		number	0	100000		[labs_dailydata]=’1’	CSF	Refers to the number of white blood cells (leukocytes) in the CSF.	Indicate the number of white blood cells (leukocytes) in the CSF.	SNOMED	104112007, White blood cell count, automated, cerebrospinal fluid (procedure)	C0855357, cerebrospinal fluid leukocytes (lab test)		clinical_features				1											1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_rbc	number	CSF Red blood cell count (cells/mm^3)		number	0	1000000		[labs_dailydata]=’1’	CSF	Refers to the number of red blood cells (erythrocytes) in the CSF.	Indicate the number of red blood cells (erythrocytes) in the CSF.	SNOMED	104111000, Red blood cell count, automated, cerebrospinal fluid (procedure)	C3888459, CSF red blood cell count		clinical_features				1											1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_glu	number	CSF Glucose (mg/dL)		number	0	1801		[labs_dailydata]=’1’	CSF	Refers to the glucose level in the CSF.	Indicate the glucose level in the CSF.	SNOMED	365815007, Finding of cerebrospinal fluid: glucose level (finding)	C0202040, Glucose measurement, CSF		clinical_features				1											1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_pro	number	CSF Total protein (mg/dL)		number	0	2000		[labs_dailydata]=’1’	CSF	Refers to the protein level in the CSF.	Indicate the protein level in the CSF.	SNOMED	365808004, Finding of cerebrospinal fluid protein level (finding)	C0201943, Measurement of protein in cerebrospinal fluid specimen		clinical_features				1											1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_cul	radio	CSF Culture result	1, Growth| 0, No growth | 99, Unknown					[labs_dailydata]=’1’	CSF	Refers to a positive CSF culture result, in which an organism was grown on culture.	Select the single most appropriate option corresponding to CSF culture result.	SNOMED	104174003, Microbial culture of cerebrospinal fluid (procedure)	C0430403, Cerebrospinal fluid culture (procedure)		clinical_features				1											1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_culres	user_list	Specify the CSF culture result					pathogens_All	[labs_dailydata]=’1’	CSF	Refers to the organism(s) grown on CSF culture.	Indicate the organism(s) detected on CSF culture.		104174003, Microbial culture of cerebrospinal fluid (procedure)	C0430403, Cerebrospinal fluid culture (procedure)		clinical_features				1											1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_other	radio	Other CSF findings	1, Yes | 0, No					[labs_dailydata]=’1’	CSF	Refers to other CSF findings, not listed above.	Indicate ‘Yes’ if there are other CSF findings not listed above.		104174003, Microbial culture of cerebrospinal fluid (procedure)	C0430403, Cerebrospinal fluid culture (procedure)		clinical_features				1											1
daily	LABORATORY RESULTS: Record the value furthest from normal range between 00:00 to 24:00 on day of assessment.	labs_csf_other_spec	text	Please specify other CSF findings						[labs_csf_other]=’1’	CSF	Refers to other CSF findings, not listed above.	If ‘Yes’, specify the CSF findings not listed above.		104174003, Microbial culture of cerebrospinal fluid (procedure)	C0430403, Cerebrospinal fluid culture (procedure)		clinical_features				1											1
daily	IMAGING	imagi_dailydata	radio	Enter Imaging data for this date?	1, Yes | 0, No							This refers only to those imaging or radiological test(s) that were performed at the time that the patient stayed in the clinical facility (hospital) and collected on the date of assessment.	Indicate ‘Yes’, if imaging or radiological test(s) were performed at the time that the patient stayed in the clinical facility (hospital) and collected on the date of assessment.							1	1	1	1	1	1	1							1
daily	IMAGING	imagi_xray	radio	Chest X-ray performed	1, Yes | 0, No | 99, Unknown					[imagi_dailydata]=’1’		This refers to any chest x-ray that was performed at the time the patient stayed in the clinical facility (hospital) and collected on the date of assessment. Chest x-ray refers to radiological visualization of the chest and organs of the thoracic cavity; not restricted to visualization of the lungs, using x-rays.	Indicate ‘Yes’, if any chest x-ray was performed at the time the patient stayed in the clinical facility (hospital) and collected on the date of assessment.	SNOMED	SNOMED	C0039985, Plain chest X-ray			1	1	1	1	1	1	1	1							1
daily	IMAGING	imagi_xray_date	date_dmy	Chest X-ray date		date_dmy		today		[imagi_xray] = ‘1’		This refers to the date when the chest x-ray was performed.	Enter the date when the chest x-ray was performed (use the format DD/MM/YYYY).									1				1							1
daily	IMAGING	imagi_xray_result	radio	Chest X-ray findings associated with this illness.	1, Normal or no acute change | 5, Abnormal or acute change | 99, Unknown					[imagi_xray] = ‘1’		This refers to chest X-ray findings associated with this illness.	Select the single most appropriate option corresponding to the chest X-ray findings associated with this illness.	SNOMED	SNOMED	C0239026, Standard chest X-ray normal | C0436503, Standard chest X-ray abnormal			1	1	1	1	1	1	1	1							1
daily	IMAGING	imagi_xray_newinfilt	radio	New infiltrates present on X-ray	1, Yes, bilateral | 2, Yes, unilateral | 0, No | 99, Unknown					[imagi_xray_result]=’5’		This refers to new pulmonary infiltrates present on the current chest x-ray, not visualised on previous chest radiographs of the patient. Pulmonary infiltrates result when a substance denser than air (e.g., pus, oedema, blood, surfactant, protein, or cells) is present within the lung parenchyma. Bilateral pulmonary infiltrates are present in both lungs. Unilateral pulmonary infiltrates are present in one lung only.	Select the single most appropriate option corresponding to the new pulmonary infiltrates present on the current chest x-ray, not visualised on previous chest radiographs of the patient.						1	1	1	1	1	1	1	1							1
daily	IMAGING	imagi_xray_infiltyp	checkbox	Infiltrates on X-ray consistent with	1, Viral pneumonitis | 2, Bacterial pneumonia |3, Pulmonary oedema| 99, Unknown					[imagi_xray_newinfilt] = ‘1’ or [imagi_xray_newinfilt]=’2’		This refers to the pathological condition with which the pulmonary infiltrates on chest x-ray may be consistent with. Viral pneumonitis characteristically produces bilateral perihilar peribronchial thickening and interstitial infiltrates which, particularly in children, due to their small-calibre airways, can result in areas of atelectasis or air trapping. Bacterial pneumonia characteristically produces focal segmental (i.e. bronchopneumonia) or lobar pulmonary opacities (i.e. lobar pneumonia). Pulmonary oedema may be characterised by cephalisation of upper lobe vessels, interstitial opacities, peribronchovascular cuffing, septal lines (Kerley B lines), airspace opacification (filling of the alveoli with fluid) which can have a perihilar or ‘batwing’ distribution when severe and acute; and pleural effusion.	Select all that apply.	SNOMED	SNOMED	C0032310, Pneumonia, Viral | C0004626, Pneumonia, Bacterial | C0034063, Pulmonary Oedema			1	1	1		1	1	1	1							1
daily	IMAGING	imagi_xray_pleueff	radio	Pleural effusion on X-ray	1, Yes | 0, No | 99, Unknown					[imagi_xray_result]=’5’		This refers to presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces.	Indicate ‘Yes’, if pleural effusion was visualised on chest x-ray.	SNOMED	SNOMED	C0032227, Pleural effusion (disorder)			1	1	1		1	1	1	1				1			1
daily	IMAGING	imagi_xray_resultpleu	radio	Pleural effusion on X-ray details	1, Unilateral | 2, Bilateral					[imagi_xray_pleueff]=’1’		This refers to the location of the pleural effusion.	Indicate the location of the pleural effusion.						1	1	1		1	1	1	1
daily	IMAGING	imagi_xray_resultpleusite	checkbox	Side(s) where pleural effusion identified	1, Right | 2, Left					[imagi_xray_pleueff]=’1’		This refers to the side where the unilateral pleural effusion is located.	Indicate the side of the pleural effusion.								1					1
daily	IMAGING	imagi_ctchest	radio	CT chest performed	1, Yes | 0, No | 99, Unknown					[imagi_dailydata]=’1’		This refers to computed tomography imaging of the chest.	Indicate ‘Yes’, if any CT chest was performed at the time the patient stayed in the clinical facility (hospital) and collected on the date of assessment.						1	1	1				1								1
daily	IMAGING	imagi_ctchest_result	radio	CT chest findings associated with this illness	1, Normal or no acute change | 5, Abnormal or acute change | 99, Unknown					[imagi_ctchest] = ‘1’		Refers to the findings identified on the CT chest. Pulmonary infiltrates refers to the presence of pulmonary or lung infiltrates and can include alveolar, air space, interstitial, or nodular infiltrates and typically refers to a substance or type of cell that is foreign to the lung, or accumulates in greater than normal quantity within it.	Select the single most appropriate option corresponding to the chest CT findings associated with this illness.						1	1					1								1
daily	IMAGING	imagi_ctchest_infiltra	radio	New infiltrates present on CT	1, Yes, bilateral | 2, Yes, unilateral | 0, No | 99, Unknown					[imagi_ctchest_result]=’5’		This refers to new pulmonary infiltrates present on the current chest CT scan, not visualised on previous chest radiographs of the patient. Pulmonary infiltrates result when a substance denser than air (e.g., pus, oedema, blood, surfactant, protein, or cells) is present within the lung parenchyma. Bilateral pulmonary infiltrates are present in both lungs. Unilateral pulmonary infiltrates are present in one lung only.	Select the single most appropriate option corresponding to the new pulmonary infiltrates present on the current chest CT scan, not visualised on previous chest radiographs of the patient.						1	1					1								1
daily	IMAGING	imagi_ctchest_infiltyp	checkbox	Infiltrates on CT chest consistent with	1, Viral pneumonitis | 2, Bacterial pneumonia |3, Pulmonary oedema| 99, Unknown					[imagi_ctchest_infiltra] = ‘1’ or [imagi_ctchest_infiltra]=’2’		This refers to the pathological condition with which the pulmonary infiltrates on chest x-ray may be consistent with. Viral pneumonitis characteristically produces bilateral perihilar peribronchial thickening and interstitial infiltrates which, particularly in children, due to their small-calibre airways, can result in areas of atelectasis or air trapping. Bacterial pneumonia characteristically produces focal segmental (i.e. bronchopneumonia) or lobar pulmonary opacities (i.e. lobar pneumonia). Pulmonary oedema may be characterised by cephalisation of upper lobe vessels, interstitial opacities, peribronchovascular cuffing, septal lines (Kerley B lines), airspace opacification (filling of the alveoli with fluid) which can have a perihilar or ‘batwing’ distribution when severe and acute; and pleural effusion.	Select all that apply.	SNOMED	SNOMED	C0032310, Pneumonia, Viral | C0004626, Pneumonia, Bacterial | C0034063, Pulmonary Oedema			1	1					1								1
daily	IMAGING	imagi_ctchest_pleueff	radio	Pleural effusion on CT chest	1, Yes | 0, No | 99, Unknown					[imagi_ctchest_result]=’5’		This refers to presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces.	Indicate ‘Yes’, if pleural effusion was visualised on chest CT scan.	SNOMED	SNOMED	C0032227, Pleural effusion (disorder)			1	1	1				1					1			1
daily	IMAGING	imagi_ctchest_resultpleudet	radio	Pleural effusion on CT chest details	1, Unilateral | 2, Bilateral					[imagi_ctchest_pleueff]=’1’		This refers to the location of the pleural effusion.	Indicate the location of the pleural effusion.						1	1					1
daily	IMAGING	imagi_ctbrain	radio	CT brain performed	1, Yes | 0, No | 99, Unknown					[imagi_dailydata]=’1’		This refers to computed tomography imaging of the brain.	Indicate ‘Yes’, if any Brain CT scan was performed at the time the patient stayed in the clinical facility (hospital) and collected on the date of assessment.							1					1								1
daily	IMAGING	imagi_ctbrain_date	date_dmy	CT brain date		date_dmy		today		[imagi_ctbrain] = ‘1’		This refers to the date of the brain CT scan.	Enter the date when the CT was performed. (Use the format DD/MM/YYYY)																				1
daily	IMAGING	imagi_ctbrain_findings	text	CT brain findings						[imagi_ctbrain] = ‘1’		This refers to the key findings of the brain CT scan.	Write the key findings of the Brain CT scan.							1					1								1
daily	IMAGING	imagi_mrib	radio	MRI brain performed	1, Yes | 0, No | 99, Unknown					[imagi_dailydata]=’1’		This refers to magnetic resonance imaging (MRI) of the brain.	Indicate ‘Yes’, if any Brain MRI scan was performed at the time the patient stayed in the clinical facility (hospital) and collected on the date of assessment.							1					1								1
daily	IMAGING	imagi_mrib_date	date_dmy	MRI brain date		date_dmy		today		[imagi_mrib] = ‘1’		This refers to the date of the brain MRI scan.	Enter the date when the MRI was performed. (Use the format DD/MM/YYYY)																				1
daily	IMAGING	imagi_mrib_findings	text	MRI brain findings						[imagi_mrib] = ‘1’		This refers to the key findings of the brain MRI scan.	Write the key findings of the Brain MRI scan.							1					1								1
daily	IMAGING	imagi_ultrasound	radio	Ultrasound performed	1, Yes | 0, No | 99, Unknown					[imagi_dailydata]=’1’		This refers to any ultrasound imaging that was performed at the time the patient stayed in the clinical facility (hospital) and collected on the date of assessment.	Indicate ‘Yes’, if ultrasound imaging was performed at the time the patient stayed in the clinical facility (hospital) and collected on the date of assessment.	SNOMED	SNOMED	C0041618, Ultrasonography				1	1	1			1	1
daily	IMAGING	imagi_ultrasound_date	date_dmy	Ultrasound date		date_dmy		today		[imagi_ultrasound] = ‘1’		This refers to the date when the ultrasound imaging was performed.	Enter the date when the ultrasound was performed. (Use the format DD/MM/YYYY)									1				1
daily	IMAGING	imagi_ultrasound_site	radio	Ultrasound region	1, Chest only | 2, Abdomen only | 3, Chest and abdomen | 4, Cranial | 5, Joints | 99, Unknown					[imagi_ultrasound]=’1’		This refers to the region of the body which was assessed using ultrasound imaging.	Indicate the region of the body which was assessed using ultrasound imaging.	SNOMED	SNOMED	C0883613, Ultrasound chest | C0203464, Ultrasonography of abdomen | C4750624, Ultrasonography of chest and abdomen				1	1	1			1	1
daily	IMAGING	imagi_ultrasound_findi	radio	Ultrasound findings associated with this illness	1, Normal or no acute change | 5, Abnormal or acute change | 99, Unknown					[imagi_ultrasound]=’1’		This refers to ultrasound imaging findings associated with this illness.	Select the single most appropriate option corresponding to the ultrasound imaging findings associated with this illness.	SNOMED	SNOMED	C0581117, Ultrasound scan normal | C0581118, Ultrasound scan abnormal				1	1	1			1	1
daily	IMAGING	imagi_ultrasound_asc	radio	Ascites	1, Yes | 0, No | 99, Unknown					[imagi_ultrasound_findi]=’5’		Ascites refers to a pathological increase of fluid in the peritoneal cavity.	Indicate ‘Yes’ If ascites were identified on ultrasound on date of assessment. Indicate ‘No’ if there was no ascites on ultrasound on date of assessment. If the peritoneal cavity was not examined by ultrasound for ascites on date of assessment indicate ‘Unknown’.	SNOMED	SNOMED	C0003962, Ascites			1		1					1				1
daily	IMAGING	imagi_ultrasound_ascsit	radio	Ascites grading	1, Small | 2, Moderate | 3, Severe					[imagi_ultrasound_asc] = ‘1’		Mild/small ascites (grade 1) is detectable only by ultrasonography and typically requires approximately 100mL of fluid (where normal volume is approximately 25-50mL); Moderate ascites (grade 2) implying at least 500-1000mL of peritoneal fluid and detected with physical examination; Severe ascites (grade 3) refers to the manifestation of grossly distended abdomen, may be described as tense ascites.	Select the single most appropriate option corresponding to the grade of ascites detected on ultrasound imaging.								1					1
daily	IMAGING	imagi_ultrasound_consoli	radio	Consolidation	1, Yes | 0, No | 99, Unknown					[imagi_ultrasound_findi]=’5’		This refers to the presence of a radio-opaque area in the lung. The opacification is caused by fluid or solid material within the airways or lung parenchyma.	Indicate ‘Yes’ if consolidation was identified on ultrasound on date of assessment. Indicate ‘No’ if there was no pleural effusion(s) on ultrasound on date of assessment. Indicate ‘Unknown’ if the pleural space was not examined by ultrasound for pleural effusion(s) on date of assessment.	SNOMED	SNOMED					1	1				1	1
daily	IMAGING	imagi_ultrasound_pleff	radio	Pleural effusion	1, Yes | 0, No | 99, Unknown					[imagi_ultrasound_findi]=’5’		Pleural effusion refers to a pathological increase of fluid in the pleural space.	Indicate ‘Yes’ if pleural effusion(s) was identified on ultrasound on date of assessment. Indicate ‘No’ if there was no pleural effusion(s) on ultrasound on date of assessment. Indicate ‘Unknown’ if the pleural space was not examined by ultrasound for pleural effusion(s) on date of assessment.	SNOMED	SNOMED	C0032227, Pleural effusion (disorder)				1	1				1	1
daily	IMAGING	imagi_ultrasound_plefr	number	Pleural effusion right size (cm)		number	0	20		[imagi_ultrasound_pleff] = ‘1’		Refers to the depth of the pleural effusion in centimetres (cm).	Indicate the depth of pleural effusion on the right side in centimetres (cm).								1					1
daily	IMAGING	imagi_ultrasound_plefl	number	Pleural effusion left size (cm)		number	0	20		[imagi_ultrasound_pleff] = ‘1’		Refers to the depth of the pleural effusion in centimetres (cm).	Indicate the depth of pleural effusion on the left side in centimetres (cm).								1					1
daily	IMAGING	imagi_ultrasound_peric	radio	Pericardial effusion	1, Yes | 0, No | 99, Unknown					[imagi_ultrasound_findi]=’5’		Pericardial effusion refers to a pathological increase of fluid in the pericardial space.	If pericardial effusion was identified on ultrasound on date of assessment Indicate ‘Yes’. If there was no pericardial effusion on ultrasound on date of assessment Indicate ‘No’. If the pericardial space was not examined by ultrasound for a pericardial effusion on date of assessment Indicate ‘Unknown’.	SNOMED	SNOMED					1	1				1	1
daily	IMAGING	imagi_ultrasound_perics	number	Pericardial effusion size (cm)		number	0	5		[imagi_ultrasound_peric] = ‘1’		Refers to the depth of the pericardial effusion in centimetres (cm).	Indicate the depth of pericardial effusion on the left side in centimetres (cm).								1					1
daily	IMAGING	imagi_liversize	number	Liver size (cm)		number	0	30		[imagi_ultrasound] = ‘1’		Refers to the craniocaudal length of the liver along the midclavicular line, in centimeters (cm).	Indicate the craniocaudal length of the liver along the midclavicular line, in centimeters (cm).	SNOMED	SNOMED	C0426688, Liver size (observable entity)					1					1
daily	IMAGING	imagi_gallbladder	number	Gallbladder wall (mm)		number	0	20		[imagi_ultrasound] = ‘1’		Refers to the thickness of the gallbladder wall, in millimeters (mm).	Indicate the thickness of the gallbladder wall, in millimeters (mm).								1					1
daily	IMAGING	imagi_ultrasound_unlisted	radio	Other finding(s)	1, Yes | 0, No | 99, Unknown					[imagi_ultrasound] = ‘1’		Refers to other ultrasound findings which are clinically relevant.	Indicate ‘Yes’, if there are other ultrasound imaging findings which are clinically relevant.								1					1
daily	IMAGING	imagi_ultrasound_unlistedoth	text	Specify other findings						[imagi_ultrasound_unlisted] = ‘1’		Refers to other ultrasound imaging findings which are clinically relevant.	If ‘Yes’, specify the other ultrasound imaging findings which are clinically relevant.								1					1
daily	IMAGING	imagi_ecg	radio	Electrocardiogram (ECG)	1, Yes-normal | 2, Yes-abnormal | 0, No | 99, Unknown					[imagi_dailydata]=’1’		Refers to a study that evaluates the effect of a treatment on cardiac electrical activity, as assessed by electrocardiography.	Select the most appropriate options which corresponds to the ECG findings.	SNOMED	164854000, Electrocardiogram normal (finding) | 102594003, Electrocardiogram abnormal (finding)
daily	IMAGING	imagi_ecg_spec	text	ECG summary						[imagi_ecg]=’2’		Refers to a summary of the key ECG findings	If ‘Yes-abnormal’ give a summary of the key ECG findings.
daily	IMAGING	imagi_ecg_date	date_dmy	ECG date		date_dmy		today		[imagi_ecg]=’1’ or [imagi_ecg]=’2’		Refers to the date of the ECG	Enter the date when the ECG was performed.. (Use the format DD/MM/YYYY)
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_medtype	user_list	Select agents administered while hospitalised or at discharge (one form per medication)					drugs_Type			This refers to all medications administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.	Indicate the type of agent, for all medications administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.						1	1	1	1	1	1	1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_treat	radio	Is this medication treating the disease?	1, Yes | 0, No							This refers to whether the medication is being used to treat the disease caused by the pathogen of interest.	Indicate ‘Yes’ if this medication is being used to treat the disease caused by the pathogen of interest.						1		1	1	1	1	1	1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_antiviralagent	user_list	Antiviral					drugs_Antiviral	[medi_medtype] = ‘8’		Refers to any agent(s) prescribed specifically to treat a suspected or confirmed viral infection. Examples of neuraminidase inhibitors include oseltamivir, ribavirin, acyclovir and lopinavir/ritonavir. Topical preparations are not included.	Select the antiviral agent(s) administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.					clinical_features, treatment	1	1			1	1	1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_antibioagent	user_list	Antibiotic					drugs_Antibiotics	[medi_medtype]=’2’		Antibiotics refers to any agent(s) that selectively target bacteria.	Select the antibiotic agent(s) administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.	SNOMED	346325008 |Medicinal product acting as antibacterial agent (product)|	C0279516, Antibacterial		clinical_features, treatment	1	1	1		1	1	1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_topicantibiotgent	radio	Topical antibiotic	1, Penicillins | 2, Cephalosporins | 3, Tetracyclines | 4, Aminoglycosides | 5, Macrolides | 6, Sulfonamides and trimethoprim | 7, Quinolones | 99, Unknown | 88, Other					[medi_medtype]=’16’		Refers to the antibiotic class of topical antibiotic(s) administered during admission and/or prescribed on discharge.	Indicate the class of topical antibiotic(s) administered during admission and/or prescribed on discharge										1	1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_corticost	user_list	Corticosteroid					drugs_Steroids	[medi_medtype]=’10’		Corticosteroids (commonly referred to as ‘steroids’) refers to all types of therapeutic corticosteroid, made in the adrenal cortex (the outer part of the adrenal gland). They are also made in the laboratory. Examples include: prednisolone, prednisone, methyl-prednisolone, dexamethasone, hydrocortisone, fluticasone, betametasone. Topical preparations are not included, but inhaled preparations are included.	Select the corticosteroid(s) administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.	SNOMED	788326005 |Product containing adrenal cortex hormone (product)|	CL554601, Therapeutic corticosteroid		clinical_features, treatment	1	1	1	1	1	1	1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_anticoaguagent	user_list	Anticoagulation					drugs_Anticoagulant	[medi_medtype]=’3’		An anticoagulant refers to any agent capable of preventing blood clot formation, or platelet aggregation. This includes agents such as heparin, warfarin, aspirin, clopidogrel, and subcutaneously administered anticoagulants, among many others. Topical preparations are not included.	Select the anticoagulant(s) administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.	SNOMED	81839001 |Medicinal product acting as anticoagulant agent (product)|	C0003280, Anticoagulant agent			1	1		1			1								1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_anticoaguagent_ind	radio	Anticoagulation indication	1, Therapeutic (treatment of DVT/PE) | 2, Enhanced prophylaxis for infection with pathogen of interest | 3, Routine inpatient prophylaxis | 99, Unknown					[medi_medtype]=’3’		This refers to the indication of the anticoagulant(s).	Select the single most appropriate option corresponding to the indication of the anticoagulant(s).						1	1		1			1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_antifungagent	user_list	Antifungal agent					drugs_Antifungal	[medi_medtype]=’4’		Refers to any agent(s) inhibiting the growth of or killing fungi, prescribed specifically to treat a suspected or confirmed fungal infection.	Select the antifungal agent(s) administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.						1	1			1	1	1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_inotropesvasopressor	radio	Inotropes / vasopressor	1, Vasopressin | 2, Phenylephrine | 3, Epinephrine | 4, Norepinephrine | 5, Dopamine | 6, Angiotensin-II | 7, Terlipressin | 88, Other					[medi_medtype] = ‘14’		This refers to continuous use of a vasopressor or inotrope for at least one hour. Agents include norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. Commonly used ‘positive’ inotropes include dobutamine, dopamine, milrinone and adrenaline (epinephrine).	Select the vasopressor or inotrope agent administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.	SNOMED	870386000, Vasopressor therapy (procedure) | 1296972008, Inotropic therapy (procedure)	C5396785, Vasopressor therapy | C5880944, Inotropic therapy		clinical_features, treatment		1					1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_analgesic	radio	Analgesic agent	1, Paracetamol | 2, NSAIDs | 3, Opiates (Tramadol, Codeine, Morphine) | 4, Ketamine | 99, Unknown | 88, Other					[medi_medtype]=’1’		This refers to any agents that alleviate pain without loss of consciousness. These include opioid, non-opioid and adjuvant analgesic agents.	Indicate the analgesic agent(s) administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.									1	1	1									1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_antipruritic	radio	Antipruritic agent	1, Hydrocortisone | 2, Calamine | 3, Antihistamines | 4, Hydroxyzine | 99, Unknown | 88, Other					[medi_medtype]=’7’		This refers to any agent(s) that relieve itching (pruritus).	Select the antipruritic agent(s) administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.										1	1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_immunosupp	user_list	Immunosuppressive drugs (non-steroid)					drugs_Immunosuppressants	[medi_medtype]=’13’		This refers to a patient who is known to have taken prescribed medications that are known to have an immunosuppressing effect (excluding steroids/corticosteroids).	Select the single most appropriate option corresponding to the indication of the immunosuppressant(s).											1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_ivig	radio	Type of intravenous immunoglobulin	1, Polyclonal immunoglobulin | 2, Specific immunoglobulin | 99, Unknown | 88, Other					[medi_medtype]=’15’		This refer to the type of intravenous immunoglobulin.	Select the single most appropriate option which represents the type of intravenous immunoglobulin administered.											1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_ivig_oth	text	Specify other type of intravenous immunoglobulin						[medi_ivig] = ‘88’		If ‘Other’, specify the type of intravenous immunoglobulin.	Specify the type of intravenous immunoglobulin.											1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_route	radio	Medication route	1, Oral | 2, Subcutaneous |3, Inhaled |4, IV | 5, Topical | 99, Unknown | 88, Other					[medi_medtype]=’8’ or [medi_medtype]=’10’ or [medi_medtype]=’3’ or [medi_medtype]=’1’ or [medi_medtype]=’7’ or [medi_medtype]=’13’ or [medi_medtype_otherl2]=’8’ or [medi_medtype_otherl2]=’10’ or [medi_medtype_otherl2]=’3’ or [medi_medtype_otherl2]=’1’ or [medi_medtype_otherl2]=’7’ or [medi_medtype_otherl2]=’13’		This refers ot the route of administration of the medication.	Select the single most appropriate option which represents the route of administration of the medication.						1	1	1	1	1	1	1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_route_oth	text	Specify other route						[medi_route]=’88’		This refers ot the route of administration of the medication.	If ‘Other’, indicate the route of administration of the medication.						1	1	1		1	1	1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_localanest	radio	Local anaesthetic	1, Lidocaine | 2, Bupivacaine | 3, Ropivacaine | 88, Other					[medi_medtype] =’17’												1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_localanest_other	text	Specify other Local anaesthetic						[medi_localanest]=’88’												1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_medstartdate	date_dmy	Date medication started / first dose		date_dmy		today		[medi_treat]=’1’		This refers to the date the medication was started / first dose was administered.	Enter the date when the medication was started / first dose was given. (Use the format DD/MM/YYYY)			C5236155, Date of First Dose		treatment	1	1	1	1	1	1	1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_medongoing	radio	Therapy ongoing?	1, Yes | 2, No | 99, Unknown					[medi_treat]=’1’		This refers to ongoing therapy with medication being used to treat the disease caused by the pathogen of interest.	Indicate if there is ongoing therapy with medication being used to treat the disease caused by the pathogen of interest.									1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_medenddate	date_dmy	Date medication stopped / last dose		date_dmy		today		[medi_treat]=’1’		This refers to the date the medication was stopped / last dose was administered.	Enter the date when the medication was ended / last dose was given. (Use the format DD/MM/YYYY)			C1762893, Date last dose		treatment	1	1	1	1	1	1	1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_numdays	number	Total number of days treatment given		number	0			[medi_treat]=’1’		This refers to the total number of days for which a dose was received or instructed to take on discharge prescription.	Enter the total number of days for which a dose was received or instructed to take on discharge prescription.			C5786895, Treatment Duration in Days		treatment	1	1	1	1	1	1	1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_stopreason	radio	Reasons for treatment stopping	1, Improvements | 2, Deterioration | 3, Death | 4, Other adverse events | 99, Unknown | 88, Other					[medi_medongoing] = ‘2’		This refers to the reason for stopping treatment.	Select the single most appropriate option corresponding to the reason for stopping treatment.
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_stopreason_oth	text	Please specify other reason						[medi_stopreason] = ‘88’		This refers to the reason for stopping treatment.	If Other, please specify the reason for stopping treatment.
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_frequency	text	Frequency						[medi_treat]=’1’		Refers to the frequency of specified medicine administration in a 24-hour period (00:00 to 24:00 hours). Examples include ‘every 4 hours’, ‘twice daily’ etc.	Indicate the frequency of specified medicine administration in a 24-hour period (00:00 to 24:00 hours). Examples include ‘every 4 hours’, ‘twice daily’ etc.					treatment		1					1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_dose	number	Dose		number	0			[medi_treat]=’1’		This refers to the dosage of the medication administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.	Write the dose; do not include units as this is asked in the following question.					treatment	1	1			1	1	1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_units	dropdown	Units	1, mg | 2, g | 3, µg | 4, IU | 5, mg/kg | 6, mg/day | 7, mL | 8, mL/h | 9, % | 10, tablets | 88, Other					[medi_treat]=’1’		This refers to the dosage of the medication administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.	Write the units of the dosage.					treatment					1	1		1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_units_oth	text	Units (other)						[medi_units]=’88’		This refers to the dosage of the medication administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.	Write the units of the dosage.					treatment					1	1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_numdoses	number	Total number of doses (Number of times the drug was injected / swallowed / infused / inserted / applied / inhaled)		number	0			[medi_treat]=’1’		This refers to the total number of doses of the medication which administered any time during the patient’s admission in the clinical facility (hospital), including in the emergency department, and prescribed on discharge.	Write the total number of doses of the medication. If the same medication was administered through different routes, indicate the total number of doses from all routes of administration (injected / swallowed / infused / inserted / applied / inhaled).					treatment					1	1		1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_offlab	radio	Was this an off-label or compassionate use of the medication?	1, Yes | 0, No | 99, Unknown							This refers to the practice of prescribing or using a drug or a vaccine for an indication that is not specified in the national regulatory licensing.	Select ‘Yes’ if this medication was used for an indication that is not specified in the national regulatory licensing.						1				1	1	1	1							1
medication	MEDICATION: Record medications administered or prescribed from day of presentation to day of discharge / outcome (one form per medication).	medi_offlab_spec1	text	Specify the off-label or compassionate use medication						[medi_offlab]=’1’		This refers to the practice of prescribing or using a drug or a vaccine for an indication that is not specified in the national regulatory licensing.	Specify medication which was used for an indication that is not specified in the national regulatory licensing.						1				1	1	1	1							1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_collectiondate	date_dmy	Collection date		date_dmy		today				This refers to the date of collection of a clinical specimen for pathogen testing.	Enter the date when the samples were collected. This may be different to the day in which the results are reported. (Use the format DD/MM/YYYY)						1	1	1	1	1	1	1	1							1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_biospecimentype	user_list	Biospecimen type					pathogens_SampleType			This refers to the type of a clinical specimen collected for pathogen testing. Nasal / Nasopharyngeal (NP) swab refers to collection biological material from within the nasal passages/nasopharynx. Throat swab refers to collection biological material from within the throat/oropharynx. Combined nasal/NP + throat swab refers to collection using both nasal / nasopharyngeal (NP) swab and throat swab. Sputum refers to material coughed up from the lungs and expectorated via the mouth. Bronchoalveolar Lavage (BAL) refers to washing out of the lungs with saline or mucolytic agents for diagnostic or therapeutic purposes. Endotracheal aspirate (ETA) refers to collection of specimen from endotracheal tube. Eye swab refers to collection of biological sample from the surface of the eye. Lesion swab refers to collection of biological sample from a lesion on the skin or mucous membrane. Semen refers to the secretion of male reproductive organs discharged upon ejaculation. Faeces / rectal swab refers to biological sample collected from faecal matter or from the rectum by swabbing.	Select the single most appropriate option that represents the type of clinical specimen collected for pathogen testing.						1	1	1	1	1	1	1	1							1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_pathtested	user_list	Pathogen tested / detected					pathogens_All			This refers to the pathogen(s) tested for using the biological sample.	Indicate the pathogen(s) which were tested for using the biological sample.						1	1	1	1	1	1	1	1				1			1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_labtestmethod	radio	Lab test method	1, PCR (NAAT) | 3, Culture | 6, RDT | 7, ELISA | 8,Other NAAT | 99, Unknown							This refers to the laboratory method used to test for the pathogen.	Select the single most appropriate option that represents the laboratory method used to test for the pathogen.						1	1	1	1	1	1	1	1							1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_marker	checkbox	Lab marker	1, NS1 Ag | 2, IgG | 3, IgM | 6, IgA | 4, Viral load / serotype (PCR/NAAT) | 5, Not applicable | 99, Unknown							This refers to the laboratory marker used to test for the pathogen	Select the single most appropriate option that represents the laboratory marker used to test for the pathogen.						1	1	1	1	1	1	1	1				1			1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_naat	radio	NAAT subtype	1, RT-PCR| 2, LAMP | 3, TMA / TMP | 88, Other | 99, Unknown					[test_labtestmethod]=’1’ or [test_labtestmethod]=’8’																1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_naat_other	text	Specify other NAAT subtype						[test_naat]=’88’																1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_result	radio	Pathogen test result	1, Detected | 0, Not detected | 2, Equivocal | 99, Unknown							This refers to the results of the pathogen(s) tested for using the biological sample.	Select the single most appropriate option that represents results of the pathogen(s) tested for using the biological sample.						1	1	1	1	1	1	1	1				1			1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_denguetyp	radio	Dengue virus type	1, DENV1 | 2, DENV2 | 3, DENV3 | 4, DENV4					[test_labtestmethod] = ‘1’ and [test_pathtested]=’96’		This refers to the serotype label of the viral species of Dengue virus, which is a single-stranded, positive-sense RNA virus of the Flaviviridae family and Flavivirus genus, detected using the PCR test.	Select the single most appropriate option that represents the serotype label of the viral species of Dengue virus detected using the PCR test.	SNOMED	60588009, Dengue virus, type 1 (organism) | 41328007, Dengue virus, type 2 (organism) | 8467002, Dengue virus, type 3 (organism) | 36700002, Dengue virus, type 4 (organism)						1					1							1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_fluresist	radio	If pathogen detected is influenza: Oseltamivir resistance identified	1, Yes | 0, No | 3, Not Tested | 99, Unknown					[test_pathtested]=’183’ or [test_pathtested]=’184’ or [test_pathtested]=’185’ or [test_pathtested]=’186’ or [test_pathtested]=’187’ or [test_pathtested]=’188’ or [test_pathtested]=’189’ or [test_pathtested]=’190’		Refers to identification of Oseltamivir resistance.	Indicate ‘Yes’ if oseltamivir resistance was identified.												1	1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_ctvalue	number	Cycle threshold (CT) value		number	10	50		[test_result]=’1’ and [test_labtestmethod]=’1’		This refers to the cycle threshold (CT) for nucleic acid detection in specimen using real-time polymerase chain reaction.	Indicate the CT value.						1	1			1	1	1	1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_vload	number	Viral load (copies/mL)		number				[test_result]=’1’ and [test_labtestmethod]=’1’		This refers to the quantity of virus in a given volume of fluid	Indicate the Viral load.								1					1				1			1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_genrep	radio	Sequence available in genomic data repository	1, Yes | 0, No							This refers to availability of the pathogen genomic sequence in a data repository.	Indicate ‘Yes’ if the sequence is available in a genomic data repository.							1					1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_genrep_db	user_list	Genomic repository					pathogens_GenomicRepository	[test_genrep]=’1’		Refers to the genomic repository which contains the pathogen sequence data.	Select the genomic repository which contains the pathogen sequence data.							1					1
pathogen_testing	PATHOGEN TESTING: Results of all types of sample and pathogen testing	test_genrep_ref	text	Repository sequence identifier						[test_genrep]=’1’		Refers to the identifier of the sequence in the repository.	Write the identiifer of the sequence in the genomic repository.							1					1
photographs	PHOTOGRAPHS	photo_date	date_dmy	Date of Image		date_dmy		today				Refers to date when the image was captured.	Enter the date when the image was taken. (Use the format DD/MM/YYYY)										1	1
photographs	PHOTOGRAPHS	photo_type	radio	What is being photographed?	1, Skin lesion | 2, Mucosal lesion | 99, Unknown | 88, Other							Refers to type of pathology being captured in the photograph.	Select the single most appropriate option that represents the type of pathology being captured in the photograph.										1	1
photographs	PHOTOGRAPHS	photo_upload	file	Upload image here								Refers to the image / photograph capturing the pathology.	Upload the photograph of the pathology here.										1	1
photographs	PHOTOGRAPHS	photo_site	radio	What part of the body is photographed?	1, Head, neck or face | 2, Inside of mouth | 3, Front torso | 4, Back torso | 5, Right arm or hand | 6, Left arm or hand | 7, Peri-anal | 8, Pubic region | 9, Right leg or foot | 10, Left leg or foot | 99, Unknown | 88, Other							Refers to the part of the body being captured in the photograph.	Select the single most appropriate option that represents the part of the body being captured in the photograph.										1	1
photographs	PHOTOGRAPHS	photo_site_oth	text	Specify other location						[photo_site]=’88’		Refers to the part of the body being captured in the photograph, not specified above.	If ‘Other’, specify the part of the body being captured in the photograph, not specified above.										1	1
photographs	PHOTOGRAPHS	photo_sampleyn	radio	Was a sample of the photographed area taken?	1, Yes | 2, No | 99, Unknown							Refers to a biological sample of the photographed part of the body.	Indicate ‘Yes’ if a biological sample of the photographed part of the body was taken.										1	1
photographs	PHOTOGRAPHS	photo_sampleid	text	Please enter the sample ID						[photo_sampleyn] = ‘1’		Refers to identification number (ID) of the sample.	Write the sample ID.										1	1
photographs	PHOTOGRAPHS	photo_desc	notes	Please provide any other relevant additional description of the photo or it’s location.								Refers to any other relevant additional description of the photo or it’s location, not specified above.	Indicate any other relevant additional description of the photo or it’s location, not specified above.										1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_neurological	descriptive	Neurological complications							Nervous system	Defined as any complications of the nervous system	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.						1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_strokecva	radio	Stroke / cerebrovascular accident	1, Yes | 0, No | 99, Unknown						Nervous system	Defined as a sudden loss of neurological function secondary to haemorrhage or ischemia in the brain parenchyma due to a vascular event. Stroke may be a clinical diagnosis, with or without supportive radiological findings.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	230690007, Cerebrovascular accident	C3554760, Stroke		clinical_features	1	1		1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_severeneuro	radio	Severe neurological disease	1, Yes | 0, No | 99, Unknown						Nervous system	This refers to various neurological manifestations including meningitis, encephalitis, encephalopathy, acute symptomatic seizures, intracranial haemorrhage or stroke, and Guillain-Barre syndrome (GBS). Meningitis is an inflammatory disease of the leptomeninges, the tissues surrounding the brain and spinal cord, and is defined by an abnormal number of white blood cells in the cerebrospinal fluid (CSF) within an appropriate clinical context and with or without supportive radiological findings. Encephalitis refers to inflammation of the brain. In comparison with meningitis, in encephalitis, abnormalities in brain function are expected, including altered mental status, motor or sensory deficits, altered behaviour and personality changes, and speech or movement disorders. It is defined by an altered mental status lasting ?24 hours along with two of the following criteria: documented fever >/= 38°C (100.4°F); white blood cell count (WBC) in cerebrospinal fluid (CSF) >/= 5 cells/mm^3; generalized or partial seizures not fully attributable to a preexisting seizure disorder; new onset of focal neurological findings; presence of compatible acute lesion on neuroimaging; abnormality on electroencephalography that is consistent with encephalitis and not attributable to another cause. As outlined by the 2013 International Encephalitis Consortium. Seizures are defined as an intermittent abnormality of nervous system physiology characterised by a transient occurrence of sudden, violent, irregular movement of the body, caused by involuntary contraction of muscles due to abnormal excessive or synchronous neuronal activity in the brain. An established history of epilepsy is not required. Stroke refers to a sudden loss of neurological function secondary to haemorrhage or ischemia in the brain parenchyma due to a vascular event. Stroke may be a clinical diagnosis, with or without supportive radiological findings. Intracranial haemorrhage refers to haemorrhage/bleeding occurring within the skull. Intracranial haemorrhage encompasses four broad types of haemorrhage: epidural haemorrhage, subdural haemorrhage, subarachnoid haemorrhage, and intraparenchymal haemorrhage. Guillain-Barre syndrome refers to a rapidly progressive autoimmune disorder of the peripheral nervous system characterized by limb paraesthesia, areflexia, and generalized muscle weakness or paralysis that often begins in the legs and spreads to the arms, torso, and face. Required features include progressive weakness of the arms and/or legs, ranging from minimal weakness of the legs to total paralysis of all four limbs, and including the trunk, bulbar and facial muscles, and external ophthalmoplegia; and areflexia or decreased deep tendon reflexes in weak limbs. Supportive features include symptom progression over days to four weeks; Relatively symmetric, bilateral symptoms; Pain in the trunk or limbs; Cranial nerve symptoms or signs; Autonomic dysfunction; Sensory dysfunction that is mild; No fever at symptom onset; CSF with elevated protein and normal to mildly elevated leukocyte count (usually <5 cells/mm3); Electrodiagnostic abnormalities consistent with GBS; Recovery starting two to four weeks after progression halts.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	7180009 |Meningitis (disorder)| 45170000 |Encephalitis (disorder)| 81308009 |Disorder of brain (disorder)|41370002 |Myelitis (disorder)|230690007 |Cerebrovascular accident (disorder)|1386000 |Intracranial haemorrhage (disorder)|40956001 |Guillain-Barre syndrome (GBS) (disorder)|			clinical_features		1			1	1	1								1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_encephalopathy	radio	Encephalopathy	1, Yes | 0, No | 99, Unknown						Nervous system	Encephalopathy broadly refers brain dysfunction which may be due to a functional and / or structural disorder caused by a vareity of aetiologies, including diseases of other organ systems (e.g. liver disease, kidney disease), medications, chemicals, and injuries. It presents with a range of symptoms including altered mental status, confusion, memory loss, and behavioral changes	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.					clinical_features		1		1	1	1	1	1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_seizure	radio	Seizure	1, Yes | 0, No | 99, Unknown						Nervous system	Defined as an intermittent abnormality of nervous system physiology characterised by a transient occurrence of sudden, violent, irregular movement of the body, caused by involuntary contraction of muscles due to abnormal excessive or synchronous neuronal activity in the brain. An established history of epilepsy is not required.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	91175000, Seizure	C2748942, Seizure		clinical_features	1	1	1	1	1	1	1	1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_focalneuro	radio	Focal neurological signs	1, Yes | 0, No | 99, Unknown						Nervous system	Defined as as impairments of nerve, spinal cord, or brain function that affect a specific region of the body, e.g. weakness in the left arm, the right leg, paresis, or plegia, identified in neurological examination.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	264552009, Neurological deficit	C0746857, Focal neurological deficit		clinical_features		1	1	1	1	1	1	1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_encephalitis	radio	Encephalitis	1, Yes | 0, No | 99, Unknown						Nervous system	Encephalitis refers to inflammation of the brain. It is defined by an altered mental status lasting greater or equal to 24 hours along with two of the following criteria: documented fever greater or equal to 38° C (100.4°F); white blood cell count (WBC) in cerebrospinal fluid (CSF) greater or equal to 5/mm³; generalized or partial seizures not fully attributable to a preexisting seizure disorder; new onset of focal neurological findings; presence of compatible acute lesion on neuroimaging; abnormality on electroencephalography that is consistent with encephalitis and not attributable to another cause. As outlined by the 2013 International Encephalitis Consortium.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	45170000, Encephalitis	C0014038, Encephalitis		clinical_features	1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_meningitis	radio	Meningitis	1, Yes | 0, No | 99, Unknown						Nervous system	Meningitis is defined by an abnormal number of white blood cells in the cerebrospinal fluid (CSF) within an appropriate clinical context and with or without supportive radiological findings.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	7180009, Meningitis	C0025289, Meningitis		clinical_features	1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_gbs	radio	Guillain-Barre syndrome (GBS)	1, Yes | 0, No | 99, Unknown						Nervous system	Refers to a rapidly progressive autoimmune disorder of the peripheral nervous system characterized by limb paresthesias, areflexia, and generalized muscle weakness or paralysis that often begins in the legs and spreads to the arms, torso, and face.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.		C0018378			clinical_features		1		1	1	1	1	1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_cnsinf	radio	CNS infection	1, Yes | 0, No | 99, Unknown						Nervous system	This refers to An infectious process that affects the brain and/or spinal cord, may include encephalitis, poliomyelitis, arachnoiditis, and meningitis.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.					clinical_features						1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_atm	radio	Acute Transverse Myelitis (ATM)	1, Yes | 0, No | 99, Unknown						Nervous system		Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.									1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_perneur	radio	Peripheral neuropathy	1, Yes | 0, No | 99, Unknown						Nervous system		Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.									1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_cvs	descriptive	Cardiovascular complications							Cardiovascular	Defined as any complications of the cardiovascular system	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.						1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_myocardial	radio	Myocardial infarction	1, Yes | 0, No | 99, Unknown						Cardiovascular	Defined as myocardial ischaemia leading to injury/necrosis, diagnosed by clinical findings, altered electrocardiography and elevated cardiac enzymes.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	22298006, Myocardial infarction	C3280935, Myocardial infarction		clinical_features	1	1		1			1								1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_cardiacisc	radio	Cardiac ischaemia	1, Yes | 0, No | 99, Unknown						Cardiovascular	Defined as diminished blood and oxygen supply to the heart muscle as indicated by typical symptomatology (e.g. chest pain) and confirmed by an electrocardiogram (showing ischaemic changes, e.g. ST depression or elevation) and/or cardiac enzyme elevation (e.g. raised troponin I).	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	414795007, Myocardial ischaemia	C0746731, Acute myocardial ischaemia		clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_endocardit	radio	Endocarditis	1, Yes | 0, No | 99, Unknown						Cardiovascular	This refers to an inflammation of the endocardium (inner lining of the heart). It is often caused by a primary disorder or microorganisms including bacteria, viruses, fungi, and rickettsiae Diagnosis of infective endocarditis is according to modified Duke criteria, using evidence from microbiological results, echocardiogram and clinical signs.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	56819008, Endocarditis	C0014118, Endocarditis		clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_cardiomyop	radio	Cardiomyopathy	1, Yes | 0, No | 99, Unknown						Cardiovascular	This refers to structural and functional disorders of myocardium commonly diagnosed by echocardiography. Cardiomyopathy can be primary (genetic) or secondary (e.g. following myocardial infarction).	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	85898001, Cardiomyopathy	C3809229, Cardiomyopathy		clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_chf	radio	Congestive heart failure	1, Yes | 0, No | 99, Unknown						Cardiovascular	Defined as failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and oedema. Signs and symptoms include shortness of breath, pitting oedema, enlarged tender liver, engorged neck veins, and pulmonary rales. There are many ways to assess cardiac function (e.g. echocardiography, right heart catheterization, functional testing and supportive biochemical tests). However, there is no diagnostic test for heart failure, since it is largely a clinical diagnosis that is based upon a careful history and physical examination.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	42343007, Congestive heart failure	C3551869, Congestive heart failure		clinical_features	1	1		1	1	1	1								1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_cardiarrhy	radio	Cardiac arrhythmia	1, Yes | 0, No | 99, Unknown						Cardiovascular	Refers to any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart, confirmed by electrocardiographic monitoring.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	698247007, Cardiac arrhythmia	C3275765, Arrhythmia		clinical_features	1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_cardiarrest	radio	Cardiac arrest	1, Yes | 0, No | 99, Unknown						Cardiovascular	Cardiopulmonary arrest or circulatory arrest is defined as the sudden cessation of cardiac activity in an individual who becomes unresponsive, without normal breathing and no signs of circulation.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	410429000, Cardiac arrest	C4015675, Cardiac arrest		clinical_features	1	1	1	1	1	1	1	1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_myocarditis	radio	Myocarditis	1, Yes | 0, No | 99, Unknown						Cardiovascular	This refers to inflammation of the muscle tissue of the heart (myocarditis) / an inflammatory process affecting the pericardium (pericarditis). It may be diagnosed clinically, with assistance from an echocardiogram, EKG, laboratory or radiological tests.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	50920009, Myocarditis;	C0027059, Myocarditis;		clinical_features	1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_pericarditis	radio	Pericarditis	1, Yes | 0, No | 99, Unknown						Cardiovascular	This refers to inflammation of the muscle tissue of the heart (myocarditis) / an inflammatory process affecting the pericardium (pericarditis). It may be diagnosed clinically, with assistance from an echocardiogram, EKG, laboratory or radiological tests.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	3238004, Pericarditis;	C4230735, Pericarditis;		clinical_features	1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_respiratory	descriptive	Respiratory complications							Respiratory	Defined as any complications of the respiratory system	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.						1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_pneum	radio	Pneumonia / pneumonitis	1, Yes | 0, No | 99, Unknown						Respiratory	Pneumonia is an infection of one or both lungs that causes the air sacs to become inflamed and fill with fluid or pus, making it difficult to breathe. This inflammation is commonly caused by bacteria, viruses, or fungi and can result in symptoms such as cough, fever, chills, and shortness of breath.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	233604007				1	1			1	1	1								1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_pneum_etio	radio	Is the etiological pathogen different to the primary diagnosis	1, Yes | 2, No | 99, Unknown						Respiratory	Pneumonia is an infection of one or both lungs that causes the air sacs to become inflamed and fill with fluid or pus, making it difficult to breathe. This inflammation is commonly caused by bacteria, viruses, or fungi and can result in symptoms such as cough, fever, chills, and shortness of breath.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.												1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_pneum_type	radio	Etiology of pneumonia	1, Viral | 2, Bacterial | 3, Fungal						Respiratory	Pneumonia is an infection of one or both lungs that causes the air sacs to become inflamed and fill with fluid or pus, making it difficult to breathe. This inflammation is commonly caused by bacteria, viruses, or fungi and can result in symptoms such as cough, fever, chills, and shortness of breath.	Indicate ‘Yes’ if the pathogen causing pneumonia as a complication is different from the pathogen of interest at admission.						1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_pneum_acq	radio	Acquisition setting of pneumonia	1, Community acquired | 2, Hospital acquired | 3, Ventilator acquired | 99, Unknown						Respiratory	This refers to the setting in which the pneumonia was acquired: community, hospital, ventilator-associated, or unknown.													1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_pneumothor	radio	Pneumothorax	1, Yes | 0, No | 99, Unknown						Respiratory	Defined as the abnormal presence of air in the pleural cavity (between the lungs and the chest wall), causing collapse of the lung. It may be diagnosed clinically, usually with radiological confirmation.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	36118008, Pneumothorax	C3553768, Pneumothorax		clinical_features	1	1				1	1								1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_pleuraleff	radio	Pleural effusion	1, Yes | 0, No | 99, Unknown						Respiratory	Defined as increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumours, connective tissue disorders, and trauma. It may be diagnosed clinically, with or without radiological or interventional confirmation.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	60046008, Pleural effusion	C0032227, Pleural effusion		clinical_features	1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_copneumoni	radio	Cryptogenic organising pneumonia (COP)	1, Yes | 0, No | 99, Unknown						Respiratory	This refers to an idiopathic diffuse interstitial lung disease, diagnosed radiologically (multiple consolidative or ground glass opacities) or histologically (granulation tissue and chronic inflammatory infiltrate in alveoli). Formerly known as bronchiolitis obliterans organizing pneumonia (BOOP).	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	719218000, Cryptogenic organizing pneumonia	C0242770, Cryptogenic organizing pneumonia		clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_bronchioli	radio	Bronchiolitis	1, Yes | 0, No | 99, Unknown						Respiratory	This refers to Inflammation of the bronchioles. In adults, bronchiolitis is a general term used to describe a nonspecific Inflammation of the bronchioles characterized by swelling of the bronchioles and mucus accumulation. It is usually caused by the respiratory syncytial virus and affects children. Signs and symptoms include coughing, wheezing, and shortness of breath. In the majority of cases, open or thoracoscopic lung biopsy is required to make a definitive diagnosis, although tissue confirmation may not be necessary in patients with a clear predisposition and typical radiological findings. In infants and children, bronchiolitis is defined as an illness in children <2 years of age, characterized by wheezing and airway obstruction due to primary infection or reinfection with a viral or bacterial pathogen, resulting in inflammation of the small airways/bronchioles. This is a clinical diagnosis, generally in children < 2 years old.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	4120002, Bronchiolitis	C0006271, Bronchiolitis		clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_ards	radio	Acute Respiratory Distress Syndrome (ARDS)	1, Yes | 0, No | 99, Unknown						Respiratory	Acute respiratory distress syndrome (ARDS) is a non-cardiogenic pulmonary oedema and diffuse lung inflammation syndrome that often complicates critical illness. Diagnosis of ARDS is based on fulfilling three criteria: a) Acute onset (within 1 week) b) Bilateral opacities on chest radiography or computed tomography (CT), or bilateral B lines and/or consolidations on ultrasound not fully explained by effusions, atelectasis, or nodules/masses. c)PaO2/FiO2 (arterial to inspired oxygen) ratio of ?300 or SpO2/FiO2 (pulse oximetric saturation to inspired oxygen) ratio of ?315.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	67782005, Acute respiratory distress	C1848829, Acute respiratory distress		clinical_features	1	1	1		1	1	1	1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_git	descriptive	Gastrointestinal complications							Gastrointestinal	Defined as any complications of the gastrointestinal system	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.						1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_ascite	radio	Ascites	1, Yes | 0, No | 99, Unknown						Gastrointestinal	This refers to pathological increase in amount of fluid in the abdominal cavity (ascites). It may be diagnosed clinically, with or without radiological or interventional confirmation. Symptoms associated with ascites include increasing abdominal girth, abdominal discomfort and distension, shortness of breath.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	389026000, Ascites	C3554541, Peritoneal effusion		clinical_features			1					1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_pancreatit	radio	Pancreatitis	1, Yes | 0, No | 99, Unknown						Gastrointestinal	This refers to acute inflammation of the pancreas. Acute pancreatitis is diagnosed clinically with supporting biochemical (e.g serum amylase or serum lipase) and/or radiological and/or histological evidence. All evidence should be considered together, since no single feature is diagnostic of acute pancreatitis.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	75694006, Pancreatitis	C4011703, Pancreatitis		clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_acutehepat	radio	Acute hepatitis	1, Yes | 0, No | 99, Unknown						Gastrointestinal	This refers to acute hepatic injury from inflammation resulting in fever, abdominal pain, jaundice accompanied with increased liver function tests (serum alanine transaminase (ALT) and / or aspartate transaminase (AST) activity). Etiologies include viral hepatitis, drugs, toxins, and autoimmune disorders.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	37871000, Acute hepatitis	C0267797, Acute hepatitis		clinical_features			1	1	1	1		1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_severeliver	radio	Severe liver disease (new onset)	1, Yes | 0, No | 99, Unknown						Gastrointestinal	Defined as new onset cirrhosis and portal hypertension with variceal bleeding, ascites, jaundice or status post liver transplantation.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	235856003 | Disorder of liver (disorder) | 24484000 |Severe (severity modifier) (qualifier value)|	CL1793619, Severe liver disease		clinical_features		1	1	1	1	1	1	1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_hepaticenc	radio	Hepatic encephalopathy (any grade)	1, Yes | 0, No | 99, Unknown					[compl_severeliver] = ‘1’	Gastrointestinal	This refers to a neuropsychiatric syndrome caused by advanced liver insufficiency and/or portosystemic shunt without evidence of other primary neurological disease. Clinical features include lethargy; confusion (can progress to coma); asterixis; pathologic nystagmus; brisk oculovestibular reflexes; decorticate and decerebrate posturing; muscle spasticity; and bilateral extensor plantar reflexes.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	13920009, Hepatic encephalopathy	C0019151, Hepatic encephalopathy		clinical_features			1	1	1	1		1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_jaundice	radio	Jaundice	1, Yes | 0, No | 99, Unknown						Gastrointestinal	This refers to a clinical manifestation of hyperbilirubinemia, characterized by the yellowish staining of the skin, mucous membrane and/or sclera.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	18165001, Jaundice	C3549846, Jaundice		clinical_features		1			1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_liverdysfu	radio	Liver dysfunction	1, Yes | 0, No | 99, Unknown						Gastrointestinal	This refers to a finding that indicates abnormal liver function, may refer to any of the following: Jaundice; Hyperbilirubinemia (blood bilirubin level twice the upper limit of the normal range); An increase in alanine transaminase (ALT) or aspartate transaminase (AST) that is twice the upper limit of the normal range.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	235856003, Disorder of liver (disorder)	C3552261, Liver and intrahepatic bile duct disorder		clinical_features	1	1				1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_heme	descriptive	Haematological complications							Haematology	Defined as any complications of the haematological system	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.						1	1	1		1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_thrombemb	radio	Thromboembolism	1, Yes | 0, No | 99, Unknown						Haematology	Defined as the occlusion of the lumen of a blood vessel by a thrombus that has migrated from a distal site via the blood stream.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	371039008, Thromboembolic disorder	C3550383, Thromboembolism		clinical_features	1	1			1	1	1								1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_thrombemb_pe	radio	Pulmonary embolism (PE)	1, Yes | 0, No | 99, Unknown					[compl_thrombemb]=1	Haematology	Defined as the occlusion of a pulmonary artery by thrombus, air or fat. Physician diagnosis based on clinical signs and/or radiological tests (e.g. computed tomographic pulmonary angiography and/or ventilation/perfusion scanning).	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	233935004, Pulmonary thromboembolism	C0524702, Pulmonary thromboembolism		clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_thrombemb_dvt	radio	Deep vein thrombosis (DVT)	1, Yes | 0, No | 99, Unknown					[compl_thrombemb]=1	Haematology	Defined as the presence of a blood clot in a deep vein, predominantly in the lower extremity, but may include the pelvis or upper extremity. Symptoms may include pain, swelling, warmth, and redness in the affected area. Physician diagnosis based on clinical signs and/or appropriate diagnostic imaging e.g. ultrasonography.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	128053003, Deep venous thrombosis	C3536663, Acute deep venous thrombosis		clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_thrombemb_oth	radio	Other thromboembolism (not PE or DVT)	1, Yes | 0, No | 99, Unknown					[compl_thrombemb]=1	Haematology	This refers to thromboembolic diagnoses not specified above.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.					clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_thrombemb_spec	text	Specify other thromboembolism						[compl_thrombemb_oth]=’1’	Haematology	This refers to the other thromboembolic diagnoses not specified above.	If ‘Other’, write the other thromboembolic diagnoses the patient experienced at any time during hospitalisation.					clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_severebleed	radio	Severe bleeding (requiring intervention)	1, Yes | 0, No | 99, Unknown						Haematology	Defined as bleeding resulting in haemodynamic compromise necessitating intervention, namely transfusion. This includes World Health Organisation (WHO) Bleeding Scale grade 3 or 4.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	10421000132103, Haemorrhage requiring transfusion	C4023144, Bleeding requiring red cell transfusion		clinical_features	1		1	1	1	1	1	1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_severebleed_site	checkbox	Severe bleeding site(s)	1, Skin | 7, Petechiae | 2, Nose | 3, Gums | 4, GI tract | 5, Urinary tract | 6, Vagina | 88, Other(s) | 99, Unknown					[compl_severebleed] = ‘1’	Haematology	This refers to the location of bleeding/haemorrhage site(s). Petechiae refer to small reddish or purplish spots in skin or mucous membrane as a result of localised haemorrhage. Nose bleeding refers to haemorrhage localized in the nose. Gum bleeding refers to haemorrhage affecting the gingiva. Gastrointestinal (GI) bleeding refers to haemorrhage in any segment of the gastrointestinal tract from oesophagus to rectum. Urinary tract bleeding refers to haemorrhage originating from any part of the urinary system. Vaginal bleeding refers to haemorrhage originating from vagina, unrelated to normal menstruation.	Select the most appropriate option(s) corresponding to the location of bleeding/haemorrhage site(s).	SNOMED	297968009, Bleeding skin | 271813007 Petechiae | 249366005, Bleeding from nose | 86276007, Bleeding gums | 74474003, Gastrointestinal haemorrhage |34436003, blood in urine | 289530006, Bleeding from vagina	C0574741, Bleeding skin | C3808808, Epistaxis | C0017565, Gingival haemorrrhage | C0017181, Gastrointestinal haemorrhage |C3805433, haematuria | C0566961, Fresh bleeding from vagina		clinical_features	1		1	1		1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_severebleed_site_oth	text	Specify other site(s) of bleeding						[compl_severebleed_site(88)]=’1’	Haematology	This refers to the location of bleeding/haemorrhage site(s).	If ‘Other’, Write the other location of site(s) where the patient has experienced bleeding/haemorrhage at any time from onset of this illness and presentation or admission.					clinical_features	1		1	1		1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_anaemia	radio	Anaemia	1, Yes | 0, No | 99, Unknown						Haematology	Defined as a reduction in the number of red blood cells, the amount of haemoglobin, and/or the volume of packed red blood cells. Signs and symptoms of anaemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. The World Health Organization thresholds are used for defining anaemia, in adult males aged over 15 years anaemia is defined by a haemoglobin <130g/L (<8.1mmol/L); for non-pregnant females aged over 15 years thresholds are <120g/L (<7.4mmol/L), for children aged under 5 years and pregnant women as a haemoglobin <110 g/L (6.8 mmol/L)	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	271737000, Anaemia	C4229468, Anaemia		clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_coagulatio	radio	Coagulation disorder / DIC	1, Yes | 0, No | 99, Unknown						Haematology	Coagulopathy (bleeding disorder) is defined as a condition in which there is a deviation from or interruption of the normal coagulation properties of the blood (normal blood clotting is disrupted). Disseminated intravascular coagulation (DIC) is a specific type of coagulopathy which blood starts to coagulate throughout the whole body. Acute DIC is confirmed by demonstrating increased thrombin generation (e.g. decreased fibrinogen) and increased fibrinolysis (e.g. elevated fibrin degradation products and D-dimer). The diagnosis of chronic DIC may be largely based upon evidence of microangiopathy on the blood film and increased levels of fibrin degradation products and particularly D-dimer.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	64779008, Blood coagulation disorder	C4229995, Coagulation disorder		clinical_features	1	1	1	1	1	1	1	1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_renalgut	descriptive	Renal/genitourinary complications							Renal/Genitourinary	Defined as any complications of the renal/genitourinary system	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.						1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_acuterenal	radio	Acute renal injury / acute renal failure	1, Yes | 0, No | 99, Unknown						Renal/Genitourinary	Acute kidney injury is defined when one of the following criteria is met: Serum creatinine rises by >= 26umol/L or 0.3mg/dL within 48 hours; or serum creatinine rises >= 1.5 fold from the reference value, which is known or presumed to have occurred within the prior 7 days; or urine output is <0.5ml/kg/hr for >6 consecutive hours.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	14669001 |Acute kidney injury (disorder)|	C2609414 | Acute kidney injury		clinical_features	1	1	1	1	1	1	1	1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_uti	radio	Urinary tract infection	1, Yes | 0, No | 99, Unknown						Renal/Genitourinary	This refers to inflammatory responses of the epithelium of the urinary tract to microbial invasions. They are often bacterial infections with associated bacteruria and pyuria.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	68566005, Urinary tract infectious disease (disorder)	C0042029, Urinary tract infection		clinical_features						1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_urineret	radio	Urinary retention	1, Yes | 0, No | 99, Unknown						Renal/Genitourinary	This refers to accumulation of urine within the bladder because of the inability to urinate.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.											1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_urineret_spec	text	please specify						[compl_urineret] = ‘1’	Renal/Genitourinary	This refers to accumulation of urine within the bladder because of the inability to urinate.	If ‘Yes’, please specify											1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_ent	radio	Ear/Nose/Throat complications	1, Yes | 0, No | 99, Unknown						ENT	Defined as any complications of the ear / nose and throat system	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.											1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_deepneck	radio	Deep neck space infections	1, Yes | 0, No | 99, Unknown						ENT	This refers to an infection of the deep fascial planes in the neck.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.											1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_msk	descriptive	Musculoskeletal complication							Musculoskeletal	Defined as any complications of the musculoskeletal system	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.						1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_rhabdomyol	radio	Rhabdomyolysis	1, Yes | 0, No | 99, Unknown						Musculoskeletal	Rhabdomyolysis is a syndrome characterised by muscle necrosis and the release of myoglobin into the blood, resulting from muscle injury. Diagnosis is made in a patient with either an acute neuromuscular illness or dark urine without other symptoms, plus a marked acute elevation in creatine kinase. The creatine kinase is typically at least five times the upper limit of normal (there is no diagnostic threshold to establish the diagnosis, however). Muscle biopsy, electromyography, radiological imaging and the presence of myoglobinuria are not required for the diagnosis.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	240131006, Rhabdomyolysis	C4014084, Rhabdomyolysis		clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_myositis	radio	Myositis	1, Yes | 0, No | 99, Unknown						Musculoskeletal	Myositis is defined as an inflammatory process affecting the skeletal muscles. Causes include infections, injuries, and autoimmune disorders. It may be a clinical diagnosis with supporting evidence from laboratory tests e.g. elevated serum creatine kinase; histological confirmation is not required to make the diagnosis. Myositis can occur without subsequent progression to rhabdomyolysis.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	26889001, Myositis	C4014723, Myositis		clinical_features	1	1			1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_skin	descriptive	Skin complication							Skin	Defined as any complications of the skin	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.										1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_cellulitis	radio	Cellulitis	1, Yes | 0, No | 99, Unknown						Skin	Defined as an acute, diffuse, and suppurative inflammation of loose connective tissue, particularly the deep subcutaneous tissues, and sometimes muscle, which is most commonly seen as a result of infection. Diagnosis is made on clinical signs and symptoms, it can be supported by microbiological evidence.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	128045006, Cellulitis	C0007642, Cellulitis		clinical_features					1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_cellulitis_site	checkbox	Site(s) of cellulitis	1, Skin | 2, Nose | 3, Gums | 4, GI tract | 5, Urinary tract | 6, Vagina | 99, Unknown | 88, Other					[compl_cellulitis] = ‘1’	Skin	This refers to the site(s) in which cellulitis was identified.	Select the most appropriate site(s) in which cellulitis was identified at any time during hospitalisation. If ‘Other’, Specify the other site(s) in the space provided below.	SNOMED	128277003 | Cellulitis of head (disorder) |37223007 | Cellulitis of neck (disorder) |46876003 | Cellulitis of trunk (disorder) |449671007 | Cellulitis of upper limb (disorder) |449710006 | Cellulitis of lower limb (disorder) |26330000 | Cellulitis of perineum (disorder)	C0007642, Cellulitis		clinical_features					1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_cellulitis_site_oth	text	Specify other site(s) of cellulitis						[compl_cellulitis_site(88)]=’1’	Skin	This refers to the other site(s) in which cellulitis was identified.	If ‘Other’, write the site(s) in which cellulitis was identified at any time during hospitalisation.					clinical_features					1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_skabscess	radio	Skin abscess	1, Yes | 0, No | 99, Unknown						Skin	This refers to a circumscribed area of pus or necrotic debris in the skin.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.											1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_eschar	radio	Skin tissue loss or eschar	1, Yes | 0, No | 99, Unknown						Skin	Eschar is defined as a dry, dark scab or falling away of dead skin, typically caused by a burn, an insect bite (e.g. some rickettsial infections), or infection with anthrax.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	409590008, Skin eschar	C0521172, Skin eschar		clinical_features					1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_scar	radio	Skin scarring	1, Yes | 0, No | 99, Unknown						Skin	This refers to a permanent mark left on the skin in the process of wound healing.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.											1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_nec	radio	Necrotising infection	1, Yes | 0, No | 99, Unknown						Skin	This refers to infection associated with death of skin and underlying soft tissue.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.											1									1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_eye	descriptive	Opthalmological complication							Ocular	Defined as any complications of the eye	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.											1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_eyeinf	radio	Ocular infection	1, Yes | 0, No | 99, Unknown						Ocular	This refers to an infectious process affecting any part of the eye.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.											1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_cornealsubepi	radio	Corneal subethelial infiltrates	1, Yes | 0, No | 99, Unknown						Ocular	This refers to subepithelial corneal infiltrates.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.											1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_cornealstroma	radio	Corneal stromal infiltrates	1, Yes | 0, No | 99, Unknown						Ocular	This refers to stromal corneal infiltrates.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.											1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_sys	descriptive	Systemic complication							Systemic/General	Defined as any systemic complications	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.						1	1	1	1	1	1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_bacteraemi	radio	Bacteraemia	1, Yes | 0, No | 99, Unknown						Systemic/General	Defined as the presence of bacteria in blood, most often detected through blood culture investigation. Episodes of suspected artefactual contamination of a blood culture should not be recorded.	Indicate ‘Yes’ if bacteraemia occurred at any time during hospitalisation. Indicate ‘No’, if bacteraemia never occurred or if only bacteria grown were believed to be skin contaminants (e.g. coagulase negative Staphylococci or diphtheroids).	SNOMED	5758002, Bacteremia	C0004610, Bacteremia		clinical_features	1	1			1	1	1								1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_hyperglyce	radio	Hyperglycemia	1, Yes | 0, No | 99, Unknown						Systemic/General	For adults, is defined as an abnormally high level of glucose in the blood, blood glucose level that is consistently above 126mg/dL or 7 mmol/L. For children, is defined as a blood glucose level consistently above 8.3 mmol/L.	Indicate ‘Yes’ if bacteraemia occurred at any time during hospitalisation. Indicate ‘No’, if bacteraemia never occurred or if only bacteria grown were believed to be skin contaminants (e.g. coagulase negative Staphylococci or diphtheroids).	SNOMED	80394007, Hyperglycaemia	C4015534, Hyperglycaemia		clinical_features	1					1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_hypoglycem	radio	Hypoglycaemia	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to abnormally low level of glucose in the blood. For adults, is defined as an abnormally low level of glucose in the blood, a blood glucose level that is consistently below 70mg/dL or 4 mmol/L. For children, is defined as a blood glucose level below 3 mmol/L.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	302866003, Hypoglycaemia	C0858246, Hypoglycaemia		clinical_features	1				1	1	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_shock	radio	Shock	1, Yes | 0, No | 99, Unknown						Systemic/General	Shock refers to circulatory failure, causing inadequate oxygen delivery to meet cellular metabolic needs. It is defined by the presence of any two of the following: evidence of hypoperfusion (e.g. capillary refill >2 seconds, cold clammy skin, and rapid/weak pulse, altered mental status), narrow pulse pressure (less than or equal to 20mmHg), hypotension for age, and tachycardia (>100bpm).	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	27942005, Shock	C0036974, Shock		clinical_features			1			1		1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_reshock	radio	Re-shock episodes	1, Yes | 0, No | 99, Unknown						Systemic/General	Re-shock or recurrent shock is defined as a separate episode of shock which occurs at least 2-6 hours after the clinical resolution of an initial episode of shock, where clinical resolution refers to a pulse pressure >25mmHg without signs of impaired perfusion. This does not include persistent shock (where no resolution is seen).	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.					clinical_features			1					1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_reshockep	radio	Number of re-shock episodes	1, 1 | 2, 2 | 3, 3 | 4, 4+ | 99, Unknown					[compl_reshock]=’1’	Systemic/General	This refers to the number of times re-shock was identified while the patient was hospitalised.	If ‘Yes’, select the single most appropriate option which corresponds to the number of re-shock episodes the patient has experienced at any time during hospitalisation.					clinical_features			1					1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_sepsis	radio	Sepsis	1, Yes | 0, No | 99, Unknown						Systemic/General	As defined according to the 2016 SCCM/ESICM task force as a life-threatening organ dysfunction caused by a dysregulated host response to infection with the following: Organ dysfunction determined by a Sequential Organ Failure Assessment (SOFA) score of greater or equal to 2 points (or quick SOFA/qSOFA score of greater or equal to 2); and a Physician-diagnosed infection (which can be supported by clinical signs and symptoms, radiologic and/or microbiologic evidence).	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.	SNOMED	91302008, Sepsis	C0243026, Sepsis		clinical_features			1		1	1		1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_hypothermia	radio	Hypothermia	1, Yes | 0, No | 99, Unknown						Systemic/General	This refers to abnormally low body temperature.	Indicate ‘Yes’, if the patient experienced this at any time during hospitalisation.											1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_ndiab	radio	New-onset diabetes mellitus	1, Yes | 0, No | 99, Unknown																	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_plarthalgia	radio	Polyartralgia	1, Yes | 0, No | 99, Unknown																	1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_otherdesc	descriptive	Other Complications							Other								1	1	1	1	1	1	1	1							1
outcome	COMPLICATIONS: Experienced at any time from day of presentation to day of discharge / outcome.	compl_unlisted	list	Other complication(s)	1, Yes | 0, No | 99, Unknown				conditions_Complications		Other	This refers to other complication(s) not specified above.	Specify all other complication(s), not listed above, the patient experienced at any time during hospitalisation.					clinical_features	1	1	1	1	1	1	1	1							1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ivfluid	radio	Intravenous (parenteral) fluids	1, Yes | 0, No | 99, Unknown							This refers to intravenous fluid which includes crystalloid, albumin, gelatin, starches or other solutions.	Indicate ‘Yes’, if the patient received intravenous fluids at any time during hospitalisation.								1												1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ivfluid_type	user_list	Intravenous fluid type					drugs_IVfluids	[inter_ivfluid]=’1’		This refers to the type of parenteral or intravenous (IV) fluid is prescribed as a replacement of fluid, electrolytes, calories, vitamins, and other nutritional substances. Intravenous fluids may be crystalloids (commonly including 0.9% Sodium Chloride (Normal Saline), Lactated Ringer(USP), 0.45% Sodium Chloride (Half-normal saline), 0.45% normal saline + 4% Glucose (Half-normal saline with dextrose), 0.18%-0.3% Sodium Chloride + 4% Glucose (Hypotonic saline with dextrose), 5% Glucose (Dextrose 5% in Water), Ringeracetate or Plasmalyte) or colloids (commonly including gelatins, starches or albumin).	Select the most appropriate option corresponding to the type of intravenous or parenteral fluid(s) administered.						1		1												1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ivfluid_cryst	number	Total crystalloid volume given during admission (mL)		number	0			[inter_ivfluid]=’1’		Crystalloid fluids refer to aqueous solutions of mineral salts and other small, water-soluble molecules. They are commonly used for fluid resuscitation in the presence of hypovolemia, hemorrhage, sepsis, and dehydration Common crystalloids include 0.9% Sodium Chloride (Normal Saline), Lactated Ringer(USP), 0.45% Sodium Chloride (Half-normal saline), 0.45% normal saline + 4% Glucose (Half-normal saline with dextrose), 0.18%-0.3% Sodium Chloride + 4% Glucose (Hypotonic saline with dextrose), 5% Glucose (Dextrose 5% in Water), Ringeracetate or Plasmalyte.	Record the total volume of crystalloid fluids the patient received during admission in millilitres (mL).								1												1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ivfluid_colloid	number	Total colloid volume given during admission (mL)		number	0			[inter_ivfluid]=’1’		Colloid fluids are solutions that contain large molecules, such as proteins or polysaccharides, which remain in the bloodstream for a longer duration compared to crystalloids. These fluids help maintain or expand intravascular volume by drawing water into the blood vessels via oncotic pressure. Common colloids include gelatins, starches or albumin.	Record the total volume of colloid fluid the patient received during admission in millilitres (mL).								1												1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ivfluid_reas	checkbox	Reason(s) for IV fluid (check all that apply)	1, Shock | 2, High/rising haematocrit | 3, Anorexia | 4, Persistent vomiting | 88, Other					[inter_ivfluid] =’1’		This refers to the reason(s) (indication(s)) for parenteral / intravenous (IV) fluid therapy at any time during the admission. If multiple indications, select all that apply. Shock refers to circulatory failure, causing inadequate oxygen delivery to meet cellular metabolic needs. It is defined by the presence of any two of the following: evidence of hypoperfusion (e.g. capillary refill >2 seconds, cold clammy skin, and rapid/weak pulse, altered mental status), narrow pulse pressure (less than or equal to 20mmHg), hypotension for age, and tachycardia (>100bpm). High/rising haematorit refers to an elevation above the normal ratio of the volume of red blood cells to the total volume of blood. Anorexia refers to the lack or loss of appetite accompanied by an aversion to food and the inability to eat.	Select all that apply.	SNOMED	27942005, Shock | 165413005, Haematocrit above reference range (finding) | 79890006, Loss of appetite (finding) | 196746003, Persistent vomiting (disorder)						1												1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ivfluid_reas_oth	text	Specify other reason for IV fluid						[inter_ivfluid_reas(88)]=’1’		This refers to the reason(s) (indication(s)) for parenteral / intravenous (IV) fluid therapy at any time during the admission.	If ‘Other’, specify the reason(s) (indication(s)) for parenteral / intravenous (IV) fluid therapy at any time during the admission.								1												1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ivfluid_start	datetime_dmy	Date first IV fluid started		datetime_dmy		today		[inter_ivfluid] =’1’		This refers to the date when the first parenteral / intravenous (IV) fluid was started.	Enter the date. (Use the format DD/MM/YYYY)								1												1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ivfluid_end	datetime_dmy	Date last IV fluid ended		datetime_dmy				[inter_ivfluid] =’1’		This refers to the date when the last parenteral / intravenous (IV) fluid was ended.	Enter the date. (Use the format DD/MM/YYYY)								1												1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_bpt	radio	Blood product transfusion	1, Yes | 0, No | 99, Unknown							This refers to a transfusion of blood (whole blood or packed red blood cells) or other blood products excluding human normal immunoglobulin (e.g. albumin, granulocytes, platelets, fresh-frozen plasma (FFP), FP24, PF-24, cryoprecipitate, protein C concentrate, cryosupernatant, or a specific non-recombinant clotting factor) at any time on the date of assessment.	Indicate ‘Yes’, if the patient received blood products or blood product transfusion at any time during admission. If ‘Yes’ Select the product(s) below.	SNOMED	116859006, Transfusion of blood product (procedure) |						1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_bpt_type	checkbox	Select all blood product transfusion that were administered	1, Platelets | 2, Cryoprecipitate | 3, Whole blood | 4, Frozen fresh plasma | 5, Fibrinogen concentrate | 6, Packed RBC (red cell concentrate)					[inter_bpt] =’1’		This refers to a transfusion of blood (whole blood or packed red blood cells) or other blood products excluding human normal immunoglobulin (e.g. albumin, granulocytes, platelets, fresh-frozen plasma (FFP), FP24, PF-24, cryoprecipitate, protein C concentrate, cryosupernatant, or a specific non-recombinant clotting factor) at any time on the date of assessment. Platelets refers to the transfer of blood platelets from a donor to a recipient or reinfusion to the donor. Cryoprecipitate refers to a frozen blood product prepared from frozen plasma that contains fibrinogen (factor I), antihemophilic factor (factor VIII), factor XIII, von Willebrand factor (vWF) and fibronectin. Whole blood refers to intravenous administration of whole blood (blood that contains plasma and red blood cells) into an individual. Packed RBC refers to red blood cells from a unit of whole blood following removal of most of the plasma, leaving a unit with a haematocrit of about 60%. Fresh frozen plasma refers to the plasma that is separated from the whole blood and frozen quickly after a blood donation in order to be used for blood transfusions. Fibrinogen concentrate is a haemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.	Select the most appropriate option(s) corresponding to the blood product(s) that were administered.	SNOMED	12719002, Platelet transfusion (procedure) | 116795008, Transfusion of cryoprecipitate (procedure) | 180207008, Intravenous blood transfusion of packed cells (procedure) | 116861002, Transfusion of fresh frozen plasma (procedure) | 776201000, Product containing only human fibrinogen (medicinal product) |						1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_bpt_plate	number	Platelets, total number of units		number	0	200		[inter_bpt_type(1)] = ‘1’		Platelets refers to the transfer of blood platelets from a donor to a recipient or reinfusion to the donor.	Record the total number of units the patient received during admission.	SNOMED	12719002, Platelet transfusion (procedure)						1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_bpt_cryo	number	Cryoprecipitate, total number of units		number	0	200		[inter_bpt_type(2)]=’1’		Cryoprecipitate refers to a frozen blood product prepared from frozen plasma that contains fibrinogen (factor I), antihemophilic factor (factor VIII), factor XIII, von Willebrand factor (vWF) and fibronectin. Cryoprecipitate refers to a frozen blood product prepared from frozen plasma that contains fibrinogen (factor I), antihemophilic factor (factor VIII), factor XIII, von Willebrand factor (vWF) and fibronectin.	Record the total number of units the patient received during admission.	SNOMED	116795008, Transfusion of cryoprecipitate (procedure)						1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_bpt_rbc	number	Whole blood, total number of units		number	0	100		[inter_bpt_type(3)]=’1’		Whole blood refers to intravenous administration of whole blood (blood that contains plasma and red blood cells) into an individual.	Record the total number of units the patient received during admission.	SNOMED	180207008, Intravenous blood transfusion of packed cells (procedure						1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_bpt_ffp	number	Fresh frozen plasma (FFP), total number of units		number	0	200		[inter_bpt_type(4)]=’1’		Fresh frozen plasma refers to the plasma that is separated from the whole blood and frozen quickly after a blood donation in order to be used for blood transfusions.	Record the total number of units the patient received during admission.	SNOMED	116861002, Transfusion of fresh frozen plasma (procedure)						1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_bpt_fibrin	number	Fibrinogen concentrate, total number of units		number	0	100		[inter_bpt_type(5)]=’1’		Fibrinogen concentrate is a hemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.	Record the total number of units the patient received during admission.	SNOMED	776201000, Product containing only human fibrinogen (medicinal product)						1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_bpt_rcc	number	Packed RBC (red cell concentrate), total number of units		number	0	200		[inter_bpt_type(6)]=’1’		Packed RBC refers to red blood cells from a unit of whole blood following removal of most of the plasma, leaving a unit with a haematocrit of about 60%.	Record the total number of units the patient received during admission.	SNOMED							1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ivimmunogl	radio	Intravenous immunoglobulin	1, Yes | 0, No | 99, Unknown							This refers to immunoglobulin preparations, containing primarily Immunoglobulin G (IgG), that are used as intravenous infusions. Examples include Octagam®, Intragam P®, KIOVIG®, Flebogamma 5% DIF®, Carimune NF®, Gamunex®, Gammagard S/D®, Gammagard Liquid®, Gammaked® and Privigen®.	Indicate ‘Yes’, if the patient received intravenous immunoglobulin at any time during admission.	SNOMED	698802001, Administration of immunoglobulin by intravenous route (procedure) |						1												1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_diuretics	radio	Diuretics	1, Yes | 0, No | 99, Unknown							This refers to class of agents that increases the production of urine by the kidney. Via various mechanism of actions, diuretics retain water in urine, thus provides a means of forced diuresis.	Indicate ‘Yes’, if the patient received diuretic therapy at any time during admission.	SNOMED	30492008 | Medicinal product acting as diuretic (product) |	C0012798, Diuretic					1					1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_nacetylcys	radio	N-acetyl cysteine	1, Yes | 0, No | 99, Unknown							This refers to N-acetyl derivative of cysteine; used as a mucolytic agent to reduce the viscosity of mucous secretions.	Indicate ‘Yes’, if the patient received N-acetyl cysteine (NAC) at any time during admission.	SNOMED	77731008, Product containing acetylcysteine (medicinal product)	C0001047, acetylcysteine					1					1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_fluiddrain	radio	Fluid drainage	1, Yes | 0, No | 99, Unknown							This refers to the procedure of removing fluid from the pleural space or peritoneal cavity.	Indicate ‘Yes’, if this was fluid drainage from the pleural or peritoneal cavity was performed at any time during admission.								1					1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_fluiddrain_reas	radio	Reason for this drainage	1, Ascites | 2, Pleural effusion					[inter_fluiddrain] = ‘1’		This refers to the reason (indication) for fluid drainage. Ascites refers to the abnormal accumulation of fluid in the peritoneal cavity. Pleural effusion refers to presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces.	Select the most appropriate option corresponding to the reason (indication) for fluid drainage.	SNOMED	389026000, Ascites (disorder) | 60046008, Pleural effusion (disorder)						1					1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_plasmaex	radio	Plasmapheresis / plasma exchange	1, Yes | 0, No | 99, Unknown							Plasmapheresis (plasma exchange) refers to the extracorporeal separation of blood components, resulting in a filtered product. Methods include discontinuous flow centrifugation, continuous flow centrifugation and plasma filtration.	Indicate ‘Yes’, if the patient received plasmapharesis at any time during admission.	SNOMED	20720000, Plasmapheresis (procedure)	C0032134, Plasmapheresis					1				1								1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_plasmaex_days	number	Days on plasma exchange support during admission		number	0			[inter_plasmaex] = ‘1’		This refers to the total number of calendar days the patient was on plasma exchange support (plasmapharesis). Plasmapheresis (plasma exchange) refers to the extracorporeal separation of blood components, resulting in a filtered product. Methods include discontinuous flow centrifugation, continuous flow centrifugation and plasma filtration.	Write the total number of calendar days the patient was on plasma exchange support (plasmapheresis).								1				1								1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_isolation	radio	Was the patient isolated at home or in hospital?	1, Yes | 0, No | 99, Unknown							This refers to isolation of the patient at home or in hospital during this admission for pathogen of interest.	Indicate ‘Yes’ if the patient was isolation at home or in hospital during this admission for pathogen of interest.							1					1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_isolation_date	date_dmy	Date individual entered isolation		date_dmy		today		[inter_isolation]=’1’		This refers to the start date of isolation of the patient at home or in hospital during this admission for pathogen of interest.	Enter the date. (Use the format DD/MM/YYYY)							1					1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_surg	radio	Any surgical intervention performed in relation to the infection with pathogen of interest?	1, Yes | 0, No | 99, Unknown							This refers to any surgical intervention that was performed in relation to the infection with pathogen of interest.	Indicate ‘Yes’ if a surgical intervention was performed in relation to the infection with pathogen of interest.										1	1									1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_surg_type	text	What was the surgery? (e.g. debridement of infected tissue)						[inter_surg]=’1’		This refers to any surgical intervention that was performed in relation to the infection with pathogen of interest.	If ‘Yes’, write the name of surgical intervention / procedure that was performed in relation to the infection with pathogen of interest.										1	1									1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_surg_date	date_dmy	Date of first surgery		date_dmy		today		[inter_surg]=’1’		This refers to the date of the first surgical intervention that was performed in relation to the infection with pathogen of interest.	Enter the date of the first surgery. (Use the format DD/MM/YYYY)										1	1									1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_surg_sec	radio	Was a second surgical intervention performed in relation to the infection with pathogen of interest?	1, Yes | 0, No | 99, Unknown					[inter_surg]=’1’		This refers to any surgical intervention that was performed in relation to the infection with pathogen of interest.	Indicate ‘Yes’ if a second surgical intervention was performed in relation to the infection with pathogen of interest.										1	1									1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_surg_secdate	date_dmy	Date of second surgery		date_dmy		today		[inter_surg_sec]=’1’		This refers to the date of the second surgical intervention that was performed in relation to the infection with pathogen of interest.	Enter the date of the second surgery. (Use the format DD/MM/YYYY)										1	1									1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_other	radio	Other intervention(s) or procedure(s)	1, Yes | 0, No | 99, Unknown							This refers to any other specific therapeutic intervention(s) or procedure(s) administered at any time during the admission, not otherwise characterised that you believe may be relevant.	Indicate ‘Yes’ if other intervention(s) or procedure(s) were used between 00:00 and 24:00 hours on day of assessment.	SNOMED	71388002, Procedure (procedure)	C0184661, Interventional procedure					1		1	1	1								1
outcome	INTERVENTIONS: Record interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_other_spec	text	Please specify other intervention(s) or procedure(s)						[inter_other] = ‘1’		This refers to any other specific therapeutic intervention(s) or procedure(s) administered at any time during the admission, not otherwise characterised that you believe may be relevant.	If ‘Yes’, please specify the therapeutic intervention(s) or procedure(s)not otherwise characterised that you believe may be relevant.	SNOMED	71388002, Procedure (procedure)	C0184661, Interventional procedure					1		1	1	1								1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_suppleo2	radio	Any supplemental oxygen?	1, Yes | 0, No | 99, Unknown							This refers to any method of supplemental oxygen therapy that may be delivered via nose cannula, mask or non-invasive or invasive ventilation.	Indicate ‘Yes’, if the patient experienced was given or prescribed supplemental oxygen therapy at any time during hospitalisation.	SNOMED	250774007, Inspired oxygen concentration (observable entity)|	C0428648, Inspired oxygen concentration		patient_outcome, clinical_features, treatment	1	1	1		1	1	1								1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_suppleo2_ongoing	radio	Still on supplemental oxygen?	1, Yes | 0, No | 99, Unknown					[inter_suppleo2]=’1’		This refers to ongoing oxygen therapy that may be delivered via nose cannula, mask or non-invasive or invasive ventilation.	Indicate ‘Yes’, if the patient is still on supplemental oxygen therapy.											1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_suppleo2_dur	number	Number of calendar days the patient received any respiratory support during admission		number	0			[inter_suppleo2]=’1’		This refers to the total number of calendar days the patient received this respiratory support during admission (includes use at any time during admission).	Write the total number of calendar days the patient received this respiratory support during admission (includes use at any time during admission).					clinical_features, treatment	1	1	1		1	1	1								1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_suppleo2_flow	radio	Maximum O2 flow volume (L/min)	1, <2 L/min | 2, 2-5 L/min | 3, 6-10 L/min | 4, 11-15 L/min | 5, >15 L/min | 99, Unknown					[inter_suppleo2] = ‘1’		This refers to the maximum flow volume of O2 delivered to the patient at any time during hospitalisation.	Select the maximum flow volume of O2 delivered to the patient at any time during hospitalisation.	SNOMED	427081008, Delivered oxygen flow rate (observable entity)	C1960999, Delivered oxygen flow rate		clinical_features	1	1	1		1	1	1								1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_nasalprongs	radio	Nasal prongs	1, Yes | 0, No | 99, Unknown					[inter_suppleo2]=’1’		This refers to the mode in which the patient received supplemental oxygen on day of assessment. Nasal prongs or nasal cannluae deliver oxygen through two small prongs or cannulae insterted into the nostrils.	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen at any time during hospitalisation	SNOMED	SNOMED	C0445087, Nasal prongs			1	1	1		1	1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_nasalprongs_ongoing	radio	Still ongoing?	1, Yes | 0, No | 99, Unknown					[inter_nasalprongs]=’1’		This refers to ongoing non-invasive ventilation.	Indicate ‘Yes’, if the patient is still on supplemental oxygen through nasal prongs.											1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_nasalprongs_dur	number	Number of calendar days the patient received supplemental oxygen through nasal prongs		number	0			[inter_nasalprongs]=’1’		This refers to the total number of calendar days the patient received non-invasive ventilation.	Write the total number of calendar days the patient received supplemental oxygen through nasal prongs during admission (includes use at any time during admission).						1	1			1	1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_facemask	radio	Face mask	1, Yes | 0, No | 99, Unknown					[inter_suppleo2]=’1’		This refers to the mode in which the patient received supplemental oxygen on day of assessment. A simple oxygen face mask is a device placed over a patient’s nose, mouth, or tracheostomy to administer oxygen to the airway.	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen at any time during hospitalisation	SNOMED	SNOMED	C1299377, Oxygen administration by mask			1	1	1		1	1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_facemask_ongoing	radio	Still ongoing?	1, Yes | 0, No | 99, Unknown					[inter_facemask]=’1’		This refers to ongoing non-invasive ventilation.	Indicate ‘Yes’, if the patient is still on supplemental oxygen through face mask.											1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_facemask_dur	number	Number of calendar days the patient received supplemental oxygen through face mask		number	0			[inter_facemask]=’1’		This refers to the total number of calendar days the patient received non-invasive ventilation.	Write the total number of calendar days the patient received supplemental oxygen through face mask during admission (includes use at any time during admission).						1	1			1	1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_hfno	radio	High flow nasal oxygen	1, Yes | 0, No | 99, Unknown					[inter_suppleo2]=’1’		This refers to the mode in which the patient received supplemental oxygen on day of assessment. High -flow nasal oxygen therapy is a non-invasive respiratory support that delivers warmed, humidified, oxygen-enriched air to patients through a high-flow nasal cannula at flow rates greater than those typically delivered by standard-flow oxygen devices.	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen to the patient at any time during hospitalisation.	SNOMED	SNOMED	C4761117, High-flow nasal cannula oxygen therapy			1	1	1		1	1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_hfno_ongoing	radio	Still ongoing?	1, Yes | 0, No | 99, Unknown					[inter_hfno]=’1’		This refers to ongoing non-invasive ventilation.	Indicate ‘Yes’, if the patient is still on high-flow nasal oxygen.											1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_hfno_dur	number	Number of calendar days the patient received high-flow nasal oxygen		number	0			[inter_hfno]=’1’		This refers to the total number of calendar days the patient received high-flow nasal oxygen.	Write the total number of calendar days the patient received high-flow nasal oxygen during admission (includes use at any time during admission).						1	1			1	1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_nivent	radio	Non-invasive ventilation	1, Yes | 0, No | 99, Unknown					[inter_suppleo2]=’1’		This refers to the mode in which the patient received supplemental oxygen on day of assessment. Non-invasive ventilation refers to the provision of ventilatory support through the patient’s upper airway using a mask or similar device, without the need for tracheal intubation. Examples include Continuous Positive Airway Pressure (CPAP) and Biphasic Continuous Positive Airway Pressure (BiPAP).	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen at any time during hospitalisation	SNOMED	SNOMED	C1997883, Noninvasive Ventilation			1	1	1		1	1	1								1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_nivent_type	radio	Type of non-invasive respiratory support	1, CPAP | 2, BIPAP | 99, Unknown | 88, Other					[inter_nivent]=’1’		Non-invasive respiratory support or ventilation (NIV) refers to the provision of ventilatory support through the patient’s upper airway using a mask or similar device. It includes high-flow nasal cannula, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BPAP).	Select the single most appropriate option corresponding to the type of NIV used at any time during hospitalisation	SNOMED	SNOMED	C0199451, Continuous Positive Airway Pressure | C0419004, Dual pressure spontaneous ventilation support’			1	1	1		1	1	1								1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_nivent_typ_oth	text	Specify other type of non-invasive ventilation						[inter_nivent_type]=’88’		Non-invasive respiratory support or ventilation (NIV) refers to the provision of ventilatory support through the patient’s upper airway using a mask or similar device. It includes high-flow nasal cannula, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BPAP).	If ‘Other’, specify other type of non-invasive ventilation.						1	1	1		1	1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_nivent_ongoing	radio	Still ongoing?	1, Yes | 0, No | 99, Unknown					[inter_nivent]=’1’		This refers to ongoing non-invasive ventilation.	Indicate ‘Yes’, if the patient is still on non-invasive ventilation.											1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_nivent_dur	number	Number of calendar days the patient received non-invasive ventilation		number	0			[inter_nivent]=’1’		This refers to the total number of calendar days the patient received non-invasive ventilation.	Write the total number of calendar days the patient received non-invasive ventilation during admission (includes use at any time during admission).						1	1			1	1	1								1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_invent	radio	Invasive ventilation	1, Yes | 0, No | 99, Unknown					[inter_suppleo2]=’1’		This refers to the mode in which the patient received supplemental oxygen on day of assessment. Invasive ventilation indicates that patient has undergone tracheal intubation, for the purpose of invasive mechanical ventilation. Invasive mechanical ventilation (IMV) is a method to mechanically assist or replace spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs. The mode of intubation may be orotracheal, nasotracheal, or via a cricothyrotomy or tracheotomy.	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen to the patient at any time during hospitalisation	SNOMED	SNOMED	C1868981, Invasive mechanical ventilation			1	1	1		1	1	1								1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_invent_ongoing	radio	Still ongoing?	1, Yes | 0, No | 99, Unknown					[inter_invent]=’1’		This refers to ongoing invasive ventilation.	Indicate ‘Yes’, if the patient is still on invasive ventilation.											1									1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_invent_dur	number	Number of calendar days the patient received invasive ventilation		number	0			[inter_invent]=’1’		This refers to the total number of calendar days the patient received invasive ventilation.	Write the total number of calendar days the patient received invasive ventilation during admission (includes use at any time during admission).						1	1			1	1	1								1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ecmo	radio	ECLS / ECMO	1, Yes | 0, No | 99, Unknown					[inter_suppleo2]=’1’		This refers to the mode in which the patient received supplemental oxygen on day of assessment. Extracorporeal Membrane Oxygenation (ECMO) also called to as Extracorporeal life support (ECLS) refers to application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger.	Indicate ‘Yes’, if this mode of respiratory support was used to deliver supplemental oxygen to the patient at any time during hospitalisation	SNOMED	SNOMED	C0015357, Extracorporeal Membrane Oxygenation			1	1	1		1	1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ecmo_typ	radio	Type of ECLS / ECMO	1, Veno-venous (VV) | 2, Veno-arterial (VA) | 99, Unknown					[inter_ecmo]=’1’		The two main types of Extracorporeal Membrane Oxygenation (ECMO), also called Extracorporeal life support (ECLS), are veno-venous (venous-venous), which is used to support the lungs and veno-arterial (venous-arterial), which is used to support the lungs and heart.	Select the single most appropriate option corresponding to the type of ECLS / ECMO used at any time during hospitalisation.	SNOMED	SNOMED	C5192099, Venovenous ECMO | C5192097, Venoarterial ECMO			1	1	1		1	1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ecmo_ongoing	radio	Still ongoing?	1, Yes | 0, No | 99, Unknown					[inter_ecmo]=’1’		This refers to ongoing ECMO/ECLS.	Indicate ‘Yes’, if the patient is still on ECMO/ECLS.											1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_ecmo_dur	number	Number of calendar days the patient received ECLS / ECMO		number	0			[inter_ecmo]=’1’		This refers to the number of calendar days the patient received Extracorporeal Membrane Oxygenation (ECMO), also called Extracorporeal life support (ECLS).	Write the total number of calendar days the patient received ECLS/ECMO during admission (includes use at any time during admission).						1	1			1	1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_prone	radio	Prone positioning	1, Yes | 0, No | 99, Unknown					[inter_suppleo2]=’1’		Prone positioning refers to the act of having the patient lying in the prone position to assist ventilation. This includes both invasive ventilation/intubated patients and non-intubated or self-ventilating patients.	Indicate ‘Yes’, for any patients if they have been in the prone position to aid their ventilation at any time during admission.	SNOMED	431182000 | Placing subject in prone position (procedure) |	CL1407586, Prone ventilation			1	1			1	1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_prone_when	radio	When was the prone positioning?	1, During invasive ventilation | 2, Whilst self-ventilating | 99, Unknown					[inter_prone] = ‘1’		This refers to the type of assisted ventilation when the patient was placed in prone position. This may be either invasive ventilation / intubated patients or non-intubated / self-ventilating patients.	Specify the type of assisted ventilation administered when the patient was placed in prone position.	SNOMED	SNOMED	CL1407586, Prone ventilation			1	1			1	1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_prone_awake	radio	Awake proning?	1, Yes | 0, No | 99, Unknown					[inter_prone] = ‘1’		This refers to the practice of proning patients while awake, without sedation, to improve oxygenation.	Indicate ‘Yes’, if awake proning was used at any time during admission.												1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_othersuppleo2	radio	Other respiratory support intervention(s) or procedure(s)	1, Yes | 0, No | 99, Unknown					[inter_suppleo2]=’1’		This refers to any other specific respiratory support intervention(s) or procedure(s) not otherwise characterised that you believe may be relevant.	Indicate ‘Yes’ if other respiratory support intervention(s) or procedure(s) were used at any time during hospitalisation	SNOMED	SNOMED	C0184661, Interventional procedure			1		1		1	1	1								1
outcome	RESPIRATORY SUPPORT: Record all respiratory interventions given or prescribed from day of presentation to day of discharge / outcome.	inter_othersuppleo2_spec	text	Please specify other respiratory support intervention(s) or procedure(s)						[inter_othersuppleo2] = ‘1’		This refers to any other specific respiratory support intervention(s) or procedure(s) not otherwise characterised that you believe may be relevant.	If ‘Yes’, please specify the respiratory support intervention(s) or procedure(s) not otherwise characterised that you believe may be relevant.	SNOMED	SNOMED	C0184661, Interventional procedure			1		1		1	1	1								1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_critcare	radio	Were advanced care (including acute organ support and critical care) therapeutic interventions administered during this admission?	1, Yes | 0, No | 99, Unknown							This refers to any advanced care (including acute organ support and critical care) therapeutic intervention(s) or procedure(s) that were administered at any time during hospitalisation. This section does not include respiratory organ support interventions, which are recorded separately in another section.	Indicate ‘Yes’, if any advanced care (including acute organ support and critical care) therapeutic intervention(s) or procedure(s) were administered at any time during hospitalisation.						1	1	1	1	1	1	1								1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_icu	radio	ICU / ITU / HDU / Intermediate Care Unit admission	1, Yes | 0, No | 99, Unknown					[crito_critcare]=’1’		This refers to intensive care units (ICU), intensive therapy/treatment units (ITU), critical care units, high dependency units (HDU) or unit of similar level.	Indicate ‘Yes’ if the patient was admitted to ICU (or unit of similar level) at least once at any time during their hospitalisation.					patient_outcome, treatment	1	1	1	1	1	1	1								1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_icu_ongoing	radio	Still in ICU / ITU / HDU / Intermediate Care Unit?	1, Yes | 0, No | 99, Unknown					[crito_icu] = ‘1’		This refers to ongoing admission in the ICU / ITU / HDU / Intermediate Care Unit.	Indicate ‘Yes’ if the patient is stll admitted to ICU (or unit of similar level) .									1		1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_icu_date	date_dmy	Date of first ICU / ITU / HDU / Intermediate Care Unit admission		date_dmy		today		[crito_icu] = ‘1’		This refers to the date of first admission to the ICU (or unit of similar level).	Enter the date of the first admission to the ICU (or unit of similar level). (Use the format DD/MM/YYYY)					treatment	1	1	1	1	1	1	1								1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_icu_disdate	date_dmy	Date of first ICU discharge		date_dmy		today		[crito_icu] = ‘1’		This refers to the date of first discharge from the ICU (or unit of similar level).	Enter the date of the first discharge from the ICU (or unit of similar level). (Use the format DD/MM/YYYY)						1	1		1			1								1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_icu_dur	number	Duration of first ICU / ITU / HDU / Intermediate Care Unit admission (days)		number	0			[crito_icu] = ‘1’		This refers to the total duration of first admission to the ICU (or unit of similar level).	Write the total number of calendar days the patient was admitted to ICU.						1	1	1	1	1	1	1								1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_icu_readm	radio	Was the patient admitted to ICU / ITU / HDU / Intermediate Care Unit more than once?	1, Yes | 0, No | 99, Unknown					[crito_icu] = ‘1’		Refers to any admission to an intensive care unit (or unit of similar level) at any time during the patient’s admission.	Indicate ‘Yes’ if the patient was admitted to ICU more than once at any time during their hospitalisation.					treatment			1	1	1	1									1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_icu_findate	date_dmy	Date of final ICU / ITU / HDU / Intermediate Care Unit admission		date_dmy		today		[crito_icu_readm] = ‘1’		This refers to the date of first admission to the ICU (or unit of similar level).	Enter the date of the final admission to the ICU (or unit of similar level). (Use the format DD/MM/YYYY)					treatment			1	1	1	1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_icu_findur	number	Duration of final ICU / ITU / HDU / Intermediate Care Unit admission (days)		number	0			[crito_icu_readm] = ‘1’		This refers to the total duration of final admission to the ICU (or unit of similar level).	Write the total number of calendar days the patient was admitted to ICU.					treatment			1	1	1	1									1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_neuromuscu	radio	Neuromuscular blocking agents	1, Yes | 0, No | 99, Unknown					[crito_critcare]=’1’		This refers to the use of neuromuscular blockers at any time during the patient’s admission. Examples include Atracurium, Cisatracurium, Nimbex, Norcuron, Pancuronium, Pavulon, Rocuronium, Tracrium, Vecuronium, Zemuron.	Indicate ‘Yes’, if neuromuscular blockers were used any time during this admission.	SNOMED	87586001, Product containing neuromuscular blocker (product)	C0027866, Neuromuscular Blocking Agents					1	1	1	1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_nitricoxid	radio	Inhaled nitric oxide	1, Yes | 0, No | 99, Unknown					[crito_critcare]=’1’		This refers to nitric oxide as an inhalant at any time during the patient’s admission. Inhaled nitric oxide is tpically used for hypoxic respiratory failure, among other uses.	Indicate ‘Yes’ if inhaled nitric oxide was used any time during this admission.	SNOMED	1255879001 | Administration of nitric oxide (procedure) |	C1135443, Administration of inhaled nitric oxide			1	1	1	1	1	1	1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_tracheosto	radio	Tracheostomy inserted	1, Yes | 0, No | 99, Unknown					[crito_critcare]=’1’		This refers to the surgical formation of an opening into the trachea through the neck, or the opening so created.	Indicate ‘Yes’ if a tracheostomy was inserted on the patient at any time during admission.	SNOMED	232685002, Insertion of tracheostomy tube (procedure)	C0396630, Insertion of tracheostomy tube			1	1	1	1	1	1	1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_rtt	radio	Renal replacement therapy (RRT) or dialysis	1, Yes | 0, No | 99, Unknown					[crito_critcare]=’1’		This refers to treatments that substitute for the blood-filtering function of the kidneys. It includes dialysis (hemodialysis or peritoneal dialysis), hemofiltration, and hemodiafiltration at any time during the patient’s admission.. It may be intermittent or continuous.	Indicate ‘Yes’, if the patient received continuous renal replacement therapy or intermittent haemodialysis at any time during hospitalisation.	SNOMED	714749008, Continuous renal replacement therapy (procedure) | 895382009, Prolonged intermittent renal replacement therapy (procedure)	C3649547, Continuous Renal Replacement Therapy | C5197699, Prolonged Intermittent Renal Replacement Therapy		treatment	1	1	1	1	1	1	1								1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_rtt_ongoing	radio	Still ongoing?	1, Yes | 0, No | 99, Unknown					[crito_rtt]=’1’		This refers to ongoing renal replacement therapy (RRT) or dialysis	Indicate ‘Yes’, if the patient is still on renal replacement therapy (RRT) or dialysis									1		1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_rtt_dur	number	Number of calendar days on RRT or dialysis duration during admission		number	0			[crito_rtt] = ‘1’		This refers to the total number of days the patient received RRT or dialysis at any time during this admission.	Write the total number of calendar days the patient received RRT or dialysis at any time during this admission. Even if the patient received this more than once in one calendar day (i.e. between 00:00 and 24:00 hours), this counts as one to the total number of days.					treatment		1	1	1	1	1	1								1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_inotropesv	radio	Inotropes / vasopressors	1, Yes | 0, No | 99, Unknown					[crito_critcare]=’1’		This refers to continuous use of a vasopressor or inotrope for at least one hour at any time during the patient’s admission.. Agents include norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. Commonly used ‘positive’ inotropes include dobutamine, dopamine, milrinone and adrenaline (epinephrine).	Indicate ‘Yes’, if the patient received Inotropes / vasopressors for at least one hour at any time during hospitalisation.	SNOMED	870386000, Vasopressor therapy (procedure) | 1296972008, Inotropic therapy (procedure)	C5396785, Vasopressor therapy | C5880944, Inotropic therapy		patient_outcome, treatment	1	1	1	1	1	1	1								1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_inotropesv_ongoing	radio	Still ongoing?	1, Yes | 0, No | 99, Unknown					[crito_inotropesv] = ‘1’		This refers to ongoing inotropic/vasoactive therapy.	Indicate ‘Yes’, if the patient is still on inotropic/vasoactive therapy.									1		1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_inotropesv_dur	text	Total inotropes / vasopressor duration during admission (days)						[crito_inotropesv] = ‘1’		The refers to the total number of days during this admission that the patient received inotropic/vasoactive therapy.	Write the total number of calendar days the patient received inotropic or vasoactive therapy at any time during this admission.					treatment		1	1	1	1	1	1								1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_critcareunlst	radio	Other critical care intervention(s) or procedure(s)	1, Yes | 0, No | 99, Unknown					[crito_critcare]=’1’		This refers to any other specific critical care therapeutic intervention(s) or procedure(s) not otherwise characterised that you believe may be relevant.	Indicate ‘Yes’ if other critical care intervention(s) or procedure(s) were used at any time during hospitalisation.						1	1	1	1	1	1	1								1
outcome	ADVANCED CARE INTERVENTIONS: Record all advanced care interventions given from day of presentation to day of discharge / outcome.	crito_critcareunlst_oth	text	If other: Please specify other critical care intervention(s) or procedure(s)						[crito_critcareunlst] = ‘1’		This refers to any other specific critical care therapeutic intervention(s) or procedure(s) not otherwise characterised that you believe may be relevant.	If ‘Yes’, please specify the critical care therapeutic intervention(s) or procedure(s)not otherwise characterised that you believe may be relevant.						1	1	1	1	1	1	1								1
outcome	DIAGNOSIS	diagn_primary	user_list	Primary diagnosis					outcome_Diseases			Refers to the primary (main) diagnosis for which the patient sought care or was admitted to the facility.	Select the most appropriate option which indicates the diagnosis.						1	1	1	1	1	1	1	1							1
outcome	DIAGNOSIS	diagn_primary_type	checkbox	Type of diagnosis	1, Clinical diagnosis | 2, Lab-confirmed | 3, Radiologically confirmed (e.g., chest X-ray, CT) | 99, Unknown |88, Other							Refers to the method used to diagnose the condition. Clinical diagnosis refers to relying on clinical signs and symptoms. Lab confirmed refers to using laboratory investigations. Radiologically confirmed refers to relying on imaging modalities.	Select the most appropriate option which indicates the type of diagnosis.						1	1	1	1	1	1	1	1							1
outcome	DIAGNOSIS	diagn_secondary	user_list	Secondary diagnosis					outcome_Diseases			Refers to the secondary diagnosis which were present at the time the patient sought care or develoeped during the admission.	Select the most appropriate option which indicates the diagnosis.						1	1	1	1	1	1	1	1
outcome	DIAGNOSIS	diagn_secondary_type	checkbox	Type of diagnosis	1, Clinical diagnosis | 2, Lab-confirmed | 3, Radiologically confirmed (e.g., chest X-ray, CT) | 99, Unknown |88, Other							Refers to the method used to diagnose the condition. Clinical diagnosis refers to relying on clinical signs and symptoms. Lab confirmed refers to using laboratory investigations. Radiologically confirmed refers to relying on imaging modalities.	Select the most appropriate option which indicates the type of diagnosis.						1	1	1	1	1	1	1	1
outcome	DIAGNOSIS	diagn_additional	radio	Additional diagnosis	1, Yes | 0, No | 99, Unknown							Refers to the additional diagnosis which were present at the time the patient sought care or develoeped during the admission.	Select the most appropriate option which indicates the diagnosis.						1	1	1	1	1	1	1	1
outcome	DIAGNOSIS	diagn_additional_list	user_list	Additional diagnosis					outcome_Diseases	[diagn_additional]=’1’		Refers to the additional diagnosis which were present at the time the patient sought care or develoeped during the admission.	Select the most appropriate option which indicates the diagnosis.						1	1	1	1	1	1	1	1
outcome	DIAGNOSIS	diagn_additional_type	checkbox	Type of diagnosis	1, Clinical diagnosis | 2, Lab-confirmed | 3, Radiologically confirmed (e.g., chest X-ray, CT) | 99, Unknown |88, Other					[diagn_additional]=’1’		Refers to the method used to diagnose the condition. Clinical diagnosis refers to relying on clinical signs and symptoms. Lab confirmed refers to using laboratory investigations. Radiologically confirmed refers to relying on imaging modalities.	Select the most appropriate option which indicates the type of diagnosis.						1	1	1		1	1	1	1
outcome	DIAGNOSIS	diagn_additional2	radio	Other Additional diagnosis	1, Yes | 0, No | 99, Unknown							Refers to the additional diagnosis which were present at the time the patient sought care or develoeped during the admission.	Select the most appropriate option which indicates the diagnosis.						1	1	1		1	1	1	1							1
outcome	DIAGNOSIS	diagn_additional2_list	user_list	Additional diagnosis					outcome_Diseases	[diagn_additional2]=’1’		Refers to the additional diagnosis which were present at the time the patient sought care or develoeped during the admission.	Select the most appropriate option which indicates the diagnosis.						1	1	1		1	1	1	1							1
outcome	DIAGNOSIS	diagn_additional2_type	checkbox	Type of diagnosis	1, Clinical diagnosis | 2, Lab-confirmed | 3, Radiologically confirmed (e.g., chest X-ray, CT) | 99, Unknown |88, Other					[diagn_additional2]=’1’		Refers to the method used to diagnose the condition. Clinical diagnosis refers to relying on clinical signs and symptoms. Lab confirmed refers to using laboratory investigations. Radiologically confirmed refers to relying on imaging modalities.	Select the most appropriate option which indicates the type of diagnosis.						1	1	1		1	1	1	1							1
outcome	DIAGNOSIS	diagn_mpox_clade	radio	If diagnosis is Mpox: clade	1, Ia | 2, Ib | 3, I sub-type unknown | 4, IIa | 5, IIb | 6, II sub-type unknown | 7, Not done | 99, Unknown| 88, Other					[diagn_primary]=’33’ or [diagn_secondary]=’33’ or [diagn_additional_list]=’33’ or [diagn_additional2_list]=’33’		Refers to the clade of Mpox virus identified during mpox testing.	Select the single most appropriate option that represents the clade of Mpox virus identified during mpox testing.										1	1
outcome	DIAGNOSIS	diagn_mpox_cladeoth	text	Specify other mpox clade						[diagn_mpox_clade]=’88’		Refers to the clade of Mpox virus identified during mpox testing.	If ‘Other’, write the clade of Mpox virus identified during mpox testing.										1	1
outcome	DIAGNOSIS	diagn_denguetyp	radio	If any diagnosis is Dengue: type	1, DENV1 | 2, DENV2 | 3, DENV3 | 4, DENV4					[diagn_primary]=’10’ or [diagn_secondary]=’10’ or [diagn_additional_list]=’10’ or [diagn_additional2_list]=’10’		This refers to the serotype label of the viral species of Dengue virus, which is a single-stranded, positive-sense RNA virus of the Flaviviridae family and Flavivirus genus, detected using the PCR test.	Select the single most appropriate option that represents the serotype label of the viral species of Dengue virus detected using the PCR test.	SNOMED	60588009, Dengue virus, type 1 (organism) | 41328007, Dengue virus, type 2 (organism) | 8467002, Dengue virus, type 3 (organism) | 36700002, Dengue virus, type 4 (organism)						1
outcome	DIAGNOSIS	diagn_dengueclass	radio	What was the final classification of dengue?	1, Uncomplicated dengue | 2, Dengue with warning signs | 3, Severe dengue					[diagn_primary]=’10’ or [diagn_secondary]=’10’ or [diagn_additional_list]=’10’ or [diagn_additional2_list]=’10’		This refers to the 2009, World Health Organisation dengue classification.	Select the most appropriate option corresponding to the final classification of dengue (based on the 2009 World Health Organisation dengue classification).	SNOMED	722862003, Dengue without warning signs (disorder) | 722863008, Dengue with warning signs (disorder) | 20927009, Dengue hemorrhagic fever (disorder)			patient_outcome			1
outcome	DIAGNOSIS	diagn_dengueclass_dss	radio	Dengue shock syndrome	1, Yes | 0, No | 99, Unknown					[diagn_dengueclass]=’3’		Dengue shock syndrome (DSS) refers to severe plasma leakage leading to shock and/or fluid accumulation with respiratory distress.	Indicate ‘Yes’ if the patient experiences this complication of severe dengue which the patient experienced during this admission.	SNOMED	409671005, Dengue shock syndrome (disorder) |			patient_outcome			1
outcome	DIAGNOSIS	diagn_dengueclass_sevbl	radio	Severe bleeding	1, Yes | 0, No | 99, Unknown					[diagn_dengueclass]=’3’		This refers to severe bleeding as evaluated by clinician.	Indicate ‘Yes’ if the patient experiences this complication of severe dengue which the patient experienced during this admission.					patient_outcome			1
outcome	DIAGNOSIS	diagn_dengueclass_sevorgimp	radio	Severe organ impairment	1, Yes | 0, No | 99, Unknown					[diagn_dengueclass]=’3’		This refers to severe organ involvement which can include; Liver involvement is indicated by an AST or ALT greater or equal to 1000 IU/L, nervous system involvement evidenced by impaired consciousness, cardiac involvement (myocarditis), or other organ system involvement.	Indicate ‘Yes’ if the patient experiences this complication of severe dengue which the patient experienced during this admission.					patient_outcome			1
outcome	DIAGNOSIS	diagn_hepatitis_type	radio	If any diagnosis is Hepatitis: Type	1, A | 2, B | 3, C | 4, D | 5, E | 88, Other					[diagn_primary]=’16’ or [diagn_secondary]=’16’ or [diagn_additional_list]=’16’ or [diagn_additional2_list]=’16’		This refers to both DNA and RNA viruses as well viruses from humans and animals, following a non-taxonomic classification of unrelated viruses, that cause liver inflammation and dysfunction.	If ‘Lab confirmed’ Hepatitis virus infection, select the single most appropriate option corresponding to the type of Hepatitis virus detected.	SNOMED	40468003, Viral hepatitis, type A (disorder) | 66071002, Viral hepatitis type B (disorder) | 50711007, Viral hepatitis type C (disorder) | 707341005, Viral hepatitis type D (disorder) | 7111000119109, Viral hepatitis type E (disorder)						1					1
outcome	DIAGNOSIS	diagn_hepatitis_type_oth	text	Specify other hepatitis type						[diagn_hepatitis_type]=’88’		This refers to both DNA and RNA viruses as well viruses from humans and animals, following a non-taxonomic classification of unrelated viruses, that cause liver inflammation and dysfunction.	If ‘Other’, specify the type of Hepatitis virus.								1					1
outcome	DIAGNOSIS	diagn_chick_type	radio	If diagnosis is Chikungunya: Type	1, Chikungunya (classical articular form + fever) | 2, Chikungunya with extra-articular manifestations | 3, Severe chikungunya					[diagn_primary]=’47’ or [diagn_secondary]=’47’ or [diagn_additional_list]=’47’												1
outcome	DIAGNOSIS	diagn_bacte	text	If any diagnosis is Bacterial infection: Specify						[diagn_primary]=’5’ or [diagn_secondary]=’5’ or [diagn_additional_list]=’5’ or [diagn_additional2_list]=’5’		Refers to the method of identifying or excluding a bacterial infection in this admission.	Select the single most appropriate option that represents the method of identifying or excluding a bacterial infection in this admission.	SNOMED	87628006, Bacterial infectious disease (disorder)					1	1		1	1	1
outcome	DIAGNOSIS	diagn_bacte_cont	radio	Bacterial infection (if Lab confirmed)	1, Community acquired | 2, Hospital acquired | 99, Unknown					[diagn_primary]=’5’ or [diagn_secondary]=’5’ or [diagn_additional_list]=’5’ or [diagn_additional2_list]=’5’		Refers to the method of identifying or excluding a bacterial infection in this admission.	Select the single most appropriate option that represents the method of identifying or excluding a bacterial infection in this admission.	SNOMED	87628006, Bacterial infectious disease (disorder)					1	1		1	1	1
outcome	DIAGNOSIS	diagn_pathounlist	list	Other pathogen(s) detected	1, Yes | 0, No | 99, Unknown				pathogens_Other			This refers to the detection of other pathogens, not listed above.	Specify other detected pathogens, not listed above.												1	1
outcome	DIAGNOSIS	diagn_pathounlist_cont	radio	Other pathogen(s) (if Lab confirmed)	1, Community acquired | 2, Hospital acquired | 99, Unknown					[diagn_pathounlist]=’1’		Refers to the method of identifying or excluding a bacterial infection in this admission.	Select the single most appropriate option that represents the method of identifying or excluding a bacterial infection in this admission.												1	1
outcome	JOINT ASSESSMENT	joint_date	date_dmy	Date of assessment (CHICK-DAS Scale)																		1
outcome	JOINT ASSESSMENT	joint_tjtdsc	descriptive	Instructions:Tick each joint that is tender on palpation. DAS28 joints are listed below. Ankle joints (non-DAS28) are collected separately for CHIK-DAS TJC30.																		1
outcome	JOINT ASSESSMENT	joint_tjt	radio	Tender Joint Count (DAS28 joints) completed	1, Yes | 0, No																	1
outcome	JOINT ASSESSMENT	joint_tjt_shoulder	radio	Shoulders (glenohumeral)	0, 0 | 1, 1 | 2, 2 | 99, Unknown					[joint_tjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_tjt_elbow	radio	Elbows	0, 0 | 1, 1 | 2, 2 | 99, Unknown					[joint_tjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_tjt_wrist	radio	Wrists (radiocarpal)	0, 0 | 1, 1 | 2, 2 | 99, Unknown					[joint_tjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_tjt_mcp	radio	Small joints of hand (MCP joints)	0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 99, Unknown					[joint_tjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_tjt_pip	radio	Small joints of hand (PIP joints)	0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 99, Unknown					[joint_tjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_tjt_knee	radio	Knees	0, 0 | 1, 1 | 2, 2 | 99, Unknown					[joint_tjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_tjt_descankle	descriptive	Tender Ankles (CHIK-DAS addition)						[joint_tjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_tjt_ankle	radio	Ankles (for CHIK-DAS TJC30)	0, 0 | 1, 1 | 2, 2 | 99, Unknown					[joint_tjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_tjt_calc28	calc	TJC28 — Tender Joint Count (DAS28)	if([joint_tjt_shoulder]=99,0,[joint_tjt_shoulder]) + if([joint_tjt_elbow]=99,0,[joint_tjt_elbow]) + if([joint_tjt_wrist]=99,0,[joint_tjt_wrist]) + if([joint_tjt_mcp]=99,0,[joint_tjt_mcp]) + if([joint_tjt_pip]=99,0,[joint_tjt_pip]) + if([joint_tjt_knee]=99,0,[joint_tjt_knee])																	1
outcome	JOINT ASSESSMENT	joint_tjt_calc30	calc	TJC30 — Tender Joint Count (CHIK-DAS)	[joint_tjt_calc28] +if([joint_tjt_ankle]=99,0,[joint_tjt_ankle])																	1
outcome	JOINT ASSESSMENT	joint_sjtdsc	descriptive	Instructions: Tick each joint that is swollen on examination																		1
outcome	JOINT ASSESSMENT	joint_sjt	radio	Swollen Joint Count (DAS28 joints) completed	1, Yes | 0, No																	1
outcome	JOINT ASSESSMENT	joint_sjt_shoulder	radio	Shoulders (glenohumeral)	0, 0 | 1, 1 | 2, 2 | 99, Unknown					[joint_sjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_sjt_elbow	radio	Elbows	0, 0 | 1, 1 | 2, 2 | 99, Unknown					[joint_sjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_sjt_wrist	radio	Wrists (radiocarpal)	0, 0 | 1, 1 | 2, 2 | 99, Unknown					[joint_sjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_sjt_mcp	radio	Small joints of hand (MCP joints)	0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 99, Unknown					[joint_sjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_sjt_pip	radio	Small joints of hand (PIP joints)	0, 0 | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 | 99, Unknown					[joint_sjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_sjt_knee	radio	Knees	0, 0 | 1, 1 | 2, 2 | 99, Unknown					[joint_sjt]=’1’												1
outcome	JOINT ASSESSMENT	joint_sjt_calc28	calc	SJC28 — Swollen Joint Count (DAS28)	if([joint_sjt_shoulder]=99,0,[joint_sjt_shoulder]) + if([joint_sjt_elbow]=99,0,[joint_sjt_elbow]) + if([joint_sjt_wrist]=99,0,[joint_sjt_wrist]) + if([joint_sjt_mcp]=99,0,[joint_sjt_mcp]) + if([joint_sjt_pip]=99,0,[joint_sjt_pip]) + if([joint_sjt_knee]=99,0,[joint_sjt_knee])																	1
outcome	JOINT ASSESSMENT	joint_crp	number	CRP — C-Reactive Protein (mg/L)		number																1
outcome	JOINT ASSESSMENT	joint_vas	slider	Global Health VAS — Patient-reported	Very well | | Very poor	number																1
outcome	JOINT ASSESSMENT	joint_stiff	radio	Stiffness NRS — Patient-reported (0–10)	0, 0 — No stiffness | 1, 1 | 2, 2 | 3, 3 | 4, 4 | 5, 5 | 6, 6 | 7, 7 | 8, 8 | 9, 9 | 10, 10 — Worst stiffness																	1
outcome	JOINT ASSESSMENT	joint_nrs	text	ESR (mm/hr) — if using DAS28-ESR variant																		1
outcome	JOINT ASSESSMENT	joint_calc_das28	calc	DAS28 Score	if([joint_tjt]=’1’,0.56*sqrt(if([joint_tjt_calc28]=99,0,[joint_tjt_calc28]))+0.28*sqrt(if([joint_sjt_calc28]=99,0,[joint_sjt_calc28]))+0.36*log(if([joint_crp]=’’,0,[joint_crp])+1)+0.014*[joint_vas]+0.96,’’)																	1
outcome	JOINT ASSESSMENT	joint_calc_chikdas	calc	CHIK-DAS Score	if([joint_tjt]=’1’,50+((-1.54+0.080*[joint_stiff]+0.119*if([joint_tjt_ankle]=99,0,[joint_tjt_ankle])+0.310*[joint_calc_das28])/0.0628),’’)																	1
outcome	OUTCOME	outco_date	date_dmy	Outcome date		date_dmy		today				This refers to the date of the outcome.	Enter the date of the outcome. (Use the format DD/MM/YYYY)						1	1	1	1	1	1	1	1							1
outcome	OUTCOME	outco_outcome	user_list	Outcome					outcome_Outcome			This refers to the outcome.	Select the outcome that is true on the outcome date. Palliative care includes palliative discharge.					patient_outcome, clinical_features	1	1	1	1	1	1	1	1				1			1
outcome	OUTCOME	outco_selfcare	radio	Ability to self-care at discharge versus before illness	1, Same as before illness | 2, Worse | 3, Better | 99, Unknown					[outco_outcome] = ‘1’		This refers to the ability to perform basic personal care activities and instrumental activities of daily living at discharge compared to before onset of illness.	Select the single most appropriate option that represents the ability to perform basic personal care activities and instrumental activities of daily living at discharge compared to before onset of illness.						1				1	1	1	1							1
outcome	OUTCOME	outco_oxyth	radio	If discharged alive: Oxygen therapy post-discharge treatment	1, Yes | 0, No | 99, Unknown					[outco_outcome] = ‘1’		This refers to the patient’s need for oxygen therapy post-discharge from hospital facility.	Indicate ‘Yes’ if the patient needs oxygen therapy post-discharge from the hospital facility.						1	1				1	1								1
outcome	OUTCOME	outco_carerel	radio	If discharged alive or still hospitalised: Ongoing health care needs relating to this admission for pathogen of interest	1, Yes | 0, No | 99, Unknown					[outco_outcome] = ‘1’ or [outco_outcome]=’2’		This refers to the need for ongoing health care relating to this admission for pathogen of interest	Indicate ‘Yes’ if the patient needs ongoing health care relating to this admission for pathogen of interest.						1	1	1	1	1	1	1	1							1
outcome	OUTCOME	outco_carenonrel	radio	If discharged alive or still hospitalised: Ongoing health care needs NOT related to pathogen episode	1, Yes | 0, No | 99, Unknown					[outco_outcome] = ‘1’ or [outco_outcome]=’2’		This refers to the need for ongoing health care not relating to this admission for pathogen of interest	Indicate ‘Yes’ if the patient needs ongoing health care not relating to this admission for pathogen of interest.						1	1	1	1			1	1
outcome	OUTCOME	outco_carefordif	radio	If Still hospitalised or transfer to other facility: Medically fit for discharge (pathogen resolved) but remains in hospital for other reason (e.g. awaiting alternate care, resident in long term health care or mental health facility)	1, Yes | 0, No | 99, Unknown					[outco_outcome]=’2’ or [outco_outcome]=’3’		This refers to the patient being medical fit for discharge (pathogen infection has resolved) but remaining in hospital for other reasons (e.g. awaiting alternate care, resident in long term health care or mental health facility).	Indicate ‘Yes’ if the patient is medical fit for discharge (pathogen infection has resolved) but remains in hospital for other reasons (e.g. awaiting alternate care, resident in long term health care or mental health facility)						1	1	1	1	1	1	1	1							1
outcome	OUTCOME	outco_transfersite	radio	If transfer to other facility: is the transfer facility a study site?	1, Yes | 0, No | 99, Unknown					[outco_outcome]=’3’		This refers to whether the transfer facility is a study site	Indicate ‘Yes’ if the transfer facility is a study site											1
outcome	OUTCOME	outco_transfersite_pin	text	What is the Participant Identification Number at the new facility?						[outco_transfersite]=’1’		This refers to the participant identification number at the transfer facility.	Indicate the participant identification number at the transfer facility.											1
outcome	OUTCOME	outco_ceiling	radio	Was a maximal level of medical support (‘ceiling of care’) set for the patient during their admission?	1, Yes | 0, No | 99, Unknown							This refers to the maximal level of medical support set for the patient during the current admission.	Indicate ‘Yes’, if a maximal level of medical support for set for this patient during the current admission.												1								1
outcome	OUTCOME	outco_ceiling_descri	notes	Describe what this was (e.g. not for invasive ventilation; not for ICU; or not for CPR)						[outco_ceiling]=’1’		This refers to the maximal level of medical support set for the patient during the current admission.	If ‘Yes’, describe the maximal level of medical support set for this patient during the current admission.												1								1
pregnancy	PREGNANCY DETAILS	preg_form	descriptive	Complete this form only for pregnant patients, postpartum patients (≤28 days after delivery), or neonates whose mothers are not included in the study.								Calendar date (DD–MM–YYYY) on which the CRF was completed.												1								1
pregnancy	PREGNANCY DETAILS	preg_date	date_dmy	Date of form completion		date_dmy																		1								1
pregnancy	PREGNANCY DETAILS	pregdet_medirep	radio	Medically assisted reproduction?	1, Yes | 0, No | 99, Unknown							This refers to medical procedures used primarily to address infertility.																				1
pregnancy	PREGNANCY DETAILS	pregdet_edd	date_dmy	Estimated date of delivery (EDD)		date_dmy		today				This refers to the expected date on which a pregnant woman will give birth. If not available, provide LMP below if possible												1								1
pregnancy	PREGNANCY DETAILS	pregdet_lmp	date_dmy	Date of last menstrual period (LMP)		date_dmy		today				This refers to the date of the first day of the most recent menstrual cycle.												1								1
pregnancy	PREGNANCY DETAILS	pregdet_parity	number	Parity		number	0					This refers to the number of pregnancies that have progressed to a viable gestational age (usually ≥20 weeks), regardless of whether the infant was born alive or stillborn. Multiple births (e.g., twins) from a single pregnancy are counted as one parity event.												1								1
pregnancy	PREGNANCY DETAILS	pregdet_gravidity	number	Gravidity		number	0					This refer to the total number of times a woman has been pregnant, regardless of the outcome of the pregnancies. This includes current pregnancy, miscarriages, abortions, ectopic pregnancies, and stillbirths.												1								1
pregnancy	PREGNANCY DETAILS	pregdet_prevcs	number	Number of previous surgical (caesarean section) deliveries.		number	0					This refers to the number of previous surgical deliveries of one or more intrauterine fetuses though an abdominal incision (cesaerian section).												1								1
pregnancy	PREGNANCY DETAILS	pregdet_fetnum	number	Number of embryos/foetuses in this pregnancy.		number	0					This refers to the number of embryos/fetuses in this pregnancy												1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_comor	radio	Co-morbidities during the current pregnancy	1, Yes | 0, No | 99, Unknown							Pre-existing or pregnancy-related medical conditions present at any time during the current pregnancy that may affect maternal or fetal health.												1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_diabetes	radio	Diabetes	1, Yes | 0, No | 99, Unknown					[preg_comor]=’1’		Disordered glucose metabolism present during the current pregnancy, including pre-existing type 1 or type 2 diabetes mellitus or diabetes first diagnosed during pregnancy (gestational diabetes).												1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_obesity	radio	Obesity	1, Yes | 0, No | 99, Unknown					[preg_comor]=’1’		A maternal condition defined by a pre-pregnancy or early pregnancy body mass index (BMI) of ≥30 kg/m².												1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_hypertension	radio	Hypertension	1, Yes | 0, No | 99, Unknown					[preg_comor]=’1’		Elevated blood pressure (≥140/90 mmHg) present during the current pregnancy, whether pre-existing or diagnosed during pregnancy												1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_sicklecell	radio	Sickle cell	1, Yes | 0, No | 99, Unknown					[preg_comor]=’1’		A hemoglobin disorder characterized by the presence of sickle hemoglobin, including sickle cell disease or sickle cell trait, present during the current pregnancy.												1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_renal	radio	Renal diseases	1, Yes | 0, No | 99, Unknown					[preg_comor]=’1’		Acute or chronic impairment of kidney function present during the current pregnancy, including chronic kidney disease, nephropathy, or pregnancy-associated renal dysfunction												1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_immsup	radio	Immunosuppression	1, Yes | 0, No | 99, Unknown					[preg_comor]=’1’		A state of reduced immune function due to medical treatment present during the current pregnancy, such as systemic corticosteroids, biologic therapies, chemotherapy, or post-transplant immunosuppressive drugs.												1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_immcom	radio	Immunocompromised	1, Yes | 0, No | 99, Unknown					[preg_comor]=’1’		Impaired immune function due to an underlying medical condition present during the current pregnancy, such as HIV infection, congenital immunodeficiency, or malignancy.												1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_othcomor	radio	Other	1, Yes | 0, No | 99, Unknown					[preg_comor]=’1’		Any other maternal medical condition present during the current pregnancy that is not listed above.												1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_othcomor_spec	text	If other, specify						[preg_othcomor]=’1’														1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_smoking	radio	Smoking status	1, Current smoker | 2, Former smoker (stopped PRIOR TO pregnancy) | 3, Former smoker (stopped DURING pregnancy) | 0, Never smoked							Maternal tobacco use												1								1
pregnancy	PREGNANCY-COMORBIDITIES	preg_substance	radio	Substance use during pregnancy	1, Yes | 0, No | 99, Unknown							Use of non-prescribed psychoactive substances (e.g., alcohol, cannabis, opioids, stimulants) at any time during pregnancy.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_mat	radio	Maternal pregnancy complications?	1, Yes | 0, No | 99, Unknown																			1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_preecl	radio	Pre-eclampsia	1, Yes | 0, No | 99, Unknown					[pregcomp_mat] = ‘1’		New-onset hypertension (≥140/90 mmHg) after 20 weeks’ gestation with proteinuria or end-organ dysfunction												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_preecl_week	number	Gestational week of onset		number				[pregcomp_preecl]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_ecl	radio	Eclampsia	1, Yes | 0, No | 99, Unknown					[pregcomp_mat] = ‘1’		Occurrence of generalized seizures in a woman with pre-eclampsia, not attributable to other causes.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_ecl_week	number	Gestational week of onset		number				[pregcomp_ecl]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_hellp	radio	HELLP Syndrome	1, Yes | 0, No | 99, Unknown					[pregcomp_mat] = ‘1’		Severe pre-eclampsia variant characterized by Hemolysis, Elevated Liver enzymes, and												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_hellp_week	number	Gestational week of onset		number				[pregcomp_hellp]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_gdm	radio	Gestational diabetes	1, Yes | 0, No | 99, Unknown					[pregcomp_mat] = ‘1’		Glucose intolerance with onset or first recognition during pregnancy, diagnosed by standard glucose testing.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_gdm_week	number	Gestational week of onset		number				[pregcomp_gdm]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_pih	radio	Pregnancy-induced hypertension	1, Yes | 0, No | 99, Unknown					[pregcomp_mat] = ‘1’		New-onset hypertension after 20 weeks’ gestation without proteinuria or systemic features.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_pih_week	number	Gestational week of onset		number				[pregcomp_pih]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_utbleed	radio	Uterine bleeding	1, Yes | 0, No | 99, Unknown					[pregcomp_mat] = ‘1’		Vaginal bleeding occurring during pregnancy, excluding normal implantation bleeding.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_utbleed_week	number	Gestational week of onset		number				[pregcomp_utbleed]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_malaria	radio	Malaria infection in pregnancy	1, Yes | 0, No | 99, Unknown					[pregcomp_mat] = ‘1’		Laboratory-confirmed Plasmodium infection during pregnancy.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_malaria_week	number	Gestational week of onset		number				[pregcomp_malaria]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_oth	radio	Other maternal pregnancy complication(s)	1, Yes | 0, No | 99, Unknown					[pregcomp_mat] = ‘1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_othspec	text	Specify other maternal pregnancy complication(s)						[pregcomp_oth] = ‘1’														1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_placfetab	radio	Placental / amniotic fluid / foetal abnormalities identified antenatally	1, Yes | 0, No | 99, Unknown							Structural or functional abnormalities detected by ultrasound or prenatal testing.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_lowaf	radio	Diminished amniotic fluid	1, Yes | 0, No | 99, Unknown					[pregcomp_placfetab] = ‘1’		Amniotic fluid volume below normal for gestational age.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_lowaf_week	number	Gestational week of onset		number				[pregcomp_lowaf]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_highaf	radio	Excessive amniotic fluid	1, Yes | 0, No | 99, Unknown					[pregcomp_placfetab] = ‘1’		Amniotic fluid volume above normal for gestational age.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_highaf_week	number	Gestational week of onset		number				[pregcomp_highaf]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_pprevia	radio	Placenta previa	1, Yes | 0, No | 99, Unknown					[pregcomp_placfetab] = ‘1’		Placenta partially or completely covering the internal cervical os.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_pprevia_week	number	Gestational week of onset		number				[pregcomp_pprevia]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_plowlying	radio	Low-lying placenta	1, Yes | 0, No | 99, Unknown					[pregcomp_placfetab] = ‘1’		Placenta located near but not covering the internal cervical os.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_plowlying_week	number	Gestational week of onset		number				[pregcomp_plowlying]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_pinsuff	radio	Placental insufficiency	1, Yes | 0, No | 99, Unknown					[pregcomp_placfetab] = ‘1’		Inadequate placental function resulting in impaired fetal growth or wellbeing.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_pinsuff_week	number	Gestational week of onset		number				[pregcomp_pinsuff]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_iugr	radio	Intrauterine growth restriction	1, Yes | 0, No | 99, Unknown					[pregcomp_placfetab] = ‘1’		Estimated fetal weight below the 10th percentile for gestational age due to pathological causes.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_iugr_week	number	Gestational week of onset		number				[pregcomp_iugr]=’1’		Completed gestational week at which the condition was first diagnosed or documented.												1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_othpyn	radio	Other placental / amniotic fluid / foetal abnormalities identified antenatally	1, Yes | 0, No | 99, Unknown					[pregcomp_placfetab] = ‘1’														1								1
pregnancy	PREGNANCY-RELATED COMPLICATIONS	pregcomp_othpspec	text	specify other placental / amniotic fluid / foetal abnormalities identified antenatally						[pregcomp_othpyn] = ‘1’														1								1
pregnancy	PREGNANCY MEDICATIONS	pregmed_immunosup	radio	Any immunosuppressive treatment during pregnancy?	1, Yes | 0, No | 99, Unknown							Use of medications that reduce immune function, including systemic corticosteroids, biologics, chemotherapy, or transplant-related drugs.												1								1
pregnancy	PREGNANCY MEDICATIONS	pregmed_immunosup_num	number	How many immunosuppressive drugs?		number				[pregmed_immunosup] = ‘1’		Number of distinct immunosuppressive agents taken concurrently or sequentially during pregnancy.												1								1
pregnancy	PREGNANCY MEDICATIONS	pregmed_immunosup_name	text	Name(s) of immunosuppressive drug(s).						[pregmed_immunosup] = ‘1’		Generic name(s) of immunosuppressive medication(s) used.												1								1
pregnancy	PREGNANCY MEDICATIONS	pregmed_otheryn	radio	Any other pregnancy medications?	1, Yes | 0, No | 99, Unknown							Use of any prescribed or over-the-counter medication (excluding immunosuppressants) during pregnancy.												1								1
pregnancy	PREGNANCY MEDICATIONS	pregmed_othernum	number	How many pregnancy medications?		number				[pregmed_otheryn] = ‘1’		Number of distinct medications taken during pregnancy.												1								1
pregnancy	PREGNANCY MEDICATIONS	pregmed_othername	text	Name(s) of medication(s).						[pregmed_otheryn] = ‘1’		Generic name(s) of medications used.												1								1
pregnancy	PREGNANCY VACCINES	pregmed_antvacc	checkbox	Antenatal vaccines administered	1, COVID-19 | 2, Hepatitis B | 3, Yellow fever | 4, Chickenpox | 88, Other							Vaccines received during pregnancy (e.g., tetanus, influenza, COVID-19).												1
pregnancy	PREGNANCY VACCINES	pregmed_antvacc_oth	text	If other, specify						[pregmed_antvacc(88)]=’1’														1
pregnancy	PREGNANCY-RELATED TESTING	pregtest_yn	radio	Were biological samples taken tested during pregnancy?	1, Yes | 0, No | 99, Unknown							Any maternal biological specimen collected and analyzed during pregnancy.												1								1
pregnancy	PREGNANCY-RELATED TESTING	pregtest_type	checkbox	Which of the following samples were taken?	1, Amniotic fluid | 2, Placenta | 3, Cord blood | 4, Vaginal swab | 5, Faecal/rectal swab | 6, Pregnancy tissue | 99, Unknown | 88, Other					[pregtest_yn] = ‘1’		Any maternal biological specimen collected and analyzed during pregnancy.												1								1
pregnancy	PREGNANCY-RELATED TESTING	pregtest_desc	text	Describe the sample testing and results.						[pregtest_yn] = ‘1’		Laboratory method used and qualitative/quantitative result.												1								1
pregnancy	PREGNANCY OUTCOME	pregout_bboutc	radio	Pregnancy outcome	1, Livebirth (even if infant died after birth) | 2, Miscarriage (<22 weeks) | 3, Termination by choice | 4, Termination - ultrasound abnormality | 5, Termination - other/unknown reason | 6, Stillbirth (intra-uterine / intrapartum death from 22 gest weeks) | 7, Ectopic pregnancy | 8, Ongoing | 99, Unknown							Final outcome of pregnancy (live birth, stillbirth, miscarriage, termination).												1								1
pregnancy	PREGNANCY OUTCOME	pregout_weeks	number	Gestational age at outcome (completed weeks)		number				[pregout_bboutc] = ‘1’ or [pregout_bboutc] = ‘2’ or [pregout_bboutc] = ‘3’ or [pregout_bboutc] = ‘4’ or [pregout_bboutc] = ‘5’ or [pregout_bboutc] = ‘6’		Gestational age at delivery or pregnancy end, calculated in completed weeks.												1								1
pregnancy	PREGNANCY OUTCOME	pregout_bbtest	radio	Baby tested for mother’s infection of interest?	1, Yes | 0, No | 99, Unknown							Infant tested for the pathogen affecting the mother.												1								1
pregnancy	PREGNANCY OUTCOME	pregout_bbresl	radio	Specify test result from mother’s infection of interest	1, Positive | 0, Negative | 99, Unknown					[pregout_bbtest] = ‘1’		Laboratory result of infant testing related to maternal infection.												1								1
pregnancy	PREGNANCY OUTCOME	pregout_bboutc_termreas	text	If termination for ultrasound abnormality or other reason, specify						[pregout_bboutc] = ‘4’ or [pregout_bboutc] = ‘5’		Specify clinical indication for pregnancy termination.												1								1
pregnancy	PREGNANCY OUTCOME	pregout_bboutc_stillb	radio	If stillbirth: macerated or fresh?	1, Macerated | 2, Fresh | 99, Unknown					[pregout_bboutc] = ‘6’		Fresh: death occurred during labor or shortly before delivery ;Macerated: death occurred days before delivery, with skin change												1								1
pregnancy	PREGNANCY OUTCOME	pregout_matdeath	radio	Did mother die in pregnancy?	1, Yes | 0, No | 99, Unknown							Death occurring during pregnancy or within 42 days of pregnancy end.												1								1
pregnancy	PREGNANCY OUTCOME	pregout_matdeath_age	number	Age at death		number	0			[pregout_matdeath] = ‘1’		Maternal age in completed years at time of death.												1								1
pregnancy	PREGNANCY OUTCOME	pregout_matdeath_cause	text	Cause(s) of death						[pregout_matdeath] = ‘1’		Underlying and contributing medical causes.												1								1
pregnancy	PREGNANCY OUTCOME	pregout_matdeath_place	radio	Place of death	1, At home | 2, Hospital/medical facility | 99, Unknown					[pregout_matdeath] = ‘1’		Location where death occurred (e.g., hospital, home).												1								1
pregnancy	PREGNANCY OUTCOME	pregout_matdeath_time	radio	Death timepoint	1, Pre-delivery | 2, During delivery | 3, Post-delivery (within 40 days) | 99, Unknown					[pregout_matdeath] = ‘1’		Timing relative to pregnancy (antenatal, intrapartum, postpartum).												1								1
pregnancy	PREGNANCY OUTCOME	pregout_othdet	text	Other details about pregnancy, not specified above.																				1								1
pregnancy	PREGNANCY OUTCOME	pregout_nbornincl	radio	Is the newborn included in the study?	1, Yes | 0, No | 99, Unknown							Indicates whether the infant is formally enrolled.												1								1
pregnancy	PREGNANCY OUTCOME	pregout_nborpin	text	Indicate the newborn’s Participant Identification Number (PIN)						[pregout_nbornincl]=’1’		Unique study identifier for the newborn.												1								1
neonate	NEWBORN OUTCOMES	nborn_sex	radio	Newborn sex at birth	1, Male | 2, Female | 99, Unknown | 88, Other							This refers to the physical sexual characteristics at birth.												1							1
neonate	NEWBORN OUTCOMES	nborn_modedel	radio	Mode of delivery	1, Vaginal | 2, Assisted vaginal | 3, Elective caesarean (before labour, before rupture of membranes) | 4, Emergency caesarean (after labour and/or rupture of membranes)							This refers to the method by which a foetus is delivered.												1							1
neonate	NEWBORN OUTCOMES	nborn_placedel	radio	Place of delivery	1, At home | 2, Hospital/medical facility | 99, Unknown							This refers to the place of delivery of the foetus.												1							1
neonate	NEWBORN OUTCOMES	nborn_ga	number	Gestational age (weeks)		number	0					This refers to the gestational age of the foetus (written in completed weeks). It can be calculated from the woman’s last menstrual period (LMP) or calculated using the best obstetrical estimated due date (EDD) based on the following formula: Gestational Age = (28 - (EDD - Reference Date)) / 7. The reference date is the date in which you are trying to determine the gestational age.												1							1
neonate	NEWBORN OUTCOMES	nborn_gamethod	radio	How was gestation estimated?	1, LMP | 2, EDD | 99, Unknown							This refers to the method of estimating the gestational age. LMP refers to the date of the first day of the most recent menstrual cycle. EDD refers to the estimated date of delivery.												1							1
neonate	NEWBORN OUTCOMES	nborn_birthweight	number	Newborn weight at birth		number	0					This refers to the measurement of a newborn’s weight immediately after birth, typically recorded within the first minutes of life.												1							1
neonate	NEWBORN OUTCOMES	nborn_birthweight_units	radio	Newborn weight at birth (select units)	1, g | 2, lb	units						Measured weight at birth (g or lb).												1							1
neonate	NEWBORN OUTCOMES	nborn_birthweight_g	number	Newborn weight at birth (g)		number	0					This refers to the measurement of a newborn’s weight immediately after birth, typically recorded within the first minutes of life.												1							1
neonate	NEWBORN OUTCOMES	nborn_birthweight_lb	number	Newborn weight at birth (lb)		number	0					This refers to the measurement of a newborn’s weight immediately after birth, typically recorded within the first minutes of life.												1							1
neonate	NEWBORN OUTCOMES	nborn_length	number	Newborn length at birth		number	0					This refers to the measurement of a newborn’s length from the top of their head to the bottom of one of their heels												1							1
neonate	NEWBORN OUTCOMES	nborn_length_units	radio	Newborn length at birth (select units)	1, cm | 2, in	units						Crown–heel length at birth (inches or cm).												1							1
neonate	NEWBORN OUTCOMES	nborn_length_cm	number	Newborn length at birth (cm)		number	0					This refers to the measurement of a newborn’s length from the top of their head to the bottom of one of their heels												1							1
neonate	NEWBORN OUTCOMES	nborn_length_in	number	Newborn length at birth (in)		number	0					This refers to the measurement of a newborn’s length from the top of their head to the bottom of one of their heels												1							1
neonate	NEWBORN OUTCOMES	nborn_infhc	number	Head circumference at birth		number	0					This refers to the measurement of the largest area of the head (distance from around the back of the head to above the eyebrows and ears).												1							1
neonate	NEWBORN OUTCOMES	nborn_infhc_units	radio	Head circumference at birth (select units)	1, cm | 2, in	units						Occipito-frontal circumference at birth (cm).												1							1
neonate	NEWBORN OUTCOMES	nborn_infhc_cm	number	Head circumference at birth (cm)		number	0					This refers to the measurement of the largest area of the head (distance from around the back of the head to above the eyebrows and ears).												1							1
neonate	NEWBORN OUTCOMES	nborn_infhc_in	number	Head circumference at birth (in)		number	0					This refers to the measurement of the largest area of the head (distance from around the back of the head to above the eyebrows and ears).												1							1
neonate	NEWBORN OUTCOMES	nborn_apgar	number	APGAR score at 5 mins (1-1)		number	1	10				This refers to a score to evaluate a newborn’s adjustment to extrauterine life. Five items - heart rate, respiratory effort, muscle tone, reflex irritability, and color - are evaluated 6 seconds after birth and again five minutes later on a scale from -2, being the lowest, 2 being normal. The five numbers are added for the Apgar score. A score of -3 represents severe distress, 4-7 indicates moderate distress, and a score of 7-1 predicts an absence of difficulty in adjusting to extrauterine life.												1							1
neonate	NEWBORN OUTCOMES	nborn_resusc	radio	Resuscitation required following delivery	1, Yes | 0, No | 99, Unknown							This refers to measures applied for the restoration of life to a newborn.												1							1
neonate	NEWBORN OUTCOMES	nborn_resuscdet	text	Give details						[nborn_resusc] = ‘1’		This refers to measures applied for the restoration of life to a newborn.												1							1
neonate	NEWBORN OUTCOMES	nborn_nicu	radio	Admission to NICU	1, Yes, related to pathogen of interest | 2, Yes, not related to pathogen of interest | 3, No, due to non-availability of NICUs | 0, No | 4, Not applicable | 99, Unknown							This refers to admission of the newborn to the neonatal intensive care unit.												1							1
neonate	NEWBORN OUTCOMES	nborn_hospdur	number	Duration of hospital stay		number	0					This refers to the total duration of hospital stay during the current admisssion (in days).												1							1
neonate	NEWBORN OUTCOMES	nborn_outc	radio	Neonatal outcome	1, Discharged healthy | 2, Discharged with complications/sequelae | 3, Still in neonatal ward | 4, Referred to other hospital | 5, Death | 99, Unknown | 6, Not applicable							This refers to the outcome of the newborn.
neonate	NEWBORN OUTCOMES	nborn_compyn	radio	Did any neonatal complications occur?	1, Yes | 0, No | 99, Unknown							This refers to any complications which occurred during the neonatal period.												1							1
neonate	NEWBORN OUTCOMES	nborn_compsel	checkbox	Select all that apply.	1, Respiratory distress syndrome | 2, Intraventricular haemorrhage | 3, Necrotising enterocolitis | 4, Neonatal encephalopathy | 5, Chronic lung disease | 6, Severe jaundice requiring phototherapy | 7, Major congenital anomaly | 8, Severe infection/sepsis | 9, Meningitis | 10, Exchange transfusion | 99, Unknown | 88, Other					[nborn_compyn] = ‘1’		This refers to any complications which occurred during the neonatal period.												1							1
neonate	NEWBORN OUTCOMES	nborn_compoth	text	If other: Specify						[nborn_compsel(88)] =’1’		This refers to any complications which occurred during the neonatal period.												1							1
neonate	NEWBORN OUTCOMES	nborn_death	radio	Newborn or infant death	1, Yes | 0, No | 99, Unknown							This refers to death of the newborn or infant												1							1
neonate	NEWBORN OUTCOMES	nborn_deathage	number	Age at death		number	0			[nborn_death] = ‘1’		This refers to the age of the newborn or infant at the time of death.												1							1
neonate	NEWBORN OUTCOMES	nborn_deathage_units	radio	Age at death (select units)	1, Days | 2, Months	units				[nborn_death] = ‘1’														1							1
neonate	NEWBORN OUTCOMES	nborn_deathage_days	number	Age at death (Days)		number	0			[nborn_death] = ‘1’		This refers to the age of the newborn or infant at the time of death.												1							1
neonate	NEWBORN OUTCOMES	nborn_deathage_months	number	Age at death (Months)		number	0			[nborn_death] = ‘1’		This refers to the age of the newborn or infant at the time of death.												1							1
neonate	NEWBORN OUTCOMES	nborn_deathcause	text	Cause(s) of death						[nborn_death] = ‘1’		This refers to the cause of death of the newborn or infant.												1							1
neonate	NEWBORN OUTCOMES	nborn_birthdefectyn	radio	Congenital anomaly present?	1, Yes | 0, No | 99, Unknown							This refers to structural or functional abnormalities of the foetus which occurred during development in-utero.												1							1
neonate	NEWBORN OUTCOMES	nborn_birthdefectnum	number	How many?		number	0			[nborn_birthdefectyn] = ‘1’		This refers to structural or functional abnormalities of the foetus which occurred during development in-utero.												1							1
neonate	NEWBORN OUTCOMES	nborn_birthdefect1	text	Describe congenital anomaly						[nborn_birthdefectyn] = ‘1’ and [nborn_birthdefectnum] >= 1		This refers to structural or functional abnormalities of the foetus which occurred during development in-utero.												1							1
neonate	NEWBORN OUTCOMES	nborn_birthdefect1_date	date_dmy	Date of congenital anomaly diagnosis		date_dmy		today		[nborn_birthdefectyn] = ‘1’ and [nborn_birthdefectnum] >= 1		This refers to structural or functional abnormalities of the foetus which occurred during development in-utero.												1							1
neonate	NEWBORN OUTCOMES	nborn_birthdefect2	text	Describe congenital anomaly						[nborn_birthdefectyn] = ‘1’ and [nborn_birthdefectnum] >= 2		This refers to structural or functional abnormalities of the foetus which occurred during development in-utero.												1							1
neonate	NEWBORN OUTCOMES	nborn_birthdefect2_date	date_dmy	Date of congenital anomaly diagnosis		date_dmy		today		[nborn_birthdefectyn] = ‘1’ and [nborn_birthdefectnum] >= 2		This refers to structural or functional abnormalities of the foetus which occurred during development in-utero.												1							1
neonate	NEWBORN OUTCOMES	nborn_birthdefect3	text	Describe congenital anomaly						[nborn_birthdefectyn] = ‘1’ and [nborn_birthdefectnum] >= 3		This refers to structural or functional abnormalities of the foetus which occurred during development in-utero.												1							1
neonate	NEWBORN OUTCOMES	nborn_birthdefect3_date	date_dmy	Date of congenital anomaly diagnosis		date_dmy		today		[nborn_birthdefectyn] = ‘1’ and [nborn_birthdefectnum] >= 3		This refers to structural or functional abnormalities of the foetus which occurred during development in-utero.												1							1
neonate	NEWBORN LESIONS	nborn_lesion	radio	Neonatal skin or mucosal lesions	1, Yes | 0, No | 99, Unknown							This refers to the presence of skin or mucosal lesions observed in the neonate.												1
neonate	NEWBORN LESIONS	nborn_lesion_age	number	Age at onset of lesions (completed weeks)		number	0			[nborn_lesion] = ‘1’		This refers to the age (in completed weeks) at which lesions first appeared.												1
neonate	NEWBORN LESIONS	nborn_lesion_num	radio	Maximum number of lesions observed	1, Mild (< 25 skin lesions) | 2, Moderate (25-99 skin lesions) | 3, Severe (100-250 skin lesions) | 4, Very severe (> 250 skin lesions) | 99, Unknown					[nborn_lesion] = ‘1’		This refers to the maximum number of lesions observed.												1
neonate	NEWBORN LESIONS	nborn_lesion_site	checkbox	Lesion site(s) and pain score (0 = no pain 10 = worst pain)	1, Head/face/neck | 2, Inside of mouth | 3, Torso | 4, Arms and/or hands | 5, Legs and/or feet | 6, External genitalia | 7, Perianal | 8, Vaginal canal | 9, Rectum | 88, Other					[nborn_lesion] = ‘1’		Anatomical location(s) of lesions and pain severity rated 0–10.												1
neonate	NEWBORN LESIONS	nborn_lesion_site_oth	text	If other, specify lesion site						[nborn_lesion_site(88)] = ‘1’		This refers to lesion sites not listed above.												1
neonate	NEWBORN LESIONS	nborn_lesion_type	checkbox	Type(s) of lesions currently present	1, Vesicle | 2, Pustule | 3, Ulcerated lesion | 4, Crusted/scabbed mature lesion | 5, Residual evidence of resolved lesions (scar/discoloration) | 6, Haemorrhagic / bleeding lesions					[nborn_lesion] = ‘1’		This refers to the morphological type(s) of lesions present today.												1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_sympt	radio	Neonatal symptoms at clinical examination	1, Yes | 0, No | 99, Unknown							This refers to signs or symptoms identified during neonatal clinical examination.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_fever	radio	Fever	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		In neonates, fever refers to a measured body temperature ?38.0 °C, and hypothermia may also indicate infection.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_cough	radio	Cough	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		This refers to the presence of a cough.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_wheezing	radio	Wheezing	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		Defined as a high-pitched breath sound resulting from a narrowing or obstruction of the small airway.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_rhinorrhoe	radio	Runny nose (rhinorrhoea)	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		Defined as increased mucosal discharge of the nose.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_respdistress	radio	Respiratory distress	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		This refer to a pathological increase in the effort and frequency of breathing movements.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_tachypnoea	radio	Fast breathing (tachypnoea)	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		In neonates, tachypnoea is defined as a respiratory rate greater than 60 breaths per minute.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_nasalflar	radio	Nasal flaring	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		In neonates, nasal flaring refers to widening of the nostrils during inspiration and is a clinical sign of increased work of breathing.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_grunt	radio	Grunting	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		In neonates, grunting refers to an expiratory sound produced by partial closure of the glottis and is a sign of respiratory distress.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_apnoea	radio	Apnoea	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		Defined as a transient absence in spontaneous respiration.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_nasalcongestion	radio	Nasal congestion	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		Defined as reduced ability to pass air through the nasal cavity often leading to mouth breathing.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_vomit	radio	Vomiting	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		Defined as the expulsion of the stomach or small intestines through the mouth.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_diarrhoea	radio	Diarrhoea	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		In neonates, diarrhoea refers to a change in stool frequency or consistency compared with the infant’s normal pattern.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_consti	radio	Constipation	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		In neonates, constipation refers to infrequent, difficult, or painful passage of stools compared with the neonate’s usual bowel pattern.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_lowurine	radio	Reduced urine output	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		In neonates, reduced urine output is defined as urine output <1 ml/kg/hour.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_jaund	radio	Jaundice	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		Defined as a clinical manifestation of hyperbilirubinemia, characterized by the yellowish staining of the skin, mucous membrane and/or sclera.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_skinpallor	radio	Skin pallor	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		This refers to unnatural pale appearance of the skin.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_ftt	radio	Failure to thrive	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		In neonates, failure to thrive refers to inadequate weight gain or weight loss beyond expected physiological limits.”												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_hypotonia	radio	Decreased tone / hypotonia	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		This refers to reduced muscle tone compared with what is expected for the neonate’s gestational age and clinical condition.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_bulgefont	radio	Bulging fontanelle	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		In neonates, bulging fontanelle refers to outward bulging or fullness of the anterior fontanelle when the infant is calm and in an upright position, and may indicate increased intracranial pressure.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_hypotherm	radio	Hypothermia	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		This refers to abnormally reduced body temperature due to failed thermoregulation.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_feedingdiff	radio	Feeding difficulty	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		In neonates, feeding difficulty includes poor suck, weak latch, fatigue during feeding, or inability to complete feeds.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_hepatomegally	radio	Hepatomegaly	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		Defined as an pathological enlargement of the liver												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_anaemia	radio	Anaemia	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		This refers to a reduction in the number of red blood cells, the amount of haemoglobin, and/or the volume of packed red blood cells relative to neonatal reference ranges.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_seizconv	radio	Seizures	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		Defined as an intermittent abnormality of nervous system physiology characterised by a transient occurrence of sudden, violent, irregular movement of the body, caused by involuntary contraction of muscles due to abnormal excessive or synchronous neuronal activity in the brain.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_keratitis	radio	Keratitis	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		This refers to inflammation of the cornea of the eye.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_conjunctiv	radio	Conjunctivitis	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		Defined as inflammation of the conjunctiva												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_ocularother	radio	Other ocular findings	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		Any abnormal eye findings beyond primary diagnosis.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_ocularother_spec	text	Please specify						[nborn_ocularother] = ‘1’														1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_lymph	radio	Lymphadenopathy	1, Yes-painful | 2, Yes-not painful | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		Defined as a clinical finding of abnormal enlargement of the lymph nodes.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_lymph_site	checkbox	Specify lymphadenopathy site(s)	1, Axillary (arm pits) | 2, Cervical (neck)| 3, Inguinal (groin) | 99, Unknown | 88, Other					[nborn_lymph]=’1’ or [nborn_lymph]=’2’		This refers to the location in which lymphadenopathy was identified.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_lymph_site_oth	text	Specify other lymphadenopathy site(s)						[nborn_lymph_site(88)]=’1’		This refers to the location in which lymphadenopathy was identified.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_haemorrhag	radio	Bleeding (haemorrhage)	1, Yes | 0, No | 99, Unknown					[nborn_haemorrhag] = ‘1’		Defined as the presence of blood in a location in which it is not physiologically normal or loss of blood from the circulation, either internally or externally. This can include epistaxis (blood from nose), gingival bleeding (blood from gums/gingiva), blood from any part of the gastrointestinal tract (gastrointestinal bleeding) or genitourinary tracts (vagina or urethra) including hematuria.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_haemorrhag_site	multi_list	Specify bleeding site(s)					conditions_Site	[nborn_haemorrhag] = ‘1’		This refers to the location of bleeding/haemorrhage site(s).												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_haemorrhag_site_oth	text	Specify other bleeding / haemorrhage site(s)						[nborn_haemorrhag_site(88)]=’1’		This refers to the location of bleeding/haemorrhage site(s). Petechiae refer to small reddish or purplish spots in skin or mucous membrane as a result of localised haemorrhage. Nose bleeding refers to haemorrhage localized in the nose. Gum bleeding refers to haemorrhage affecting the gingiva. Gastrointestinal (GI) bleeding refers to haemorrhage in any segment of the gastrointestinal tract from oesophagus to rectum. Urinary tract bleeding refers to haemorrhage originating from any part of the urinary system. Vaginal bleeding refers to haemorrhage originating from vagina, unrelated to normal menstruation.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_other	radio	Other symptom(s)	1, Yes | 0, No | 99, Unknown					[nborn_sympt] = ‘1’		This refers to the presence of an alternative sign or abnormality not listed above.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_other_spec	text	If yes, specify other						[nborn_other]=’1’														1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_imaging	radio	Imaging conducted	1, Cranial ultrasound | 2, MRI | 88, Other | 0, None					[nborn_sympt] = ‘1’		Any radiologic study performed (e.g., ultrasound, MRI, X-ray).												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_imaging_oth	text	Specify						[nborn_imaging] = ‘88’														1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_imaging_res	radio	Imaging results	1, Normal findings | 2, Abnormal findings					[nborn_imaging] <> ‘0’		Summary of findings.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_imaging_res_det	text	If abnormal findings, provide details						[nborn_imaging_res] = ‘2’		Description of abnormal imaging findings.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_conginfectyn	radio	Congenitally-acquired infections	1, Yes | 0, No | 99, Unknown							This refers to suspected or confirmed infections in the newborn that are acquired in utero and persisting after birth.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_conginfecttype	checkbox	Type of congenitally-acquired infections	1, CMV | 2, Syphilis | 3, Toxoplasmosis | 4, HIV | 5, HCV | 6, HBV | 7, HSV-1 | 8, HSV-2 | 99, Unknown | 88, Other					[nborn_conginfectyn] = ‘1’		This refers to type(s) of suspected or confirmed infections in the newborn that are acquired in utero and persisting after birth.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_conginfectother	text	Specify other congenitally-acquired infections						[nborn_conginfecttype(88)] = ‘1’		This refers to other suspected or confirmed infections, not specified above, in the newborn that are acquired in utero and persisting after birth.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_breastfed	radio	Was baby ever breastfed?	1, Yes | 0, No | 99, Unknown							Infant received breast milk at least once after birth.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_breastfed_status	radio	Breastfeeding status	1, Currently breastfed | 0, Breastfeeding discontinued					[nborn_breastfed]=’1’		Current breastfeeding status of the infant at the time of assessment, regardless of exclusivity.												1							1
neonate	NEWBORN SIGNS AND SYMPTOMS	nborn_breastfed_dur	number	If breastfeeding discontinued, how long did breastfeeding last? (in weeks)		number				[nborn_breastfed_status]=’0’		Total number of weeks breastfeeding occurred before permanent discontinuation.												1							1
neonate	NEWBORN LABORATORY TESTS	nborn_labtestyn	radio	Infant Mpox testing performed?	1, Yes | 0, No | 99, Unknown							Laboratory testing conducted to detect Mpox virus in the infant.												1
neonate	NEWBORN LABORATORY TESTS	nborn_specimen	radio	Mpox specimen type	1, Amniotic fluid | 2, Cord blood during pregnancy | 3, Cord blood after delivery | 4, Placental sample during pregnancy | 5, Placental sample after delivery | 6, Skin lesion | 7, Blood | 8, Nasopharyngeal swab | 9, Urine |88, Other					[nborn_labtestyn] = ‘1’		Biological sample used (e.g., lesion swab, blood).												1
neonate	NEWBORN LABORATORY TESTS	nborn_specimenother	text	Specify						[nborn_specimen] = ‘88’														1
neonate	NEWBORN LABORATORY TESTS	nborn_labmethod	radio	Mpox laboratory method	1, PCR | 2, Ortho PCR | 3, Serology | 999, Other					[nborn_labtestyn] = ‘1’		Diagnostic technique used (e.g., PCR).												1
neonate	NEWBORN LABORATORY TESTS	nborn_pcrres	radio	PCR result	1, Positive | 0, Negative					[nborn_labmethod] = ‘1’		Qualitative PCR outcome (positive/negative).												1
neonate	NEWBORN LABORATORY TESTS	nborn_pcrct	number	PCR Cycle Threshold (CT)		number	0			[nborn_labmethod] = ‘1’		Number of amplification cycles required to detect viral DNA; lower CT indicates higher viral load.												1
neonate	NEONATE DETAILS	nborn_motherincl	radio	Is the mother included in the study ?	1, Yes | 0, No | 99, Unknown							This refers to inclusion of the mother in the same study.												1							1
neonate	NEONATE DETAILS	nborn_motherpin	text	specify their PIN						[nborn_motherincl]=’1’		This refers to the participant identification number allocated to the mother of a newborn in the study.												1							1
follow_up	FOLLOW-UP ASSESSMENT	follow_date	date_dmy	Date of follow up		date_dmy		today				This refers to the date of the patient follow-up.	Enter the date of follow up. (Use the format DD/MM/YYYY)										1	1	1	1							1
follow_up	FOLLOW-UP ASSESSMENT	follow_outcome	user_list	Patient outcome					followup_outcome			This refers to an assessment of the patient outcome on follow-up.	Select the single most appropriate option that represents the patient outcome.										1	1	1	1							1
follow_up	FOLLOW-UP ASSESSMENT	follow_outcome_date	date_dmy	First / earliest date on which the selected outcome was true		date_dmy		today				This refers to the first / earliest date on which the selected outcome was true.	Enter the first or earliest date in which the selected outcome occurred. (Use the format DD/MM/YYYY)										1	1	1	1
follow_up	FOLLOW-UP ASSESSMENT	follow_outcome_reas	text	Reason for outcome						[follow_outcome]=’11’		This refers to re-hospitalisation due to infection with pathogen of interest.	Write the date of hospitalisation. Use DD/MM/YYYY format.	SNOMED	1269557005, Reason for hospital admission (observable entity)	C5817481, Reason for hospital admission							1	1	1	1
follow_up	FOLLOW-UP ASSESSMENT	follow_skindamage	radio	Is the patient’s skin damaged following resolution of acute illness	1, Yes | 0, No | 99, Unknown					[follow_outcome]<>’3’ and [follow_outcome]<>’7’ and [follow_outcome]<>’6’ and [follow_outcome]<>’8’		This refers to the presence of scarring, altered pigmentation, contractures or other deformities secondary to resolved skin lesions.	Indicate ‘Yes’ if the patient has any skin damage related to the resolution of active skin lesions.										1	1
follow_up	FOLLOW-UP ASSESSMENT	follow_skindamage_type	checkbox	Select all that apply	1, Atrophic scars | 2, Hypertrophic scars | 3, Deformities | 4, Hypopigmentation | 5, Hyperpigmentation | 6, Contractures | 88, Other					[follow_skindamage]=’1’		This refers to the presence of scarring, altered pigmentation, contractures or other deformities secondary to resolved skin lesions. Atrophic scars refer to scars that form a depression compared to the level of the surrounding skin because of damage to the collagen, fat or other tissues below the skin. Hypertrophic scar refers to a permanent mark on the skin caused by deposits of excessive amounts of collagen during wound healing. It is elevated and does not extend beyond the original boundaries of the wound; the elevation may stabilize or regress spontaneously. Deformities refer to alterations or deviations from normal shape or size which result in a disfigurement to normal body structures. Hypopigmentation refers to abnormal lightening of skin due to decreased melanin production or deposition. Hyperpigmentation refers to darkening of the skin due to excessive melanin deposition. Contracture refers to a prolonged shortening of the muscle or other soft tissue around a joint, preventing movement of the joint.	Select all type(s) of skin damage following resolution of acute illness.										1	1
follow_up	FOLLOW-UP ASSESSMENT	follow_skindamage_type_oth	notes	Specify other type of skin damage						[follow_skindamage_type(88)]=’1’		This refers to the presence of any other type(s) of skin damage that you feel is secondary to infection with pathogen of interest, and is pertinent to include here.	Write the other type(s) of skin damage following resolution of acute illness.										1	1
follow_up	FOLLOW-UP ASSESSMENT	follow_seque	radio	Does the patient have any sequelae?	1, Yes | 0, No | 99, Unknown					[follow_outcome]<>’3’ and [follow_outcome]<>’7’ and [follow_outcome]<>’6’		This refers to any other complication(s) or sequalae, not specified above.	Indicate ‘Yes’ if the patient has any other complication(s) or sequalae not specified above.										1	1	1	1							1
follow_up	FOLLOW-UP ASSESSMENT	follow_seque_type	multi_list	Select all that apply					followup_sequelae	[follow_seque]=’1’		This refers to any other complication(s) or sequalae, not specified above. Decreased vision refers to vision considered to be inferior to normal vision as represented by accepted standards of acuity, field of vision, or motility. Blindness refers to the inability to see or the loss or absence of perception of visual stimuli. Urethral stricture refers to the narrowing of the urethra associated with inflammation or scar tissue. Vaginal stricture refers to narrowing of the vagina owing to scar formation. Rectal stricture refers to narrowing of the rectum secondary to scar formation. Dyspareunia refers to recurrent genital pain occurring during, before, or after sexual intercourse in either the males or the females. Depression refers to an affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities and the mood disturbance is prominent and relatively persistent.	Select all other complication(s) or sequalae, not specified above.										1	1	1	1
follow_up	BARTHEL INDEX SCORE	follow_barthel	radio	Is the Barthel Index being assessed for this patient to capture daily living ability data?	1, Yes | 0, No | 99, Unknown							Following questions are used to calculate the Barthel Index score: The Barthel Index for Activities of Daily Living is an ordinal scale which measures a person’s ability to complete activities of daily living/	Indicate ‘Yes’ if this score is being assessed on the follow-up visit to capture quality of life.												1
follow_up	BARTHEL INDEX SCORE	follow_barthel_feeding	radio	Are you able to feed yourself?	1, Independent | 2, Needs some help | 3, Needs extensive help | 4, Unable to feed oneself					[follow_barthel]=’1’		This refers to the ability of the patient to feed themselves.	Select the most appropriate option which most closely corresponds with the patient’scurent level of ability. Record actual, and not potential, functioning.												1
follow_up	BARTHEL INDEX SCORE	follow_barthel_bathing	radio	Are you able to bathe yourself?	1, Independent | 2, Needs some help | 3, Needs extensive help | 4, Unable to bathe oneself					[follow_barthel]=’1’		This refers to the ability of the patient to bathe themselves.	Select the most appropriate option which most closely corresponds with the patient’scurent level of ability. Record actual, and not potential, functioning.												1
follow_up	BARTHEL INDEX SCORE	follow_barthel_grooming	radio	Are you able to groom yourself?	1, Independent | 2, Needs some help | 3, Needs extensive help | 4, Unable to groom oneself					[follow_barthel]=’1’		This refers to the ability of the patient to groom themselves.	Select the most appropriate option which most closely corresponds with the patient’scurent level of ability. Record actual, and not potential, functioning.												1
follow_up	BARTHEL INDEX SCORE	follow_barthel_dressing	radio	Are you able to dress yourself?	1, Independent | 2, Needs some help | 3, Needs extensive help | 4, Unable to dress oneself					[follow_barthel]=’1’		This refers to the ability of the patient to dress themselves.	Select the most appropriate option which most closely corresponds with the patient’scurent level of ability. Record actual, and not potential, functioning.												1
follow_up	BARTHEL INDEX SCORE	follow_barthel_bowel	radio	Do you have control over your bowels?	1, Continent | 2, Occasional incontinence | 3, Frequent incontinence | 4, Incontinent					[follow_barthel]=’1’		This refers to voluntary control of bowel movement. Continent refers to complete voluntary control. Occasional incontinence refers to loss of voluntary control once a week. Frequent incontinence refers to loss of voluntary control more than once a week. Incontinent refers to complete lack of voluntary control, inability to manage alone or requiring use of enemas for bowel movement.	Select the most appropriate option which most closely corresponds with the patient’scurent level of ability. Record actual, and not potential, functioning.												1
follow_up	BARTHEL INDEX SCORE	follow_barthel_bladder	radio	Do you have control over your bladder?	1, Continent | 2, Occasional incontinence | 3, Frequent incontinence | 4, Incontinent					[follow_barthel]=’1’		This refers to voluntary control of bowel movement. Continent refers to complete voluntary control. Occasional incontinence refers to loss of voluntary control once a week. Frequent incontinence refers to loss of voluntary control more than once a week. Incontinent refers to complete lack of voluntary control, inability to manage alone or requiring catherisation.	Select the most appropriate option which most closely corresponds with the patient’scurent level of ability. Record actual, and not potential, functioning.												1
follow_up	BARTHEL INDEX SCORE	follow_barthel_toilet	radio	Are you able to use the toilet by yourself?	1, Independent | 2, Needs some help | 3, Needs extensive help | 4, Unable to use the toilet					[follow_barthel]=’1’		This refers to ability to use toilet independently.	Select the most appropriate option which most closely corresponds with the patient’scurent level of ability. Record actual, and not potential, functioning.												1
follow_up	BARTHEL INDEX SCORE	follow_barthel_transfer	radio	Are you able to transfer from bed to chair and back?	1, Independent | 2, Needs some help | 3, Needs extensive help | 4, Unable to transfer					[follow_barthel]=’1’		This refers to ability to transfer from bed to chair and back.	Select the most appropriate option which most closely corresponds with the patient’scurent level of ability. Record actual, and not potential, functioning.												1
follow_up	BARTHEL INDEX SCORE	follow_barthel_walking	radio	Are you able to walk on a flat surface?	1, Independent | 2, Needs some help | 3, Uses a wheelchair independently | 4, Unable to walk					[follow_barthel]=’1’		This refers to ability to walk on flat suraces.	Select the most appropriate option which most closely corresponds with the patient’scurent level of ability. Record actual, and not potential, functioning.												1
follow_up	BARTHEL INDEX SCORE	follow_barthel_stairs	radio	Are you able to go up and down stairs?	1, Independent | 2, Needs some help | 3, Unable to use stairs					[follow_barthel]=’1’		This refers to ability to mobilise up and down a flight of stairs.	Select the most appropriate option which most closely corresponds with the patient’scurent level of ability. Record actual, and not potential, functioning.												1
withdrawal	WITHDRAWAL	withd_date	date_dmy	Date of withdrawal		date_dmy		today				This refers to withdrawal of the patient consent.	Enter the date of withdrawal of patient consent. (Use the format DD/MM/YYYY)																				1
withdrawal	WITHDRAWAL	withd_reas	text	Reason for withdrawal								This refers to withdrawal of the patient consent.	Write the reason for withdrawal of patient consent.																				1
withdrawal	WITHDRAWAL	withd_active	radio	Did the participant withdraw from active participation in the study?	1, Yes | 0, No | 99, Unknown							This refers to withdrawal of the patient consent.	Indicate ‘Yes’ if the participant withdrew from active participation in the study.																				1
withdrawal	WITHDRAWAL	withd_datacoll	radio	Did the participant withdraw consent to use data collected up until the point of withdrawal?	1, Yes | 0, No | 99, Unknown							This refers to withdrawal of the patient consent.	Indicate ‘Yes’ if the participant withdrew consent to use data collected up until the point of withdrawal.																				1
withdrawal	WITHDRAWAL	withd_datasample	radio	Did the participant withdraw consent to use samples collected up until the point of withdrawal?	1, Yes | 0, No | 99, Unknown							This refers to withdrawal of the patient consent.	Indicate ‘Yes’ if the participant withdrew consent to use samples collected up until the point of withdrawal.																				1